0001062993-16-010548.txt : 20160714 0001062993-16-010548.hdr.sgml : 20160714 20160714082439 ACCESSION NUMBER: 0001062993-16-010548 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20160430 FILED AS OF DATE: 20160714 DATE AS OF CHANGE: 20160714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COUNTERPATH CORP CENTRAL INDEX KEY: 0001236997 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 200004161 STATE OF INCORPORATION: NV FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35592 FILM NUMBER: 161766552 BUSINESS ADDRESS: STREET 1: 300-505 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V7X 1M3 BUSINESS PHONE: 604-320-3344 MAIL ADDRESS: STREET 1: 300-505 BURRARD STREET CITY: VANCOUVER STATE: A1 ZIP: V7X 1M3 FORMER COMPANY: FORMER CONFORMED NAME: COUNTERPATH SOLUTIONS, INC. DATE OF NAME CHANGE: 20050928 FORMER COMPANY: FORMER CONFORMED NAME: XTEN NETWORKS, INC DATE OF NAME CHANGE: 20040507 FORMER COMPANY: FORMER CONFORMED NAME: BROAD SCOPE ENTERPRISES INC DATE OF NAME CHANGE: 20030529 10-K 1 form10k.htm FORM 10-K Counterpath Corporation - Form 10-K - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

(Mark One)

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended April 30, 2016

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______________ to ______________

Commission file number 001-35592

COUNTERPATH CORPORATION
(Exact Name of Registrant as Specified in its Charter)

Nevada 20-0004161
(State or Other Jurisdiction of Incorporation or (IRS Employer Identification No.)
Organization)  

Suite 300, One Bentall Centre, 505 Burrard Street, Vancouver, British Columbia, Canada V7X 1M3
(Address of principal executive offices)      (Zip Code)

(604) 320-3344
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class Name of each exchange on which registered
Common Stock, par value $0.001 NASDAQ Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act:

Nil

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes [   ]      No [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes [   ]      No [X]

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X]      No [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes [X]      No [   ]


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [   ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer”, “non-accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [  ] Accelerated filer [  ]
Non-accelerated filer [  ]
(Do not check if a smaller reporting company)
Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [   ]      No [X]

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was sold, or the average bid and asked prices of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter.

Approximately $6,133,484 based on a price of $2.90 per share, being the average of bid and ask prices on October 31, 2015 as quoted on NASDAQ. Effective November 2, 2015, our Company effected a one-for-ten reverse stock split of the shares of our common stock with each resulting fractional share being round up to the next whole share.

APPLICABLE ONLY TO CORPORATE REGISTRANTS:

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date: 4,555,348 shares of common stock issued and outstanding as of July 8, 2016.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive proxy statement relating to the registrant’s annual meeting of stockholders to be held on September 12, 2016 are incorporated by reference into Part III of this annual report on Form 10-K.

2


COUNTERPATH CORPORATION
APRIL 30, 2016 ANNUAL REPORT ON FORM 10-K

INDEX

    Page
  PART I  
Item 1. Business 5
Item 1A. Risk Factors 12
Item 1B. Unresolved Staff Comments 19
Item 2. Properties 19
Item 3. Legal Proceedings 19
Item 4. Mine Safety Disclosures 19
  PART II  
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 20
Item 6. Selected Financial Data 23
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 24
Item 7A. Quantitative and Qualitative Disclosures about Market Risk 33
Item 8. Financial Statements and Supplementary Data 33
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 63
Item 9A. Controls and Procedures 63
Item 9B. Other Information 63
  PART III  
Item 10. Directors, Executive Officers and Corporate Governance 64
Item 11. Executive Compensation 64
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 64
Item 13. Certain Relationships and Related Transactions, and Director Independence 64
Item 14. Principal Accountant Fees and Services 64
  PART IV  
Item 15. Exhibits and Financial Statement Schedules 64
Item 16. Form 10-K Summary 67

3


Forward-Looking Statements

This annual report, including the documents incorporated herein and therein by reference, contains forward-looking statements as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the United States Securities Exchange Act of 1934. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of these terms or other comparable terminology. Forward-looking statements in this annual report may include statements about:

  any potential loss of or reductions in orders from certain significant customers;
     
  our dependence on our customers to sell our applications or services using our applications;
     
  claims that we infringe intellectual property rights of others;
     
  our ability to protect our intellectual property;
     

competitive factors, including, but not limited to, industry consolidation, entry of new competitors into our market, and new product and marketing initiatives by our competitors;

     
  our ability to predict our revenue, operating results and gross margin accurately;
     
  the length and unpredictability of our sales cycles;
     
our ability to expand or enhance our product offerings including in response to industry demands or market trends;
     
  our ability to sell our products in certain markets;
     
  our ability to manage growth;
     
  the attraction and retention of qualified employees and key personnel;
     
  the interoperability of our products with service provider networks;
     
  the quality of our products and services, including any undetected errors or bugs in our software; and
     
  our ability to maintain proper and effective internal controls.

These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled "Risk Factors", that may cause our company's or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including securities laws of the United States and Canada, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

References

In this annual report, unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to "common shares" refer to our shares of common stock. Unless otherwise indicated, the terms "we", "us" and "our" as used in this annual report refer to CounterPath Corporation and its wholly-owned subsidiaries.

4


PART I

Item 1. Business.

Overview

We design, develop and sell software and services that enable enterprises and telecommunication service providers to deliver Unified Communications (UC) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol, or IP, based networks. We are capitalizing upon numerous industry trends, including the rapid adoption of mobile technology, the proliferation of bring-your-own-device to work programs, the need for secure business communications, the need for centralized provisioning, the migration towards cloud-based services and the migration towards all IP networks. We are also capitalizing on a trend where communication services such as Skype and WhatsApp are becoming more available over-the-top (OTT) of the incumbent operators’ networks or enterprise networks (a.k.a. Internet OTT providers). We offer our solutions under perpetual license agreements that generate one-time license revenue and under subscription license agreements that generate recurring license revenue. We sell our solutions through our own online store, through third-party online stores, directly using our in-house sales team and through channel partners. Our channel partners include original equipment manufacturers, value added distributers and value added resellers. Enterprises typically leverage our Enterprise OTT solutions to increase employee productivity and to reduce certain costs. Telecommunication service providers typically deploy our Operator OTT solutions as part of a broad strategy to defend their subscriber base from competitive threats by offering innovative new services. Our original equipment manufacturers and value added resellers typically integrate our solutions into their products and then sell a bundled solution to their end customers, which include both telecommunication service providers and enterprises.

Our business model is based on winning new customers, expanding sales of new and existing products and services to existing customers, and renewing subscriptions and software support agreements. We target customers of all sizes and across a broad range of industries, including call centers, financial services, government, retail, technology and telecommunications. We have sold at least $10,000 of software and services to more than 550 different customers in over 65 countries, including some of the world’s largest businesses, global financial institutions and leading telecommunication service providers.

We were incorporated under the laws of the State of Nevada on April 18, 2003.

On June 18, 2015, we received notice from the NASDAQ advising that our common shares had not regained compliance with the minimum $1.00 bid price per share requirement, but that the NASDAQ staff had determined that our company would be eligible for an additional 180 calendar day period, or until December 14, 2015, to regain compliance with the foregoing requirement. Effective November 2, 2015, we effected a one-for-ten reverse stock split of the shares of our common stock. As a result, our authorized capital decreased from 45,359,640 shares of common stock to 4,535,991 shares of common stock. On November 16, 2015, we received notice from the NASDAQ that the closing bid price of our common stock has been $1.00 or greater for 30 consecutive business day’s and that we had regained compliance with listing rule 5550(a)(2).

Our principal executive offices are located at Suite 300, 505 Burrard Street, Vancouver, British Columbia, Canada V7X 1M3. Our telephone number is (604) 320-3344. Our website address is www.counterpath.com. Through a link on the investor relations section of our website, we make available the following filings after they are electronically filed with or furnished to the SEC: Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and any amendments to those reports filed or furnished pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. All such filings are available free of charge. The information contained in our website does not form part of this annual report.

Industry

The telecommunication industry is undergoing a fundamental transition from legacy circuit switched networks to packet switched networks that are more flexible and economical to operate. At the same time, consumers and businesses are rapidly adopting new mobile technologies. We believe enterprises want to capitalize upon these trends by launching innovative OTT services to increase employee mobility, increase employee productivity, and reduce certain costs. At the same time, telecommunication service providers are facing a number of threats, including the commoditization of their legacy voice businesses, the decline in short message service (SMS) revenues, regulatory changes that increase competition in certain areas and reduce certain revenues, and the proliferation of third party OTT services such as Skype, WhatsApp and Viber that are intermediating customer relationships and reducing certain revenue streams. Given these factors, some telecommunication service providers are looking to defend their businesses by launching their own innovative OTT services to counter some of the threats they are facing, and to possibly create new revenue streams. In addition, both enterprises and telecommunication service providers are looking to simplify their IT operations by procuring cloud-based services rather than purchasing systems outright and running them independently. The migration towards cloud-based services typically reduces up-front capital expenditures and simplifies IT operations.

5


Enterprises are adopting mobile technology at a rapid pace. In fact, according to International Data Corporation, an industry research organization, 1.43 billion smartphones and 206.8 million tablets were shipped in 2015. We believe enterprises want to leverage mobile technology to increase employee productivity and to reduce certain costs. At the same time, bring-your-own-device to work programs are becoming common in the workplace, enabling enterprises to reduce up-front technology acquisition costs, while allowing employees to work on the device of their choice. This rapid penetration of mobile technology in the work place, coupled with need to support and manage an increasingly diverse set of mobile devices, creates new challenges for IT organizations, including the need to extend the corporate IT environment to the mobile device, the ability to provide and manage corporate applications remotely, and the need for secure communications. IT departments are often challenged to provide users with the benefits of mobility, while simultaneously satisfying enterprise security and compliance requirements. Our solutions address these issues by enabling enterprises to launch what we call “Enterprise OTT Services”. Our Bria mobile and tablet softphones allow mobile workers to leverage the full suite of corporate PBX (Private Branch Exchange) functionality as if they were in the office and connected to the secure enterprise network, while our Bria Desktop softphones enable users to replace or augment their traditional desk phones. Our Stretto Platform simplifies the IT manager’s job by enabling the efficient provisioning and management of the enterprise’s softphones. It also enables mobile workers to seamlessly transfer live calls between access networks, increasing productivity and employee satisfaction.

Enterprises are also adapting to the new and increasingly complex environment by shifting away from purchasing stand-alone software applications and running them on in-house servers, to purchasing cloud-based services. This typically reduces capital spending and simplifies operations by reducing the number of servers and applications IT staff must install, configure, manage and support. Our Stretto PlatformTM can be purchased as cloud based services that generate recurring revenue for our company. We also offer a complete cloud-based solution to businesses. Known as Cloud Solutions, these offerings are sold under a subscription licensing agreement and includes our Bria Softphones and access to our Stretto Platform Provisioning Module. It enables small enterprises to quickly launch unified communications services using our solutions, without deploying additional server hardware in the datacenter.

Telecommunication service providers, including cable, wireless and Voice over IP operators are also facing a shifting landscape driven by new technology and changing subscriber habits. Some wireline and cable subscribers are “cutting the cord” and cancelling their home-phone service in favour of cellular service. At the same time, video OTT services such as Apple TV and Netflix are gaining significant traction, leading some subscribers to cancel their television service or “down-shift” to less expensive bundles, placing additional pressure on top-line revenues at some service providers. Mobile subscribers, on the other hand, are scaling back their use of certain services such as SMS and international long-distance voice in favour of third-party OTT services such as WhatsApp and Viber. We believe many telecommunication service providers aim to strengthen subscriber relationships, reduce churn and prevent or slow revenue erosion by launching their own, superior, white labelled “Operator OTT Services” with unique value added features that are difficult for third-parties to replicate. Our solutions enable service providers to provision single identity, one number services that increase a subscriber’s usage of their home or cellular phone number, convergence services that facilitate call handoff between different access networks, Voice over IP services for inexpensive long-distance calling when roaming, and messaging services for efficient communications.

Products

Our solutions range from software products to cloud based services. Our software products include applications for smartphones, tablets and desktop computers, a Software Development Kit (SDK) for software developers seeking to add voice, video and messaging capabilities to their existing applications, and server-based software solutions for configuring, managing and supporting softphones and for deploying advanced messaging & collaboration services. Many of these software products are also available to customers in the form of cloud based hosted services.

6


Softphones

Our softphone applications support voice, video, messaging, presence and collaboration services over IP networks. Our softphone applications have undergone rigorous interoperability testing against leading PBXs, SIP (Session Initiation Protocol) application servers and IMS (IP Multimedia Subsystem) cores, ensuring that our softphone applications can be readily deployed in our customers’ networks. In addition to maintaining certification with leading SIP infrastructure vendors (such as Cisco, Avaya, BroadSoft and Genesys), our softphones are tightly integrated with solutions from Salesforce.com, VMware, Amazon Web Services, Good Technologies and Citrix, to name a few. We are also actively engaged in interoperability activities with leading USB headset and Bluetooth device vendors to provide advanced levels of functionality when deployed in conjunction with CounterPath products.

Bria Desktop (Windows, Mac), Bria Tablet (iPad, Android) and Bria Mobile (iPhone, Android, Blackberry)
   

The Bria softphone suite enables consumers and business users to make VoIP audio and video calls, send Instant Messages and manage their presence, share their screen and collaborate with other users, all in an easy-to-use software application. The product suite works on desktop computers and laptops, smartphones and tablets, using various operating systems.

   

Using the latest technology and SIP standards, our softphone applications provide business users with carrier-grade communication solutions that can be tailored to meet the needs of any size organization. For larger customers, we offer the ability to customize the softphone application by allowing our customers to include their corporate logos and branding, as well as to select specific features to be included. We have developed our Branding Portal to allow customers to efficiently customize their applications.

   
Bria Virtual Edition
   

Bria Virtual Edition (VE) is a secure, VoIP softphone application for the Virtual Desktop Infrastructure (VDI) and Desk-top-as-a-Service (DaaS) markets. Bria VE software supports PC-over-IP (PCoIP) Zero Client as offered by a number of leading VDI vendors, including Dell, HP, Samsung and LG support our VDI offering.

   
X-Lite
   

X-Lite is a standards-based VoIP softphone application that runs on desktop computers. X-Lite interoperates with enterprise and carrier infrastructure equipment from major vendors, but excludes some key functionality offered in our commercial products, such as the ability to: brand the product, import contacts, centrally provision the softphone, utilize royalty bearing codecs, or support multiple accounts.

   

X-Lite is offered free of charge, is available for download on our website and may not be redistributed to third parties. We believe that offering X-Lite for free is an effective marketing tool for our company, as it allows potential customers to test and evaluate our software. We also believe offering X-Lite for free supports our business by encouraging companies that develop SIP compliant equipment, such as phones, video phones, network gateways, multipoint conference units and conference servers to test their equipment against our softphone. We believe this testing improves interoperability, facilitates our sales, and helps build positive brand recognition. The X-Lite graphical user interface supports advertising that could potentially be used to generate revenue in the future. We do not currently generate revenue from third- party advertising on the X-Lite softphone.

7



Software Development Kit (SDK)
   

Our SDK is a product targeted at developers that are seeking to incorporate advanced Unified Communications (UC) capabilities into their existing applications. For example, there is strong market demand within the healthcare vertical for adding UC capabilities to healthcare applications that were originally designed for managing prescriptions and appointment for patients. We are targeting a number of industries, including the hospitality, finance and government verticals.

   

Our SDK delivers standard-compliant voice, video and messaging capabilities for desktop, tablet and mobile devices, and can be integrated into existing customer applications with a minimal amount of effort. Our SDK is used in our own softphone products, thereby delivering the benefit of our experience in deploying millions of SIP softphone clients.

Stretto Platform

The Stretto Platform (Stretto) is a carrier-grade software platform for enterprises and service providers.

The Stretto Platform is agnostic to existing network elements, enabling deployments to be made on top of existing session border controllers, IMS components, VoIP switches, PBXs and cloud communication services.

The Stretto Platform includes a number of modules that can be separately purchased by customers, including:

o

Provisioning: The Provisioning module enables the IT or operations staff of an organization to deploy, provision, and manage ongoing configuration upgrades to Bria softphones. The organization can control over 250 settings, including default codec selection, NAT traversal settings and keep-alive timer values as specified by IT or operations staff. This module plays a critical role in authenticating end users, and includes integration with the enterprise’s existing directory services using protocols such as LDAP and OAuth.

     
o

User Experience Metrics: The User Experience Metrics module enables the IT or operations staff of an organization to record and analyze critical analytics and Voice Quality Monitoring (VQM) data that summarizes service quality, device usage, and feature usage.

     
o

Help Desk Assistant: The Help Desk Assistant module enables the IT help-desk staff of an organization to directly access an end-user’s Bria application for trouble shooting.

     
o

Push Notification: The Push Notification module enables our Bria mobile applications to eliminate high battery drain during daily use. The Push Notification module wakes our Bria softphone applications on the end user’s mobile device when an incoming call, message or voicemail is pushed from a network to the client.

     
o

Call Continuity: The Call Continuity module provides a seamless handover of active calls between the user’s various devices (e.g. a call started on a desktop client can be seamlessly moved to the user’s mobile device) and can also be moved between WiFi and cellular networks.

     
o

XMPP Messaging and Presence: The XMPP Messaging and Presence delivers standards- compliant secure messaging and presence services, including the ability to synchronize messages across all of the user’s devices.

8


Cloud Solutions

CounterPath Cloud Solutions combine the Bria Stretto™ client suite for desktops, smartphones, tablets and virtual desktops with CounterPath's cloud-hosted Stretto Platform™. Using a hosted "software as a service" business model, enterprises, operators and telecommunication channel partners can easily and efficiently deploy a cost effective system for procuring, distributing, provisioning and managing Bria Stretto clients from the cloud as well as offering hosted messaging and collaboration solutions.

The Bria Stretto clients in CounterPath's Cloud Solutions are always up-to-date with the most current release and available through multiple distribution channels, such as iTunes, Google Play, BlackBerry App World, or direct download links. Bria Stretto offers high-quality VoIP communications, delivered in an intuitive user interface, and include premium features such as video calling, messaging and presence and advanced audio and video codecs, where available.

The Stretto Platform provides customers with an easy-to-use system to provision, upgrade and manage Bria Stretto clients through either the Stretto Admin web interface or an API. Most softphone settings, outside of some user preferences, are hidden; instead the softphone relies on the Provisioning Module to provision these settings remotely. This enables administrators to centrally manage all of their communications across all device platforms.

Our Cloud Solutions also provide customers with access to hosted messaging and hosted collaboration services.

Sales and Marketing

We derive revenue from the sale of software licenses, software customization services, technical support services associated with the software licenses, implementation services, training services, and cloud based services. We recognize perpetual software and services revenue at the time of delivery, provided all other revenue recognition criteria have been met. We recognize software as a service revenue over the term of the service contract, which is generally twelve months.

We focus on selling our software products to enterprises, to telecommunication service providers, and to channel partners who would then typically resell our products to enterprises or telecommunication service providers. Our customers include: (1) small, medium and large sized businesses; (2) telecommunications service providers and Internet telephony service providers; (3) channel partners, including original equipment manufacturers, value added distributors and value added resellers, serving the telecommunication market; and (4) end users who purchase our applications directly from our online store or from third party online stores. To date, we have sold software and services to more than 550 different customers in over 65 countries, including some of the world’s largest businesses, global financial institutions and leading telecommunication service providers (where each customer has purchased at least $10,000 of software and services).

We typically work with our customers to streamline the process of delivering our software to their end users. This includes customization and pre-configuring the information required to connect to the customer's network and enabling or disabling certain features of our products. Our software products are typically co-labelled with our brand and our customer's brand, or privately labelled with our customer's brand. Co-labelling of our products means that the user interface that displays on the computer screen for the end user to see remains as is, but the customer's brand is also placed on the user interface. Private labelling of our products means that the customer can request that we change any and all features of the user interface and can remove all references to our company from the user interface. We receive professional service revenue for configuration and customization of our software.

9


Marketing

Our products are marketed through a variety of means including by:

  our customers and partners;
     
  advertising on our website;
     
  direct market campaigns;
     
  co-marketing with our partners, suppliers and customers;
     
  offering trial use of X-Lite, our free softphone with fewer features than our commercial versions;
     
  attending industry trade shows; and
     
  attending developer conferences.

Intellectual Property

We rely on a combination of intellectual property rights, including patents, trade secrets, copyrights and trademarks, as well as customary contractual protections to protect our intellectual property.

We own or hold the exclusive license to nineteen U.S. patents with counterparts granted or pending in other jurisdictions around the world. In addition, we are pursuing three in-house developed patent applications and one licensed patent application from Columbia University. These four U.S. patent applications are pending, with counterparts pending in other jurisdictions around the world.

In September, 2015, we were granted patent No. US 9131006: Method And System for Extending Services to Cellular Devices. This patent builds on a previous patent (US 8165576) of the same name by further protecting unique methods for the seamless handover of communication services from a fixed or cellular network to a packet switched network.

We also hold a number of registered trademarks in the United States.

In addition to the protections described above, we generally control access to, and use of our proprietary software and other confidential information through the use of internal and external controls. These controls include contractual protections with employees, contractors, customers and partners. Our software is protected by U.S. and certain international copyright laws.

We have acquired certain patent rights from Openwave Systems Inc. including a patent for maintaining Internet voice communication to mobile devices where the IP address changes from location to location. We also hold exclusive rights to a patent which is a continuation to previously granted patents. This patent explains communication methods between mobile and packet networks using a gateway connected to both networks preserving single identity on both networks. We also hold the exclusive right to certain technologies developed at Columbia University for which we pay a license fee of 5% of net revenues where the technologies are incorporated into the products we sell. We incorporate a number of third party software programs into our software applications pursuant to license agreements.

We may not receive competitive advantages from the rights granted under our patents and other intellectual property rights. Our competitors may develop technologies that are similar or superior to our proprietary technologies, duplicate our proprietary technologies or design around the patents owned or licensed by us. Our existing and future patents may be circumvented, blocked, licensed to others or challenged as to inventorship, ownership, scope, validity or enforceability. Furthermore, our pending and future patent applications may not be issued with the scope of claims sought by us, if at all, or the scope of claims we are seeking may not be sufficiently broad to protect our proprietary technologies. Moreover, we have adopted a strategy of seeking limited patent protection with respect to the technologies used in or relating to our products. If our products, patents or patent applications are found to conflict with any patents held by third parties, we could be prevented from selling our products, our patents may be declared invalid or our patent applications may not result in issued patents. In foreign countries, we may not receive effective patent, copyright and trademark protection. We may be required to initiate litigation in order to enforce any patents issued to us, or to determine the scope or validity of a third party's patent or other proprietary rights. In addition, in the future we may be subject to lawsuits by third parties seeking to enforce their own intellectual property rights, as described in “Risk Factors - Risks Associated with our Business and Industry” – “We may in the future be subject to damaging and disruptive intellectual property litigation that could materially and adversely affect our business, results of operations and financial condition, as well as the continued viability of our company” and “We could lose our competitive advantages if we are not able to protect any proprietary technology and intellectual property rights against infringement and any related litigation could be time consuming and costly”.

10


We license our software pursuant to agreements that impose restrictions on customers' ability to use the software, such as prohibiting reverse engineering and limiting the use of copies. We also seek to avoid disclosure of our intellectual property by requiring employees and consultants with access to our proprietary information to execute nondisclosure and assignment of intellectual property agreements and by restricting access to our source code. Other parties may not comply with the terms of their agreements with us, and we may not be able to enforce our rights adequately against these parties.

Research and Development

Development of our products is primarily done through our Canadian wholly-owned subsidiary, CounterPath Technologies Inc., and our U.S. wholly-owned subsidiary, BridgePort Networks, Inc. Our research and development team consists of a core software development department and a quality assurance department. Core software development is responsible for designing, developing and maintaining our software across our supported operating systems. Quality assurance is responsible for testing the software before release to customers on all of our platforms. Total research and development expenditures for the year ended April 30, 2016 were $4,737,055 (2015- $5,669,217).

After Sales Service and Support

We sell our software on an as-is or limited warranty basis to end users, and we are not required to update or upgrade the software nor are we generally responsible for failure of our software to work on our customer's computer network; however, we offer two levels of renewable annual support to our non-end user customers for a specified percentage of the software license fees. Basic support includes product bug-fixes, nine (9) a.m. to five (5) p.m. Pacific Time (-8GMT), telephone support and email support during the one-year period following the date of sale. Bug-fixes are software updates which fix a known deficiency in the software product. Our extended support includes basic support and product upgrades. Product upgrades are separate from bug-fixes and include new or enhanced product features. For additional fees, we provide professional services, which include assisting our customers in customizing, deploying and implementing our applications. We currently maintain a support forum on the Internet at www.counterpath.com/support.html and product user manuals are available online at www.counterpath.com.

Warranty

In circumstances where we provide a warranty on our software, we warrant that our software will perform substantially in accordance with the materials accompanying the software for periods of up to twelve months from the date of sale to cover defects in workmanship.

Audio and Video Codecs

Our softphone applications are integrated with audio and video codecs, which are licensed by third-parties either as free open source software or under a royalty bearing license. A codec is a software application that encodes and decodes audio or video data according to a specification.

11


Competition

There are numerous developers that compete with our company for market share. Small software development companies typically compete on the basis of price, while large original equipment manufacturers typically compete by selling their proprietary software applications as a component to an overall proprietary communications system. We compete by offering applications with extensive features that are compatible with a broad spectrum of communication systems and with various devices and operating systems.

Government Approval

We have obtained Export Commodity Classification Numbers from the United States government for our software that contains encryption technology. We use these classifications to determine whether export licenses are required to export our software to foreign countries. We are not aware of any permits that are specific to our industry which are required in order for our company to operate or to sell our products and services in such jurisdictions.

Employees

As of April 30, 2016, we employed 71 people full-time, 20 of whom are engaged in marketing and sales, 26 in research and development, 16 in services and support, 9 in general and administration, 1 part-time person engaged in marketing and sales, and contracted with 41 contractors. We are not subject to any collective bargaining agreements and we consider relations with our employees to be excellent.

We hire full-time employees and contractors who are authorized to work in the United States through our wholly-owned subsidiary, BridgePort Networks, Inc. Our wholly-owned subsidiary, CounterPath Technologies Inc. employs full-time employees and contractors who are authorized to work in Canada.

Item 1A. Risk Factors.

Much of the information included in this annual report includes or is based upon estimates, projections or other “forward looking statements”. Such forward looking statements include any projections or estimates made by us and our management in connection with our business operations. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumption or other future performance suggested herein.

Such estimates, projections or other “forward looking statements” involve various risks and uncertainties as outlined below. We caution the reader that important factors in some cases have affected and, in the future, could materially affect actual results and cause actual results to differ materially from the results expressed in any such estimates, projections or other “forward looking statements”.

Risks Associated with our Business and Industry

Lack of cash flow which may affect our ability to continue as a going concern.

Presently our operating cash flows are not sufficient to meet operating and capital expenses. Our business plan calls for continued research and development of our products and expansion of our market share. We will require additional financing to fund working capital and pay for operating expenses and capital requirements until we achieve a positive cash flow. However, our management projects that under our current operating plan that sufficient cash is available to meet our ongoing operating expenses and working capital requirements through July 31, 2017.

However, there is no assurance that actual cash requirements will not exceed our estimates. In particular, additional capital may be required in the event that:

12



  we incur delays and additional expenses as a result of technology failure;
     
  we are unable to create a substantial market for our products; or
     
  we incur any significant unanticipated expenses.

The occurrence of any of the aforementioned events could adversely affect our ability to meet our proposed business plans.

We depend on a mix of revenues and outside capital to pay for the continued development of our technology and the marketing of our products. Such outside capital may include the sale of additional stock and/or commercial borrowing. There can be no assurance that capital will continue to be available if necessary to meet these continuing development costs or, if the capital is available, that it will be on terms acceptable to us. Disruptions in financial markets and challenging economic conditions have and may continue to affect our ability to raise capital. The issuance of additional equity securities by us would result in a dilution, possibly a significant dilution, in the equity interests of our current stockholders. Obtaining commercial loans, assuming those loans would be available, will increase our liabilities and future cash commitments.

Our revenue, operating results and gross margin can fluctuate significantly and unpredictably from quarter - to - quarter and from year - to - year, and we expect that they will continue to do so, which could have a material adverse effect on our operating results.

The rate at which our customers order our products, and the size of these orders, are highly variable and difficult to predict. In the past, we have experienced significant variability in our customer purchasing practices on a quarterly and annual basis, and we expect that this variability will continue, as a result of a number of factors, many of which are beyond our control, including:

  demand for our products and the timing and size of customer orders;
     
  length of sales cycles, which may be extended by selling our products through channel partners;
     
  length of time of deployment of our products by our customers;
     
  customers’ budgetary constraints;
     
  competitive pressures; and
     
  general economic conditions.

As a result of this volatility in our customers’ purchasing practices, our revenue has historically fluctuated unpredictably on a quarterly and annual basis and we expect this to continue for the foreseeable future. Our budgeted expense levels depend in part on our expectations of future revenue. Because any substantial adjustment to expenses to account for lower levels of revenue is difficult and takes time, if our revenue declines, our operating expenses and general overhead would likely be high relative to revenue, which could have a material adverse effect on our operating margin and operating results.

If we are not able to manage our operating expenses, then our financial condition may be adversely affected.

Operating expenses decreased to $13,923,167 for the year ended April 30, 2016 from $17,349,003 for the year ended April 30, 2015 and our revenue decreased to $11,081,358 for the year ended April 30, 2016 from $12,003,083 for the year ended April 30, 2015. Our ability to reach and maintain profitability is conditional upon our ability to manage our operating expenses. There is a risk that we will have to increase our operating expenses in the future. Factors that could cause our operating expenses to increase include our determination to spend more on sales and marketing in order to increase product sales or our determination that more research and development expenditures are required in order to keep our current software products competitive or in order to develop new products for the market. To the extent that our operating expenses increase without a corresponding increase in revenue, our financial condition would be adversely impacted.

13


We face larger and better-financed competitors, which may affect our ability to achieve or maintain profitability.

Management is aware of similar products which compete directly with our products and some of the companies developing these similar products are larger and better-financed than us and may develop products superior to those of our company. In addition to price competition, increased competition may result in other aggressive business tactics from our competitors, such as:

  emphasizing their own size and perceived stability against our smaller size and narrower recognition;
   
  providing customers “one-stop shopping” options for the purchase of network equipment and application software;
   
  offering customers financing assistance;
     
  making early announcements of competing products and employing extensive marketing efforts; and
   
  asserting infringement of their intellectual property rights.

Such competition may potentially adversely affect our profitability.

A decline in the price of our common stock could affect our ability to raise further working capital and adversely impact our operations.

A prolonged decline in the price of our common stock could result in a reduction in the liquidity of our common stock and a reduction in our ability to raise capital, or a delisting from a stock exchange on which our common stock trades. Because our operations have been partially financed through the sale of equity securities, a decline in the price of our common stock could be especially detrimental to our liquidity and our continued operations. Any reduction in our ability to raise equity capital in the future would force us to reallocate funds from other planned uses and would have a significant negative effect on our business plans and operations, including our ability to develop new products and continue our current operations. If our stock price declines, there can be no assurance that we can raise additional capital or generate funds from operations sufficient to meet our obligations.

On December 16, 2014, we received notice from NASDAQ that the closing bid price of our shares for the last 30 consecutive business days no longer met the minimum bid price requirement of $1.00 per share. NASDAQ’S listing rules provide our company with a compliance period of 180 calendar days in which to regain compliance. If at any time during the 180 day period the closing bid price of our shares is at least $1.00 for a minimum of 10 consecutive business days, we will be in compliance. Our company had until June 15, 2015 to regain compliance with the minimum $1.00 bid price per share requirement. On June 18, 2015, we received further notice from NASDAQ advising that our shares had not regained compliance with the minimum $1.00 bid price per share requirement, but that the NASDAQ staff had determined that our company would be eligible for an additional 180 calendar day period, or until December 14, 2015, to regain compliance with the foregoing requirement.

Effective November 2, 2015, our company effected a one-for-ten reverse stock split of the shares of our common stock. On November 16, 2015, we received notice from NASDAQ that the closing bid price of our common stock has been $1.00 or greater for the previous 30 consecutive business day’s and that we had regained compliance with listing rule 5550(a)(2). There can be no assurance that the closing bid price of our common stock will not fall below the minimum bid price requirement of $1.00 per share.

14


The majority of our directors and officers are located outside the United States, with the result that it may be difficult for investors to enforce within the United States any judgments obtained against us or some of our directors or officers.

The majority of our directors and officers are nationals and/or residents of countries other than the United States, and all or a substantial portion of such persons' assets are located outside the United States. As a result, it may be difficult for investors to enforce within the United States any judgments obtained against us or our officers or directors, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state thereof. Consequently, investors may be effectively prevented from pursuing remedies under United States federal securities laws against some of our directors or officers.

We may in the future be subject to damaging and disruptive intellectual property litigation that could materially and adversely affect our business, results of operations and financial condition, as well as the continued viability of our company.

We may be unaware of filed patent applications and issued patents that could relate to our products and services. Intellectual property litigation, if determined against us, could:

  result in the loss of a substantial number of existing customers or prohibit the acquisition of new customers;
   
  cause us to lose access to key distribution channels;
     
  result in substantial employee layoffs or risk the permanent loss of highly-valued employees;
     
  materially and adversely affect our brand in the market place and cause a substantial loss of goodwill;
   
  affect our ability to raise additional capital;
     
  cause our stock price to decline significantly; and
     
  lead to the bankruptcy or liquidation of our company.

Parties making claims of infringement may be able to obtain injunctive or other equitable relief that could effectively block our ability to provide our products or services and could cause us to pay substantial royalties, licensing fees or damages. The defense of any lawsuit could result in time-consuming and expensive litigation, regardless of the merits of such claims.

We could lose our competitive advantages if we are not able to protect any proprietary technology and intellectual property rights against infringement, and any related litigation could be time-consuming and costly.

Our success and ability to compete depends to a significant degree on our proprietary technology incorporated in our software. If any of our competitors copy or otherwise gain access to our proprietary technology or develops similar technologies independently, we would not be able to compete as effectively. We also consider our family of registered and unregistered trademarks including CounterPath, Bria, eyebeam, X-Lite, and Softphone.com invaluable to our ability to continue to develop and maintain the goodwill and recognition associated with our brand. The measures we take to protect the proprietary technology software, and other intellectual property rights, which presently are based upon a combination of patents, patents pending, copyright, trade secret and trademark laws, may not be adequate to prevent their unauthorized use. Further, the laws of foreign countries may provide inadequate protection of such intellectual property rights.

We may need to bring legal claims to enforce or protect such intellectual property rights. Any litigation, whether successful or unsuccessful, could result in substantial costs and divert resources from intended uses. In addition, notwithstanding any rights we have secured in our intellectual property, other persons may bring claims against us that we have infringed on their intellectual property rights, including claims based upon the content we license from third parties or claims that our intellectual property right interests are not valid. Any claims against us, with or without merit, could be time consuming and costly to defend or litigate, divert our attention and resources, result in the loss of goodwill associated with our service marks or require us to make changes to our website or other of our technologies.

15


Our products may become obsolete and unmarketable if we are unable to respond adequately to rapidly changing technology and customer demands.

Our industry is characterized by rapid changes in technology and customer demands. As a result, our products may quickly become obsolete and unmarketable. Our future success will depend on our ability to adapt to technological advances, anticipate customer demands, develop new products and enhance our current products on a timely and cost-effective basis. Further, our products must remain competitive with those of other companies with substantially greater resources. We may experience technical or other difficulties that could delay or prevent the development, introduction or marketing of new products or enhanced versions of existing products. Also, we may not be able to adapt new or enhanced services to emerging industry standards, and our new products may not be favorably received.

Unless we can establish broad market acceptance of our current products, our potential revenues may be significantly reduced.

We expect that a substantial portion of our future revenue will be derived from the sale of our software products. We expect that these product offerings and their extensions and derivatives will account for a majority of our revenue for the foreseeable future. Broad market acceptance of our software products is, therefore, critical to our future success and our ability to continue to generate revenues. Failure to achieve broad market acceptance of our software products as a result of competition, technological change, or otherwise, would significantly harm our business. Our future financial performance will depend primarily on the continued market acceptance of our current software product offerings and on the development, introduction and market acceptance of any future enhancements. There can be no assurance that we will be successful in marketing our current product offerings or any new product offerings, applications or enhancements, and any failure to do so would significantly harm our business.

Our use of open source software could impose limitations on our ability to commercialize our products.

We incorporate open source software into our products. Although we closely monitor our use of open source software, the terms of many open source software licenses have not been interpreted by U.S. courts, and there is a risk that such licenses could be construed in a manner that could impose unanticipated conditions or restrictions on our ability to sell our products. In such event, we could be required to make our proprietary software generally available to third parties, including competitors, at no cost, to seek licenses from third parties to continue offering our products, to re-engineer our products or to discontinue the sale of our products in the event re-engineering cannot be accomplished on a timely basis or at all, any of which could adversely affect our revenues and operating expenses.

We may not be able to obtain necessary licenses of third-party technology on acceptable terms, or at all, which could delay product sales and development and adversely impact product quality.

We have incorporated third-party licensed technology into our current products. We anticipate that we are also likely to need to license additional technology from third-parties to develop new products or product enhancements in the future. Third-party licenses may not be available or continue to be available to us on commercially reasonable terms. The inability to retain any third-party licenses required in our current products or to obtain any new third-party licenses to develop new products and product enhancements could require us to obtain substitute technology of lower quality or performance standards or at greater cost, and delay or prevent us from making these products or enhancements, any of which could seriously harm the competitive position of our products.

Our products must interoperate with many different networks, software applications and hardware products, and this interoperability will depend on the continued prevalence of open standards.

16


Our products are designed to interoperate with our customers’ existing and planned networks, which have varied and complex specifications, utilize multiple protocol standards, software applications and products from numerous vendors and contain multiple products that have been added over time. As a result, we must attempt to ensure that our products interoperate effectively with these existing and planned networks. To meet these requirements, we have and must continue to undertake development and testing efforts that require significant capital and employee resources. We may not accomplish these development efforts quickly or cost-effectively, or at all. If our products do not interoperate effectively, installations could be delayed or orders for our products could be cancelled, which would harm our revenue, gross margins and our reputation, potentially resulting in the loss of existing and potential customers. The failure of our products to interoperate effectively with our customers’ networks may result in significant warranty, support and repair costs, divert the attention of our engineering personnel from our software development efforts and cause significant customer relations problems.

Additionally, the interoperability of our products with multiple different networks is significantly dependent on the continued prevalence of standards for IP multimedia services, such as SIP or Session Initiation Protocol. Some of our existing and potential competitors are network equipment providers who could potentially benefit from the deployment of their own proprietary non-standards-based architectures. If resistance to open standards by network equipment providers becomes prevalent, it could make it more difficult for our products to interoperate with our customers’ networks, which would have a material adverse effect on our ability to sell our products to service providers.

We are subject to the credit risk of our customers, which could have a material adverse effect on our financial condition, results of operations and liquidity.

We are subject to the credit risk of our customers. Businesses that are good credit risks at the time of sale may become bad credit risks over time. In times of economic recession, the number of our customers who default on payments owed to us tends to increase. If we fail to adequately assess and monitor our credit risks, we could experience longer payment cycles, increased collection costs and higher bad debt expense.

We are exposed to fluctuations in interest rates and exchange rates associated with foreign currencies.

A majority of our revenue activities are transacted in U.S. dollars. However, we are exposed to foreign currency exchange rate risk inherent in conducting business globally in numerous currencies, of which the most significant to our operations for the year ended April 30, 2016 is the Canadian dollar. We are primarily exposed to a fluctuating Canadian dollar as our operating expenses are primarily denominated in Canadian dollars while our revenues are primarily denominated in U.S. dollars. We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. Our company’s foreign currency risk management program includes foreign currency derivatives with cash flow hedge accounting designation that utilizes foreign currency forward contracts to hedge exposures to the variability in the U.S. dollar equivalent of anticipated non-U.S. dollar-denominated cash flows. These instruments generally have a maturity of less than one year. For these derivatives, our company reports the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) in stockholders’ equity and reclassifies it into earnings in the same period in which the hedged transaction affects earnings, and within the same line item on the consolidated statements of operations as the impact of the hedged transaction. There can be no assurance that our hedging program will not result in a negative impact on our earnings and earnings per share. We did not enter into any forward contracts for hedging purposes during fiscal 2016 (2015 - none).

We also routinely enter into foreign currency forward contracts, not designated as hedging instruments, to protect us from fluctuations in exchange rates. As of April 30, 2016 and April 30, 2015, we had no foreign currency forward contracts.

Risks Associated with our Common Stock

Our directors control a substantial number of shares of our common stock, decreasing your influence on stockholder decisions.

Based on the 4,542,348 shares of common stock that were issued and outstanding as of April 30, 2016, our directors owned approximately 30% of our outstanding common stock. As a result, our directors as a group could have a significant influence in delaying, deferring or preventing any potential change in control of our company; they will be able to strongly influence the actions of our board of directors even if they were to cease being directors of our company and can effectively control the outcome of actions brought to our stockholders for approval. Such a high level of ownership may adversely affect the exercise of your voting and other stockholder rights.

17


We do not expect to pay dividends in the foreseeable future.

We do not intend to declare dividends for the foreseeable future, as we anticipate that we will reinvest any future earnings in the development and growth of our business. Therefore, investors will not receive any funds unless they sell their common stock, and stockholders may be unable to sell their shares on favorable terms. We cannot assure you of a positive return on investment or that you will not lose the entire amount of your investment in our common stock.

The exercise of all or any number of outstanding warrants or stock options or the issuance of other stock-based awards or any issuance of shares to raise funds may dilute your holding of shares of our common stock.

If the holders of outstanding warrants, stock options and deferred share units exercise or convert all of their warrants, vested stock options and vested deferred share units as at April 30, 2016, then we would be required to issue an additional 599,712 shares of our common stock, which would represent approximately 13% of our issued and outstanding common stock after such issuances. The exercise of any or all outstanding warrants or stock options that are exercisable below market price will result in dilution to the interests of other holders of our common stock.

We may in the future grant to certain or all of our directors, officers, insiders and key employees stock options to purchase the shares of our common stock, bonus shares and other stock based compensation as non-cash incentives to such persons. Subject to applicable stock exchange rules, if any, we may grant these stock options and other stock based compensation at exercise prices equal to or less than market prices, and we may grant them when the market for our securities is depressed. The issuance of any additional shares of common stock or securities convertible into common stock will cause our existing shareholders to experience dilution of their holding of our common stock.

In addition, shareholders could suffer dilution in their net book value per share depending on the price at which such securities are sold. Such issuance may cause a reduction in the proportionate ownership and voting power of all other shareholders. The dilution may result in a decline in the price of our shares of common stock or a change in the control of our company.

We may be considered a “penny stock.” Penny stock rules will limit the ability of our stockholders to sell their shares of common stock.

The SEC has adopted regulations which generally define “penny stock” to be any equity security that has a market price (as defined) less than $5.00 per share or an exercise price of less than $5.00 per share, subject to certain exceptions. In addition, since our common stock commenced trading on the NASDAQ Capital Market below the $4.00 minimum bid price per share requirement, our common stock would be considered a penny stock if we fail to satisfy the net tangible assets and revenue tests in Rule 3a51-1 under the Securities Exchange Act of 1934. Our securities may be covered by the penny stock rules, which impose additional sales practice requirements on broker-dealers who sell to persons other than established customers and “accredited investors”. The term “accredited investor” refers generally to institutions with assets in excess of $5,000,000 or individuals with a net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouse. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document in a form prepared by the SEC which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction and monthly account statements showing the market value of each penny stock held in the customer's account. The bid and offer quotations, and the broker-dealer and salesperson compensation information, must be given to the customer orally or in writing prior to effecting the transaction and must be given to the customer in writing before or with the customer's confirmation.

18


In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from these rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written agreement to the transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market for the stock that is subject to these penny stock rules. Consequently, these penny stock rules may affect the ability of broker-dealers to trade our securities. We believe that the penny stock rules discourage investor interest in and limit the marketability of our common stock.

The Financial Industry Regulatory Authority, or FINRA, has adopted sales practice requirements, which may limit a stockholder's ability to buy and/or sell shares of our common stock.

The FINRA has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer's financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the market for its shares.

Securities analysts may not publish favorable research or reports about our business or may publish no information which could cause our stock price or trading volume to decline.

The trading market for our common stock will be influenced by the research and reports that industry or financial analysts publish about us and our business. We do not control these analyst reports. As a relatively small public company, we may be slow to attract research coverage and the analysts who publish information about our common stock will have had relatively little experience with our company, which could affect their ability to accurately forecast our results and make it more likely that we fail to meet their estimates. If any of the analysts who cover us issue an adverse opinion regarding our stock price, our stock price may decline. If one or more of these analysts cease coverage of our company or fail to regularly publish reports covering us, we could lose visibility in the market, which in turn could cause our stock price or trading volume to decline.

Item 1B. Unresolved Staff Comments.

Not Applicable.

Item 2. Properties.

We do not own any real property. Our Canadian operations are conducted in three leased offices located in Vancouver and Victoria, British Columbia and Ottawa, Ontario. Our U.S. operations are conducted in two leased offices located in Chicago, Illinois, and Dedham, Massachusetts. Our head office is located on the 3rd Floor at Suite 300, One Bentall Centre, 505 Burrard Street, Vancouver, British Columbia, Canada, V7X 1M3.

Item 3. Legal Proceedings.

None.

Item 4. Mine Safety Disclosures

Not applicable.

19


PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Our common stock is traded on the NASDAQ Capital Market and the Toronto Stock Exchange. The following table sets forth, for the periods indicated, the high and low sale prices for our common stock on the NASDAQ Capital Market and Toronto Stock Exchange based on inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions as reported by the NASDAQ Capital Market and the Toronto Stock Exchange, respectively.

Quarter Ended NASDAQ(1)
(U.S. dollars)
The Toronto Stock
Exchange(2)
(Canadian dollars)
  High Low High Low
July 31, 2014 $21.80 $9.90 $21.90 $10.50
October 31, 2014 $13.00 $8.30 $15.80 $9.10
January 31, 2015 $9.60 $4.90 $10.50 $5.50
April 30, 2015 $7.50 $4.10 $9.50 $5.10
July 31, 2015 $9.70 $4.10 $10.10 $5.00
October 31, 2015 $6.20 $2.38 $7.00 $3.50
January 31, 2016 $5.25 $2.02 $6.20 $3.00
April 30, 2016 $2.40 $2.11 $3.49 $2.51

  (1)

Since July 11, 2012, our stock has been trading on the NASDAQ Capital Market under the trading symbol "CPAH".

  (2)

Since August 20, 2012, our stock has been trading on the Toronto Stock Exchange under the trading symbol "CCV".

Our shares of common stock are issued in registered form. Computershare located at 510 Burrard St., 2nd Floor, Vancouver, BC, Canada V6C 3B9 (Telephone: 604.661.9400; Facsimile: 604.661.9549) is the registrar and transfer agent for our shares of common stock.

On July 8, 2016, the shareholders' list of our shares of common stock showed 104 registered shareholders and 4,555,348 shares outstanding.

Dividend Policy

To date, we have not declared or paid any dividends on our shares of common stock and do not expect to declare or pay any dividends on our shares of common stock in the foreseeable future. Payment of any dividends will depend upon our future earnings, if any, our financial condition, and other factors as deemed relevant by our board of directors. Although there are no restrictions that limit the ability to pay dividends on our shares of common stock, our intention is to retain future earnings for use in our operations and the expansion of our business.

Equity Compensation Plan Information

The following table provides a summary of the number of options granted, shares purchasable or deferred share units granted under our various compensation plans, the weighted average exercise price and the number of options remaining available for grant, shares purchasable or deferred share units available for grant all as at April 30, 2016.

20



Plan Category Number of Securities to be Weighted-Average exercise Number of Securities
  issued upon exercise of price of outstanding remaining available for
  outstanding options, options, warrants and future issuance under
  warrants and rights rights equity compensation plans
       
Equity compensation      
plans approved by      
security holders:      
       
         2010 Stock Option      
         Plan 410,730 $12.99 111,343
       
         Employee Share      
         Purchase Plan N/A 86,203
       
         Deferred Share Unit      
         Plan 254,939 N/A 121,048
       
Equity compensation      
plans not approved by N/A N/A N/A
security holders      
       
Total 665,669 $12.99 318,594

2010 Stock Option Plan

The purpose of the 2010 Stock Option Plan is to retain the services of valued key employees, directors, officers and consultants and to encourage such persons with an increased initiative to make contributions to our company. Under the 2010 Stock Option Plan, eligible employees, consultants and certain other persons who are not eligible employees, may receive awards of “non-qualified stock options”. Individuals, who, at the time of the option grant, are employees of our company or any related company (as defined in the 2010 Stock Option Plan) who are subject to tax in the United States may receive “incentive stock options” or “non-qualified stock options”, and stock options granted to non-United States residents may receive awards of “options”.

As of April 30, 2016, there were 410,730 stock options outstanding entitling the holders thereof the right to purchase one share of common stock for each option held.

Employee Share Purchase Plan

On October 1, 2008, our shareholders approved the employee share purchase plan (the “ESPP”) for employees, directors, officers and consultants of our company and our subsidiaries. The purpose of the plan is to give employees access to an equity participation vehicle in addition to our stock option plans by way of an opportunity to purchase shares of our common stock through payroll deductions and encourage them to use their combined best efforts on behalf of our company to improve its profits through increased sales, reduction of costs and increased efficiency. Participation in the ESPP is voluntary. Within the limits of the ESPP, our company matches fifty percent (50%) of the aggregate number of shares purchased by the participants. We are permitted to issue up to 120,000 shares of our common stock under the ESPP. As of April 30, 2016, we have 86,203 shares of our common stock available for issuance under the ESPP.

Deferred Share Unit Plan

Under the terms of the deferred share unit plan (the “DSUP”) as approved by the shareholders on October 22, 2009, each deferred share unit (each, a “DSU”) is equivalent to one share of common stock. The maximum number of shares of common stock that may be reserved for issuance to any one participant pursuant to DSU’s granted under the DSUP and any share compensation arrangement is 5% of the number of shares of common stock of our company outstanding at the time of reservation. A DSU granted to a participant who is a director of our company shall vest immediately on the award date. A DSU granted to a participant other than a director will generally vest as to one-third (1/3) of the number of DSU’s granted on the first, second and third anniversaries of the award date. Fair value of the DSU’s, which is based on the closing price of our company’s common stock on the date of grant, is recorded as compensation expense in the period of grant. As of April 30, 2016, we have issued and outstanding 254,939 DSU’s under the DSUP. As of April 30, 2016, 24,014 previously issued DSU’s have been converted to 24,014 shares of common stock.

21


Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 Issuer Purchases of Equity Securities 
Total number
of shares
purchased
Average price
paid per share
(Canadian
dollars)
Total number of
shares purchased
as part of publicly
announced plans
or programs
Maximum
number of shares
that may yet be
purchased under
the plans or
programs
Feb 1, 2016 to Feb 29, 2016 500(1) $3.32 500
Mar 1, 2016 to Mar 31, 2016 100(2)(3) $3.03 100 273,864
Apr 1, 2016 to Apr 30, 2016 400(2) $2.75 400 273,464
Total 1,000 $3.06(4) 1,000 273,464

  (1)

Purchased pursuant to a normal course issuer bid announced on March 16, 2015, which commenced on March 19, 2015 and expired on March 18, 2016 to purchase up to 243,403 shares of our common stock.

     
  (2)

Purchased pursuant to a normal course issuer bid announced on March 16, 2016, which commenced on March 19, 2016 and expiring on March 18, 2017 to purchase up to 273,864 shares of our common stock.

     
  (3)

100 shares of our common stock were purchased under the normal course issuer bid that expired March 18, 2016 and nil shares of our common stock were purchased under the normal course issuer bid expiring March 18, 2017.

     
  (4)

Weighted average price.

On March 16, 2015, we announced our intention to purchase, by way of a normal course issuer bid, for cancellation purposes, up to 243,403 shares of our common stock, representing approximately 10% of our then outstanding public float. Purchases were made on the open market through the facilities of the TSX, Nasdaq Capital Market or such other stock exchange or quotation system upon which the our shares were then listed or quoted, including other Canadian marketplaces, at market prices prevailing at the time of purchase. The purchases took place over a 12-month period beginning on March 19, 2015 and expiring on March 18, 2016. The daily purchase restriction was 100 shares, subject to certain prescribed exemptions.

On March 16, 2016, we announced our intention to purchase, by way of a normal course issuer bid, for cancellation purposes, up to 273,864 shares of our common stock, representing approximately 10% of our then outstanding public float. We believe that our shares trade in a price range that does not adequately reflect their underlying value based on our business prospects.

Purchases will be made on the open market through the facilities of the TSX, Nasdaq Capital Market or such other stock exchange or quotation system upon which the our shares are then listed or quoted, including other Canadian marketplaces, at market prices prevailing at the time of purchase and may take place over a 12-month period beginning on March 21, 2016 and expiring on March 20, 2017. We are permitted to make block purchases once per calendar week in accordance with the rules of the TSX. The daily purchase restriction is 1,000 shares, subject to certain prescribed exemptions. All shares purchased by our company under the normal course issuer bid will be returned to treasury and cancelled.

22


In connection with the normal course issuer bid, we renewed our automatic share purchase plan with National Bank Financial Inc., in order to facilitate purchases of our shares. Under the purchase plan, National Bank may purchase shares on our behalf at times when we would ordinarily not be permitted to purchase shares due to internal trading blackout periods, insider trading rules or otherwise. The purchase plan has been approved by the TSX and was implemented as of March 21, 2016. Purchases will be made by National Bank on the open market based upon the parameters prescribed by the TSX, applicable laws and the terms and conditions of the purchase plan.

To our knowledge, none of our directors, senior officers or other insiders (as defined in the TSX Company Manual) intends to sell any shares under the normal course issuer bid. However, sales by such persons through the facilities of the TSX may occur if the personal circumstances of any such person change or if any such person makes a decision unrelated to these normal course purchases. The benefits to any such person whose shares are purchased would be the same as the benefits available to all other holders whose shares are purchased.

Stockholders may obtain a copy of the notice submitted to the TSX with respect to the normal course issuer bid, without charge, by contacting our Chief Financial Officer.

Recent Sales of Unregistered Securities

On April 4, 2016, the Company entered into an agreement to issue 25,000 shares of the Company’s common stock in exchange for advisory services. These shares would be issued in three tranches: (i) first tranche of 10,000 shares of the Company’s common stock was issued on April 22, 2016; (ii) second tranche of 10,000 shares of the Company’s common stock was issued on May 25, 2016; (iii) and the third tranche of 3,500 shares of the Company’s common stock was issued on June 30, 2016.

Item 6. Selected Financial Data.

Selected Consolidated Financial Information

The following tables set out selected consolidated audited financial information for the periods indicated. The selected consolidated financial information set out below for the fiscal years ended April 30, 2016 and 2015, and as at April 30, 2016 and April 30, 2015, has been derived from the consolidated financial statements and accompanying notes for the fiscal years ended April 30, 2016 and 2015. Each investor should read the following information in conjunction with those statements and the related notes thereto.

    April 30,     April 30,  
Selected Consolidated Balance Sheet Data   2016     2015  
Cash $ 2,159,738   $ 2,852,422  
Current assets $ 5,553,661   $ 6,326,187  
Current liabilities $ 3,815,705   $ 4,245,683  
Total liabilities $ 3,861,647   $ 4,304,006  
Total assets $ 12,966,131   $ 14,223,164  

Selected Consolidated Statements of Operations Data   Years Ended April 30,  
    2016     2015  
          Percent of           Percent  
          Total           of Total  
    Amount     Revenue     Amount     Revenue  
Revenue $ 11,081,358     100%   $ 12,003,083     100%  
                         
Operating expenses   13,923,167     126%     17,349,003     145%  
Loss from operations   (2,841,809 )   (26% )   (5,345,920 )   (45% )
Interest and other income, net   2,901     −%     20,440     −%  
Fair value adjustment on derivative instrument   (47,690 )   −%         −%  
Foreign exchange gain/(loss)   195,003     2%     883,613     7%  
Net income/(loss)   ($2,691,595 )   (24% )   ($4,441,867 )   (37% )

23



Selected Consolidated Statements of Operations Data   Years Ended April 30,  
    2016     2015  
          Percent of           Percent  
          Total           of Total  
    Amount     Revenue     Amount     Revenue  
                         
Net income/loss per share                        
-Basic   ($0.61 )         ($1.05 )      
-Diluted (1)   ($0.61 )         ($1.05 )      
                         
Weighted average common shares outstanding                        
-Basic   4,433,402           4,249,252        
-Diluted (1)   4,433,402           4,249,252        

1.

As at April 30, 2016 and 2015 common share equivalents of 812,169 and 385,280, respectively, were not included in the computation of diluted weighted average common shares as the effect was anti-dilutive.


Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis should be read in conjunction with the financial statements and related notes and the other financial information appearing elsewhere in this annual report.

Our financial statements are stated in United States dollars and are prepared in accordance with United States generally accepted accounting principles. All references to "common shares" refer to our shares of common stock. As used in this annual report, the terms “we”, “us” and “our” means CounterPath Corporation, unless otherwise indicated.

Overview

Background

We were incorporated under the laws of the State of Nevada on April 18, 2003.

On August 2, 2007, we acquired all of the shares of NewHeights Software Corporation through the issuance of 7,680,168 shares of our common stock and 369,836 preferred shares issued from a subsidiary of our company, which preferred shares were exchangeable into 369,836 shares of common stock.

On February 1, 2008, we acquired all of the shares of FirstHand Technologies Inc. through the issuance of 5.9 million shares of our common stock. On February 1, 2008, we acquired all of the issued and outstanding shares of BridgePort Networks, Inc. by way of merger in consideration for the assumption of all of the assets and liabilities of BridgePort Networks.

On June 18, 2015, we received notice from the NASDAQ advising that our shares had not regained compliance with the minimum $1.00 bid price per share requirement, but that the NASDAQ staff had determined that our company would be eligible for an additional 180 calendar day period, or until December 14, 2015, to regain compliance with the foregoing requirement. Effective November 2, 2015, we effected a one-for-ten reverse stock split of the shares of our common stock. As a result, our authorized capital decreased from 45,359,640 shares of common stock to 4,535,991 shares of common stock. On November 16, 2015, we received notice from the Nasdaq that the closing bid price of our common stock has been $1.00 or greater for the consecutive business day’s and that we had regained compliance with listing rule 5550(a)(2).

Business of CounterPath

Our business focuses on the design, development, marketing and sales of personal computer and mobile application software, gateway server software and related professional services, such as pre and post sales, technical support and customization services. Our software products are sold into the telecommunications sector, specifically the Voice over Internet protocol (VoIP), unified communications and fixed-mobile convergence markets. VoIP, unified communications and fixed-mobile convergence are general terms for technologies that use Internet or mobile protocols for the transmission of packets of data which may include voice, video, text, fax, and other forms of information that have traditionally been carried over the dedicated circuit-switched connections of the public switched telephone network.

24


Our strategy is to sell our solutions to our customers, enabling them to offer advanced unified communication services to their employees, customers and other end users. Customers that we are targeting include: (1) small, medium and large sized businesses; (2) telecommunications service providers, Internet telephony service providers, (3) channel partners serving the telecommunication and enterprise market; and (4) end users who purchase our applications directly from our online store or from third party online stores.

Revenue

We derive revenue from the sale of software licenses, software customization services, technical support services associated with the software licenses, implementation services, training services, and cloud based hosting services. We recognize perpetual software and services revenue at the time of delivery, provided all other revenue recognition criteria have been met. We recognize software as a service revenue over the term of the service contract, which is generally twelve months.

Post contract customer support services include e-mail and telephone support, unspecified rights to bug fixes and product updates and upgrades and enhancements available on a when-and-if available basis, and are recognized rateably over the term of the service period, which is generally twelve months.

We offer our products and services directly through our sales force and indirectly through channel partners. Our channel partners include original equipment manufacturers (OEMs) in the telecommunications sector and value added dealers and resellers. We also sell our products directly from our on-line store and through third-party on-line stores.

The amount of product configuration and customization required by a customer typically increases as the order size increases from a given customer. The number of software licenses purchased has a direct impact on the average selling price. Services and pricing may vary depending upon a customer's requirements for technical support, implementation and training.

We believe that our revenue and results of operations may vary significantly from quarter-to-quarter as a result of varying sales and deployment cycles, new product introductions and variations in customer ordering patterns.

Operating Expenses

Operating expenses consist of cost of sales, sales and marketing, research and development, and general and administrative expenses. Personnel-related costs are the most significant component of each of these expense categories.

Cost of sales primarily consists of: (a) salaries and benefits related to personnel, (b) related overhead, (c) billable and non-billable travel, lodging, and other out-of-pocket expenses, (d) payments to third party vendors for compression/decompression software known as codecs, (e) amortization of capitalized software that is implemented into our products and (f) warranty expense.

Sales and marketing expense consists primarily of: (a) salaries and related personnel costs including stock-based compensation, (b) commissions, (c) travel, lodging and other out-of-pocket expenses, (d) marketing programs such as trade shows and (e) other related overhead. Commissions are recorded as expense when earned by the employee. We expect increases in sales and marketing expense for the foreseeable future as we further increase the number of sales professionals and increase our marketing activities with the intent to grow our revenue. We expect sales and marketing expense to decrease as a percentage of total revenue, however, as we leverage our current sales and marketing personnel as well as our distribution partnerships.

25


Research and development expense consists primarily of: (a) salaries and related personnel costs including stock-based compensation, (b) payments to contractors for design and consulting services, (c) costs relating to the design and development of new products and enhancement of existing products, (d) quality assurance and testing and (e) other related overhead. To date, all of our research and development costs have been expensed as incurred.

General and administrative expense consists primarily of: (a) salaries and personnel costs including stock-based compensation related to our executive, finance, human resource and information technology functions, (b) accounting, legal, tax advisory and regulatory fees and (c) other related overhead.

Application of Critical Accounting Policies and Use of Estimates

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires that we make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ significantly from these estimates under different assumptions or conditions. There have been no material changes to these estimates for the periods presented in this annual report.

We believe that of our significant accounting policies, which are described in Note 2 to our annual financial statements, the following accounting policies involve a greater degree of judgment and complexity. Accordingly, the following policies are the most critical to aid in fully understanding and evaluating our financial condition and results of operations.

Revenue Recognition

We recognize revenue in accordance with ASC 985-605 "Software Revenue Recognition".

In all of our arrangements, we do not recognize any revenue until we can determine that persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and we deem collection to be probable. For distribution and reseller arrangements, fees are fixed or determinable and collection probable when there are no rights to exchange or return and fees are not dependable upon payment from the end-user. If any of these criteria are not met, revenue is deferred until such time that all criteria have been met.

A substantial percentage of our revenue is generated by multiple-element arrangements, such as products, maintenance and support, professional services and training. When arrangements include multiple elements, we allocate the total fee among the various elements using the residual method. Under the residual method, revenue is recognized when vendor-specific objective evidence, or VSOE, of fair value exists for all of the undelivered elements of the arrangement, but does not exist for one or more of the delivered elements of the arrangement. Each arrangement requires us to analyze the individual elements in the transaction and to estimate the fair value of each undelivered element, which typically includes maintenance and services. Revenue is allocated to each of the undelivered elements based on its respective fair value, with the fair value determined by the price charged when that element is sold separately.

For contracts with elements related to customized network solutions and certain network build-outs, we apply FASB Emerging Issues Task Force Issue ASC 605-25, "Revenue Arrangements with Multiple Deliverables" and revenues are recognized under ASC 605-35, "Accounting for Performance of Construction-Type and Certain Production-Type Contracts", generally using the percentage-of-completion method.

In using the percentage-of-completion method, revenues are generally recorded based on a completion of milestones as described in the agreement. Profit estimates on long-term contracts are revised periodically based on changes in circumstances and any losses on contracts are recognized in the period that such losses become known.

Post contract customer support (PCS) services include e-mail and telephone support, unspecified rights to bug fixes and product updates and upgrades and enhancements available on a when-and-if available basis, and are recognized rateably over the term of the service period, which is generally twelve months.

26


PCS service revenue generally is deferred until the related product has been accepted and all other revenue recognition criteria have been met. Professional services and training revenue is recognized as the related service is performed.

Stock-Based Compensation

Stock options granted are accounted for under ASC 718 "Share-Based Payment" and are recognized at the fair value of the options as determined by an option pricing model as the related services are provided and the options earned. ASC 718 requires public companies to recognize the cost of employee services received in exchange for equity instruments, based on the fair value of those instruments on the measurement date which generally is the grant date, with limited exceptions.

Stock-based compensation represents the cost related to stock-based awards granted to employees and non-employee consultants. We measure stock-based compensation cost at measurement date, based on the estimated fair value of the award, and generally recognize the cost as expense on a straight-line basis (net of estimated forfeitures) over the employee requisite service period or the period during which the related services are provided by the non-employee consultants and the options are earned. We estimate the fair value of stock options using a Black-Scholes option valuation model.

The expected volatility of options granted has been determined using the volatility of our company's stock. The expected life of options granted after April 30, 2006 has been determined based on analysis of historical data. We have not paid and do not anticipate paying cash dividends on our shares of common stock; therefore, the expected dividend yield is assumed to be zero. In addition, ASC 718 requires companies to utilize an estimated forfeiture rate when calculating the expense for the period. We applied an estimated forfeiture rate of 15.0% in the year ended April 30, 2016 in determining the expense recorded in our consolidated statement of operations. Cost of sales and operating expenses include stock-based compensation expense, and deferred share unit plan expense. For the year ended April 30, 2016, we recorded an expense of $906,914 in connection with share-based payment awards. A future expense of non-vested options of $593,978 is expected to be recognized over a weighted-average period of 2.08 years. A future expense of non-vested deferred share units of $189,523 is expected to be recognized over a weighted-average period of 1.63 years.

Research and Development Expense for Software Products

Research and development expense includes costs incurred to develop intellectual property. The costs for the development of new software and substantial enhancements to existing software are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. We have determined that technological feasibility is established at the time a working model of software is completed. Because we believe our current process for developing software will be essentially completed concurrently with the establishment of technological feasibility, no costs have been capitalized to date.

Accounts Receivable and Allowance for Doubtful Accounts

We extend credit to our customers based on evaluation of an individual customer's financial condition and collateral is generally not required. Accounts outstanding beyond the contractual payment terms are considered past due. We determine our allowance for doubtful accounts by considering a number of factors, including the length of time accounts receivable are beyond the contractual payment terms, our previous loss history, and a customer's current ability to pay its obligation to us. We write-off accounts receivable when they are identified as uncollectible. All outstanding accounts receivable are periodically reviewed for collectability on an individual basis.

Goodwill

We have goodwill related to the acquisitions of NewHeights Software Corporation and FirstHand Technologies Inc. The determination of the net carrying value of goodwill and the extent to which, if any, there is impairment, are dependent on material estimates and judgments on our part, including the estimate of the value of future net cash flows, which are based upon further estimates of future revenues, expenses and operating margins.

27


Goodwill—Impairment Assessments

We review goodwill for impairment annually and whenever events or changes in circumstances indicate its carrying value may not be recoverable in accordance with FASB ASC 350, Goodwill and Other Intangible Assets. The provisions of ASC 350 require that a two-step impairment test be performed on goodwill. In the first step, we compare the fair value of our reporting unit to its carrying value. If the fair value of the reporting unit exceeds the carrying value of the net assets assigned to that unit, goodwill is not considered impaired and we are not required to perform further testing. If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, then we must perform the second step of the impairment test in order to determine the implied fair value of the reporting unit’s goodwill. If the carrying value of our reporting unit’s goodwill exceeds its implied fair value, then we would record an impairment loss equal to the difference.

Determining the fair value of our reporting unit involves the use of significant estimates and assumptions. These estimates and assumptions include future economic and market conditions and determination of appropriate market comparables. We base our fair value estimates on assumptions we believe to be reasonable but that are unpredictable and inherently uncertain. Actual future results may differ from those estimates. Our most recent annual goodwill impairment analysis, which was performed at the end of the fourth quarter of fiscal 2016, did not result in an impairment charge for fiscal year 2016, nor did we record any goodwill impairment in fiscal 2015.

Derivative Instruments

We periodically enter into foreign currency forward contracts, not designated as hedging instruments, to protect us from fluctuations in exchange rates. During the year, we had a $1,000,000 notional value foreign currency forward contract that matured on August 20, 2015. A loss of $47,690 was recognized on maturity of the forward contract. As of April 30, 2016 and April 30, 2015, we had no foreign currency forward contracts outstanding. Notional amounts do not quantify risk or represent assets or liabilities of our company, but are used in the calculation of cash settlements under the contracts.

Use of Estimates

The preparation of our financial statements in conformity with generally accepted accounting principles in the United States requires our management to make estimates and assumptions which affect the amounts reported in these consolidated financial statements, the notes thereto, and the disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.

Results of Operations

Our operating activities during the year ended April 30, 2016, consisted primarily of selling our IP telephony software and related services to telecom service providers, enterprises and channel partners serving the telecom and enterprise segments, and the continued development of our IP telephony software products.

We generate our revenue primarily in U.S. dollars and incur a majority of our expenses in Canadian dollars. As a result of the decline in the Canadian dollar against the U.S. dollar over the twelve months ended April 30, 2016, we benefited by recording reduced operating costs on translation of Canadian dollar costs as compared to the twelve months ended April 30, 2015. For the twelve months ended April 30, 2016 as compared to twelve months ended April 30, 2015, the foreign exchange benefit resulting from the decline in the Canadian dollar was approximately $1,168,000.

28


Revenue

Revenues for the year ended April 30, 2016 and 2015 were as follows:

    2016     2015     Period-to-Period Change  
          Percent           Percent           Percent  
          of Total           of Total           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
Revenue by Type                                    
 Software $ 6,031,618     54%   $ 7,151,076     60%     ($1,119,458 )   (16% )
 Service   5,049,740     46%     4,852,007     40%     197,733     4%  
Total revenue $ 11,081,358     100%   $ 12,003,083     100%     ($921,725 )   (8% )
                                     
Revenue by Region                                    
 International $ 3,889,348     35%   $ 4,285,151     36%     ($395,803 )   (9% )
 North America   7,192,010     65%     7,717,932     64%     (525,922 )   (7% )
Total revenue $ 11,081,358     100%   $ 12,003,083     100%     ($921,725 )   (8% )

For the year ended April 30, 2016, we generated $11,081,358 in revenue compared to $12,003,083 for the year ended April 30, 2015, representing a decrease of $921,725. We generated $6,031,618 in software revenue for the year ended April 30, 2016 compared to $7,151,076 for the year ended April 30, 2015, representing a decrease of $1,119,458. The decrease in software revenue for the year ended April 30, 2016 was a result of decreases in sales to service providers, enterprises, and channel partners. For the year ended April 30, 2016, service revenue was $5,049,740 compared to $4,852,007 for the year ended April 30, 2015, representing an increase of $197,733. The increase in service revenue for the year ended April 30, 2016 was primarily a result of an increase in sales to channel partners partially offset by a decrease in sales to enterprises and service providers. International revenue outside of North America decreased by 9% during the year ended April 30, 2016 compared to the year ended April 30, 2015, as a result of decreases in international sales to enterprises, channel partners, and service providers, particularly in EMEA (Europe, Middle East and Africa). North American revenue decreased by 7% during the year ended April 30, 2016 compared to year ended April 30, 2015, primarily as a result of decreases in sales to North American enterprises and service providers partially offset by an increase in sales to North American based channel partners.

Operating Expenses

Cost of Sales

Cost of sales for the year ended April 30, 2016 and 2015 were as follows:

    April 30, 2016     April 30, 2015     Period-to-Period Change  
          Percent           Percent           Percent  
          of           of           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
Year ended $ 1,667,087     15%   $ 2,222,071     19%     ($554,984 )   (25% )

Cost of sales was $1,667,087 for the year ended April 30, 2016 compared to $2,222,071 for the year ended April 30, 2015. The decrease of $554,984 was attributable to a reversal of a provision for potential licensing fees that have been accrued in prior years of approximately $269,000 that are not expected to be paid, a decrease in wages, benefits and consulting fees of approximately $177,000, a decrease in current licenses and permits of approximately $64,600, amortization of approximately $25,500 and a decrease in other expenses of approximately $18,500. Cost of sales expressed as a percent of revenue decreased to 15% of revenue for the year ended April 30, 2016 compared to 19% for the year ended April 30, 2015.

29


Sales and Marketing

Sales and marketing expenses for the year ended April 30, 2016 and 2015 were as follows:

    April 30, 2016     April 30, 2015     Period-to-Period Change  
                                     
          Percent           Percent           Percent  
          of           of           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
Year ended $ 4,145,351     37%   $ 4,935,671     41%     ($790,320 )   (16% )

Sales and marketing expenses were $4,145,351 for the year ended April 30, 2016 compared to $4,935,671 for the year ended April 30, 2015. The decrease of $790,320 was primarily attributable to a decrease in wages, benefits, commissions and consulting fees of approximately $723,400, travel and trade show expenses of approximately $43,100, and a decrease in other expenses of approximately $23,900.

Research and Development

Research and development expenses for the year ended April 30, 2016 and 2015 were as follows:

    April 30, 2016     April 30, 2015     Period-to-Period Change  
          Percent           Percent           Percent  
          of           of           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
Year ended $ 4,737,055     43%   $ 5,669,217     47%     ($932,162 )   (16% )

Research and development expenses were $4,737,055 for the year ended April 30, 2016 compared to $5,669,217 for the year ended April 30, 2015. The decrease of $932,162 resulted primarily from a decrease wages, benefits and consulting fees of approximately $799,900, a decrease in rent of approximately $61,900, a decrease in travel expenses of approximately $57,000, and a decrease in other expenses of approximately $13,400.

General and Administrative

General and administrative expenses for the years ended April 30, 2016 and 2015 were as follows:

    April 30, 2016     April 30, 2015     Period-to-Period Change  
          Percent           Percent           Percent  
          of           of           Increase /  
    Amount     Revenue     Amount     Revenue     Amount     (Decrease)  
Year ended $ 3,373,674     30%   $ 4,522,044     38%     ($1,148,370 )   (25% )

General and administrative expenses for the year ended April 30, 2016 were $3,373,674 compared to $4,522,044 for the year ended April 30, 2015. The decrease of $1,148,370 in general and administrative expenses was primarily attributable to a decrease in wages, benefits, commissions, directors fees and consulting fess of approximately $420,100, a decrease bad debt reserve of approximately $353,000, a decrease in legal and professional fees of approximately $162,500, a decrease in other expenses of approximately $90,500, a decrease in patent costs of approximately $65,500, and a decrease in investor relations of approximately $56,700.

Interest and Other Income

Interest and other income for the year ended April 30, 2016 was $5,211 compared to $21,669 for the year ended April 30, 2015. Interest expense for the year ended April 30, 2016, was $2,310 compared to $1,229 for the year ended April 30, 2015.

Foreign exchange gain for the year ended April 30, 2016, was $195,003 compared to a foreign exchange gain of $883,613 for the year ended April 30, 2015. The foreign exchange gain (loss) represents the gain (loss) on account of translation of the intercompany accounts of our subsidiary which maintains their records in Canadian dollars and transactional gains and losses. The foreign exchange gain (loss) includes the translation of quarterly intercompany transfer pricing invoices from our Canadian subsidiary to us. The decrease in foreign exchange gain is a result of an incrementally smaller decline in the Canadian dollar against the U.S. dollar in the year ended April 30, 2016.

30


Fair value adjustment on derivative instruments for the year ended April 30, 2016 resulted in a loss of $47,690 compared to a loss of $nil for the year ended April 30, 2015. On June 7, 2015, we entered into a $1,000,000 notional value foreign currency forward contract that matured on August 20, 2015.

Liquidity and Capital Resources

As at April 30, 2016, we had $2,159,738 in cash compared to $2,852,422 at April 30, 2015, representing a decrease of $692,684. Our working capital was $1,737,956 at April 30, 2016 compared to $2,080,504 at April 30, 2015, representing a decrease of $342,548. Management anticipates that future capital requirements of our company will be funded through cash flows generated from operations and from working capital for the next twelve months and we may seek additional funding to meet ongoing operating expenses.

We have $1,540,467 in cash held outside of the United States, and there is no intent to repatriate at this time. Should we decide to repatriate in the future, taxes would need to be accrued and paid.

Operating Activities

Our operating activities resulted in a net cash outflow of $2,105,823 for the year ended April 30, 2016. This compares to a net cash outflow of $3,336,380 for the year ended April 30, 2015, representing a $1,230,557 decrease in cash outflows from operations. The net cash outflow from operating activities for the year ended April 30, 2016 was primarily a result of a net loss of $2,691,595, a decrease in accounts payable of $314,804 and adjustments for a non-cash foreign exchange gain of $248,371. The net cash outflow was offset by a decrease in accounts receivable of $96,187 and by adjustments for non-cash expenses including $906,914 for stock based compensation and $199,335 of depreciation and amortization.

The net cash outflow from operating activities of $3,336,380 for the year ended April 30, 2015 was primarily a result of a net loss of $4,441,867, a non-cash foreign exchange gain of $293,323 and a decrease in accounts payable of $150,819. The net cash outflow was offset by an increase in unearned revenue of $241,160 and by adjustments for non-cash expenses including $1,000,070 for stock based compensation and $209,382 of depreciation and amortization.

Investing Activities

Investing activities resulted in a net cash outflow of $41,431 for the year ended April 30, 2016, primarily due to the purchase of equipment and trademarks during the year. This compares with a net cash outflow of $214,514 for the year ended April 30, 2015, primarily due to the purchase of equipment. At April 30, 2016, we did not have any material commitments for future capital expenditures.

Financing Activities

Financing activities resulted in a net cash inflow of $1,481,692 for the year ended April 30, 2016 compared to a net cash outflow of $310,959 for the year ended April 30, 2015. The net cash inflow was primarily a result of a non-brokered private placement under which we issued 293,000 units at a price of $5.00 per unit for gross proceeds of $1,465,000.

Pursuant to a normal course issuer bid commencing on March 19, 2016 and expiring March 18, 2017, we are authorized to purchase up to 273,864 shares of our common stock through the facilities of the TSX and other Canadian marketplaces or U.S. marketplaces. Pursuant to a normal course issuer bid commencing March 19, 2014 and expiring March 18, 2015, we repurchased 36,133 shares at an average price of $9.30 (CDN$10.51) for an aggregate purchase price of $336,033. During the period from March 19, 2015 to March 18, 2016, we repurchased 11,360 shares at an average price of $3.80 (CDN$4.97) for a total of $43,168 and during the period March 19, 2016 to April 30, 2016, we repurchased 400 shares at an average price of $2.14 (CDN$2.75) for a total of $856. As of April 30, 2016, a total of 75,788 shares have been cancelled and the remaining 400 repurchased shares are in the process of being cancelled since the normal course issuer bid was initiated.

31


Off-Balance Sheet Arrangements

We do not have, and do not have any present plans to implement, any off-balance sheet arrangements.

New Accounting Pronouncements

In May 2014, FASB issued ASU 2014-09, Revenue From Contracts With Customers (“Topic 606”). Topic 606 removes inconsistencies and weaknesses in revenue requirements, provides a more robust framework for addressing revenue issues, improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, provides more useful information to users of financial statements through improved disclosure requirements and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The guidance in this update supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance throughout the Industry Topics of the Codification. In August 2015, ASU 2015-14 was issued which delayed the effective date for public entities to reporting periods beginning after December 15, 2017. Early adoption is not permitted. We are currently evaluating the impact of the adoption of this new standard.

In August 2014, FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and provide related footnote disclosures. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. The standard allows for either a full retrospective or modified retrospective transition method. We do not expect this standard to have a material impact our consolidated financial statements upon adoption.

In February 2016, FASB issued ASU 2016-02, Leases. The guidance would require lessees to recognize most leases on their balance sheets as lease liabilities with corresponding right-of-use assets. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2018. We are currently evaluating the impact of its pending adoption of ASU 2016-02 on our consolidated financial statements.

In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross versus Net), which clarifies the guidance in the new revenue standard on assessing whether an entity is a principal or an agent in a revenue transaction. This conclusion impacts whether an entity reports revenue on a gross or net basis. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies the guidance in the new revenue standard regarding an entity’s identification of its performance obligations in a contract, as well as an entity’s evaluation of the nature of its promise to grant a license of intellectual property and whether or not that revenue is recognized over time or at a point in time. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In May 2016, the FASB issued ASU 2016-11, Revenue Recognition: Customer Payments and Incentives, which clarifies the guidance in recognizing costs for consideration given by a vendor to a customer as a component of cost of sales. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In May 2016, the FASB issued ASU 2016-12, Revenue from Contracts with Customers: Narrow-Scope Improvements and Practical Expedients which amends the guidance in the new revenue standard on collectability, noncash consideration, presentation of sales tax, and transition. The amendments are intended to address implementation issues and provide additional practical expedients to reduce the cost and complexity of applying the new revenue standard. These amendments have the same effective date as the new revenue standard. While we are currently evaluating the method of adoption and the impact of the new revenue standard, as amended, on our Consolidated Financial Statements and related disclosures, we believe the adoption of the new standard may have a significant impact on the accounting for certain transactions with multiple elements or “bundled” arrangements because the requirement to have VSOE for undelivered elements under current accounting standards is eliminated under the new standard. Accordingly, we may be required to recognize as revenue a portion of the sales price upon delivery of the software, as compared to the current requirement of recognizing the entire sales price ratably over an estimated offering period. We continue to evaluate the impact of the new revenue standard on our Consolidated Financial Statements and related disclosures.

32


In June 2016, the FASB issued ASU 2016-13, Financial Instruments: Measurement of Credit Losses on Financial Instruments which amends the guidance on measuring credit losses on financial assets held at amortized cost. The amendment is intended to address the issue that the previous “incurred loss” methodology was restrictive for Company’s ability to record credit losses based on not yet meeting the “probable” threshold. The new language will require these assets to be valued at amortized cost presented at the net amount expected to be collected will a valuation provision. The amendments will be effective for fiscal years beginning after December 15, 2019. We are evaluating the impact of this amendment on our consolidated financial statements and related disclosures.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk.

Not Applicable.

Item 8. Financial Statements and Supplementary Data.

33


COUNTERPATH CORPORATION
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
April 30, 2016

  Page
   
Report of Independent Registered Public Accounting Firm 35
   
Consolidated Balance Sheets 36
   
Consolidated Statements of Operations 37
   
Consolidated Statements of Comprehensive Income and Loss 37
   
Consolidated Statements of Cash Flows 38
   
Consolidated Statements of Changes in Stockholders' Equity 39
   
Notes to the Consolidated Financial Statements 40-62

34


 
Tel: 604 688 5421 BDO Canada LLP
Fax: 604 688 5132 600 Cathedral Place
www.bdo.ca 925 West Georgia Street
  Vancouver BC V6C 3L2 Canada
     

Report of Independent Registered Public Accounting Firm
 

Board of Directors and Stockholders
CounterPath Corporation

We have audited the accompanying consolidated balance sheets of CounterPath Corporation (the “Company”) as of April 30, 2016 and 2015, and the related consolidated statements of operations, comprehensive income and loss, cash flows and changes in stockholders’ equity for each of the two years in the period ended April 30, 2016. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States of America). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of CounterPath Corporation at April 30, 2016 and 2015, and the consolidated results of its operations and its cash flows for each of the two years in the period ended April 30, 2016, in conformity with accounting principles generally accepted in the United States of America.

/s/ BDO Canada LLP

Chartered Professional Accountants

Vancouver, Canada
July 13, 2016

35


COUNTERPATH CORPORATION
CONSOLIDATED BALANCE SHEETS
(Stated in U.S. Dollars)

    April 30,     April 30,  
    2016     2015  
             
Assets            
   Current assets:            
       Cash $  2,159,738   $  2,852,422  
       Accounts receivable (net of allowance for doubtful accounts of 
       $547,173 (2015 - $294,719)) – Note 2(b)
  3,209,279     3,305,466  
       Prepaid expenses and deposits   184,644     168,299  
           Total current assets   5,553,661     6,326,187  
             
   Deposits   93,868     97,667  
   Equipment – Note 3   142,563     271,736  
   Goodwill – Note 2(b)   7,001,228     7,311,449  
   Other assets   174,811     216,125  
Total Assets $  12,966,131   $  14,223,164  
             
Liabilities and Stockholders’ Equity            
   Current liabilities:            
       Accounts payable and accrued liabilities – Note 4 $  1,943,108   $  2,305,580  
       Unearned revenue   1,808,857     1,866,986  
       Customer deposits   2,384      
       Accrued warranty – Note 2(b)   61,356     73,117  
           Total current liabilities   3,815,705     4,245,683  
             
   Deferred lease inducements   35,379     47,760  
   Unrecognized tax benefit – Notes 2(b) and 7   10,563     10,563  
           Total liabilities   3,861,647     4,304,006  
             
   Stockholders’ equity:            
   Preferred stock, $0.001 par value             
       Authorized: 100,000,000             
       Issued and outstanding: April 30, 2016 – nil; April 30, 2015 – nil        
   Common stock, $0.001 par value – Note 6             
       Authorized: 100,000,000             
       Issued and outstanding:             
       April 30, 2016 – 4,542,348; April 30, 2015 – 4,233,395   4,542     4,233  
   Treasury stock       (1 )
   Additional paid-in capital   70,065,082     67,638,003  
   Accumulated deficit   (58,022,500 )   (55,330,905 )
   Accumulated other comprehensive income (loss) – currency translation 
   adjustment
  (2,942,640 )   (2,392,172 )
           Total stockholders’ equity   9,104,484     9,919,158  
Liabilities and Stockholders’ Equity $  12,966,131   $  14,223,164  
             
Commitments – Note 10            

See accompanying notes to the consolidated financial statements

36


COUNTERPATH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(Stated in U.S. Dollars)

    Years Ended  
    April 30,  
    2016     2015  
             
Revenue – Note 8:            
   Software $  6,031,618   $  7,151,076  
   Service   5,049,740     4,852,007  
             Total revenue   11,081,358     12,003,083  
Operating expenses:            
   Cost of sales (includes depreciation of $7,225 (2015 - $32,710))   1,667,087     2,222,071  
   Sales and marketing   4,145,351     4,935,671  
   Research and development   4,737,055     5,669,217  
   General and administrative   3,373,674     4,522,044  
             Total operating expenses   13,923,167     17,349,003  
Loss from operations   (2,841,809 )   (5,345,920 )
Interest and other income (expense), net            
   Interest and other income   5,211     21,669  
   Interest expense   (2,310 )   (1,229 )
   Foreign exchange gain   195,003     883,613  
   Fair value adjustment on derivative instruments – Note 9   (47,690 )    
Net loss for the year $  (2,691,595 ) $  (4,441,867 )
             
Net loss per share:            
   Basic – Note 11 $  (0.61 ) $  (1.05 )
   Diluted – Note 11 $  (0.61 ) $  (1.05 )
             
   Weighted average common shares outstanding:            
   Basic – Note 11   4,433,402     4,249,252  
   Diluted – Note 11   4,433,402     4,249,252  

See accompanying notes to the consolidated financial statements

COUNTERPATH CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Stated in U.S. Dollars)

Net loss for the year $  (2,691,595 ) $  (4,441,867 )
Other comprehensive loss:            
   Foreign currency translation adjustments   (550,468 )   (1,408,044 )
Comprehensive loss $  (3,242,063 ) $  (5,849,911 )

See accompanying notes to the consolidated financial statements

37


COUNTERPATH CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Stated in U.S. Dollars)

    Years Ended  
    April 30,  
    2016     2015  
             
Cash flows from operating activities:            
   Net loss for the year $  (2,691,595 ) $  (4,441,867 )
   Adjustments to reconcile net loss to net cash used in 
   operating activities:
       
           Deferred lease inducements   (9,882 )   (6,602 )
           Depreciation and amortization   199,335     209,382  
           Foreign exchange (gain) loss   (248,371 )   (293,323 )
           Stock-based compensation   906,914     1,000,070  
           Issuance of common stock for services   38,783      
   Changes in assets and liabilities:            
           Accounts payable and accrued liabilities   (314,804 )   (150,819 )
           Accounts receivable   96,187     96,025  
           Accrued warranty   (11,761 )   3,958  
           Customer deposits   2,384     (9,553 )
           Deferred lease inducements       54,362  
           Prepaid expenses and deposits   (14,884 )   (2,693 )
           Other assets       (21,412 )
           Unearned revenue   (58,129 )   241,160  
           Unrecognized tax benefit       (15,068 )
Net cash used in operating activities   (2,105,823 )   (3,336,380 )
             
Cash flows from investing activities:            
   Purchase of equipment   (27,692 )   (214,514 )
   Purchase of intangibles   (13,739 )    
Net cash used in investing activities   (41,431 )   (214,514 )
             
Cash flows from financing activities:            
   Common stock issued   1,520,574     11,689  
   Common stock repurchased   (38,882 )   (322,648 )
Net cash used in by financing activities   1,481,692     (310,959 )
             
Foreign exchange effect on cash   (27,122 )   (458,523 )
             
Decrease in cash   (692,684 )   (4,320,376 )
             
Cash, beginning of the year   2,852,422     7,172,798  
Cash, end of the year $  2,159,738   $  2,852,422  
             
Supplemental disclosure of cash flow information            
   Cash paid for:            
             Interest $  2,310   $  1,229  
             Taxes $  –   $  –  
             
   Non cash transactions – Notes 5 and 6            

See accompanying notes to the consolidated financial statements

38


COUNTERPATH CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
for the Years Ended April 30, 2016 and 2015
(Stated in U.S. Dollars)

    Common shares     Treasury Shares     Preferred Shares                          
                                                    Accumulated        
    Number           Number           Number           Additional           Other        
    of           of           of           Paid-in     Accumulated     Comprehensive        
    Shares     Par Value     Shares     Par Value     Shares     Par Value     Capital     Deficit     Income (Loss)     Total  
                                                             
Balance, April 30, 2014   4,259,987     4,260     (1,620 )   (2 )           66,948,866     (50,889,038 )   (984,128 )   15,079,958  
                                                             
Shares issued:                                                            
Exercise of stock options   6,789     7                     (11,504 )           (11,497 )
Share repurchase plan           (35,213 )   (35 )           (311,048 )           (311,083 )
Cancellation of shares   (35,632 )   (36 )   35,633     36                          
Stock-based compensation – Note 6                           1,000,070             1,000,070  
Employee share purchase program   2,251     2                     11,619             11,621  
Net income (loss) or the year                               (4,441,867 )       (4,441,867 )
Foreign currency translation adjustment                                   (1,408,044 )   (1,408,044 )
Balance, April 30, 2015   4,233,395     4,233     (1,200 )   (1 )           67,638,003     (55,330,905 )   (2,392,172 )   9,919,158  
                                                             
Shares issued:                                                            
Private placement – Note 6   293,000     293                     1,441,546             1,441,839  
Issuance of common stock for services – Note 6   10,000     10                     38,773             38,783  
Share repurchase plan           (10,460 )   (10 )           (6,256 )           (6,266 )
Cancellation of shares – Note 6   (11,260 )   (11 )   11,260     11             (32,616 )           (32,616 )
Stock-based compensation – Note 6                           906,914             906,914  
Employee share purchase program   17,213     17                     78,718             78,735  
Net income (loss) for the year                               (2,691,595 )       (2,691,595 )
Foreign currency translation adjustment                                   (550,468 )   (550,468 )
                                                             
Balance, April 30, 2016   4,542,348   $  4,542     (400 $       $  –   $  70,065,082   $  (58,022,500 ) $  (2,942,640 ) $  9,104,484  

See accompanying notes to the consolidated financial statements

39


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 1 Nature of Operations

CounterPath Corporation (the “Company”) was incorporated in the State of Nevada on April 18, 2003. The shares of the Company’s common stock are quoted for trading on the NASDAQ Capital Market in the United States of America and on the Toronto Stock Exchange in Canada.

On August 2, 2007, the Company acquired of all of the shares of NewHeights Software Corporation (“NewHeights”) through the issuance of 7,680,168 shares of the Company’s common stock and 369,836 preferred shares issued from a subsidiary of the Company exchangeable into 369,836 shares of the Company’s common stock. For accounting purposes, the Company was deemed to be the acquirer of NewHeights based on certain factors including the number of common shares issued in the transaction as a proportion of the total common shares outstanding, and the composition of the board after the transaction.

On February 1, 2008, the Company acquired FirstHand Technologies Inc. (“FirstHand”), a private Ontario, Canada corporation, through the issuance of 5,900,014 shares of the Company’s common stock. For accounting purposes, the Company was deemed to be the acquirer of FirstHand based on certain factors including the number of common shares issued in the transaction as a proportion of the total common shares outstanding, and the composition of the board after the transaction.

On February 1, 2008, the Company acquired BridgePort Networks, Inc. (“BridgePort”), a private Delaware corporation, by way of merger in consideration for the assumption of all of the assets and liabilities of BridgePort. For accounting purposes, the Company was deemed to be the acquirer of BridgePort based on certain factors primarily being the composition of the board after the transaction.

On February 5, 2008, the Company's wholly-owned subsidiaries, NewHeights and CounterPath Solutions R&D Inc. were amalgamated under the name CounterPath Technologies Inc.

On November 1, 2010, the Company's wholly-owned subsidiaries, FirstHand and CounterPath Technologies Inc. were amalgamated under the name CounterPath Technologies Inc.

The Company focuses on the design, development, marketing and sales of software applications and related services, such as pre and post sales technical support and customization services, that enable enterprises and telecommunication service providers to deliver Unified Communications (UC) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol, or IP, based networks. The Company’s products are sold either directly or through channel partners, to small, medium and large businesses (“enterprises”) and telecom service providers, in North America, and in Europe, Middle East, Africa (“collectively EMEA”), Asia Pacific and Latin America.

Note 2 Significant Accounting Policies

These consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America and are stated in U.S. dollars except where otherwise disclosed. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for the period necessarily involves the use of estimates, which have been made using careful judgment. Actual results may vary from these estimates.

These consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities and commitments in the normal course of business.

40


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 2 Significant Accounting Policies - (cont’d)

  a) Basis of Presentation

These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, CounterPath Technologies Inc., a company existing under the laws of the province of British Columbia, Canada, and BridgePort incorporated under the laws of the state of Delaware. The results of NewHeights (which subsequently was amalgamated with another subsidiary to become CounterPath Technologies Inc.) are included from August 2, 2007, the date of acquisition. The results of FirstHand (which subsequently was amalgamated with CounterPath Technologies Inc.) and BridgePort are included from February 1, 2008, the date of acquisition. All inter-company transactions and balances have been eliminated.

  b) Significant Accounting Policies

Revenue Recognition:

The Company recognizes revenue in accordance with the Accounting Standard Codification (“ASC”) 985-605 “Software Revenue Recognition”. In accordance with these standards, revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collection of the related accounts receivable is deemed probable. In making these judgments, management evaluates these criteria as follows:

  •  

Persuasive evidence of an arrangement. The Company considers a noncancelable agreement signed by the Company and the customer to be representative of persuasive evidence of an arrangement.

   
  •  

Delivery has occurred. The Company considers delivery to have occurred when the product has been delivered to the customer and no post-delivery obligations exist. In instances where customer acceptance is required, delivery is deemed to have occurred when customer acceptance has been achieved.

   
 

Fees are fixed or determinable. The Company considers the fee to be fixed or determinable unless the fee is subject to refund or adjustment or is not payable within normal payment terms. If the fee is subject to refund or adjustment, the Company recognizes revenue when the refund or adjustment right lapses. If offered payment terms exceed the Company’s normal terms, the Company recognizes revenue as the amounts become due and payable or upon the receipt of cash when extended payment terms beyond 180 days are offered.

   
  •  

Collection is deemed probable. Collection is deemed probable if, based upon the Company’s evaluation, the Company expects that the customer will be able to pay amounts under the arrangement as payments become due. If the Company determines that collection is not probable, revenue is deferred and recognized upon the receipt of cash.

A substantial amount of the Company’s sales involve multiple element arrangements, such as products, support, professional services, and training. When arrangements include multiple elements, the Company allocates the total fee to delivered elements using the residual method when vendor specific objective evidence (VSOE) does not exist for the delivered element. Under the residual method, revenue is recognized when VSOE of fair value exists for all of the undelivered elements of the arrangement, but does not exist for one or more of the delivered elements of the arrangement. Each arrangement requires the Company to analyze the individual elements in the transaction and to estimate the fair value of each undelivered element, which typically represents support services.

41


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 2 Significant Accounting Policies (cont’d)

  b) Significant Accounting Policies – (cont’d)

Revenue is allocated to each of the undelivered elements based on its respective fair value.

For contracts with elements related to customized network solutions and certain network build-outs, for transactions accounted for as sales of products or services, we apply Financial Accounting Standards Board (“FASB”) ASC Subtopic 605-25 “Revenue Recognition – Multiple-Element Arrangements” and revenues are recognized under ASC 605-35”Revenue Recognition – Construction type and Production type Contract”, for long-term transactions entered to supply software, or software systems, that require significant modification or customization, generally using the percentage-of-completion method.

For multi-element arrangements, the Company allocates revenue to all deliverables based on their selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) VSOE, (ii) third-party evidence of selling price (“TPE”), and (iii) best estimate of selling price (“ESP”). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company’s best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis.

In using the percentage-of-completion method, revenues are generally recorded based on completion of milestones as described in the agreement. Profit estimates on long-term contracts are revised periodically based on changes in circumstances and any losses on contracts are recognized in the period that such losses become known.

Service revenue includes sales of support and other services, including professional services, training, and reimbursable travel. Support services include telephone support, e-mail support and unspecified rights to product updates and upgrades, and are recognized ratably over the term of the service period, which is generally twelve months. Support revenue is generally deferred until the related product has been accepted and all other revenue recognition criteria have been met. Professional services and training revenue is recognized as the related service has been performed.

Stock-Based Compensation:

The Company adopted ASC 718 “Compensation – Stock Compensation”, using the modified prospective method on May 1, 2006. Under this application, the Company is required to record compensation expense, based on the fair value of the awards, for all awards granted after the date of adoption and for the unvested portion of previously granted awards that remain outstanding as at the date of adoption. In accordance with ASC 718, the compensation expense is amortized on a straight-line basis over the requisite service period which approximates the vesting period.

Stock options granted to non-employees were accounted for in accordance with ASC 718 and ASC 505-50 “Equity based payments to non-employees” and were measured at the fair value of the options as determined by an option pricing model on the measurement date and compensation expense is amortized over the vesting period or, if none exists, over the service period. With the adoption of ASC 718, the Company has elected to use the Black-Scholes option pricing model to determine the fair value of stock options granted. The Company has estimated the fair value of option awards to employees and non-employees for the years ended April 30, 2016 and April 30, 2015 using the assumptions more fully described in Note 6.

42


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 2 Significant Accounting Policies (cont’d)

  b) Significant Accounting Policies – (cont’d)

Use of Estimates:

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the Company’s management to make estimates and assumptions which affect the amounts reported in these consolidated financial statements, the notes thereto, and the disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.

Equipment and Amortization:

Equipment is recorded at cost. Depreciation is provided for using the straight-line method over the estimated useful lives as follows:

  Computer hardware Two years
  Computer software Two years
  Leasehold improvements Shorter of lease term or estimated economic life
  Office furniture Five years
  Website Three years

Research and Development:

Research and development expense includes costs incurred to develop intellectual property. The costs for the development of new software and substantial enhancements to existing software are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. Management has determined that technological feasibility is established at the time a working model of software is completed. Because management believes that the current process for developing software will be essentially completed concurrently with the establishment of technological feasibility, no costs have been capitalized to date.

Website Development Costs:

The Company recognizes the costs associated with developing a website in accordance with ASC Topic 350-40 “Intangibles – Internal Use Software”.

Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Training costs are not internal-use software development costs and, if incurred during this stage, are expensed as incurred.

These capitalized costs are amortized based on their estimated useful life over three years. Payroll and other related costs are not capitalized, as the amounts principally relate to maintenance.

43


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 2 Significant Accounting Policies (cont’d)

  b) Significant Accounting Policies – (cont’d)

Accounts Receivable and Allowance for Doubtful Accounts:

Accounts receivable are presented net of an allowance for doubtful accounts.

      Years Ended April 30,  
      2016     2015  
               
  Balance of allowance for doubtful debts, beginning of year $  294,719   $  240,681  
  Bad debt provision   612,769     628,113  
  Write-off of receivables   (360,315 )   (574,075 )
  Balance of allowance for doubtful debts, end of year $  547,173   $  294,719  

The Company determines the allowance for doubtful accounts by considering a number of factors, including the length of time the accounts receivable are beyond the contractual payment terms, previous loss history, and the customer’s current ability to pay its obligation. When the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, the Company records a charge to the allowance to reduce the customer’s related accounts.

Foreign Currency Translation:

The Company’s functional currency is the U.S. dollar. The Company’s wholly-owned subsidiaries with a functional currency other than the U.S. dollar are translated into amounts in the reporting currency, U.S. dollars, in accordance with ASC Topic 830 “Foreign Currency Matters”. Revenues and expenses are translated at the average exchange rate prevailing during the periods. At each balance sheet date, assets and liabilities that are denominated in a currency other than U.S. dollars are adjusted to reflect the current exchange rate which may give rise to a foreign currency translation adjustment accounted for as a separate component of stockholders’ equity and included in comprehensive loss.

For transactions undertaken by the Company in foreign currencies, monetary assets and liabilities are translated into the functional currency at the exchange rate in effect at the end of the year. Non-monetary assets and liabilities are translated at the exchange rate prevailing when the assets were acquired or the liabilities assumed. Revenues and expenses are translated at the rate approximating the rate of exchange on the transaction date. Exchange gains and losses are included in the determination of net income (loss) for the year.

44


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 2 Significant Accounting Policies (cont’d)

  b) Significant Accounting Policies – (cont’d)

Accrued Warranty:

The Company’s warranty policy generally provides for one year of warranty for its products. The Company records a liability for estimated warranty obligations at the date products are sold. The estimated cost of warranty coverage is based on the Company’s actual historical experience with its current products or similar products. For new products, the required reserve is based on historical experience of similar products until such time as sufficient historical data has been collected on the new product. Estimated liabilities for warranty exposures, which relate to normal product warranties and a one-year obligation to provide for potential future liabilities for product sales for the years ended April 30, 2016 and 2015 were as follows:

      Years Ended April 30,  
      2016     2015  
               
  Balance, beginning of year $  73,117   $  69,159  
  Usage during the year        
  Additions (reductions) during the year   (11,761 )   3,958  
  Balance, end of year $  61,356   $  73,117  

Trademarks:

Costs related to trademark applications have been deferred and are included in other assets. Once granted, trademark costs will be amortized over their useful lives.

Fair Value of Financial Instruments:

The Company’s financial instruments consist of cash, accounts receivable, accounts payable and accrued liabilities, customer deposits, foreign exchange contracts, and derivative instruments. The fair value of the financial instruments approximate book value.

As a basis for considering market participant assumptions in fair value measurements, ASC 820-10 “Fair Value Measurements” establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

The fair value hierarchy, as defined by ASC 820-10, contains three levels of inputs that may be used to measure fair value as follows:

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals; and
Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an entity’s own assumptions, as there is little, if any, related market activity.

In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.

45


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 2 Significant Accounting Policies (cont’d)

  b) Significant Accounting Policies – (cont’d)

The Company’s derivative financial instruments are valued using observable market-based inputs to industry valuation models. These valuation models require a variety of inputs, including contractual terms, market prices, yield curves, and measures of volatility obtained from various market sources.

The Company measures certain financial assets, including any foreign currency option or forward contracts at fair value. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments.

Income Taxes:

The Company accounts for income taxes by the asset and liability method in accordance with ASC Topic 740 “Income Taxes”. Under this method, current income taxes are recognized for the estimated income taxes payable for the current year. Deferred income tax assets and liabilities are recognized in the current year for temporary differences between the tax and accounting bases of assets and liabilities as well as for the benefit of losses available to be carried forward to future years for tax purposes that are likely to be realized. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized.

The Company has not recorded a deferred tax liability related to its investment in foreign subsidiaries. The Company has determined that its investment in these subsidiaries is permanent in nature and it does not intend to dispose of these investments in the foreseeable future. The amount of the deferred tax liability related to the Company's investment in foreign subsidiaries is not reasonably determinable.

We have $1,540,467 in cash held outside of the United States, and there is no intent to repatriate at this time. Should we decide to repatriate in the future, taxes would need to be accrued and paid.

Under ASC 740, the Company also adopted a two-step approach to recognizing and measuring uncertain tax positions taken or expected to be taken in a tax return. The first step is to determine if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained in an audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company recognizes interest and penalties accrued on unrecognized tax benefits within general and administrative expense. To the extent that accrued interest and penalties do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction in general and administrative expenses in the period that such determination is made.

Comprehensive Loss:

The Company has adopted ASC Topic 220 “Comprehensive Income”. Comprehensive loss is comprised of net profit or loss, and foreign currency translation adjustments.

Basic and Diluted Loss per Share:

The Company computes net loss per share in accordance with ASC Topics 260 and ASC 260-10 “Earnings per Share”.

46


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 2 Significant Accounting Policies (cont’d)

  b) Significant Accounting Policies – (cont’d)

ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the year. Diluted EPS gives effect to all dilutive potential common shares outstanding during the year including stock options and warrants using the treasury stock method. In computing diluted EPS, the average stock price for the year is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. For the year ended April 30, 2016, income per share excludes 812,169 (April 30, 2015 – 382,580) potentially dilutive common shares (related to stock options, deferred share units and warrants) as their effect was anti-dilutive.

Investment tax credits:

Investment tax credits are accounted for under the cost reduction method whereby they are netted against the expense or property and equipment to which they relate. Investment tax credits are recorded when the qualifying expenditures have been incurred and if it is more likely than not that the tax credits will be realized.

Goodwill:

Goodwill represents the excess purchase price over the estimated fair value of net assets acquired and liabilities assumed as of the acquisition date. ASC Topic 350 “Intangibles – Goodwill”. ASC 350 requires goodwill to be tested for impairment annually or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the Company's business enterprise below its carrying value. These events or circumstances could include a significant change in the business climate, legal factors, operating performance indicators, competition, or sale or disposition of a significant portion of a reporting unit. Recoverability of goodwill is measured at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair value of the reporting unit, which is measured based upon, among other factors, market multiples for comparable companies as well as a discounted cash flow analysis.

Management has determined that the Company currently has a single reporting unit which is CounterPath Corporation. If the recorded value of the assets, including goodwill, and liabilities (“net book value”) of the reporting unit exceeds its fair value, an impairment loss may be required.

Goodwill of $6,339,717 (CDN$6,704,947) and $2,083,960 (CDN$2,083,752) was initially recorded in connection with the acquisition of NewHeights on August 2, 2007 and FirstHand on February 1, 2008. Translated to U.S. dollars using the period end rate, the goodwill balance at April 30, 2016 was $5,341,481 (CDN$6,704,947) (April 30, 2015 - $5,578,159) and $1,659,747 (CDN$2,083,752) (April 30, 2015 - $1,733,290), respectively. During the fourth quarter of its fiscal year ended April 30, 2016, the Company performed its annual impairment test. In the first step, Management compared the fair value of the Company to its carrying value based upon the market capitalization of the Company as at April 30, 2016. On this basis Management determined that the Company’s fair value exceeded its carrying value and has not recognized any impairment of goodwill in the consolidated financial statements for the year ended April 30, 2016 (2015 - $nil).

47


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 2 Significant Accounting Policies (cont’d)

  b) Significant Accounting Policies – (cont’d)

Derivative Instruments:

The Company accounts for derivative instruments, consisting of foreign currency forward contracts, pursuant to the provisions ASC 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires the Company to measure derivative instruments at fair value and record them in the balance sheet as either an asset or liability and expands financial reporting about derivative instruments and hedging activities by requiring enhanced disclosures to enable investors to better understand their effects on an entity’s financial position, results of operations and cash flows. The Company does not use derivative instruments for trading purposes. ASC 815 also requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.

The Company also routinely enters into foreign currency forward contracts, not designated as hedging instruments, to protect against fluctuations in exchange rates. Gains or losses arising out of marked to market fair value valuation of forward contracts, not designated as hedges, and are recognized in net income.

The Company records foreign currency forward contracts on its Consolidated Balance Sheets as derivative instruments assets or liabilities depending on whether the net fair value of such contracts is a net asset or net liability, respectively (see Note 9 “Derivative Financial Instruments and Risk Management,” of the Notes to the Consolidated Financial Statements). The Company did not hold any foreign currency derivatives designated as cash flow hedges in the year ended April 30, 2016 (2015 - none).

  c) New Accounting Pronouncements

In May 2014, FASB issued ASU 2014-09, Revenue From Contracts With Customers (“Topic 606”). Topic 606 removes inconsistencies and weaknesses in revenue requirements, provides a more robust framework for addressing revenue issues, improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, provides more useful information to users of financial statements through improved disclosure requirements and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The guidance in this update supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance throughout the Industry Topics of the Codification. In August 2015, ASU 2015-14 was issued which delayed the effective date for public entities to reporting periods beginning after December 15, 2017. Early adoption is not permitted. The Company is currently evaluating the impact of the adoption of this new standard.

In August 2014, FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and provide related footnote disclosures. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. The standard allows for either a full retrospective or modified retrospective transition method. The Company does not expect this standard to have a material impact on the Company’s consolidated financial statements upon adoption.

In February 2016, FASB issued ASU 2016-02, Leases. The guidance would require lessees to recognize most leases on their balance sheets as lease liabilities with corresponding right –of-use assets. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2018. The Company is currently evaluating the impact of its pending adoption of ASU 2016-02 on its consolidated financial statements.

48


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 2 Significant Accounting Policies (cont’d)

  c) New Accounting Pronouncements – (cont’d)

In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross versus Net), which clarifies the guidance in the new revenue standard on assessing whether an entity is a principal or an agent in a revenue transaction. This conclusion impacts whether an entity reports revenue on a gross or net basis. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies the guidance in the new revenue standard regarding an entity’s identification of its performance obligations in a contract, as well as an entity’s evaluation of the nature of its promise to grant a license of intellectual property and whether or not that revenue is recognized over time or at a point in time. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In May 2016, the FASB issued ASU 2016-11, Revenue Recognition: Customer Payments and Incentives, which clarifies the guidance in recognizing costs for consideration given by a vendor to a customer as a component of cost of sales. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In May 2016, the FASB issued ASU 2016-12, Revenue from Contracts with Customers: Narrow-Scope Improvements and Practical Expedients which amends the guidance in the new revenue standard on collectability, noncash consideration, presentation of sales tax, and transition. The amendments are intended to address implementation issues and provide additional practical expedients to reduce the cost and complexity of applying the new revenue standard. These amendments have the same effective date as the new revenue standard. While we are currently evaluating the method of adoption and the impact of the new revenue standard, as amended, on our Consolidated Financial Statements and related disclosures, we believe the adoption of the new standard may have a significant impact on the accounting for certain transactions with multiple elements or “bundled” arrangements because the requirement to have VSOE for undelivered elements under current accounting standards is eliminated under the new standard. Accordingly, we may be required to recognize as revenue a portion of the sales price upon delivery of the software, as compared to the current requirement of recognizing the entire sales price ratably over an estimated offering period. We continue to evaluate the impact of the new revenue standard on our Consolidated Financial Statements and related disclosures.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments: Measurement of Credit Losses on Financial Instruments which amends the guidance on measuring credit losses on financial assets held at amortized cost. The amendment is intended to address the issue that the previous “incurred loss” methodology was restrictive for Company’s ability to record credit losses based on not yet meeting the “probable” threshold. The new language will require these assets to be valued at amortized cost presented at the net amount expected to be collected will a valuation provision. The amendments will be effective for fiscal years beginning after December 15, 2019. We are evaluating the impact of this amendment on our consolidated financial statements and related disclosures.

49


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 3 Equipment

      April 30, 2016  
            Accumulated        
      Cost     Depreciation     Net  
                     
  Computer hardware $  1,049,179   $  976,511   $  72,668  
  Computer software   1,008,373     1,002,097     6,276  
  Leasehold improvements   263,003     237,147     25,856  
  Office furniture   190,754     186,325     4,429  
  Websites   120,953     87,619     33,334  
    $  2,632,262   $  2,489,699   $  142,563  

      April 30, 2015  
            Accumulated        
      Cost     Depreciation     Net  
                     
  Computer hardware $  1,072,376   $  953,384   $  118,992  
  Computer software   1,022,687     977,430     45,257  
  Leasehold improvements   280,893     238,818     42,075  
  Office furniture   204,680     197,601     7,079  
  Websites   122,161     63,828     58,333  
    $  2,702,797   $  2,431,061   $  271,736  

Note 4 Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities at April 30, 2016 and 2015 are comprised of the following:

      April 30,  
      2016     2015  
  Accounts payable – trade $  407,737   $  500,739  
  Accrued commissions   272,282     184,791  
  Accrued vacation   617,589     688,965  
  Third party software royalties   343,447     568,814  
  Other accrued liabilities   302,053     362,271  
    $  1,943,108   $  2,305,580  

50


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 5 Related Party Transactions

During the year ended April 30, 2016, the Company through its wholly owned subsidiary, CounterPath Technologies Inc., paid $82,288 (2015 - $85,954) to Kanata Research Park Corporation (“KRP”) for leased office space. KRP is controlled by the Chairman of the Company.

On November 21, 2013, the Company, through its wholly owned subsidiary, CounterPath Technologies, entered into an agreement with 8007004 (Canada) Inc. (“8007004”) to lease office space. 8007004 is controlled by a member of the board of directors of the Company. CounterPath Technologies, paid $31,910 (2015 - $17,471) for the year ended April 30, 2016.

On July 31, 2015, the Company sold products and services to Magor Corporation for consideration of $134,250. Magor Corporation’s chairman of the board is also Chairman of the Company. As at April 30, 2016, the Company had an accounts receivable balance from Magor Corporation of $nil.

On September 4, 2015, the Company completed a non-brokered private placement (the “Private Placement”) of 293,000 units, at a price of $5.00 per unit, for gross aggregate proceeds of $1,465,000 less stock issuance costs of $23,161. In connection with the Private Placement, Kanata Research Park Corporation, a company controlled by the Chairman of the Company, purchased 150,000 units and a director of the Company purchased 10,000 units. Each unit consists of one share of common stock and one-half of one non-transferable common share purchase warrant.

The above transactions are in the normal course of operations and are recorded at amounts established and agreed to between the related parties.

Note 6 Common Stock

Private Placement

On September 4, 2015, the Company issued an aggregate of 293,000 units under a non-brokered private placement at a price of $5.00 per unit for aggregate gross proceeds of $1,465,000 less issuance costs of $23,454. Each unit consists of one share of the Company’s common stock and one-half of one common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share of the Company’s common stock at an exercise price of $7.50 per share until September 4, 2017. The warrants were evaluated against ASC 815 Derivatives and Hedging, and determined to be equity instruments.

On April 4, 2016, the Company entered into an agreement to issue 25,000 shares of the Company’s common stock in exchange for advisory services. These shares would be issued in three tranches: (i) first tranche of 10,000 shares of the Company’s common stock issued before April 30, 2016; (ii) second tranche of 10,000 shares of the Company’s common stock issued before May 31, 2016; (iii) and the third tranche of 5,000 shares of the Company’s common stock issued before June 30, 2016.

Reverse Stock Split

On October 8, 2015 the Board approved a one for ten reverse stock split effected at the opening of trading on November 2, 2015. The impact of this reverse stock split has been reflected in these consolidated financial statements.

51


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 6 Common Stock – (cont’d)

Stock Options

The Company has a stock option plan (the “2010 Stock Option Plan”) under which options to purchase common shares of the Company may be granted to employees, directors and consultants. The 2010 Stock Option Plan is effectively a merging of the Company’s 2004 and 2005 stock option plans. Stock options entitle the holder to purchase common stock at a subscription price determined by the Board of Directors of the Company at the time of the grant. The options generally vest in the amount of 12.5% on the date which is six months from the date of grant and then beginning in the seventh month at 1/42 per month for 42 months, at which time the options are fully vested.

The maximum number of shares of common stock authorized by the stockholders and reserved for issuance by the Board under 2010 Stock Option Plan is 786,000.

The Company uses the Black-Scholes option pricing model to determine the fair value of stock options granted. In accordance with ASC 718 “Share-Based Payment” for employees, the compensation expense is amortized on a straight-line basis over the requisite service period which approximates the vesting period. Compensation expense for stock options granted to non-employees is amortized over the vesting period or, if none exists, over the service period. Compensation associated with unvested options granted to non-employees is re-measured on each balance sheet date using the Black-Scholes option pricing model.

The expected volatility of options granted has been determined using the method described under ASC 718 using the historical stock price. The expected term of options granted to employees in the current fiscal period has been determined utilizing historic data as prescribed by ASC 718.

For non-employees, based on the Company’s history, the expected term of the options approximates the full term of the options. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The Company has not paid and does not anticipate paying dividends on its common stock; therefore, the expected dividend yield is assumed to be zero. In addition, ASC 718 requires companies to utilize an estimated forfeiture rate when calculating the expense for the period, whereas prior to the adoption of ASC 718 the Company recorded forfeitures based on actual forfeitures and recorded a compensation expense recovery in the period when the awards were forfeited. As a result, based on the Company’s experience, the Company applied an estimated forfeiture rate of 15% for year ended April 30, 2016 and 2015 in determining the expense recorded in the accompanying consolidated statement of operations.

For the majority of the stock options granted, the number of shares issued on the date the stock options are exercised is net of the minimum statutory withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. These withheld shares are not issued or considered common stock repurchases under our authorized plan and are not included in the common stock repurchase totals. In our consolidated financial statements, these withheld shares are netted against the number of shares that would have been issued upon vesting.

52


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 6 Common Stock – (cont’d)

Stock Options – (cont’d)

The weighted-average fair values of options granted during the years ended April 30, 2016 and 2015 were $2.35 and $4.10, respectively. The weighted-average assumptions utilized to determine such values are presented in the following table:

      Year Ended     Year Ended  
      April 30, 2016     April 30, 2015  
  Risk-free interest rate   1.66%     1.60%  
  Expected volatility   92.48%     57.58%  
  Expected term   3.7 yrs     3.7 yrs  
  Dividend yield   0%     0%  

The following is a summary of the status of the Company’s stock options as of April 30, 2016 and the stock option activity during the years ended April 30, 2016 and 2015:

      Number of     Weighted-Average  
      Options     Exercise Price per Share  
  Outstanding at April 30, 2014   370,554  

$9.40

 
  Granted   124,600  

$6.00

 
  Exercised   (33,473 ) (1)

$14.40

 
  Forfeited / Cancelled   (45,983 )

$10.30

 
  Expired   (3,917 )

$9.40

 
  Outstanding at April 30, 2015   411,781  

$15.20

 
  Granted   114,900   $3.72  
  Exercised        
  Forfeited / Cancelled   (66,216 ) $8.87  
  Expired   (49,735 ) $15.63  
  Outstanding at April 30, 2016   410,730   $12.99  
               
  Exercisable at April 30, 2016   236,795   $16.77  
  Exercisable at April 30, 2015   210,544   $17.70  

  (1) In 2015 33,236 stock options were cashlessly exercised upon which 6,789 shares of common stock were issued.

53


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 6 Common Stock – (cont’d)

Stock Options − (cont’d)

The following table summarizes information regarding stock options outstanding as of April 30, 2016:

    Number of Aggregate   Number of Aggregate
  Exercise Options Intrinsic   Options Intrinsic
  Price Outstanding Value Expiry Date Exercisable Value
  $2.41 56,000 December 14, 2020
  $4.50 5,000 March 9, 2020 1,360
  $4.70 540 September 26, 2016 540
  $5.00 50,900 July 17, 2020 9,614
  $5.20 9,482 March 23, 2020 8,805
  $7.80 3,400 December 12, 2019 1,224
  $10.50 6,825 September 12, 2019 3,809
  $11.50 51,000 July 11, 2019 25,192
  $12.30 2,083 January 13, 2019 2,083
  $13.10 60,000 December 12, 2018 35,014
  $17.00 65,000 December 14, 2016 65,000
  $19.00 46,500 July 25, 2018 32,026
  $21.50 24,000 September 7, 2016 24,000
  $29.00 30,000 July 19, 2017 28,128
  April 30, 2016 410,730   236,795
             
  April 30, 2015 441,780 $6,183   210,544 $3,683

The aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company’s closing stock price of $2.12 per share as of April 30, 2016 (April 30, 2015 – $5.00), which would have been received by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options vested and exercisable as of April 30, 2016 was nil (April 30, 2015 – 12,275). The total intrinsic value of options exercised during the year ended April 30, 2016 was $nil (2015 – $33,094). The grant date fair value of options vested during the year ended April 30, 2016 was $579,614 (April 30, 2015 – $698,238).

The following table summarizes information regarding the non-vested stock purchase options outstanding as of April 30, 2015:

      Number of     Weighted Average  
      Options     Grant-Date Fair Value  
               
  Non-vested options at April 30, 2014   193,791   $8.70  
  Granted   124,600   $4.10  
  Vested   (81,685 ) $8.50  
  Forfeited   (35,469 ) $6.80  
  Non-vested options at April 30, 2015   201,237   $6.20  
  Granted   114,900   $2.35  
  Vested   (83,318 ) $6.96  
  Forfeited   (58,884 ) $4.79  
  Non-vested options at April 30, 2016   173,935   $4.15  

54


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 6 Common Stock – (cont’d)

Stock Options – (cont’d)

As of April 30, 2016, there was $593,978 of total unrecognized compensation cost related to unvested stock options. This unrecognized compensation cost is expected to be recognized over a weighted average period of 2.08 years.

Employee and non-employee stock-based compensation amounts classified in the Company’s consolidated statements of operations for the year ended April 30, 2016 and 2015 are as follows:

      Years Ended  
      April 30,  
      2016     2015  
               
  Cost of sales $  68,259   $  75,535  
  Sales and marketing   253,913     279,121  
  Research and development   80,228     65,135  
  General and administrative   180,536     235,600  
  Total stock-based compensation $  582,936   $  655,391  

Warrants

On September 4, 2015, the Company completed a non-brokered private placement (the “Private Placement”) of 293,000 units, at a price of $5.00 per unit, for gross aggregate proceeds of $1,465,000 less stock issuance costs of $23,161. Each unit consists of one share of common stock and one-half of one non-transferable common share purchase warrant. Each whole warrant entitles the holder to purchase one additional share of the Company’s common stock at an exercise price of $7.50 per share until September 4, 2017.

The following tables summarize information regarding the warrants outstanding as of April 30, 2016 and April 30, 2015.

            Weighted        
      Number of     Average        
      Warrants     Exercise Price     Expiry Dates  
  Warrants at April 30, 2014   73,250   $32.50     June 19, 2014  
  Granted            
  Exercised            
  Expired   (73,250 ) $32.50      
  Warrants at April 30, 2015            
  Granted   146,500   $7.50     September 4, 2017  
  Exercised            
  Expired            
  Warrants at April 30, 2016   146,500   $7.50     September 4, 2017  

Employee Stock Purchase Plan

Under the terms of the Employee Stock Purchase Plan (the “ESPP”) all regular salaried (non-probationary) employees can purchase up to 6% of their base salary in common shares of the Company at market price. The Company will match 50% of the shares purchased by issuing or purchasing in the market up to 3% of the respective employee’s base salary in shares. During the year ended April 30, 2016, the Company matched $39,472 (2015 - $55,378) in shares purchased by employees under the ESPP. During the year ended April 30, 2016, 36,539 shares (2015 – 18,442) were issued or purchased by employees on the open market under the ESPP.

On September 28, 2015, the number of shares reserved for issuance under the ESPP plan was increased from 70,000 shares to 120,000 shares. As of April 30, 2016, a total of 86,203 shares were available for issuance under the ESPP.

55


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 6 Common Stock – (cont’d)

Normal Course Issuer Bid Plan

Pursuant to a normal course issuer bid (“NCIB”) commencing on March 19, 2016 and expiring March 18, 2017, the Company was authorized to purchase 273,864 shares of the Company’s common stock through the facilities of the Toronto Stock Exchange (the “TSX”) and other Canadian marketplaces or U.S. marketplaces. Pursuant to an NCIB commencing March 19, 2014 and expiring March 18, 2015, the Company repurchased 36,133 shares at an average price of $9.30 (CDN$10.51) for an aggregate purchase price of $336,033. During the period from March 19, 2015 to March 18, 2016, the Company repurchased 11,360 shares at an average price of $3.80 (CDN$4.97) for a total of $43,168 and during the period March 19, 2016 to April 30, 2016, we repurchased 400 common shares at an average price of $2.14 (CDN$2.75) for a total of $856. As of April 30, 2016, a total of 75,788 shares have been cancelled and the remaining 400 repurchased shares are in the process of being cancelled since the NCIB was initiated.

Deferred Share Unit Plan

Under the terms of the DSUP which is effective as at October 22, 2009, each deferred share unit (each, a “DSU”) is equivalent to one share of common stock. The maximum number of shares of common stock that may be reserved for issuance to any one participant pursuant to DSUs granted under the DSUP and any share compensation arrangement is 5% of the number of shares of common stock of the Company outstanding at the time of reservation. A DSU granted to a participant who is a director of the Company shall vest immediately on the award date. A DSU granted to a participant other than a director will generally vest as to one-third (1/3) of the number of DSUs granted on the first, second and third anniversaries of the award date. Fair value of the DSUs, which is based on the closing price of the Company’s common stock on the date of grant, is recorded as compensation expense over the vesting period.

On September 28, 2015, the shares reserved for issuance under the DSUP plan was increased from 300,000 shares to 400,000 shares. During the year ended April 30, 2016, 55,034 (2015 – 32,661) DSUs were issued under the DSUP, of which 23,911 DSUs were granted to officers and 31,123 DSUs were granted to non-employee directors. As of April 30, 2016, a total of 121,048 shares were available for issuance under the DSUP.

The following table summarizes the Company’s outstanding DSU awards as of April 30, 2016 and 2015, and changes during the period then ended:

            Weighted Average Grant  
      Number of DSU’s     Date Fair Value per Unit  
               
  DSU’s at April 30, 2014   167,243   $10.90  
  Granted   32,662   $11.70  
  Conversions        
  Outstanding at April 30, 2015   199,905   $11.00  
  Granted   55,034   $5.20  
  Conversions        
  Outstanding at April 30, 2016   254,939   $9.79  

56


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 6 Common Stock – (cont’d)

Deferred Share Unit Plan – (cont’d)

As of April 30, 2016, there was $189,523 (2015 – $227,324) of total unrecognized compensation cost related to unvested DSU awards. This unrecognized compensation cost is expected to be recognized over a weighted average period of 1.63 years (2015 – 1.85). The total fair value of DSUs that vested during the year was $338,912 (2015 – $344,678).

Employee and non-employee DSU based compensation amounts classified in the Company’s consolidated statements of operations for the year ended April 30, 2016 and 2015 are as follows:

      Year Ended  
      April 30,  
      2016     2015  
               
  Sales and marketing $  –   $  1,667  
  Research and development   1,633     8,328  
  General and administrative   322,345     334,683  
  Total deferred share unit-based compensation $  323,978   $  344,678  

The following table summarizes information regarding the non-vested DSUs outstanding as of April 30, 2016:

            Weighted Average  
            Grant Date Fair  
      Number of DSUs     Value per Unit  
               
  Non-vested DSUs at April 30, 2014   15,678   $21.60  
  Granted   32,661   $11.70  
  Vested   (23,170 ) $16.50  
  Non-vested DSUs at April 30, 2015   25,169   $14.60  
  Granted   55,034   $5.20  
  Vested   (41,681 ) $8.13  
  Non-vested DSUs at April 30, 2016   38,522   $8.15  

57


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 7 Income Taxes

Deferred tax assets and liabilities are recognized for temporary differences between the carrying amount of the balance sheet items and their corresponding tax values as well as for the benefit of losses available to be carried forward to future years for tax purposes that are likely to be realized.

Significant components of the Company’s deferred tax assets and liabilities, after applying enacted corporate income tax rates, are as follows:

      Years Ended  
      April 30,  
      2016     2015  
  Tax loss carry forwards $  18,796,000   $  16,271,000  
  Capital losses carried forward   247,000     262,000  
  Equipment   242,000     184,000  
  Other   64,000     64,000  
  Bad debt   186,000     100,000  
  Nondeductible research and development expenses   3,084,000     3,266,000  
  Investment tax credits   490,000     494,000  
  Cumulative unrealized foreign exchange gain   410,000     467,000  
  Acquired technology and other intangibles   (1,115,000 )   (896,000 )
  Valuation allowance established by management   (22,404,000 )   (20,212,000 )
  Net deferred tax assets $  –   $  –  

The provision for income taxes differ from the amount calculated using the U.S. federal and state statutory income tax rates as follows:

      Years Ended  
      April 30,  
      2016     2015  
  Tax (recovery) based on U.S. rates $  (915,000 ) $  (1,510,000 )
  Foreign tax rate differential   (34,000 )   (75,000 )
  Non-deductible expenses        
  Change in fair value of derivative instrument        
  Non-deductible stock option compensation   295,000     374,000  
  Effect of reduction (increase) in foreign statutory rates   104,000      
  Foreign exchange gain (losses) on revaluation of deferred tax balances   384,000     787,000  
  Under provision relating to prior year   (2,026,000 )    
  Expiry of non-operating losses        
  Increase in valuation allowance   2,192,000     424,000  
  Income tax expense for year $  –   $  –  

The Company establishes its valuation allowance based on projected future operations. Management has determined that the allowance should be 100% of the deferred tax assets. When circumstances cause a change in management’s judgment about the recoverability of deferred tax assets, the impact of the change on the valuation allowance will be reflected in current income.

58


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 7 Income Taxes – (cont’d)

As at April 30, 2016, the Company had net operating loss carry-forwards available to reduce taxable income in future years as follows:

  Country   Amount     Expiration Dates  
               
  United States – US$ $  39,431,000     2027 – 2036  
  Canada – CDN$ $  15,717,000 (1)   2017 – 2034  

(1)These losses are subject to tax legislation that limits the use of the losses against future income of the Company’s Canadian subsidiaries.

The Company is subject to taxation in the U.S. and Canada. It is subject to tax examinations by tax authorities for all taxation years commencing in or after 2002. The Company does not expect any material increase or decrease in its income tax expense in the next twelve months related to examinations or changes in uncertain tax positions.

Changes in the Company’s uncertain tax positions for the year ended April 30, 2016 and April 30, 2015 were as follows:

      Years Ended  
      April 30,  
      2016     2015  
  Balance at beginning of year $  25,631   $  25,631  
  Increases related to prior year tax positions (interest and penalties)        
  Increases related to current year tax positions (interest and penalties)        
  Settlements        
  Lapses in statute of limitations   (15,068 )   (15,068 )
  Balance at end of year $  10,563   $  10,563  

Note 8 Segmented Information

The Company’s chief operating decision maker reviews financial information presented on a consolidated basis, accompanied by disaggregated information about revenues by geographic region for purposes of making operating decisions and assessing financial performance. Accordingly, the Company has concluded that it has one reportable operating segment.

Revenues are based on the country in which the customer is located. The following is a summary of total revenues by geographic area for the years ended April 30, 2016 and 2015:

      Years Ended  
      April 30,  
      2016     2015  
  North America $  7,192,010   $  7,717,932  
  EMEA   2,459,541     2,520,381  
  Asia Pacific   699,203     1,288,848  
  Latin America   730,604     475,922  
    $  11,081,358   $  12,003,083  

As at July 31, 2015, the Company adjusted geographic regions to better reflect its current operations. In prior periods geographic groupings included North America, Europe, Asia and Africa and Latin America.

59


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 8 Segmented Information - (cont’d)

All of the Company’s long-lived assets, which includes equipment, goodwill, intangible assets, and other assets, are located in Canada and the United States as follows:

      As at April 30,  
      2016     2015  
  Canada $  7,279,019   $  7,714,307  
  United States   39,583     85,003  
    $  7,318,602   $  7,799,310  

Note 9 Derivative Financial Instruments and Risk Management

In the normal course of business, the Company is exposed to fluctuations in interest rates and the exchange rates associated with foreign currencies. The Company’s primary objective for holding derivative financial instruments is to manage foreign currency exchange rate risk.

Foreign Currency Exchange Rate Risk

A majority of our revenue activities are transacted in U.S. dollars. However, the Company is exposed to foreign currency exchange rate risk inherent in conducting business globally in numerous currencies, of which the most significant to our operations for the year ended April 30, 2016 is the Canadian dollar. The Company’s foreign currency risk management program includes foreign currency derivatives with cash flow hedge accounting designation that utilizes foreign currency forward contracts to hedge exposures to the variability in the U.S. dollar equivalent of anticipated non-U.S. dollar-denominated cash flows.

The Company periodically enters into foreign currency forward contracts, not designated as hedging instruments, to protect it from fluctuations in exchange rates. As of April 30, 2016, the Company had no foreign currency forward contracts. Notional amounts do not quantify risk or represent assets or liabilities of the Company, but are used in the calculation of cash settlements under the contracts.

Fair Value Measurements

When available, the Company uses quoted market prices to determine fair value, and classifies such measurements within Level 1. In some cases where market prices are not available, the Company makes use of observable market-based inputs to calculate fair value, in which case the measurements are classified within Level 2. If quoted or observable market prices are not available, fair value is based upon internally developed models that use, where possible, current market-based parameters such as interest rates, yield curves and currency rates. These measurements are classified within Level 3.

Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. A measurement may therefore be classified within Level 3 even though there may be significant inputs that are readily observable.

Fair value measurement includes the consideration of non-performance risk. Non-performance risk refers to the risk that an obligation (either by a counterparty or the Company) will not be fulfilled. For financial assets traded in an active market (Level 1), the non-performance risk is included in the market price. For certain other financial assets and liabilities (Level 2 and 3), our fair value calculations have been adjusted accordingly.

60


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 9 Derivative Financial Instruments and Risk Management - (cont’d)

Fair Value Measurements – (cont’d)

The following table presents the Company’s assets and liabilities, that are measured at fair value on a recurring basis as of April 30, 2016 and 2015:

        Carrying           Fair Value        
  As at April 30, 2016     Amount     Fair Value     Levels     Reference  
  Cash   $  2,159,738   $  2,159,738     1        

        Carrying           Fair Value        
  As at April 30, 2015     Amount     Fair Value     Levels     Reference  
  Cash   $  2,852,422   $  2,852,422     1        

  Forward contracts   April 30,     April 30,  
      2016     2015  
  Opening balance at the beginning of the year $  −   $  −  
  Fair value of forward, at issuance        
  Change in fair value of forward contracts since issuance   (47,690 )    
  Fair value of forward contracts settled during the year   47,690      
  Fair value of forward contracts at April 30 $  −   $  −  

Fair Values of Financial Instruments

In addition to the methods and assumptions the Company uses to record the fair value of financial instruments as discussed in the Fair Value Measurements section above, the Company used the following methods and assumptions to estimate the fair value of the Company’s financial instruments:

Cash – carrying amount approximates fair value.

Accounts receivable, net – carrying amount approximates fair value.

Forward contracts – the fair value of foreign currency and commodity forward, option and cross currency contracts is based on a valuation model that discounts cash flows resulting from the differential between the contract price and the market-based forward rate.

61


COUNTERPATH CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Stated in U.S. Dollars)

Note 10 Commitments

  a) On November 27, 2013, the Company entered into an extension of an existing lease agreement, which commenced on October 1, 2014 and expires on September 30, 2019. The monthly lease payment under the extension agreement is $19,678 plus $19,308 in operating costs.
     
  b) On November 4, 2013, the Company entered into an extension of an existing lease agreement, which commenced on January 1, 2014 and expires on April 30, 2019. The monthly lease payment under the extension agreement is $3,550 plus $3,307 in operating costs. This lease expense is a related party transaction as it was incurred with a company with a director in common with the Company.
     
  c) From March 2013 to April 2014, the Company entered into various lease agreements with commencement dates between April 2013 and May 2014 and that expire between May 2016 and May 2017. The combined monthly lease payments are $7,198 plus $495 in operating expenses.

Total lease expense for the year ended April 30, 2016 is $642,377 (2015 $754,221).

Total payable over the term of the lease agreements for the years ended April 30, are as follows:

      Office Leases –     Office Leases –     Total Office  
      Related Party     Unrelated Party     Leases  
  2017 $  82,288   $  518,534   $  600,822  
  2018   82,288     496,235     578,523  
  2019   82,288     497,897     580,185  
  2020       207,457     207,457  
    $  246,864   $  1,720,123   $  1,966,987  

Note 11 Loss per common share

Computation of loss per share:

      Year ended April 30, 2016  
                  Per Share  
      Income     Shares(1)(2)     Amount  
  Basic EPS                  
  Income available to common stockholders $  (2,691,595 )   4,433,402   $  (0.61 )
                     
  Effect on dilutive securities                  
  (Gain)/Loss from derivative instruments              
  Diluted EPS $  (2,691,595 )   4,433,402   $  (0.61 )

      Year ended April 30, 2015  
                  Per Share  
      Income     Shares(1)(2)   Amount  
  Basic EPS                  
  Income available to common stockholders $  (4,441,867 )   4,249,252   $  (1.05 )
                     
  Effect on dilutive securities                  
  (Gain)/Loss from derivative instruments              
  Diluted EPS $  (4,441,867 )   4,249,252   $  (1.05 )

(1) For the years ended April 30, 2016 and April 30, 2015, common share equivalents (consisting of shares issuable on exercise of options, deferred share units, and warrants) totalling 812,169, and 382,580, respectively, were not included in the computation of diluted earnings per share because the effect was anti-dilutive.

(2) Diluted by assumed exercise of outstanding common share equivalents using the treasury stock method.

62



Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures.

Disclosure Controls and Procedures

Disclosure controls and procedures and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time period specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934 is accumulated and communicated to management including our Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure.

In connection with this annual report, as required by Rule 13a-15 under the Securities Exchange Act of 1934, we have carried out an evaluation of the effectiveness of the design and operation of our company's disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of our company's management, including our Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of April 30, 2016, our disclosure controls and procedures are effective as at the end of the period covered by this report.

Management's Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an assessment of the effectiveness of our internal control over financial reporting based on certain criteria established in Internal Control - Integrated Framework (2013 edition) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that our internal control over financial reporting is effective as of April 30, 2016.

Changes in Internal Control Over Financial Reporting

There has been no change in our internal controls over financial reporting that occurred during our latest fiscal quarter ended April 30, 2016 that has materially affected, or is reasonably likely to materially affect our internal controls over financial reporting.

Item 9B. Other Information.

None.

63


PART III

Item 10. Directors, Executive Officers and Corporate Governance.

The information required by this Item is incorporated herein by reference from our Proxy Statement for the Annual Meeting of Shareholders, to be filed with the SEC no later than 120 days after April 30, 2016.

Item 11. Executive Compensation.

The information required by this Item, is incorporated herein by reference from our Proxy Statement for the Annual Meeting of Shareholders, to be filed with the SEC no later than 120 days after April 30, 2016.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information required by this Item is incorporated herein by reference from our Proxy Statement for the Annual Meeting of Shareholders, to be filed with the SEC no later than 120 days after April 30, 2016.

Item 13. Certain Relationships and Related Transactions, and Director Independence.

The information required by this Item is incorporated herein by reference from our Proxy Statement for the Annual Meeting of Shareholders, to be filed with the SEC no later than 120 days after April 30, 2016.

Item 14. Principal Accountant Fees and Services.

The information required by this Item is incorporated herein by reference from our Proxy Statement for the Annual Meeting of Shareholders, to be filed with the SEC no later than 120 days after April 30, 2016.

PART IV

Item 15. Exhibits and Financial Statement Schedules.

List of documents filed as part of the report

The following documents are filed as part of this report:

(a)(1) Financial Statements:
     
  1. Report of Independent Registered Public Accounting Firm;
     
  2. Consolidated Balance Sheets;
     
  3. Consolidated Statements of Operations;
     
  4. Consolidated Statements of Comprehensive Income and Loss;
     
  5. Consolidated Statements of Cash Flows;
     
  6. Consolidated Statement of Changes in Stockholders’ Equity; and
     
  7. Notes to the Consolidated Financial Statements.

64



(a)(2) Financial Statement Schedules:
   
  None.
   
(a)(3) Exhibits:
   
(3) Articles of Incorporation and By-laws
   
3.1 Articles of Incorporation (incorporated by reference from our Registration Statement on Form SB-2 filed on July 16, 2003).
   
3.2 Bylaws (incorporated by reference from our Registration Statement on Form SB-2 filed on July 16, 2003).
   
3.3 Amended Bylaws (incorporated by reference from our Registration Statement on Form SB-2/A filed on September 3, 2003).
   
3.4 Articles of Merger (incorporated by reference from our Current Report on Form 8-K filed on September 15, 2005).
   
3.5 Amended Bylaws (incorporated by reference from our Current Report on Form 8-K filed on April 28, 2006).
   
3.6 Amended Bylaws (incorporated by reference from our Current Report on Form 8-K filed on April 22, 2008).
   
3.7 Amended Bylaws (incorporated by reference from our Current Report on Form 8-K filed on July 2, 2012).
   
3.8 Certificate of Amendment to Articles of Incorporation (incorporated by reference from our Quarterly Report in the Form 10-Q filed on December 12, 2013).
   
(4) Instruments defining the rights of security holders, including indentures
   
4.1 2004 Stock Option Plan effective May 18, 2004 (incorporated by reference from our Registration Statement on Form S-8 filed on June 14, 2005).
   
4.2 Form of Stock Option Agreement for 2004 Stock Option Plan (incorporated by reference from our Registration Statement on Form S-8 filed on June 14, 2005).
   
4.3 2005 Stock Option Plan effective March 4, 2005 (incorporated by reference from our Registration Statement on Form S-8 filed on June 14, 2005).
   
4.4 Form of Stock Option Agreement for 2005 Stock Option Plan (incorporated by reference from our Registration Statement on Form S-8 filed on June 14, 2005).
   
4.5 Form of Amended & Restated Stock Option and Subscription Agreement (Canadian) (incorporated by reference from our Current Report on Form 8-K filed On October 14, 2005).
   
4.6 Form of Amended & Restated Stock Option and Subscription Agreement (US) (incorporated by reference from our Current Report on Form 8-K filed On October 14, 2005).
   
4.7 2010 Stock Option Plan effective September 27, 2010 (incorporated by reference from our Definitive Proxy Statement filed on August 31, 2010).

65



4.8

Employee Share Purchase Plan adopted October 1, 2008, and amended November 6, 2008 (incorporated by reference from our Registration Statement on Form S-8 filed on January 30, 2009).

 

 

4.9

Amended Deferred Share Unit Plan effective September 25, 2013 (incorporated by reference from our Quarterly Report in the Form 10-Q filed on December 12, 2013).

 

 

4.10

Amended 2010 Stock Option Plan effective July 10, 2014 (incorporated by reference from our Quarterly Report in the Form 10-Q filed on December 11, 2014).

 

 

4.11

Amended Employee Share Purchase Plan effective July 29, 2014 (incorporated by reference from our Quarterly Report in the Form 10-Q filed on December 11, 2014).

 

 

(10)

Material Contracts

 

 

10.1

Employment Agreement between CounterPath Solutions, Inc. and David Karp dated September 11, 2006 (incorporated by reference from our Quarterly Report on Form 10-QSB filed on September 14, 2006).

 

 

10.2

Piggyback Registrations Rights Agreement among our company and various shareholders, dated as of August 2, 2007 (incorporated by reference from our Current Report on Form 8-K filed on August 8, 2007).

 

 

10.3

Form of Subscription Agreement dated October 29, 2009 between our company and various investors (incorporated by reference from our Current Report on Form 8-K filed on November 4, 2009).

 

 

10.4

Form of Subscription Agreement between our company and various investors in connection with the non-brokered private placement completed on September 4, 2015 (incorporated by reference from our Current Report on Form 8-K filed on September 8, 2015).

 

 

10.5

Form of Warrant Certificate issued to various investors in connection with the non-brokered private placement completed on September 4, 2015 (incorporated by reference from our Current Report on Form 8-K filed on September 8, 2015).

 

 

10.6

Amended Employment Agreement between Donovan Jones and CounterPath Corporation and its wholly owned subsidiary, CounterPath Technologies Inc., dated February 17, 2016 (incorporated by reference from our Quarterly Report on Form 10-Q filed on March 15, 2016).

 

 

(14)

Code of Ethics

 

 

14.1

Code of Business Conduct and Ethics and Compliance Program (incorporated by reference from our Quarterly Report on Form 10-QSB filed on September 15, 2008).

 

 

(21)

Subsidiaries of CounterPath Corporation

 

 

 

CounterPath Technologies Inc. (incorporated in the Province of British Columbia, Canada)  

 

 

 

BridgePort Networks, Inc. (incorporated in the state of Delaware)  

 

 

(23)

Consent of Experts and Counsel

 

 

23.1

Consent of BDO Canada LLP, Independent Registered Public Accounting Firm (filed herewith).

66



(31) Section 302 Certifications
   
31.1 Section 302 Certification of Donovan Jones (filed herewith).
   
31.2 Section 302 Certification of David Karp (filed herewith).
   
(32) Section 906 Certifications
   
32.1 Section 906 Certification of Donovan Jones (filed herewith).
   
32.2 Section 906 Certification of David Karp (filed herewith).

Item 16. Form 10-K Summary.

None.

67


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

COUNTERPATH CORPORATION
   
   
By: /s/ Donovan Jones
  Donovan Jones
  President, Chief Executive Officer and Director
  (Principal Executive Officer)
   
  Date: July 13, 2016

Pursuant to the requirements of Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

  Signature Title Date
       
  /s/ Terence Matthews    
  Terence Matthews Chairman and Director July 13, 2016
       
  /s/ Donovan Jones    
  Donovan Jones President, Chief Executive Officer and July 13, 2016
    Director (Principal Executive Officer)  
  /s/ David Karp    
  David Karp Chief Financial Officer, Treasurer and July 13, 2016
    Secretary (Principal Financial Officer,  
  /s/ Owen Matthews Principal Accounting Officer)  
  Owen Matthews Vice Chairman and Director July 13, 2016
       
  /s/ Bruce Joyce    
  Bruce Joyce Director July 13, 2016
       
  /s/ Chris Cooper    
  Chris Cooper Director July 13, 2016
       
  /s/ Larry Timlick    
  Larry Timlick Director July 13, 2016

68


EX-21.1 2 exhibit21-1.htm EXHIBIT 21.1 Counterpath Corporation - Exhibit 21.1- Filed by newsfilecorp.com

Exhibit 21.1

LIST OF SUBSIDIARIES OF COUNTERPATH CORPORATION

Name State/Jurisdiction of Incorporation Name Under Which Subsidiary Does Business
     
CounterPath Technologies Inc. British Columbia, Canada CounterPath Technologies Inc.
     
BridgePort Networks, Inc. Delaware BridgePort Networks, Inc.


EX-23.1 3 exhibit23-1.htm EXHIBIT 23.1 Counterpath Corporation: Exhibit 23.1 - Filed by newsfilecorp.com

Tel: 604 688 5421 BDO Canada LLP
Fax: 604 688 5132 600 Cathedral Place
www.bdo.ca 925 West Georgia Street
  Vancouver BC V6C 3L2 Canada

Consent of Independent Registered Public Accounting Firm

Counterpath Corporation
Vancouver, Canada

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3A (No. 333-200993) and Form S-8 (No.333-200992) of CounterPath Corporation of our report dated July 13, 2016 relating to the consolidated financial statements which appears in this Form 10-K.

/s/ BDO Canada LLP

Vancouver, Canada
July 13, 2016


EX-31.1 4 exhibit31-1.htm EXHIBIT 31.1 Counterpath Corporation- Exhibit 31.1- Filed by newsfilecorp.com

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Donovan Jones, certify that:

1. I have reviewed this Annual Report on Form 10-K for the year ended April 30, 2016 of CounterPath Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 13, 2016 /s/ Donovan Jones
  Donovan Jones
  President and Chief Executive Officer
  (Principal Executive Officer)


EX-31.2 5 exhibit31-2.htm EXHIBIT 31.2 Counterpath Corporation- Exhibit 31.2- Filed by newsfilecorp.com

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, David Karp, certify that:

1. I have reviewed this Annual Report on Form 10-K for the year ended April 30, 2016 of CounterPath Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: July 13, 2016 /s/ David Karp
  David Karp
  Chief Financial Officer, Treasurer and Secretary
  (Principal Financial Officer and Principal Accounting Officer)


EX-32 6 exhibit32.htm EXHIBIT 32 Counterpath Corporation- Exhibit 32- Filed by newsfilecorp.com

Exhibit 32

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT
TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002

I, Donovan Jones, certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Annual Report of CounterPath Corporation (the “Company”) on Form 10-K for the year ended April 30, 2016, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Donovan Jones
Donovan Jones
President and Chief Executive Officer
(Principal Executive Officer)

July 13, 2016

I, David Karp, certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Annual Report of CounterPath Corporation (the “Company”) on Form 10-K for the year ended April 30, 2016, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ David Karp
David Karp
Chief Financial Officer, Treasurer and Secretary
(Principal Financial Officer and Principal Accounting Officer)

July 13, 2016


EX-101.INS 7 cpah-20160430.xml XBRL INSTANCE FILE --04-30 cpah COUNTERPATH CORP 2016-04-30 0001236997 No Smaller Reporting Company No 10-K false 4555348 Yes 6133484 2016 FY 0001236997 2016-07-08 0001236997 2015-10-31 0001236997 2015-05-01 2016-04-30 0001236997 2016-04-30 0001236997 2015-04-30 0001236997 2014-05-01 2015-04-30 0001236997 2014-04-30 0001236997 us-gaap:CommonStockMember 2014-04-30 0001236997 us-gaap:TreasuryStockMember 2014-04-30 0001236997 us-gaap:PreferredStockMember 2014-04-30 0001236997 us-gaap:AdditionalPaidInCapitalMember 2014-04-30 0001236997 us-gaap:RetainedEarningsMember 2014-04-30 0001236997 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-04-30 0001236997 us-gaap:CommonStockMember 2014-05-01 2015-04-30 0001236997 us-gaap:AdditionalPaidInCapitalMember 2014-05-01 2015-04-30 0001236997 us-gaap:TreasuryStockMember 2014-05-01 2015-04-30 0001236997 us-gaap:RetainedEarningsMember 2014-05-01 2015-04-30 0001236997 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-05-01 2015-04-30 0001236997 us-gaap:CommonStockMember 2015-04-30 0001236997 us-gaap:TreasuryStockMember 2015-04-30 0001236997 us-gaap:PreferredStockMember 2015-04-30 0001236997 us-gaap:AdditionalPaidInCapitalMember 2015-04-30 0001236997 us-gaap:RetainedEarningsMember 2015-04-30 0001236997 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-04-30 0001236997 us-gaap:CommonStockMember 2015-05-01 2016-04-30 0001236997 us-gaap:AdditionalPaidInCapitalMember 2015-05-01 2016-04-30 0001236997 us-gaap:TreasuryStockMember 2015-05-01 2016-04-30 0001236997 us-gaap:RetainedEarningsMember 2015-05-01 2016-04-30 0001236997 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-05-01 2016-04-30 0001236997 us-gaap:CommonStockMember 2016-04-30 0001236997 us-gaap:TreasuryStockMember 2016-04-30 0001236997 us-gaap:PreferredStockMember 2016-04-30 0001236997 us-gaap:AdditionalPaidInCapitalMember 2016-04-30 0001236997 us-gaap:RetainedEarningsMember 2016-04-30 0001236997 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-04-30 shares iso4217:USD iso4217:USD shares utr:D pure iso4217:CAD utr:M utr:Y 2159738 2852422 3209279 3305466 184644 168299 5553661 6326187 93868 97667 142563 271736 7001228 7311449 174811 216125 12966131 14223164 1943108 2305580 1808857 1866986 2384 0 61356 73117 3815705 4245683 35379 47760 10563 10563 3861647 4304006 0 0 4542 4233 0 1 70065082 67638003 -58022500 -55330905 -2942640 -2392172 9104484 9919158 12966131 14223164 547173 294719 0.001 0.001 100000000 100000000 0 0 0 0 0.001 0.001 100000000 100000000 4542348 4233395 4542348 4233395 6031618 7151076 5049740 4852007 11081358 12003083 1667087 2222071 4145351 4935671 4737055 5669217 3373674 4522044 13923167 17349003 -2841809 -5345920 5211 21669 2310 1229 195003 883613 -47690 0 -2691595 -4441867 -0.61 -1.05 -0.61 -1.05 4433402 4249252 4433402 4249252 7225 32710 -550468 -1408044 -3242063 -5849911 -9882 -6602 199335 209382 248371 293323 906914 1000070 38783 0 -314804 -150819 -96187 -96025 -11761 3958 2384 -9553 0 -54362 14884 2693 0 21412 -58129 241160 0 -15068 -2105823 -3336380 27692 214514 13739 0 -41431 -214514 1520574 11689 38882 322648 1481692 -310959 -27122 -458523 -692684 -4320376 2852422 7172798 2159738 2310 1229 0 0 4259987 4260 -1620 -2 0 0 66948866 -50889038 -984128 15079958 6789 7 -11504 -11497 -35213 35 311048 311083 -35632 36 35633 -36 1000070 1000070 2251 2 11619 11621 -4441867 -1408044 -1408044 4233395 4233 -1200 -1 0 0 67638003 -55330905 -2392172 293000 293 1441546 1441839 10000 10 38773 38783 -10460 10 6256 6266 -11260 11 11260 -11 32616 32616 906914 906914 17213 17 78718 78735 -2691595 -550468 -550468 4542348 4542 -400 0 0 70065082 -58022500 -2942640 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 1</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Nature of Operations</u> </b> </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">CounterPath Corporation (the &#8220;Company&#8221;) was incorporated in the State of Nevada on April 18, 2003. The shares of the Company&#8217;s common stock are quoted for trading on the NASDAQ Capital Market in the United States of America and on the Toronto Stock Exchange in Canada.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> On August 2, 2007, the Company acquired of all of the shares of NewHeights Software Corporation (&#8220;NewHeights&#8221;) through the issuance of 7,680,168 shares of the Company&#8217;s common stock and 369,836 preferred shares issued from a subsidiary of the Company exchangeable into 369,836 shares of the Company&#8217;s common stock. For accounting purposes, the Company was deemed to be the acquirer of NewHeights based on certain factors including the number of common shares issued in the transaction as a proportion of the total common shares outstanding, and the composition of the board after the transaction. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> On February 1, 2008, the Company acquired FirstHand Technologies Inc. (&#8220;FirstHand&#8221;), a private Ontario, Canada corporation, through the issuance of 5,900,014 shares of the Company&#8217;s common stock. For accounting purposes, the Company was deemed to be the acquirer of FirstHand based on certain factors including the number of common shares issued in the transaction as a proportion of the total common shares outstanding, and the composition of the board after the transaction. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">On February 1, 2008, the Company acquired BridgePort Networks, Inc. (&#8220;BridgePort&#8221;), a private Delaware corporation, by way of merger in consideration for the assumption of all of the assets and liabilities of BridgePort. For accounting purposes, the Company was deemed to be the acquirer of BridgePort based on certain factors primarily being the composition of the board after the transaction.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">On February 5, 2008, the Company's wholly-owned subsidiaries, NewHeights and CounterPath Solutions R&amp;D Inc. were amalgamated under the name CounterPath Technologies Inc.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">On November 1, 2010, the Company's wholly-owned subsidiaries, FirstHand and CounterPath Technologies Inc. were amalgamated under the name CounterPath Technologies Inc.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The Company focuses on the design, development, marketing and sales of software applications and related services, such as pre and post sales technical support and customization services, that enable enterprises and telecommunication service providers to deliver Unified Communications (UC) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol, or IP, based networks. The Company&#8217;s products are sold either directly or through channel partners, to small, medium and large businesses (&#8220;enterprises&#8221;) and telecom service providers, in North America, and in Europe, Middle East, Africa (&#8220;collectively EMEA&#8221;), Asia Pacific and Latin America.</p> 7680168 369836 369836 5900014 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 2</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Significant Accounting Policies</u> </b> </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">These consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America and are stated in U.S. dollars except where otherwise disclosed. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for the period necessarily involves the use of estimates, which have been made using careful judgment. Actual results may vary from these estimates.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">These consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities and commitments in the normal course of business.</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr> <td width="5%">&#160;</td> <td valign="top" width="5%">a)</td> <td> <u>Basis of Presentation</u> </td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, CounterPath Technologies Inc., a company existing under the laws of the province of British Columbia, Canada, and BridgePort incorporated under the laws of the state of Delaware. The results of NewHeights (which subsequently was amalgamated with another subsidiary to become CounterPath Technologies Inc.) are included from August 2, 2007, the date of acquisition. The results of FirstHand (which subsequently was amalgamated with CounterPath Technologies Inc.) and BridgePort are included from February 1, 2008, the date of acquisition. All inter-company transactions and balances have been eliminated.</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr> <td width="5%">&#160;</td> <td valign="top" width="5%">b)</td> <td> <u>Significant Accounting Policies</u> </td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Revenue Recognition:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company recognizes revenue in accordance with the Accounting Standard Codification (&#8220;ASC&#8221;) 985-605 &#8220;Software Revenue Recognition&#8221;. In accordance with these standards, revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collection of the related accounts receivable is deemed probable. In making these judgments, management evaluates these criteria as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="10%">&#160;</td> <td align="left">&#8226;&#160;&#160;</td> <td align="left" width="85%"> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> <i>Persuasive evidence of an arrangement.</i> The Company considers a noncancelable agreement signed by the Company and the customer to be representative of persuasive evidence of an arrangement. </p> </td> </tr> <tr> <td width="10%">&#160;</td> <td>&#160;</td> <td width="85%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left">&#8226;&#160;&#160;</td> <td align="left" width="85%"> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> <i>Delivery has occurred.</i> The Company considers delivery to have occurred when the product has been delivered to the customer and no post-delivery obligations exist. In instances where customer acceptance is required, delivery is deemed to have occurred when customer acceptance has been achieved. </p> </td> </tr> <tr> <td width="10%">&#160;</td> <td>&#160;</td> <td width="85%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left">&#8226;</td> <td align="left" width="85%"> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> <i>Fees are fixed or determinable.</i> The Company considers the fee to be fixed or determinable unless the fee is subject to refund or adjustment or is not payable within normal payment terms. If the fee is subject to refund or adjustment, the Company recognizes revenue when the refund or adjustment right lapses. If offered payment terms exceed the Company&#8217;s normal terms, the Company recognizes revenue as the amounts become due and payable or upon the receipt of cash when extended payment terms beyond 180 days are offered. </p> </td> </tr> <tr> <td width="10%">&#160;</td> <td>&#160;</td> <td width="85%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left">&#8226;&#160;&#160;</td> <td align="left" width="85%"> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> <i>Collection is deemed probable.</i> Collection is deemed probable if, based upon the Company&#8217;s evaluation, the Company expects that the customer will be able to pay amounts under the arrangement as payments become due. If the Company determines that collection is not probable, revenue is deferred and recognized upon the receipt of cash. </p> </td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">A substantial amount of the Company&#8217;s sales involve multiple element arrangements, such as products, support, professional services, and training. When arrangements include multiple elements, the Company allocates the total fee to delivered elements using the residual method when vendor specific objective evidence (VSOE) does not exist for the delivered element. Under the residual method, revenue is recognized when VSOE of fair value exists for all of the undelivered elements of the arrangement, but does not exist for one or more of the delivered elements of the arrangement. Each arrangement requires the Company to analyze the individual elements in the transaction and to estimate the fair value of each undelivered element, which typically represents support services.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Revenue is allocated to each of the undelivered elements based on its respective fair value.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">For contracts with elements related to customized network solutions and certain network build-outs, for transactions accounted for as sales of products or services, we apply Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC Subtopic 605-25 &#8220;Revenue Recognition &#8211; Multiple-Element Arrangements&#8221; and revenues are recognized under ASC 605-35&#8221;Revenue Recognition &#8211; Construction type and Production type Contract&#8221;, for long-term transactions entered to supply software, or software systems, that require significant modification or customization, generally using the percentage-of-completion method.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">For multi-element arrangements, the Company allocates revenue to all deliverables based on their selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) VSOE, (ii) third-party evidence of selling price (&#8220;TPE&#8221;), and (iii) best estimate of selling price (&#8220;ESP&#8221;). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company&#8217;s best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In using the percentage-of-completion method, revenues are generally recorded based on completion of milestones as described in the agreement. Profit estimates on long-term contracts are revised periodically based on changes in circumstances and any losses on contracts are recognized in the period that such losses become known.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Service revenue includes sales of support and other services, including professional services, training, and reimbursable travel. Support services include telephone support, e-mail support and unspecified rights to product updates and upgrades, and are recognized ratably over the term of the service period, which is generally twelve months. Support revenue is generally deferred until the related product has been accepted and all other revenue recognition criteria have been met. Professional services and training revenue is recognized as the related service has been performed.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Stock-Based Compensation</i> : </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company adopted ASC 718 &#8220;Compensation &#8211; Stock Compensation&#8221;, using the modified prospective method on May 1, 2006. Under this application, the Company is required to record compensation expense, based on the fair value of the awards, for all awards granted after the date of adoption and for the unvested portion of previously granted awards that remain outstanding as at the date of adoption. In accordance with ASC 718, the compensation expense is amortized on a straight-line basis over the requisite service period which approximates the vesting period.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Stock options granted to non-employees were accounted for in accordance with ASC 718 and ASC 505-50 &#8220;Equity based payments to non-employees&#8221; and were measured at the fair value of the options as determined by an option pricing model on the measurement date and compensation expense is amortized over the vesting period or, if none exists, over the service period. With the adoption of ASC 718, the Company has elected to use the Black-Scholes option pricing model to determine the fair value of stock options granted. The Company has estimated the fair value of option awards to employees and non-employees for the years ended April 30, 2016 and April 30, 2015 using the assumptions more fully described in Note 6.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Use of Estimates:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the Company&#8217;s management to make estimates and assumptions which affect the amounts reported in these consolidated financial statements, the notes thereto, and the disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Equipment and Amortization:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Equipment is recorded at cost. Depreciation is provided for using the straight-line method over the estimated useful lives as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td nowrap="nowrap" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap">Computer hardware</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="40%">Two years</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" nowrap="nowrap">Computer software</td> <td align="left" nowrap="nowrap" width="40%">Two years</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap">Leasehold improvements</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="40%">Shorter of lease term or estimated economic life</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" nowrap="nowrap">Office furniture</td> <td align="left" nowrap="nowrap" width="40%">Five years</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap">Website</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="40%">Three years</td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Research and Development:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Research and development expense includes costs incurred to develop intellectual property. The costs for the development of new software and substantial enhancements to existing software are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. Management has determined that technological feasibility is established at the time a working model of software is completed. Because management believes that the current process for developing software will be essentially completed concurrently with the establishment of technological feasibility, no costs have been capitalized to date.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Website Development Costs:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company recognizes the costs associated with developing a website in accordance with ASC Topic 350-40 &#8220;Intangibles &#8211; Internal Use Software&#8221;.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Training costs are not internal-use software development costs and, if incurred during this stage, are expensed as incurred.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">These capitalized costs are amortized based on their estimated useful life over three years. Payroll and other related costs are not capitalized, as the amounts principally relate to maintenance.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Accounts Receivable and Allowance for Doubtful Accounts:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Accounts receivable are presented net of an allowance for doubtful accounts.</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>Years Ended April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="10%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Balance of allowance for doubtful debts, beginning of year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 294,719 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 240,681 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Bad debt provision</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 612,769 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 628,113 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Write-off of receivables</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (360,315 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (574,075 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Balance of allowance for doubtful debts, end of year</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 547,173 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 294,719 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company determines the allowance for doubtful accounts by considering a number of factors, including the length of time the accounts receivable are beyond the contractual payment terms, previous loss history, and the customer&#8217;s current ability to pay its obligation. When the Company becomes aware of a specific customer&#8217;s inability to meet its financial obligations to the Company, the Company records a charge to the allowance to reduce the customer&#8217;s related accounts.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Foreign Currency Translation:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company&#8217;s functional currency is the U.S. dollar. The Company&#8217;s wholly-owned subsidiaries with a functional currency other than the U.S. dollar are translated into amounts in the reporting currency, U.S. dollars, in accordance with ASC Topic 830 &#8220;Foreign Currency Matters&#8221;. Revenues and expenses are translated at the average exchange rate prevailing during the periods. At each balance sheet date, assets and liabilities that are denominated in a currency other than U.S. dollars are adjusted to reflect the current exchange rate which may give rise to a foreign currency translation adjustment accounted for as a separate component of stockholders&#8217; equity and included in comprehensive loss.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">For transactions undertaken by the Company in foreign currencies, monetary assets and liabilities are translated into the functional currency at the exchange rate in effect at the end of the year. Non-monetary assets and liabilities are translated at the exchange rate prevailing when the assets were acquired or the liabilities assumed. Revenues and expenses are translated at the rate approximating the rate of exchange on the transaction date. Exchange gains and losses are included in the determination of net income (loss) for the year.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Accrued Warranty:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company&#8217;s warranty policy generally provides for one year of warranty for its products. The Company records a liability for estimated warranty obligations at the date products are sold. The estimated cost of warranty coverage is based on the Company&#8217;s actual historical experience with its current products or similar products. For new products, the required reserve is based on historical experience of similar products until such time as sufficient historical data has been collected on the new product. Estimated liabilities for warranty exposures, which relate to normal product warranties and a one-year obligation to provide for potential future liabilities for product sales for the years ended April 30, 2016 and 2015 were as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>Years Ended April 30,</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="10%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Balance, beginning of year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 73,117 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 69,159 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Usage during the year</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Additions (reductions) during the year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (11,761 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 3,958 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Balance, end of year</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 61,356 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 73,117 </td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Trademarks:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Costs related to trademark applications have been deferred and are included in other assets. Once granted, trademark costs will be amortized over their useful lives.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Fair Value of Financial Instruments:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company&#8217;s financial instruments consist of cash, accounts receivable, accounts payable and accrued liabilities, customer deposits, foreign exchange contracts, and derivative instruments. The fair value of the financial instruments approximate book value.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">As a basis for considering market participant assumptions in fair value measurements, ASC 820-10 &#8220;Fair Value Measurements&#8221; establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity&#8217;s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The fair value hierarchy, as defined by ASC 820-10, contains three levels of inputs that may be used to measure fair value as follows:</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals; and Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an entity&#8217;s own assumptions, as there is little, if any, related market activity.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company&#8217;s derivative financial instruments are valued using observable market-based inputs to industry valuation models. These valuation models require a variety of inputs, including contractual terms, market prices, yield curves, and measures of volatility obtained from various market sources.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company measures certain financial assets, including any foreign currency option or forward contracts at fair value. Unless otherwise noted, it is management&#8217;s opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Income Taxes:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company accounts for income taxes by the asset and liability method in accordance with ASC Topic 740 &#8220;Income Taxes&#8221;. Under this method, current income taxes are recognized for the estimated income taxes payable for the current year. Deferred income tax assets and liabilities are recognized in the current year for temporary differences between the tax and accounting bases of assets and liabilities as well as for the benefit of losses available to be carried forward to future years for tax purposes that are likely to be realized. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company has not recorded a deferred tax liability related to its investment in foreign subsidiaries. The Company has determined that its investment in these subsidiaries is permanent in nature and it does not intend to dispose of these investments in the foreseeable future. The amount of the deferred tax liability related to the Company's investment in foreign subsidiaries is not reasonably determinable.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> We have $1,540,467 in cash held outside of the United States, and there is no intent to repatriate at this time. Should we decide to repatriate in the future, taxes would need to be accrued and paid. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> Under ASC 740, the Company also adopted a two-step approach to recognizing and measuring uncertain tax positions taken or expected to be taken in a tax return. The first step is to determine if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained in an audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company recognizes interest and penalties accrued on unrecognized tax benefits within general and administrative expense. To the extent that accrued interest and penalties do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction in general and administrative expenses in the period that such determination is made. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Comprehensive Loss:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company has adopted ASC Topic 220 &#8220;Comprehensive Income&#8221;. Comprehensive loss is comprised of net profit or loss, and foreign currency translation adjustments.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Basic and Diluted Loss per Share:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company computes net loss per share in accordance with ASC Topics 260 and ASC 260-10 &#8220;Earnings per Share&#8221;.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> ASC 260 requires presentation of both basic and diluted earnings per share (&#8220;EPS&#8221;) on the face of the income statement. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the year. Diluted EPS gives effect to all dilutive potential common shares outstanding during the year including stock options and warrants using the treasury stock method. In computing diluted EPS, the average stock price for the year is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. For the year ended April 30, 2016, income per share excludes 812,169 (April 30, 2015 &#8211; 382,580) potentially dilutive common shares (related to stock options, deferred share units and warrants) as their effect was anti-dilutive. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Investment tax credits:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Investment tax credits are accounted for under the cost reduction method whereby they are netted against the expense or property and equipment to which they relate. Investment tax credits are recorded when the qualifying expenditures have been incurred and if it is more likely than not that the tax credits will be realized.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Goodwill:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Goodwill represents the excess purchase price over the estimated fair value of net assets acquired and liabilities assumed as of the acquisition date. ASC Topic 350 &#8220;Intangibles &#8211; Goodwill&#8221;. ASC 350 requires goodwill to be tested for impairment annually or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the Company's business enterprise below its carrying value. These events or circumstances could include a significant change in the business climate, legal factors, operating performance indicators, competition, or sale or disposition of a significant portion of a reporting unit. Recoverability of goodwill is measured at the reporting unit level by comparing the reporting unit&#8217;s carrying amount, including goodwill, to the fair value of the reporting unit, which is measured based upon, among other factors, market multiples for comparable companies as well as a discounted cash flow analysis.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Management has determined that the Company currently has a single reporting unit which is CounterPath Corporation. If the recorded value of the assets, including goodwill, and liabilities (&#8220;net book value&#8221;) of the reporting unit exceeds its fair value, an impairment loss may be required.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> Goodwill of $6,339,717 (CDN$6,704,947) and $2,083,960 (CDN$2,083,752) was initially recorded in connection with the acquisition of NewHeights on August 2, 2007 and FirstHand on February 1, 2008. Translated to U.S. dollars using the period end rate, the goodwill balance at April 30, 2016 was $5,341,481 (CDN$6,704,947) (April 30, 2015 - $5,578,159) and $1,659,747 (CDN$2,083,752) (April 30, 2015 - $1,733,290), respectively. During the fourth quarter of its fiscal year ended April 30, 2016, the Company performed its annual impairment test. In the first step, Management compared the fair value of the Company to its carrying value based upon the market capitalization of the Company as at April 30, 2016. On this basis Management determined that the Company&#8217;s fair value exceeded its carrying value and has not recognized any impairment of goodwill in the consolidated financial statements for the year ended April 30, 2016 (2015 - $nil). </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Derivative Instruments:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company accounts for derivative instruments, consisting of foreign currency forward contracts, pursuant to the provisions ASC 815, Derivatives and Hedging (&#8220;ASC 815&#8221;). ASC 815 requires the Company to measure derivative instruments at fair value and record them in the balance sheet as either an asset or liability and expands financial reporting about derivative instruments and hedging activities by requiring enhanced disclosures to enable investors to better understand their effects on an entity&#8217;s financial position, results of operations and cash flows. The Company does not use derivative instruments for trading purposes. ASC 815 also requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company also routinely enters into foreign currency forward contracts, not designated as hedging instruments, to protect against fluctuations in exchange rates. Gains or losses arising out of marked to market fair value valuation of forward contracts, not designated as hedges, and are recognized in net income.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company records foreign currency forward contracts on its Consolidated Balance Sheets as derivative instruments assets or liabilities depending on whether the net fair value of such contracts is a net asset or net liability, respectively (see Note 9 &#8220;Derivative Financial Instruments and Risk Management,&#8221; of the Notes to the Consolidated Financial Statements). The Company did not hold any foreign currency derivatives designated as cash flow hedges in the year ended April 30, 2016 (2015 - none).</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr> <td width="5%">&#160;</td> <td valign="top" width="5%">c)</td> <td> <i>New Accounting Pronouncements</i> </td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> In May 2014, FASB issued ASU 2014-09, <i>Revenue From Contracts With Customers</i> (&#8220;Topic 606&#8221;). Topic 606 removes inconsistencies and weaknesses in revenue requirements, provides a more robust framework for addressing revenue issues, improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, provides more useful information to users of financial statements through improved disclosure requirements and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The guidance in this update supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance throughout the Industry Topics of the Codification. In August 2015, ASU 2015-14 was issued which delayed the effective date for public entities to reporting periods beginning after December 15, 2017. Early adoption is not permitted. The Company is currently evaluating the impact of the adoption of this new standard. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> In August 2014, FASB issued ASU 2014-15, <i>Presentation of Financial Statements &#8211; Going Concern</i> , which requires management to evaluate whether there is substantial doubt about an entity&#8217;s ability to continue as a going concern and provide related footnote disclosures. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. The standard allows for either a full retrospective or modified retrospective transition method. The Company does not expect this standard to have a material impact on the Company&#8217;s consolidated financial statements upon adoption. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> In February 2016, FASB issued ASU 2016-02, <i>Leases</i> . The guidance would require lessees to recognize most leases on their balance sheets as lease liabilities with corresponding right &#8211;of-use assets. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2018. The Company is currently evaluating the impact of its pending adoption of ASU 2016-02 on its consolidated financial statements. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross versus Net), which clarifies the guidance in the new revenue standard on assessing whether an entity is a principal or an agent in a revenue transaction. This conclusion impacts whether an entity reports revenue on a gross or net basis. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies the guidance in the new revenue standard regarding an entity&#8217;s identification of its performance obligations in a contract, as well as an entity&#8217;s evaluation of the nature of its promise to grant a license of intellectual property and whether or not that revenue is recognized over time or at a point in time. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In May 2016, the FASB issued ASU 2016-11, Revenue Recognition: Customer Payments and Incentives, which clarifies the guidance in recognizing costs for consideration given by a vendor to a customer as a component of cost of sales. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In May 2016, the FASB issued ASU 2016-12, Revenue from Contracts with Customers: Narrow-Scope Improvements and Practical Expedients which amends the guidance in the new revenue standard on collectability, noncash consideration, presentation of sales tax, and transition. The amendments are intended to address implementation issues and provide additional practical expedients to reduce the cost and complexity of applying the new revenue standard. These amendments have the same effective date as the new revenue standard. While we are currently evaluating the method of adoption and the impact of the new revenue standard, as amended, on our Consolidated Financial Statements and related disclosures, we believe the adoption of the new standard may have a significant impact on the accounting for certain transactions with multiple elements or &#8220;bundled&#8221; arrangements because the requirement to have VSOE for undelivered elements under current accounting standards is eliminated under the new standard. Accordingly, we may be required to recognize as revenue a portion of the sales price upon delivery of the software, as compared to the current requirement of recognizing the entire sales price ratably over an estimated offering period. We continue to evaluate the impact of the new revenue standard on our Consolidated Financial Statements and related disclosures.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments: Measurement of Credit Losses on Financial Instruments which amends the guidance on measuring credit losses on financial assets held at amortized cost. The amendment is intended to address the issue that the previous &#8220;incurred loss&#8221; methodology was restrictive for Company&#8217;s ability to record credit losses based on not yet meeting the &#8220;probable&#8221; threshold. The new language will require these assets to be valued at amortized cost presented at the net amount expected to be collected will a valuation provision. The amendments will be effective for fiscal years beginning after December 15, 2019. We are evaluating the impact of this amendment on our consolidated financial statements and related disclosures.</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr> <td width="5%">&#160;</td> <td valign="top" width="5%">a)</td> <td> <u>Basis of Presentation</u> </td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, CounterPath Technologies Inc., a company existing under the laws of the province of British Columbia, Canada, and BridgePort incorporated under the laws of the state of Delaware. The results of NewHeights (which subsequently was amalgamated with another subsidiary to become CounterPath Technologies Inc.) are included from August 2, 2007, the date of acquisition. The results of FirstHand (which subsequently was amalgamated with CounterPath Technologies Inc.) and BridgePort are included from February 1, 2008, the date of acquisition. All inter-company transactions and balances have been eliminated.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Revenue Recognition:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company recognizes revenue in accordance with the Accounting Standard Codification (&#8220;ASC&#8221;) 985-605 &#8220;Software Revenue Recognition&#8221;. In accordance with these standards, revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collection of the related accounts receivable is deemed probable. In making these judgments, management evaluates these criteria as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="10%">&#160;</td> <td align="left">&#8226;&#160;&#160;</td> <td align="left" width="85%"> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> <i>Persuasive evidence of an arrangement.</i> The Company considers a noncancelable agreement signed by the Company and the customer to be representative of persuasive evidence of an arrangement. </p> </td> </tr> <tr> <td width="10%">&#160;</td> <td>&#160;</td> <td width="85%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left">&#8226;&#160;&#160;</td> <td align="left" width="85%"> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> <i>Delivery has occurred.</i> The Company considers delivery to have occurred when the product has been delivered to the customer and no post-delivery obligations exist. In instances where customer acceptance is required, delivery is deemed to have occurred when customer acceptance has been achieved. </p> </td> </tr> <tr> <td width="10%">&#160;</td> <td>&#160;</td> <td width="85%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left">&#8226;</td> <td align="left" width="85%"> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> <i>Fees are fixed or determinable.</i> The Company considers the fee to be fixed or determinable unless the fee is subject to refund or adjustment or is not payable within normal payment terms. If the fee is subject to refund or adjustment, the Company recognizes revenue when the refund or adjustment right lapses. If offered payment terms exceed the Company&#8217;s normal terms, the Company recognizes revenue as the amounts become due and payable or upon the receipt of cash when extended payment terms beyond 180 days are offered. </p> </td> </tr> <tr> <td width="10%">&#160;</td> <td>&#160;</td> <td width="85%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left">&#8226;&#160;&#160;</td> <td align="left" width="85%"> <p align="justify" style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> <i>Collection is deemed probable.</i> Collection is deemed probable if, based upon the Company&#8217;s evaluation, the Company expects that the customer will be able to pay amounts under the arrangement as payments become due. If the Company determines that collection is not probable, revenue is deferred and recognized upon the receipt of cash. </p> </td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">A substantial amount of the Company&#8217;s sales involve multiple element arrangements, such as products, support, professional services, and training. When arrangements include multiple elements, the Company allocates the total fee to delivered elements using the residual method when vendor specific objective evidence (VSOE) does not exist for the delivered element. Under the residual method, revenue is recognized when VSOE of fair value exists for all of the undelivered elements of the arrangement, but does not exist for one or more of the delivered elements of the arrangement. Each arrangement requires the Company to analyze the individual elements in the transaction and to estimate the fair value of each undelivered element, which typically represents support services.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Revenue is allocated to each of the undelivered elements based on its respective fair value.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">For contracts with elements related to customized network solutions and certain network build-outs, for transactions accounted for as sales of products or services, we apply Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC Subtopic 605-25 &#8220;Revenue Recognition &#8211; Multiple-Element Arrangements&#8221; and revenues are recognized under ASC 605-35&#8221;Revenue Recognition &#8211; Construction type and Production type Contract&#8221;, for long-term transactions entered to supply software, or software systems, that require significant modification or customization, generally using the percentage-of-completion method.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">For multi-element arrangements, the Company allocates revenue to all deliverables based on their selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) VSOE, (ii) third-party evidence of selling price (&#8220;TPE&#8221;), and (iii) best estimate of selling price (&#8220;ESP&#8221;). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company&#8217;s best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In using the percentage-of-completion method, revenues are generally recorded based on completion of milestones as described in the agreement. Profit estimates on long-term contracts are revised periodically based on changes in circumstances and any losses on contracts are recognized in the period that such losses become known.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Service revenue includes sales of support and other services, including professional services, training, and reimbursable travel. Support services include telephone support, e-mail support and unspecified rights to product updates and upgrades, and are recognized ratably over the term of the service period, which is generally twelve months. Support revenue is generally deferred until the related product has been accepted and all other revenue recognition criteria have been met. Professional services and training revenue is recognized as the related service has been performed.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Stock-Based Compensation</i> : </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company adopted ASC 718 &#8220;Compensation &#8211; Stock Compensation&#8221;, using the modified prospective method on May 1, 2006. Under this application, the Company is required to record compensation expense, based on the fair value of the awards, for all awards granted after the date of adoption and for the unvested portion of previously granted awards that remain outstanding as at the date of adoption. In accordance with ASC 718, the compensation expense is amortized on a straight-line basis over the requisite service period which approximates the vesting period.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Stock options granted to non-employees were accounted for in accordance with ASC 718 and ASC 505-50 &#8220;Equity based payments to non-employees&#8221; and were measured at the fair value of the options as determined by an option pricing model on the measurement date and compensation expense is amortized over the vesting period or, if none exists, over the service period. With the adoption of ASC 718, the Company has elected to use the Black-Scholes option pricing model to determine the fair value of stock options granted. The Company has estimated the fair value of option awards to employees and non-employees for the years ended April 30, 2016 and April 30, 2015 using the assumptions more fully described in Note 6.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Use of Estimates:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the Company&#8217;s management to make estimates and assumptions which affect the amounts reported in these consolidated financial statements, the notes thereto, and the disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Equipment and Amortization:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Equipment is recorded at cost. Depreciation is provided for using the straight-line method over the estimated useful lives as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td nowrap="nowrap" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap">Computer hardware</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="40%">Two years</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" nowrap="nowrap">Computer software</td> <td align="left" nowrap="nowrap" width="40%">Two years</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap">Leasehold improvements</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="40%">Shorter of lease term or estimated economic life</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" nowrap="nowrap">Office furniture</td> <td align="left" nowrap="nowrap" width="40%">Five years</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap">Website</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="40%">Three years</td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Research and Development:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Research and development expense includes costs incurred to develop intellectual property. The costs for the development of new software and substantial enhancements to existing software are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. Management has determined that technological feasibility is established at the time a working model of software is completed. Because management believes that the current process for developing software will be essentially completed concurrently with the establishment of technological feasibility, no costs have been capitalized to date.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Website Development Costs:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company recognizes the costs associated with developing a website in accordance with ASC Topic 350-40 &#8220;Intangibles &#8211; Internal Use Software&#8221;.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Training costs are not internal-use software development costs and, if incurred during this stage, are expensed as incurred.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">These capitalized costs are amortized based on their estimated useful life over three years. Payroll and other related costs are not capitalized, as the amounts principally relate to maintenance.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Accounts Receivable and Allowance for Doubtful Accounts:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Accounts receivable are presented net of an allowance for doubtful accounts.</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>Years Ended April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="10%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Balance of allowance for doubtful debts, beginning of year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 294,719 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 240,681 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Bad debt provision</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 612,769 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 628,113 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Write-off of receivables</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (360,315 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (574,075 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Balance of allowance for doubtful debts, end of year</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 547,173 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 294,719 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company determines the allowance for doubtful accounts by considering a number of factors, including the length of time the accounts receivable are beyond the contractual payment terms, previous loss history, and the customer&#8217;s current ability to pay its obligation. When the Company becomes aware of a specific customer&#8217;s inability to meet its financial obligations to the Company, the Company records a charge to the allowance to reduce the customer&#8217;s related accounts.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Foreign Currency Translation:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company&#8217;s functional currency is the U.S. dollar. The Company&#8217;s wholly-owned subsidiaries with a functional currency other than the U.S. dollar are translated into amounts in the reporting currency, U.S. dollars, in accordance with ASC Topic 830 &#8220;Foreign Currency Matters&#8221;. Revenues and expenses are translated at the average exchange rate prevailing during the periods. At each balance sheet date, assets and liabilities that are denominated in a currency other than U.S. dollars are adjusted to reflect the current exchange rate which may give rise to a foreign currency translation adjustment accounted for as a separate component of stockholders&#8217; equity and included in comprehensive loss.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">For transactions undertaken by the Company in foreign currencies, monetary assets and liabilities are translated into the functional currency at the exchange rate in effect at the end of the year. Non-monetary assets and liabilities are translated at the exchange rate prevailing when the assets were acquired or the liabilities assumed. Revenues and expenses are translated at the rate approximating the rate of exchange on the transaction date. Exchange gains and losses are included in the determination of net income (loss) for the year.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Accrued Warranty:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company&#8217;s warranty policy generally provides for one year of warranty for its products. The Company records a liability for estimated warranty obligations at the date products are sold. The estimated cost of warranty coverage is based on the Company&#8217;s actual historical experience with its current products or similar products. For new products, the required reserve is based on historical experience of similar products until such time as sufficient historical data has been collected on the new product. Estimated liabilities for warranty exposures, which relate to normal product warranties and a one-year obligation to provide for potential future liabilities for product sales for the years ended April 30, 2016 and 2015 were as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>Years Ended April 30,</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="10%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Balance, beginning of year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 73,117 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 69,159 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Usage during the year</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Additions (reductions) during the year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (11,761 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 3,958 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Balance, end of year</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 61,356 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 73,117 </td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Trademarks:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Costs related to trademark applications have been deferred and are included in other assets. Once granted, trademark costs will be amortized over their useful lives.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Fair Value of Financial Instruments:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company&#8217;s financial instruments consist of cash, accounts receivable, accounts payable and accrued liabilities, customer deposits, foreign exchange contracts, and derivative instruments. The fair value of the financial instruments approximate book value.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">As a basis for considering market participant assumptions in fair value measurements, ASC 820-10 &#8220;Fair Value Measurements&#8221; establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity&#8217;s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The fair value hierarchy, as defined by ASC 820-10, contains three levels of inputs that may be used to measure fair value as follows:</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals; and Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an entity&#8217;s own assumptions, as there is little, if any, related market activity.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company&#8217;s derivative financial instruments are valued using observable market-based inputs to industry valuation models. These valuation models require a variety of inputs, including contractual terms, market prices, yield curves, and measures of volatility obtained from various market sources.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company measures certain financial assets, including any foreign currency option or forward contracts at fair value. Unless otherwise noted, it is management&#8217;s opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Income Taxes:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company accounts for income taxes by the asset and liability method in accordance with ASC Topic 740 &#8220;Income Taxes&#8221;. Under this method, current income taxes are recognized for the estimated income taxes payable for the current year. Deferred income tax assets and liabilities are recognized in the current year for temporary differences between the tax and accounting bases of assets and liabilities as well as for the benefit of losses available to be carried forward to future years for tax purposes that are likely to be realized. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company has not recorded a deferred tax liability related to its investment in foreign subsidiaries. The Company has determined that its investment in these subsidiaries is permanent in nature and it does not intend to dispose of these investments in the foreseeable future. The amount of the deferred tax liability related to the Company's investment in foreign subsidiaries is not reasonably determinable.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> We have $1,540,467 in cash held outside of the United States, and there is no intent to repatriate at this time. Should we decide to repatriate in the future, taxes would need to be accrued and paid. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> Under ASC 740, the Company also adopted a two-step approach to recognizing and measuring uncertain tax positions taken or expected to be taken in a tax return. The first step is to determine if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained in an audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company recognizes interest and penalties accrued on unrecognized tax benefits within general and administrative expense. To the extent that accrued interest and penalties do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction in general and administrative expenses in the period that such determination is made. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Comprehensive Loss:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company has adopted ASC Topic 220 &#8220;Comprehensive Income&#8221;. Comprehensive loss is comprised of net profit or loss, and foreign currency translation adjustments.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Basic and Diluted Loss per Share:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company computes net loss per share in accordance with ASC Topics 260 and ASC 260-10 &#8220;Earnings per Share&#8221;.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> ASC 260 requires presentation of both basic and diluted earnings per share (&#8220;EPS&#8221;) on the face of the income statement. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the year. Diluted EPS gives effect to all dilutive potential common shares outstanding during the year including stock options and warrants using the treasury stock method. In computing diluted EPS, the average stock price for the year is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. For the year ended April 30, 2016, income per share excludes 812,169 (April 30, 2015 &#8211; 382,580) potentially dilutive common shares (related to stock options, deferred share units and warrants) as their effect was anti-dilutive. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Investment tax credits:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Investment tax credits are accounted for under the cost reduction method whereby they are netted against the expense or property and equipment to which they relate. Investment tax credits are recorded when the qualifying expenditures have been incurred and if it is more likely than not that the tax credits will be realized.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Goodwill:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Goodwill represents the excess purchase price over the estimated fair value of net assets acquired and liabilities assumed as of the acquisition date. ASC Topic 350 &#8220;Intangibles &#8211; Goodwill&#8221;. ASC 350 requires goodwill to be tested for impairment annually or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the Company's business enterprise below its carrying value. These events or circumstances could include a significant change in the business climate, legal factors, operating performance indicators, competition, or sale or disposition of a significant portion of a reporting unit. Recoverability of goodwill is measured at the reporting unit level by comparing the reporting unit&#8217;s carrying amount, including goodwill, to the fair value of the reporting unit, which is measured based upon, among other factors, market multiples for comparable companies as well as a discounted cash flow analysis.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">Management has determined that the Company currently has a single reporting unit which is CounterPath Corporation. If the recorded value of the assets, including goodwill, and liabilities (&#8220;net book value&#8221;) of the reporting unit exceeds its fair value, an impairment loss may be required.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> Goodwill of $6,339,717 (CDN$6,704,947) and $2,083,960 (CDN$2,083,752) was initially recorded in connection with the acquisition of NewHeights on August 2, 2007 and FirstHand on February 1, 2008. Translated to U.S. dollars using the period end rate, the goodwill balance at April 30, 2016 was $5,341,481 (CDN$6,704,947) (April 30, 2015 - $5,578,159) and $1,659,747 (CDN$2,083,752) (April 30, 2015 - $1,733,290), respectively. During the fourth quarter of its fiscal year ended April 30, 2016, the Company performed its annual impairment test. In the first step, Management compared the fair value of the Company to its carrying value based upon the market capitalization of the Company as at April 30, 2016. On this basis Management determined that the Company&#8217;s fair value exceeded its carrying value and has not recognized any impairment of goodwill in the consolidated financial statements for the year ended April 30, 2016 (2015 - $nil). </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> <i>Derivative Instruments:</i> </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company accounts for derivative instruments, consisting of foreign currency forward contracts, pursuant to the provisions ASC 815, Derivatives and Hedging (&#8220;ASC 815&#8221;). ASC 815 requires the Company to measure derivative instruments at fair value and record them in the balance sheet as either an asset or liability and expands financial reporting about derivative instruments and hedging activities by requiring enhanced disclosures to enable investors to better understand their effects on an entity&#8217;s financial position, results of operations and cash flows. The Company does not use derivative instruments for trading purposes. ASC 815 also requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company also routinely enters into foreign currency forward contracts, not designated as hedging instruments, to protect against fluctuations in exchange rates. Gains or losses arising out of marked to market fair value valuation of forward contracts, not designated as hedges, and are recognized in net income.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">The Company records foreign currency forward contracts on its Consolidated Balance Sheets as derivative instruments assets or liabilities depending on whether the net fair value of such contracts is a net asset or net liability, respectively (see Note 9 &#8220;Derivative Financial Instruments and Risk Management,&#8221; of the Notes to the Consolidated Financial Statements). The Company did not hold any foreign currency derivatives designated as cash flow hedges in the year ended April 30, 2016 (2015 - none).</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr> <td width="5%">&#160;</td> <td valign="top" width="5%">c)</td> <td> <i>New Accounting Pronouncements</i> </td> </tr> </table> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> In May 2014, FASB issued ASU 2014-09, <i>Revenue From Contracts With Customers</i> (&#8220;Topic 606&#8221;). Topic 606 removes inconsistencies and weaknesses in revenue requirements, provides a more robust framework for addressing revenue issues, improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, provides more useful information to users of financial statements through improved disclosure requirements and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The guidance in this update supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance throughout the Industry Topics of the Codification. In August 2015, ASU 2015-14 was issued which delayed the effective date for public entities to reporting periods beginning after December 15, 2017. Early adoption is not permitted. The Company is currently evaluating the impact of the adoption of this new standard. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> In August 2014, FASB issued ASU 2014-15, <i>Presentation of Financial Statements &#8211; Going Concern</i> , which requires management to evaluate whether there is substantial doubt about an entity&#8217;s ability to continue as a going concern and provide related footnote disclosures. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. The standard allows for either a full retrospective or modified retrospective transition method. The Company does not expect this standard to have a material impact on the Company&#8217;s consolidated financial statements upon adoption. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;"> In February 2016, FASB issued ASU 2016-02, <i>Leases</i> . The guidance would require lessees to recognize most leases on their balance sheets as lease liabilities with corresponding right &#8211;of-use assets. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2018. The Company is currently evaluating the impact of its pending adoption of ASU 2016-02 on its consolidated financial statements. </p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross versus Net), which clarifies the guidance in the new revenue standard on assessing whether an entity is a principal or an agent in a revenue transaction. This conclusion impacts whether an entity reports revenue on a gross or net basis. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies the guidance in the new revenue standard regarding an entity&#8217;s identification of its performance obligations in a contract, as well as an entity&#8217;s evaluation of the nature of its promise to grant a license of intellectual property and whether or not that revenue is recognized over time or at a point in time. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In May 2016, the FASB issued ASU 2016-11, Revenue Recognition: Customer Payments and Incentives, which clarifies the guidance in recognizing costs for consideration given by a vendor to a customer as a component of cost of sales. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In May 2016, the FASB issued ASU 2016-12, Revenue from Contracts with Customers: Narrow-Scope Improvements and Practical Expedients which amends the guidance in the new revenue standard on collectability, noncash consideration, presentation of sales tax, and transition. The amendments are intended to address implementation issues and provide additional practical expedients to reduce the cost and complexity of applying the new revenue standard. These amendments have the same effective date as the new revenue standard. While we are currently evaluating the method of adoption and the impact of the new revenue standard, as amended, on our Consolidated Financial Statements and related disclosures, we believe the adoption of the new standard may have a significant impact on the accounting for certain transactions with multiple elements or &#8220;bundled&#8221; arrangements because the requirement to have VSOE for undelivered elements under current accounting standards is eliminated under the new standard. Accordingly, we may be required to recognize as revenue a portion of the sales price upon delivery of the software, as compared to the current requirement of recognizing the entire sales price ratably over an estimated offering period. We continue to evaluate the impact of the new revenue standard on our Consolidated Financial Statements and related disclosures.</p> <p align="justify" style="margin-left: 10%; font-family: times new roman,times,serif; font-size: 10pt;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments: Measurement of Credit Losses on Financial Instruments which amends the guidance on measuring credit losses on financial assets held at amortized cost. The amendment is intended to address the issue that the previous &#8220;incurred loss&#8221; methodology was restrictive for Company&#8217;s ability to record credit losses based on not yet meeting the &#8220;probable&#8221; threshold. The new language will require these assets to be valued at amortized cost presented at the net amount expected to be collected will a valuation provision. The amendments will be effective for fiscal years beginning after December 15, 2019. We are evaluating the impact of this amendment on our consolidated financial statements and related disclosures.</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td nowrap="nowrap" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap">Computer hardware</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="40%">Two years</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" nowrap="nowrap">Computer software</td> <td align="left" nowrap="nowrap" width="40%">Two years</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap">Leasehold improvements</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="40%">Shorter of lease term or estimated economic life</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" nowrap="nowrap">Office furniture</td> <td align="left" nowrap="nowrap" width="40%">Five years</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap">Website</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="40%">Three years</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>Years Ended April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="10%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Balance of allowance for doubtful debts, beginning of year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 294,719 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 240,681 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Bad debt provision</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 612,769 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 628,113 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Write-off of receivables</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (360,315 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (574,075 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Balance of allowance for doubtful debts, end of year</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 547,173 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 294,719 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 294719 240681 612769 628113 -360315 -574075 547173 294719 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>Years Ended April 30,</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="10%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Balance, beginning of year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 73,117 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 69,159 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Usage during the year</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Additions (reductions) during the year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (11,761 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 3,958 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="10%">&#160;</td> <td align="left" valign="bottom">Balance, end of year</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 61,356 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 73,117 </td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="2%">&#160;</td> </tr> </table> 73117 69159 0 0 -11761 3958 61356 73117 180 1540467 0.50 812169 382580 6339717 6704947 2083960 2083752 5341481 6704947 5578159 1659747 2083752 1733290 0 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 3</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Equipment</u> </b> </td> </tr> </table> <br/> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="36%"> <b>April 30, 2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">Accumulated</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Cost</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Depreciation</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Net</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Computer hardware</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 1,049,179 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 976,511 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 72,668 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Computer software</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 1,008,373 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 1,002,097 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 6,276 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Leasehold improvements</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 263,003 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 237,147 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 25,856 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Office furniture</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 190,754 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 186,325 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 4,429 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Websites</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 120,953 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 87,619 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 33,334 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 2,632,262 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 2,489,699 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 142,563 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <br/> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="36%"> <b>April 30, 2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">Accumulated</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Cost</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Depreciation</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Net</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Computer hardware</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 1,072,376 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 953,384 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 118,992 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Computer software</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 1,022,687 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 977,430 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 45,257 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Leasehold improvements</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 280,893 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 238,818 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 42,075 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Office furniture</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 204,680 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 197,601 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 7,079 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Websites</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 122,161 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 63,828 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 58,333 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 2,702,797 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 2,431,061 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 271,736 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="36%"> <b>April 30, 2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">Accumulated</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Cost</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Depreciation</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Net</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Computer hardware</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 1,049,179 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 976,511 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 72,668 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Computer software</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 1,008,373 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 1,002,097 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 6,276 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Leasehold improvements</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 263,003 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 237,147 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 25,856 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Office furniture</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 190,754 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 186,325 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 4,429 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Websites</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 120,953 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 87,619 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 33,334 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 2,632,262 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 2,489,699 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 142,563 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 1049179 976511 72668 1008373 1002097 6276 263003 237147 25856 190754 186325 4429 120953 87619 33334 2632262 2489699 142563 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="36%"> <b>April 30, 2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">Accumulated</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Cost</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Depreciation</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">Net</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="10%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Computer hardware</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 1,072,376 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 953,384 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 118,992 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Computer software</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 1,022,687 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 977,430 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 45,257 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Leasehold improvements</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 280,893 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 238,818 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 42,075 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Office furniture</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 204,680 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 197,601 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 7,079 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Websites</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 122,161 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 63,828 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 58,333 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 2,702,797 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 2,431,061 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 271,736 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 1072376 953384 118992 1022687 977430 45257 280893 238818 42075 204680 197601 7079 122161 63828 58333 2702797 2431061 271736 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 4</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Accounts Payable and Accrued Liabilities</u> </b> </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Accounts payable and accrued liabilities at April 30, 2016 and 2015 are comprised of the following:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="center" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="center" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Accounts payable &#8211; trade</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 407,737 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 500,739 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" valign="bottom">Accrued commissions</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 272,282 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 184,791 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Accrued vacation</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 617,589 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 688,965 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" valign="bottom">Third party software royalties</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 343,447 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 568,814 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Other accrued liabilities</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 302,053 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 362,271 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 1,943,108 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 2,305,580 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="center" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="center" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Accounts payable &#8211; trade</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 407,737 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 500,739 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" valign="bottom">Accrued commissions</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 272,282 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 184,791 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Accrued vacation</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 617,589 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 688,965 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" valign="bottom">Third party software royalties</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 343,447 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 568,814 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Other accrued liabilities</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 302,053 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 362,271 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td align="left" nowrap="nowrap" valign="bottom" width="5%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 1,943,108 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 2,305,580 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 407737 500739 272282 184791 617589 688965 343447 568814 302053 362271 1943108 2305580 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 5</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Related Party Transactions</u> </b> </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> During the year ended April 30, 2016, the Company through its wholly owned subsidiary, CounterPath Technologies Inc., paid $82,288 (2015 - $85,954) to Kanata Research Park Corporation (&#8220;KRP&#8221;) for leased office space. KRP is controlled by the Chairman of the Company. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> On November 21, 2013, the Company, through its wholly owned subsidiary, CounterPath Technologies, entered into an agreement with 8007004 (Canada) Inc. (&#8220;8007004&#8221;) to lease office space. 8007004 is controlled by a member of the board of directors of the Company. CounterPath Technologies, paid $31,910 (2015 - $17,471) for the year ended April 30, 2016. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> On July 31, 2015, the Company sold products and services to Magor Corporation for consideration of $134,250. Magor Corporation&#8217;s chairman of the board is also Chairman of the Company. As at April 30, 2016, the Company had an accounts receivable balance from Magor Corporation of $nil. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> On September 4, 2015, the Company completed a non-brokered private placement (the &#8220;Private Placement&#8221;) of 293,000 units, at a price of $5.00 per unit, for gross aggregate proceeds of $1,465,000 less stock issuance costs of $23,161. In connection with the Private Placement, Kanata Research Park Corporation, a company controlled by the Chairman of the Company, purchased 150,000 units and a director of the Company purchased 10,000 units. Each unit consists of one share of common stock and one-half of one non-transferable common share purchase warrant. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The above transactions are in the normal course of operations and are recorded at amounts established and agreed to between the related parties.</p> 82288 85954 31910 17471 134250 0 293000 5.00 1465000 23161 150000 10000 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 6</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Common Stock</u> </b> </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <u>Private Placement</u> </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> On September 4, 2015, the Company issued an aggregate of 293,000 units under a non-brokered private placement at a price of $5.00 per unit for aggregate gross proceeds of $1,465,000 less issuance costs of $23,454. Each unit consists of one share of the Company&#8217;s common stock and one-half of one common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share of the Company&#8217;s common stock at an exercise price of $7.50 per share until September 4, 2017. The warrants were evaluated against ASC 815 Derivatives and Hedging, and determined to be equity instruments. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> On April 4, 2016, the Company entered into an agreement to issue 25,000 shares of the Company&#8217;s common stock in exchange for advisory services. These shares would be issued in three tranches: (i) first tranche of 10,000 shares of the Company&#8217;s common stock issued before April 30, 2016; (ii) second tranche of 10,000 shares of the Company&#8217;s common stock issued before May 31, 2016; (iii) and the third tranche of 5,000 shares of the Company&#8217;s common stock issued before June 30, 2016. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <u>Reverse Stock Split</u> </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">On October 8, 2015 the Board approved a one for ten reverse stock split effected at the opening of trading on November 2, 2015. The impact of this reverse stock split has been reflected in these consolidated financial statements.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <u>Stock Options</u> </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> The Company has a stock option plan (the &#8220;2010 Stock Option Plan&#8221;) under which options to purchase common shares of the Company may be granted to employees, directors and consultants. The 2010 Stock Option Plan is effectively a merging of the Company&#8217;s 2004 and 2005 stock option plans. Stock options entitle the holder to purchase common stock at a subscription price determined by the Board of Directors of the Company at the time of the grant. The options generally vest in the amount of 12.5% on the date which is six months from the date of grant and then beginning in the seventh month at 1/42 per month for 42 months, at which time the options are fully vested. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> The maximum number of shares of common stock authorized by the stockholders and reserved for issuance by the Board under 2010 Stock Option Plan is 786,000. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The Company uses the Black-Scholes option pricing model to determine the fair value of stock options granted. In accordance with ASC 718 &#8220;Share-Based Payment&#8221; for employees, the compensation expense is amortized on a straight-line basis over the requisite service period which approximates the vesting period. Compensation expense for stock options granted to non-employees is amortized over the vesting period or, if none exists, over the service period. Compensation associated with unvested options granted to non-employees is re-measured on each balance sheet date using the Black-Scholes option pricing model.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The expected volatility of options granted has been determined using the method described under ASC 718 using the historical stock price. The expected term of options granted to employees in the current fiscal period has been determined utilizing historic data as prescribed by ASC 718.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> For non-employees, based on the Company&#8217;s history, the expected term of the options approximates the full term of the options. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The Company has not paid and does not anticipate paying dividends on its common stock; therefore, the expected dividend yield is assumed to be zero. In addition, ASC 718 requires companies to utilize an estimated forfeiture rate when calculating the expense for the period, whereas prior to the adoption of ASC 718 the Company recorded forfeitures based on actual forfeitures and recorded a compensation expense recovery in the period when the awards were forfeited. As a result, based on the Company&#8217;s experience, the Company applied an estimated forfeiture rate of 15% for year ended April 30, 2016 and 2015 in determining the expense recorded in the accompanying consolidated statement of operations. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">For the majority of the stock options granted, the number of shares issued on the date the stock options are exercised is net of the minimum statutory withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. These withheld shares are not issued or considered common stock repurchases under our authorized plan and are not included in the common stock repurchase totals. In our consolidated financial statements, these withheld shares are netted against the number of shares that would have been issued upon vesting.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> The weighted-average fair values of options granted during the years ended April 30, 2016 and 2015 were $2.35 and $4.10, respectively. The weighted-average assumptions utilized to determine such values are presented in the following table: </p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Year Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Year Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>April 30, 2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>April 30, 2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Risk-free interest rate</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 1.66% </td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 1.60% </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Expected volatility</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> 92.48% </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> 57.58% </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Expected term</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 3.7 yrs </td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 3.7 yrs </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Dividend yield</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> 0% </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> 0% </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The following is a summary of the status of the Company&#8217;s stock options as of April 30, 2016 and the stock option activity during the years ended April 30, 2016 and 2015:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Number of</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Weighted-Average</b> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Options</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Exercise Price per Share</b> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Outstanding at April 30, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 370,554 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $9.40 </p> </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 124,600 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $6.00 </p> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Exercised</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (33,473 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%"> ) <sup>(1)</sup> </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $14.40 </p> </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Forfeited / Cancelled</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> (45,983 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $10.30 </p> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Expired</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (3,917 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $9.40 </p> </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Outstanding at April 30, 2015</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 411,781 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $15.20 </p> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Granted</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 114,900 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $3.72 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Exercised</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Forfeited / Cancelled</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (66,216 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $8.87 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Expired</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (49,735 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> $15.63 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Outstanding at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 410,730 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> $12.99 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td align="center" valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Exercisable at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 236,795 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $16.77 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Exercisable at April 30, 2015</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 210,544 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $17.70 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <br/> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr> <td width="5%">&#160;</td> <td valign="top" width="5%"> <b> <sup>(1)</sup> </b> </td> <td> In 2015 33,236 stock options were cashlessly exercised upon which 6,789 shares of common stock were issued. </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The following table summarizes information regarding stock options outstanding as of April 30, 2016:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" nowrap="nowrap">&#160;</td> <td align="center" nowrap="nowrap" width="16%"> <b>Number of</b> </td> <td align="center" nowrap="nowrap" width="16%"> <b>Aggregate</b> </td> <td align="left" nowrap="nowrap" width="16%">&#160;</td> <td align="center" nowrap="nowrap" width="16%"> <b>Number of</b> </td> <td align="center" nowrap="nowrap" width="16%"> <b>Aggregate</b> </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> <b>Exercise</b> </td> <td align="center" nowrap="nowrap" width="16%"> <b>Options</b> </td> <td align="center" nowrap="nowrap" width="16%"> <b>Intrinsic</b> </td> <td align="left" nowrap="nowrap" width="16%">&#160;</td> <td align="center" nowrap="nowrap" width="16%"> <b>Options</b> </td> <td align="center" nowrap="nowrap" width="16%"> <b>Intrinsic</b> </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid"> <b>Price</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> <b>Outstanding</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> <b>Value</b> </td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> <b>Expiry Date</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> <b>Exercisable</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> <b>Value</b> </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $2.41 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 56,000 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">December 14, 2020</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $4.50 </td> <td align="right" nowrap="nowrap" width="16%"> 5,000 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">March 9, 2020</td> <td align="right" nowrap="nowrap" width="16%"> 1,360 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $4.70 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 540 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">September 26, 2016</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 540 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $5.00 </td> <td align="right" nowrap="nowrap" width="16%"> 50,900 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">July 17, 2020</td> <td align="right" nowrap="nowrap" width="16%"> 9,614 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $5.20 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 9,482 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">March 23, 2020</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 8,805 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $7.80 </td> <td align="right" nowrap="nowrap" width="16%"> 3,400 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">December 12, 2019</td> <td align="right" nowrap="nowrap" width="16%"> 1,224 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $10.50 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 6,825 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">September 12, 2019</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 3,809 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $11.50 </td> <td align="right" nowrap="nowrap" width="16%"> 51,000 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">July 11, 2019</td> <td align="right" nowrap="nowrap" width="16%"> 25,192 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $12.30 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 2,083 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">January 13, 2019</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 2,083 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $13.10 </td> <td align="right" nowrap="nowrap" width="16%"> 60,000 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">December 12, 2018</td> <td align="right" nowrap="nowrap" width="16%"> 35,014 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $17.00 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 65,000 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">December 14, 2016</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 65,000 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $19.00 </td> <td align="right" nowrap="nowrap" width="16%"> 46,500 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">July 25, 2018</td> <td align="right" nowrap="nowrap" width="16%"> 32,026 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $21.50 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 24,000 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">September 7, 2016</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 24,000 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $29.00 </td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> 30,000 </td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">July 19, 2017</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> 28,128 </td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap">April 30, 2016</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> 410,730 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="16%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> 236,795 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> &#8211; </td> </tr> <tr> <td width="5%">&#160;</td> <td align="center">&#160;</td> <td width="16%">&#160;</td> <td width="16%">&#160;</td> <td width="16%">&#160;</td> <td width="16%">&#160;</td> <td width="16%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap">April 30, 2015</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> 441,780 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> $6,183 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="16%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 210,544 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> $3,683 </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> The aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company&#8217;s closing stock price of $2.12 per share as of April 30, 2016 (April 30, 2015 &#8211; $5.00), which would have been received by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options vested and exercisable as of April 30, 2016 was nil (April 30, 2015 &#8211; 12,275). The total intrinsic value of options exercised during the year ended April 30, 2016 was $nil (2015 &#8211; $33,094). The grant date fair value of options vested during the year ended April 30, 2016 was $579,614 (April 30, 2015 &#8211; $698,238). </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The following table summarizes information regarding the non-vested stock purchase options outstanding as of April 30, 2015:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Number of</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Weighted Average</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Options</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Grant-Date Fair Value</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-vested options at April 30, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 193,791 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $8.70 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 124,600 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $4.10 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Vested</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (81,685 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $8.50 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Forfeited</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (35,469 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> $6.80 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-vested options at April 30, 2015</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 201,237 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $6.20 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 114,900 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $2.35 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Vested</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (83,318 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $6.96 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Forfeited</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (58,884 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> $4.79 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-vested options at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 173,935 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> $4.15 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> As of April 30, 2016, there was $593,978 of total unrecognized compensation cost related to unvested stock options. This unrecognized compensation cost is expected to be recognized over a weighted average period of 2.08 years. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Employee and non-employee stock-based compensation amounts classified in the Company&#8217;s consolidated statements of operations for the year ended April 30, 2016 and 2015 are as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Years Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Cost of sales</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 68,259 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 75,535 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Sales and marketing</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 253,913 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 279,121 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Research and development</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 80,228 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 65,135 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">General and administrative</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 180,536 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 235,600 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Total stock-based compensation</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 582,936 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 655,391 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <u>Warrants</u> </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> On September 4, 2015, the Company completed a non-brokered private placement (the &#8220;Private Placement&#8221;) of 293,000 units, at a price of $5.00 per unit, for gross aggregate proceeds of $1,465,000 less stock issuance costs of $23,161. Each unit consists of one share of common stock and one-half of one non-transferable common share purchase warrant. Each whole warrant entitles the holder to purchase one additional share of the Company&#8217;s common stock at an exercise price of $7.50 per share until September 4, 2017. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The following tables summarize information regarding the warrants outstanding as of April 30, 2016 and April 30, 2015.</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Weighted</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Number of</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Average</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Warrants</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Exercise Price</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Expiry Dates</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Warrants at April 30, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 73,250 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> $32.50 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">June 19, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Exercised</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Expired</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> (73,250 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> $32.50 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Warrants at April 30, 2015</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 146,500 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> $7.50 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%">September 4, 2017</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Exercised</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Expired</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Warrants at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 146,500 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> $7.50 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">September 4, 2017</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <u>Employee Stock Purchase Plan</u> </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> Under the terms of the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) all regular salaried (non-probationary) employees can purchase up to 6% of their base salary in common shares of the Company at market price. The Company will match 50% of the shares purchased by issuing or purchasing in the market up to 3% of the respective employee&#8217;s base salary in shares. During the year ended April 30, 2016, the Company matched $39,472 (2015 - $55,378) in shares purchased by employees under the ESPP. During the year ended April 30, 2016, 36,539 shares (2015 &#8211; 18,442) were issued or purchased by employees on the open market under the ESPP. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> On September 28, 2015, the number of shares reserved for issuance under the ESPP plan was increased from 70,000 shares to 120,000 shares. As of April 30, 2016, a total of 86,203 shares were available for issuance under the ESPP. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <u>Normal Course Issuer Bid Plan</u> </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> Pursuant to a normal course issuer bid (&#8220;NCIB&#8221;) commencing on March 19, 2016 and expiring March 18, 2017, the Company was authorized to purchase 273,864 shares of the Company&#8217;s common stock through the facilities of the Toronto Stock Exchange (the &#8220;TSX&#8221;) and other Canadian marketplaces or U.S. marketplaces. Pursuant to an NCIB commencing March 19, 2014 and expiring March 18, 2015, the Company repurchased 36,133 shares at an average price of $9.30 (CDN$10.51) for an aggregate purchase price of $336,033. During the period from March 19, 2015 to March 18, 2016, the Company repurchased 11,360 shares at an average price of $3.80 (CDN$4.97) for a total of $43,168 and during the period March 19, 2016 to April 30, 2016, we repurchased 400 common shares at an average price of $2.14 (CDN$2.75) for a total of $856. As of April 30, 2016, a total of 75,788 shares have been cancelled and the remaining 400 repurchased shares are in the process of being cancelled since the NCIB was initiated. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <u>Deferred Share Unit Plan</u> </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> Under the terms of the DSUP which is effective as at October 22, 2009, each deferred share unit (each, a &#8220;DSU&#8221;) is equivalent to one share of common stock. The maximum number of shares of common stock that may be reserved for issuance to any one participant pursuant to DSUs granted under the DSUP and any share compensation arrangement is 5% of the number of shares of common stock of the Company outstanding at the time of reservation. A DSU granted to a participant who is a director of the Company shall vest immediately on the award date. A DSU granted to a participant other than a director will generally vest as to one-third (1/3) of the number of DSUs granted on the first, second and third anniversaries of the award date. Fair value of the DSUs, which is based on the closing price of the Company&#8217;s common stock on the date of grant, is recorded as compensation expense over the vesting period. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> On September 28, 2015, the shares reserved for issuance under the DSUP plan was increased from 300,000 shares to 400,000 shares. During the year ended April 30, 2016, 55,034 (2015 &#8211; 32,661) DSUs were issued under the DSUP, of which 23,911 DSUs were granted to officers and 31,123 DSUs were granted to non-employee directors. As of April 30, 2016, a total of 121,048 shares were available for issuance under the DSUP. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The following table summarizes the Company&#8217;s outstanding DSU awards as of April 30, 2016 and 2015, and changes during the period then ended:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Weighted Average Grant</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Number of DSU&#8217;s</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Date Fair Value per Unit</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">DSU&#8217;s at April 30, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 167,243 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $10.90 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 32,662 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $11.70 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Conversions</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Outstanding at April 30, 2015</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 199,905 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $11.00 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Granted</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 55,034 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $5.20 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Conversions</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Outstanding at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 254,939 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> $9.79 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> As of April 30, 2016, there was $189,523 (2015 &#8211; $227,324) of total unrecognized compensation cost related to unvested DSU awards. This unrecognized compensation cost is expected to be recognized over a weighted average period of 1.63 years (2015 &#8211; 1.85). The total fair value of DSUs that vested during the year was $338,912 (2015 &#8211; $344,678). </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Employee and non-employee DSU based compensation amounts classified in the Company&#8217;s consolidated statements of operations for the year ended April 30, 2016 and 2015 are as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Year Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom">Sales and marketing</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#160; &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 1,667 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom">Research and development</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 1,633 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 8,328 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom">General and administrative</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 322,345 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 334,683 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom">Total deferred share unit-based compensation</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 323,978 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 344,678 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The following table summarizes information regarding the non-vested DSUs outstanding as of April 30, 2016:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Weighted Average</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Grant Date Fair</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Number of DSUs</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Value per Unit</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-vested DSUs at April 30, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 15,678 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $21.60 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 32,661 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $11.70 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Vested</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (23,170 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> $16.50 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Non-vested DSUs at April 30, 2015</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 25,169 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $14.60 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Granted</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 55,034 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $5.20 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Vested</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (41,681 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> $8.13 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-vested DSUs at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 38,522 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> $8.15 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Year Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Year Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>April 30, 2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>April 30, 2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Risk-free interest rate</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 1.66% </td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 1.60% </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Expected volatility</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> 92.48% </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> 57.58% </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Expected term</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 3.7 yrs </td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 3.7 yrs </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Dividend yield</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> 0% </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> 0% </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 0.0166 0.0160 0.9248 0.5758 3.7 3.7 0.00 0.00 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Number of</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Weighted-Average</b> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Options</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Exercise Price per Share</b> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Outstanding at April 30, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 370,554 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $9.40 </p> </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 124,600 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $6.00 </p> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Exercised</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (33,473 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%"> ) <sup>(1)</sup> </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $14.40 </p> </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Forfeited / Cancelled</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> (45,983 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $10.30 </p> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Expired</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (3,917 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $9.40 </p> </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Outstanding at April 30, 2015</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 411,781 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <p style="font-family: times new roman,times,serif; font-size: 10pt;margin:inherit;"> $15.20 </p> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Granted</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 114,900 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $3.72 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Exercised</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Forfeited / Cancelled</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (66,216 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $8.87 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Expired</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (49,735 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> $15.63 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Outstanding at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 410,730 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> $12.99 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td align="center" valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Exercisable at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 236,795 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $16.77 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Exercisable at April 30, 2015</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 210,544 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $17.70 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 370554 9.40 124600 6.00 -33473 14.40 -45983 10.30 -3917 9.40 411781 15.20 114900 3.72 0 0 -66216 8.87 -49735 15.63 410730 12.99 236795 16.77 210544 17.70 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" nowrap="nowrap">&#160;</td> <td align="center" nowrap="nowrap" width="16%"> <b>Number of</b> </td> <td align="center" nowrap="nowrap" width="16%"> <b>Aggregate</b> </td> <td align="left" nowrap="nowrap" width="16%">&#160;</td> <td align="center" nowrap="nowrap" width="16%"> <b>Number of</b> </td> <td align="center" nowrap="nowrap" width="16%"> <b>Aggregate</b> </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> <b>Exercise</b> </td> <td align="center" nowrap="nowrap" width="16%"> <b>Options</b> </td> <td align="center" nowrap="nowrap" width="16%"> <b>Intrinsic</b> </td> <td align="left" nowrap="nowrap" width="16%">&#160;</td> <td align="center" nowrap="nowrap" width="16%"> <b>Options</b> </td> <td align="center" nowrap="nowrap" width="16%"> <b>Intrinsic</b> </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid"> <b>Price</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> <b>Outstanding</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> <b>Value</b> </td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> <b>Expiry Date</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> <b>Exercisable</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> <b>Value</b> </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $2.41 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 56,000 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">December 14, 2020</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $4.50 </td> <td align="right" nowrap="nowrap" width="16%"> 5,000 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">March 9, 2020</td> <td align="right" nowrap="nowrap" width="16%"> 1,360 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $4.70 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 540 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">September 26, 2016</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 540 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $5.00 </td> <td align="right" nowrap="nowrap" width="16%"> 50,900 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">July 17, 2020</td> <td align="right" nowrap="nowrap" width="16%"> 9,614 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $5.20 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 9,482 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">March 23, 2020</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 8,805 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $7.80 </td> <td align="right" nowrap="nowrap" width="16%"> 3,400 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">December 12, 2019</td> <td align="right" nowrap="nowrap" width="16%"> 1,224 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $10.50 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 6,825 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">September 12, 2019</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 3,809 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $11.50 </td> <td align="right" nowrap="nowrap" width="16%"> 51,000 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">July 11, 2019</td> <td align="right" nowrap="nowrap" width="16%"> 25,192 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $12.30 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 2,083 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">January 13, 2019</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 2,083 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $13.10 </td> <td align="right" nowrap="nowrap" width="16%"> 60,000 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">December 12, 2018</td> <td align="right" nowrap="nowrap" width="16%"> 35,014 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $17.00 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 65,000 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">December 14, 2016</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 65,000 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $19.00 </td> <td align="right" nowrap="nowrap" width="16%"> 46,500 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">July 25, 2018</td> <td align="right" nowrap="nowrap" width="16%"> 32,026 </td> <td align="right" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap"> $21.50 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 24,000 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%">September 7, 2016</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 24,000 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap"> $29.00 </td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> 30,000 </td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> &#8211; </td> <td align="right" nowrap="nowrap" width="16%">July 19, 2017</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> 28,128 </td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" width="16%"> &#8211; </td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap">April 30, 2016</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> 410,730 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="16%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> 236,795 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> &#8211; </td> </tr> <tr> <td width="5%">&#160;</td> <td align="center">&#160;</td> <td width="16%">&#160;</td> <td width="16%">&#160;</td> <td width="16%">&#160;</td> <td width="16%">&#160;</td> <td width="16%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap">April 30, 2015</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> 441,780 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" width="16%"> $6,183 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" width="16%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> 210,544 </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" width="16%"> $3,683 </td> </tr> </table> 2.41 56000 0 0 0 4.50 5000 0 1360 0 4.70 540 0 540 0 5.00 50900 0 9614 0 5.20 9482 0 8805 0 7.80 3400 0 1224 0 10.50 6825 0 3809 0 11.50 51000 0 25192 0 12.30 2083 0 2083 0 13.10 60000 0 35014 0 17.00 65000 0 65000 0 19.00 46500 0 32026 0 21.50 24000 0 24000 0 29.00 30000 0 28128 0 410730 0 236795 0 441780 6183 210544 3683 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Number of</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Weighted Average</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Options</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Grant-Date Fair Value</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-vested options at April 30, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 193,791 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $8.70 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 124,600 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $4.10 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Vested</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (81,685 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $8.50 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Forfeited</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (35,469 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> $6.80 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-vested options at April 30, 2015</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 201,237 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $6.20 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 114,900 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $2.35 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Vested</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (83,318 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $6.96 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Forfeited</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (58,884 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> $4.79 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-vested options at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 173,935 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> $4.15 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 193791 8.70 124600 4.10 -81685 8.50 -35469 6.80 201237 6.20 114900 2.35 -83318 6.96 -58884 4.79 173935 4.15 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Years Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Cost of sales</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 68,259 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 75,535 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Sales and marketing</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 253,913 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 279,121 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Research and development</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 80,228 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 65,135 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">General and administrative</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 180,536 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 235,600 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Total stock-based compensation</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 582,936 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 655,391 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 68259 75535 253913 279121 80228 65135 180536 235600 582936 655391 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Weighted</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Number of</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Average</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Warrants</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Exercise Price</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Expiry Dates</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Warrants at April 30, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 73,250 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> $32.50 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">June 19, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Exercised</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Expired</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> (73,250 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> $32.50 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Warrants at April 30, 2015</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 146,500 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> $7.50 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%">September 4, 2017</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Exercised</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Expired</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Warrants at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 146,500 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> $7.50 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">September 4, 2017</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 73250 32.50 0 0 0 0 0 0 -73250 32.50 0 0 0 0 146500 7.50 0 0 0 0 0 0 146500 7.50 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Weighted Average Grant</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Number of DSU&#8217;s</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Date Fair Value per Unit</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">DSU&#8217;s at April 30, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 167,243 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $10.90 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 32,662 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $11.70 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Conversions</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Outstanding at April 30, 2015</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 199,905 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $11.00 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Granted</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 55,034 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $5.20 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Conversions</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Outstanding at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 254,939 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> $9.79 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 167243 10.90 32662 11.70 0 0 199905 11.00 55034 5.20 0 0 254939 9.79 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Year Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom">Sales and marketing</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#160; &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 1,667 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom">Research and development</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 1,633 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 8,328 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom">General and administrative</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 322,345 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 334,683 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom">Total deferred share unit-based compensation</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 323,978 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 344,678 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 0 1667 1633 8328 322345 334683 323978 344678 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Weighted Average</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>Grant Date Fair</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Number of DSUs</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Value per Unit</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-vested DSUs at April 30, 2014</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 15,678 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $21.60 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Granted</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 32,661 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $11.70 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Vested</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (23,170 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> $16.50 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Non-vested DSUs at April 30, 2015</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 25,169 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> $14.60 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Granted</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 55,034 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> $5.20 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Vested</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (41,681 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> $8.13 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-vested DSUs at April 30, 2016</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 38,522 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> $8.15 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 15678 21.60 32661 11.70 -23170 16.50 25169 14.60 55034 5.20 -41681 8.13 38522 8.15 293000 5.00 1465000 23454 7.50 25000 10000 10000 5000 0.125 42 786000 0.15 2.35 4.10 33236 6789 2.12 5.00 0 12275 0 33094 579614 698238 593978 2.08 293000 5.00 1465000 23161 7.50 0.06 0.50 0.03 39472 55378 36539 18442 70000 120000 86203 273864 36133 9.30 10.51 336033 11360 3.80 4.97 43168 400 2.14 2.75 856 75788 400 0.05 300000 400000 55034 32661 23911 31123 121048 189523 227324 1.63 1.85 338912 344678 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 7</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Income Taxes</u> </b> </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Deferred tax assets and liabilities are recognized for temporary differences between the carrying amount of the balance sheet items and their corresponding tax values as well as for the benefit of losses available to be carried forward to future years for tax purposes that are likely to be realized.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Significant components of the Company&#8217;s deferred tax assets and liabilities, after applying enacted corporate income tax rates, are as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Years Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Tax loss carry forwards</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 18,796,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 16,271,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Capital losses carried forward</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 247,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 262,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Equipment</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 242,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 184,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Other</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 64,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 64,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Bad debt</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 186,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 100,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Nondeductible research and development expenses</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 3,084,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 3,266,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Investment tax credits</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 490,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 494,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Cumulative unrealized foreign exchange gain</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 410,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 467,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Acquired technology and other intangibles</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (1,115,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (896,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Valuation allowance established by management</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (22,404,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (20,212,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Net deferred tax assets</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#160; &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#160; &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The provision for income taxes differ from the amount calculated using the U.S. federal and state statutory income tax rates as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Years Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Tax (recovery) based on U.S. rates</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (915,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (1,510,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Foreign tax rate differential</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> (34,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> (75,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-deductible expenses</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Change in fair value of derivative instrument</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-deductible stock option compensation</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 295,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 374,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Effect of reduction (increase) in foreign statutory rates</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 104,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Foreign exchange gain (losses) on revaluation of deferred tax balances</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 384,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 787,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Under provision relating to prior year</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> (2,026,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Expiry of non-operating losses</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Increase in valuation allowance</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 2,192,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 424,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Income tax expense for year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#160; &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#160; &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> The Company establishes its valuation allowance based on projected future operations. Management has determined that the allowance should be 100% of the deferred tax assets. When circumstances cause a change in management&#8217;s judgment about the recoverability of deferred tax assets, the impact of the change on the valuation allowance will be reflected in current income. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">As at April 30, 2016, the Company had net operating loss carry-forwards available to reduce taxable income in future years as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom"> <b> <u>Country</u> </b> </td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Amount</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Expiration Dates</b> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">United States &#8211; US$</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 39,431,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%">2027 &#8211; 2036</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Canada &#8211; CDN$</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 15,717,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%"> <sup>(1)</sup> </td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%">2017 &#8211; 2034</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <sup>(1)</sup> These losses are subject to tax legislation that limits the use of the losses against future income of the Company&#8217;s Canadian subsidiaries. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The Company is subject to taxation in the U.S. and Canada. It is subject to tax examinations by tax authorities for all taxation years commencing in or after 2002. The Company does not expect any material increase or decrease in its income tax expense in the next twelve months related to examinations or changes in uncertain tax positions.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Changes in the Company&#8217;s uncertain tax positions for the year ended April 30, 2016 and April 30, 2015 were as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Years Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Balance at beginning of year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 25,631 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 25,631 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Increases related to prior year tax positions (interest and penalties)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Increases related to current year tax positions (interest and penalties)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Settlements</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Lapses in statute of limitations</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (15,068 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (15,068 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Balance at end of year</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 10,563 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 10,563 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Years Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Tax loss carry forwards</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 18,796,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 16,271,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Capital losses carried forward</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 247,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 262,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Equipment</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 242,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 184,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Other</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 64,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 64,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Bad debt</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 186,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 100,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Nondeductible research and development expenses</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 3,084,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 3,266,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Investment tax credits</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 490,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 494,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Cumulative unrealized foreign exchange gain</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 410,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 467,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Acquired technology and other intangibles</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (1,115,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (896,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Valuation allowance established by management</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (22,404,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (20,212,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Net deferred tax assets</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#160; &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#160; &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 18796000 16271000 247000 262000 242000 184000 64000 64000 186000 100000 3084000 3266000 490000 494000 410000 467000 -1115000 -896000 -22404000 -20212000 0 0 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Years Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Tax (recovery) based on U.S. rates</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (915,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (1,510,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Foreign tax rate differential</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> (34,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> (75,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-deductible expenses</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Change in fair value of derivative instrument</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Non-deductible stock option compensation</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 295,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 374,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Effect of reduction (increase) in foreign statutory rates</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 104,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Foreign exchange gain (losses) on revaluation of deferred tax balances</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 384,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 787,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Under provision relating to prior year</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> (2,026,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Expiry of non-operating losses</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Increase in valuation allowance</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 2,192,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 424,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Income tax expense for year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#160; &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#160; &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> -915000 -1510000 -34000 -75000 0 0 0 0 295000 374000 104000 0 384000 787000 -2026000 0 0 0 2192000 424000 0 0 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom"> <b> <u>Country</u> </b> </td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Amount</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>Expiration Dates</b> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td valign="bottom" width="1%">&#160;</td> <td valign="bottom" width="12%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">United States &#8211; US$</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 39,431,000 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%">2027 &#8211; 2036</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Canada &#8211; CDN$</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 15,717,000 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%"> <sup>(1)</sup> </td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%">2017 &#8211; 2034</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 39431000 15717000 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Years Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Balance at beginning of year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 25,631 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 25,631 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Increases related to prior year tax positions (interest and penalties)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Increases related to current year tax positions (interest and penalties)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Settlements</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Lapses in statute of limitations</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (15,068 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> (15,068 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Balance at end of year</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 10,563 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 10,563 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 25631 25631 0 0 0 0 0 0 -15068 -15068 10563 10563 1.00 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 8</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Segmented Information</u> </b> </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The Company&#8217;s chief operating decision maker reviews financial information presented on a consolidated basis, accompanied by disaggregated information about revenues by geographic region for purposes of making operating decisions and assessing financial performance. Accordingly, the Company has concluded that it has one reportable operating segment.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Revenues are based on the country in which the customer is located. The following is a summary of total revenues by geographic area for the years ended April 30, 2016 and 2015:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Years Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">North America</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 7,192,010 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 7,717,932 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">EMEA</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 2,459,541 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 2,520,381 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Asia Pacific</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 699,203 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 1,288,848 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Latin America</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 730,604 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 475,922 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 11,081,358 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 12,003,083 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">As at July 31, 2015, the Company adjusted geographic regions to better reflect its current operations. In prior periods geographic groupings included North America, Europe, Asia and Africa and Latin America.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">All of the Company&#8217;s long-lived assets, which includes equipment, goodwill, intangible assets, and other assets, are located in Canada and the United States as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>As at April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Canada</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 7,279,019 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 7,714,307 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">United States</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 39,583 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 85,003 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 7,318,602 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 7,799,310 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" valign="bottom" width="27%"> <b>Years Ended</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">North America</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 7,192,010 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 7,717,932 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">EMEA</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 2,459,541 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> 2,520,381 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Asia Pacific</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 699,203 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 1,288,848 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Latin America</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 730,604 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 475,922 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 11,081,358 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 12,003,083 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 7192010 7717932 2459541 2520381 699203 1288848 730604 475922 11081358 12003083 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="4" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="27%"> <b>As at April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Canada</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 7,279,019 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> 7,714,307 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">United States</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 39,583 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 85,003 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 7,318,602 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> 7,799,310 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 7279019 7714307 39583 85003 7318602 7799310 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 9</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Derivative Financial Instruments and Risk Management</u> </b> </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">In the normal course of business, the Company is exposed to fluctuations in interest rates and the exchange rates associated with foreign currencies. The Company&#8217;s primary objective for holding derivative financial instruments is to manage foreign currency exchange rate risk.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <u>Foreign Currency Exchange Rate Risk</u> </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">A majority of our revenue activities are transacted in U.S. dollars. However, the Company is exposed to foreign currency exchange rate risk inherent in conducting business globally in numerous currencies, of which the most significant to our operations for the year ended April 30, 2016 is the Canadian dollar. The Company&#8217;s foreign currency risk management program includes foreign currency derivatives with cash flow hedge accounting designation that utilizes foreign currency forward contracts to hedge exposures to the variability in the U.S. dollar equivalent of anticipated non-U.S. dollar-denominated cash flows.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The Company periodically enters into foreign currency forward contracts, not designated as hedging instruments, to protect it from fluctuations in exchange rates. As of April 30, 2016, the Company had no foreign currency forward contracts. Notional amounts do not quantify risk or represent assets or liabilities of the Company, but are used in the calculation of cash settlements under the contracts.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <u>Fair Value Measurements</u> </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">When available, the Company uses quoted market prices to determine fair value, and classifies such measurements within Level 1. In some cases where market prices are not available, the Company makes use of observable market-based inputs to calculate fair value, in which case the measurements are classified within Level 2. If quoted or observable market prices are not available, fair value is based upon internally developed models that use, where possible, current market-based parameters such as interest rates, yield curves and currency rates. These measurements are classified within Level 3.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. A measurement may therefore be classified within Level 3 even though there may be significant inputs that are readily observable.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Fair value measurement includes the consideration of non-performance risk. Non-performance risk refers to the risk that an obligation (either by a counterparty or the Company) will not be fulfilled. For financial assets traded in an active market (Level 1), the non-performance risk is included in the market price. For certain other financial assets and liabilities (Level 2 and 3), our fair value calculations have been adjusted accordingly.</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">The following table presents the Company&#8217;s assets and liabilities, that are measured at fair value on a recurring basis as of April 30, 2016 and 2015:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Carrying</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Fair Value</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <b>As at April 30, 2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Amount</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Fair Value</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Levels</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Reference</b> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Cash</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 2,159,738 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 2,159,738 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">1</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <br/> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Carrying</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Fair Value</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <b>As at April 30, 2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Amount</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Fair Value</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Levels</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Reference</b> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Cash</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 2,852,422 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 2,852,422 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">1</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <br/> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom"> <b>Forward contracts</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Opening balance at the beginning of the year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Fair value of forward, at issuance</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Change in fair value of forward contracts since issuance</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (47,690 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Fair value of forward contracts settled during the year</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 47,690 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Fair value of forward contracts at April 30</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <b>Fair Values of Financial Instruments</b> </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">In addition to the methods and assumptions the Company uses to record the fair value of financial instruments as discussed in the Fair Value Measurements section above, the Company used the following methods and assumptions to estimate the fair value of the Company&#8217;s financial instruments:</p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <b>Cash &#8211;</b> carrying amount approximates fair value. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <b>Accounts receivable, net &#8211;</b> carrying amount approximates fair value. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <b>Forward contracts &#8211;</b> the fair value of foreign currency and commodity forward, option and cross currency contracts is based on a valuation model that discounts cash flows resulting from the differential between the contract price and the market-based forward rate. </p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Carrying</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Fair Value</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <b>As at April 30, 2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Amount</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Fair Value</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Levels</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Reference</b> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Cash</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 2,159,738 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 2,159,738 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">1</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 2159738 2159738 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Carrying</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Fair Value</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> <b>As at April 30, 2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Amount</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Fair Value</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Levels</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Reference</b> </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Cash</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 2,852,422 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 2,852,422 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">1</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 2852422 2852422 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom"> <b>Forward contracts</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="12%"> <b>April 30,</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> <b>2015</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Opening balance at the beginning of the year</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Fair value of forward, at issuance</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Change in fair value of forward contracts since issuance</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> (47,690 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Fair value of forward contracts settled during the year</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> 47,690 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="12%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Fair value of forward contracts at April 30</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="12%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 0 0 0 0 -47690 0 47690 0 0 0 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 10</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Commitments</u> </b> </td> </tr> </table> <br/> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr> <td width="5%">&#160;</td> <td valign="top" width="5%">a)</td> <td> On November 27, 2013, the Company entered into an extension of an existing lease agreement, which commenced on October 1, 2014 and expires on September 30, 2019. The monthly lease payment under the extension agreement is $19,678 plus $19,308 in operating costs. </td> </tr> <tr> <td width="5%">&#160;</td> <td width="5%">&#160;</td> <td>&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="top" width="5%">b)</td> <td> On November 4, 2013, the Company entered into an extension of an existing lease agreement, which commenced on January 1, 2014 and expires on April 30, 2019. The monthly lease payment under the extension agreement is $3,550 plus $3,307 in operating costs. This lease expense is a related party transaction as it was incurred with a company with a director in common with the Company. </td> </tr> <tr> <td width="5%">&#160;</td> <td width="5%">&#160;</td> <td>&#160;</td> </tr> <tr> <td width="5%">&#160;</td> <td valign="top" width="5%">c)</td> <td> From March 2013 to April 2014, the Company entered into various lease agreements with commencement dates between April 2013 and May 2014 and that expire between May 2016 and May 2017. The combined monthly lease payments are $7,198 plus $495 in operating expenses. </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> Total lease expense for the year ended April 30, 2016 is $642,377 (2015 <b>&#8211;</b> $754,221). </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Total payable over the term of the lease agreements for the years ended April 30, are as follows:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Office Leases &#8211;</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Office Leases &#8211;</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Total Office</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Related Party</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Unrelated Party</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Leases</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">2017</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 82,288 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 518,534 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%"> <b>$</b> </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#160; 600,822 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">2018</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 82,288 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 496,235 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 578,523 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">2019</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 82,288 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 497,897 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 580,185 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">2020</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 207,457 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 207,457 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 246,864 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 1,720,123 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 1,966,987 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Office Leases &#8211;</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Office Leases &#8211;</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Total Office</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Related Party</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Unrelated Party</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Leases</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">2017</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 82,288 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 518,534 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%"> <b>$</b> </td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> &#160; 600,822 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">2018</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 82,288 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 496,235 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 578,523 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">2019</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 82,288 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 497,897 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%"> 580,185 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">2020</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 207,457 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> 207,457 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 246,864 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 1,720,123 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 1,966,987 </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> </table> 82288 518534 600822 82288 496235 578523 82288 497897 580185 0 207457 207457 246864 1720123 1966987 19678 19308 3550 3307 7198 495 642377 754221 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td align="left" nowrap="nowrap"> <b>Note 11</b> </td> <td align="left" nowrap="nowrap" width="95%"> <b> <u>Loss per common share</u> </b> </td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;">Computation of loss per share:</p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="36%"> <b>Year ended April 30, 2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Per Share</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Income</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <strong> Shares <sup>(1</sup> </strong> <sup>)(2)</sup> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Amount</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Basic EPS</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Income available to common stockholders</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> (2,691,595 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 4,433,402 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> (0.61 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr> <td width="5%">&#160;</td> <td bgcolor="#e6efff" valign="bottom">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Effect on dilutive securities</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">(Gain)/Loss from derivative instruments</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Diluted EPS</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> (2,691,595 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 4,433,402 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> (0.61 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> </table> <br/> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="36%"> <b>Year ended April 30, 2015</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Per Share</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Income</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <strong> Shares <sup>(1</sup> </strong> <sup>)(2)</sup> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Amount</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Basic EPS</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Income available to common stockholders</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> (4,441,867 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 4,249,252 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> (1.05 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr> <td width="5%">&#160;</td> <td bgcolor="#e6efff" valign="bottom">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Effect on dilutive securities</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">(Gain)/Loss from derivative instruments</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Diluted EPS</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> (4,441,867 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 4,249,252 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> (1.05 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> </table> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <sup>(1)</sup> For the years ended April 30, 2016 and April 30, 2015, common share equivalents (consisting of shares issuable on exercise of options, deferred share units, and warrants) totalling 812,169, and 382,580, respectively, were not included in the computation of diluted earnings per share because the effect was anti-dilutive. </p> <p align="justify" style="margin-left: 5%; font-family: times new roman,times,serif; font-size: 10pt;"> <sup>(2)</sup> Diluted by assumed exercise of outstanding common share equivalents using the treasury stock method. </p> <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="36%"> <b>Year ended April 30, 2016</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Per Share</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Income</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <strong> Shares <sup>(1</sup> </strong> <sup>)(2)</sup> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Amount</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Basic EPS</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Income available to common stockholders</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> (2,691,595 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 4,433,402 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> (0.61 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr> <td width="5%">&#160;</td> <td bgcolor="#e6efff" valign="bottom">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Effect on dilutive securities</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">(Gain)/Loss from derivative instruments</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Diluted EPS</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> (2,691,595 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 4,433,402 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> (0.61 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> </table> -2691595 4433402 -0.61 0 0 -2691595 4433402 -0.61 <table border="0" cellpadding="0" cellspacing="0" style="border-color: black; font-size: 10pt; border-collapse: collapse; font-family: times new roman,times,serif;" width="100%"> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" colspan="7" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="36%"> <b>Year ended April 30, 2015</b> </td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" valign="bottom" width="10%"> <b>Per Share</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="center" valign="bottom">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Income</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <strong> Shares <sup>(1</sup> </strong> <sup>)(2)</sup> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="center" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> <b>Amount</b> </td> <td align="center" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">Basic EPS</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Income available to common stockholders</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> (4,441,867 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> 4,249,252 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" valign="bottom" width="10%"> (1.05 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> <tr> <td width="5%">&#160;</td> <td bgcolor="#e6efff" valign="bottom">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="1%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="10%">&#160;</td> <td bgcolor="#e6efff" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Effect on dilutive securities</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="1%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="10%">&#160;</td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" bgcolor="#e6efff" valign="bottom">(Gain)/Loss from derivative instruments</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="right" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%"> &#8211; </td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="1%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" width="10%">&#160;</td> <td align="left" bgcolor="#e6efff" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> </tr> <tr valign="top"> <td width="5%">&#160;</td> <td align="left" valign="bottom">Diluted EPS</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> (4,441,867 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">&#160;</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> 4,249,252 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">&#160;</td> <td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="1%">$</td> <td align="right" nowrap="nowrap" style="BORDER-BOTTOM: #000000 3px double" valign="bottom" width="10%"> (1.05 </td> <td align="left" nowrap="nowrap" valign="bottom" width="2%">)</td> </tr> </table> -4441867 4249252 -1.05 0 0 -4441867 4249252 -1.05 812169 382580 EX-101.SCH 8 cpah-20160430.xsd XBRL SCHEMA FILE 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 102 - Statement - CONSOLIDATED BALANCE SHEETS link:calculationLink link:presentationLink link:definitionLink 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:calculationLink link:presentationLink link:definitionLink 105 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 106 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS link:calculationLink link:presentationLink link:definitionLink 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:calculationLink link:presentationLink link:definitionLink 108 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Nature of Operations link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Equipment link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Accounts Payable and Accrued Liabilities link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Related Party Transactions link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Common Stock link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Segmented Information link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Derivative Financial Instruments and Risk Management link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Commitments link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Loss per common share link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Subsequent Event link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Equipment (Tables) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Common Stock (Tables) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Income Taxes (Tables) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Segmented Information (Tables) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Derivative Financial Instruments and Risk Management (Tables) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Commitments (Tables) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Loss per common share (Tables) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Nature of Operations (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Significant Accounting Policies (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Related Party Transactions (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Common Stock (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Income Taxes (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Commitments (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Loss per common share (Narrative) (Details) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Schedule of Accounts, Notes, Loans and Financing Receivable (Details) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Schedule of Product Warranty Liability (Details) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Property, Plant and Equipment (Details) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Schedule of Share-based Compensation, Stock Options, Activity (Details) link:calculationLink link:presentationLink link:definitionLink 144 - Disclosure - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) link:calculationLink link:presentationLink link:definitionLink 145 - Disclosure - Schedule of Nonvested Performance-based Units Activity (Details) link:calculationLink link:presentationLink link:definitionLink 146 - Disclosure - Schedule of Employee and Non-Employee Service Share-based Compensation Allocation of Recognized Period Costs (Details) link:calculationLink link:presentationLink link:definitionLink 147 - Disclosure - Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) link:calculationLink link:presentationLink link:definitionLink 148 - Disclosure - Schedule of Stockholders Equity Deferred Share Unit Plan (Details) link:calculationLink link:presentationLink link:definitionLink 149 - Disclosure - Schedule of Stockholders Equity Non Vested Deferred Share Units (Details) link:calculationLink link:presentationLink link:definitionLink 150 - Disclosure - Schedule of Allocation of Share Based Compensation Costs for Deferred Share Units (Details) link:calculationLink link:presentationLink link:definitionLink 151 - Disclosure - Schedule of Deferred Tax Assets and Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 152 - Disclosure - Schedule of Components of Income Tax Expense (Benefit) (Details) link:calculationLink link:presentationLink link:definitionLink 153 - Disclosure - Summary of Operating Loss Carryforwards (Details) link:calculationLink link:presentationLink link:definitionLink 154 - Disclosure - Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible (Details) link:calculationLink link:presentationLink link:definitionLink 155 - Disclosure - Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area (Details) link:calculationLink link:presentationLink link:definitionLink 156 - Disclosure - Schedule of Long Lived Assets by Geographical Areas (Details) link:calculationLink link:presentationLink link:definitionLink 157 - Disclosure - Fair Value, Assets Measured on Recurring Basis (Details) link:calculationLink link:presentationLink link:definitionLink 158 - Disclosure - Fair Value, Liabilities Measured on Recurring Basis (Details) link:calculationLink link:presentationLink link:definitionLink 159 - Disclosure - Schedule of Agreements by Year (Details) link:calculationLink link:presentationLink link:definitionLink 160 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 9 cpah-20160430_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 cpah-20160430_def.xml XBRL DEFINITION FILE EX-101.LAB 11 cpah-20160430_lab.xml XBRL LABEL FILE Document and Entity Information [Abstract] Document and Entity Information [Abstract] Statement [Table] Legal Entity [Axis] Entity [Domain] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Period End Date Trading Symbol Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Voluntary Filers Entity Well Known Seasoned Issuer Entity Public Float Document Fiscal Year Focus Document Fiscal Period Focus Statement of Financial Position [Abstract] Assets Current assets: Cash Accounts receivable (net of allowance for doubtful accounts of $547,173 (2015 - $294,719)) Prepaid expenses and deposits Total current assets Deposits Equipment Goodwill Other assets Total Assets Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued liabilities Unearned revenue Customer deposits Accrued warranty Derivative liability Total current liabilities Deferred lease inducements Unrecognized tax benefit Total liabilities Stockholders' equity: Preferred stock, $0.001 par value Authorized: 100,000,000 Issued and outstanding: April 30, 2016 - nil; April 30, 2015 - nil Common stock, $0.001 par value Authorized: 100,000,000 Issued and outstanding: April 30, 2016 - 4,542,348; April 30, 2015 - 4,233,395 Treasury stock Additional paid-in capital Accumulated deficit Accumulated other comprehensive income (loss) - currency translation adjustment Total stockholders' equity Liabilities and Stockholders' Equity Allowance for Doubtful Accounts Receivable, Current Preferred Stock, Par Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Statement of Operations [Abstract] Revenue Software Software Service Total revenue Operating expenses: Cost of sales (includes depreciation of $7,225 (2015 - $32,710)) Sales and marketing Research and development General and administrative Total operating expenses Loss from operations Interest and other income (expense), net Interest and other income Interest expense Foreign exchange gain Fair value adjustment on derivative instruments Net loss for the year Net loss per share: Basic Diluted Weighted average common shares outstanding: Basic Diluted Depreciation Statement of Income and Comprehensive Income [Abstract] Net loss for the year Other comprehensive loss: Foreign currency translation adjustments Comprehensive loss Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss for the year Adjustments to reconcile net loss to net cash used in operating activities: Deferred lease inducements Depreciation and amortization Foreign exchange (gain) loss Stock-based compensation Issuance of common stock for services Changes in assets and liabilities: Accounts payable and accrued liabilities Accounts receivable Accrued warranty Customer deposits Deferred lease inducements Prepaid expenses and deposits Other assets Unearned revenue Unrecognized tax benefit Net cash used in operating activities Cash flows from investing activities: Purchase of equipment Purchase of intangibles Net cash used in investing activities Cash flows from financing activities: Common stock issued Common stock repurchased Net cash used in by financing activities Foreign exchange effect on cash Decrease in cash Cash, beginning of the year Cash, end of the year Supplemental disclosure of cash flow information Cash paid for: Interest Taxes Equity Components [Axis] Equity Components [Domain] Common Shares [Member] Treasury Shares [Member] Preferred shares [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Accumulated Other Comprehensive Income (Loss) [Member] Statement of Stockholders Equity [Abstract] Beginning Balance Beginning Balance (Shares) Shares Issued (Shares) Private Placement Private Placement (Shares) Issuance of common stock for services Issuance of common stock for services (Shares) Exercise of stock options Exercise of stock options (Shares) Share repurchase plan Share repurchase plan (Shares) Cancellation of shares Cancellation of shares (Shares) Stock-based compensation Employee share purchase program Employee share purchase program (Shares) Foreign currency translation adjustment Ending Balance Ending Balance (Shares) Notes to Financial Statements [Abstract] Notes to Financial Statements [Abstract] Nature of Operations [Text Block] Significant Accounting Policies [Text Block] Equipment [Text Block] Accounts Payable and Accrued Liabilities [Text Block] Related Party Transactions [Text Block] Common Stock [Text Block] Income Taxes [Text Block] Segmented Information [Text Block] Derivative Financial Instruments and Risk Management [Text Block] Commitments [Text Block] Loss per common share [Text Block] Subsequent Event [Text Block] Basis of Presentation [Policy Text Block] Revenue Recognition [Policy Text Block] Stock-Based Compensation [Policy Text Block] Use of Estimates [Policy Text Block] Equipment and Amortization [Policy Text Block] Research and Development [Policy Text Block] Website Development Costs [Policy Text Block] Accounts Receivable and Allowance for Doubtful Accounts [Policy Text Block] Foreign Currency Translation [Policy Text Block] Accrued Warranty [Policy Text Block] Trademarks [Policy Text Block] Trademarks Fair Value of Financial Instruments [Policy Text Block] Income Taxes [Policy Text Block] Comprehensive Loss [Policy Text Block] Basic and Diluted Loss per Share [Policy Text Block] Investment tax credits [Policy Text Block] Investment tax credits Goodwill [Policy Text Block] Derivative Instruments [Policy Text Block] New Accounting Pronouncements [Policy Text Block] Interim Reporting [Policy Text Block] Impairment of Long-Lived Assets [Policy Text Block] Straight-line Method Estimations [Table Text Block] Straight-line Method Estimations Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Schedule of Product Warranty Liability [Table Text Block] Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block] Property, Plant and Equipment [Table Text Block] Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Schedule of Nonvested Performance-based Units Activity [Table Text Block] Schedule of Employee and Non-Employee Service Share-based Compensation Allocation of Recognized Period Costs [Table Text Block] Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block] Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block] Schedule of Stockholders Equity Deferred Share Unit Plan [Table Text Block] Schedule of Stockholders Equity Deferred Share Unit Plan Activity Schedule of Stockholders Equity Non Vested Deferred Share Units [Table Text Block] Schedule of Stockholders Equity Non Vested Deferred Share Units Schedule of Allocation of Share Based Compensation Costs for Deferred Share Units [Table Text Block] Schedule of Allocation of Share Based Compensation Costs for Deferred Share Units Schedule of Stockholders' Equity Note, Warrants or Rights, Valuation Assumptions [Table Text Block] Schedule of Stockholders Equity Note, Warrants or Rights, Valuation Assumptions Schedule of Stockholders' Equity Note, Warrant Liability [Table Text Block] Schedule of Stockholders' Equity Note, Warrant Liability Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Summary of Operating Loss Carryforwards [Table Text Block] Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block] Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Schedule of Long Lived Assets by Geographical Areas [Table Text Block] Schedule of Long Lived Assets by Geographical Areas Table text Block Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Fair Value, Assets Measured on Recurring Basis [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Warrant Liabilities at Fair Value [Table Text Block] Schedule of Agreements by Year [Table Text Block] Schedule of Agreements by year Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Related Party [Axis] Related Party [Domain] NewHeights [Member] NewHeights Software Corp. FirstHand [Member] FirstHand Techologies Inc. BridgePort [Member] Bridge Port Networks Inc. Mitel [Member] Mitel Networks Corp. KRP [Member] Kanata Research Park Corp. Wesley Clover [Member] Wesley Clover Investor [Member] Chairman [Member] Customer Contracts [Member] Granted to Officers or Employees [Member] Granted to Officers or Employees Granted to Non-Employee Directors [Member] Granted to Non-Employee Directors Granted to Officers [Member] Granted to Employees and Contractors [Member] Class of Stock [Axis] Class of Stock [Domain] Subsidiary Shares [Member] Units [Member] Broker Warrants [Member] Broker Warrants Employee Stock Purchase Plan [Member] Deferred Share Units [Member] Warrants [Member] Nature Of Operations 1 Nature Of Operations 1 Nature Of Operations 2 Nature Of Operations 2 Nature Of Operations 3 Nature Of Operations 3 Nature Of Operations 4 Nature Of Operations 4 Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Acquired technologies [Member] Customer assets [Member] Significant Accounting Policies 1 Significant Accounting Policies 1 Significant Accounting Policies 2 Significant Accounting Policies 2 Significant Accounting Policies 3 Significant Accounting Policies 3 Significant Accounting Policies 4 Significant Accounting Policies 4 Significant Accounting Policies 5 Significant Accounting Policies 5 Significant Accounting Policies 6 Significant Accounting Policies 6 Significant Accounting Policies 7 Significant Accounting Policies 7 Significant Accounting Policies 8 Significant Accounting Policies 8 Significant Accounting Policies 9 Significant Accounting Policies 9 Significant Accounting Policies 10 Significant Accounting Policies 10 Significant Accounting Policies 11 Significant Accounting Policies 11 Significant Accounting Policies 12 Significant Accounting Policies 12 Significant Accounting Policies 13 Significant Accounting Policies 13 Significant Accounting Policies 14 Significant Accounting Policies 14 Significant Accounting Policies 15 Significant Accounting Policies 15 Significant Accounting Policies 16 Significant Accounting Policies 16 Related Party Transactions By Transactions [Axis] Related Party Transactions By Transactions Related party Transactions By Transactions [Domain] Related party Transactions By Transactions Office Space Lease [Member] Office Space Lease Related Party Transactions 1 Related Party Transactions 1 Related Party Transactions 2 Related Party Transactions 2 Related Party Transactions 3 Related Party Transactions 3 Related Party Transactions 4 Related Party Transactions 4 Related Party Transactions 5 Related Party Transactions 5 Related Party Transactions 6 Related Party Transactions 6 Related Party Transactions 7 Related Party Transactions 7 Related Party Transactions 8 Related Party Transactions 8 Related Party Transactions 9 Related Party Transactions 9 Related Party Transactions 10 Related Party Transactions 10 Related Party Transactions 11 Related Party Transactions 11 Related Party Transactions 12 Related Party Transactions 12 Common Stock 1 Common Stock 1 Common Stock 2 Common Stock 2 Common Stock 3 Common Stock 3 Common Stock 4 Common Stock 4 Common Stock 5 Common Stock 5 Common Stock 6 Common Stock 6 Common Stock 7 Common Stock 7 Common Stock 8 Common Stock 8 Common Stock 9 Common Stock 9 Common Stock 10 Common Stock 10 Common Stock 11 Common Stock 11 Common Stock 12 Common Stock 12 Common Stock 13 Common Stock 13 Common Stock 14 Common Stock 14 Common Stock 15 Common Stock 15 Common Stock 16 Common Stock 16 Common Stock 17 Common Stock 17 Common Stock 18 Common Stock 18 Common Stock 19 Common Stock 19 Common Stock 20 Common Stock 20 Common Stock 21 Common Stock 21 Common Stock 22 Common Stock 22 Common Stock 23 Common Stock 23 Common Stock 24 Common Stock 24 Common Stock 25 Common Stock 25 Common Stock 26 Common Stock 26 Common Stock 27 Common Stock 27 Common Stock 28 Common Stock 28 Common Stock 29 Common Stock 29 Common Stock 30 Common Stock 30 Common Stock 31 Common Stock 31 Common Stock 32 Common Stock 32 Common Stock 33 Common Stock 33 Common Stock 34 Common Stock 34 Common Stock 35 Common Stock 35 Common Stock 36 Common Stock 36 Common Stock 37 Common Stock 37 Common Stock 38 Common Stock 38 Common Stock 39 Common Stock 39 Common Stock 40 Common Stock 40 Common Stock 41 Common Stock 41 Common Stock 42 Common Stock 42 Common Stock 43 Common Stock 43 Common Stock 44 Common Stock 44 Common Stock 45 Common Stock 45 Common Stock 46 Common Stock 46 Common Stock 47 Common Stock 47 Common Stock 48 Common Stock 48 Common Stock 49 Common Stock 49 Common Stock 50 Common Stock 50 Common Stock 51 Common Stock 51 Common Stock 52 Common Stock 52 Common Stock 53 Common Stock 53 Common Stock 54 Common Stock 54 Common Stock 55 Common Stock 55 Common Stock 56 Common Stock 56 Common Stock 57 Common Stock 57 Common Stock 58 Common Stock 58 Common Stock 59 Common Stock 59 Common Stock 60 Common Stock 60 Common Stock 61 Common Stock 61 Common Stock 62 Common Stock 62 Common Stock 63 Common Stock 63 Common Stock 64 Common Stock 64 Common Stock 65 Common Stock 65 Common Stock 66 Common Stock 66 Common Stock 67 Common Stock 67 Common Stock 68 Common Stock 68 Common Stock 69 Common Stock 69 Common Stock 70 Common Stock 70 Common Stock 71 Common Stock 71 Income Taxes 1 Income Taxes 1 Commitments [Axis] Commitments Commitments By Agreement [Domain] Commitments By Agreement December 30 2010 Lease Extension Agreement [Member] December 30 2010 Lease Extension Agreement April 29 2005 Lease for Office Premises [Member] April 29 2005 Lease for Office Premises July 17 2009 Subleasing Arrangement [Member] July 17 2009 Subleasing Arrangement January 11 2011 Lease Agreement [Member] January 11 2011 Lease Agreement May 1 2009 Modification of Existing Lease Agreement for Office Premises [Member] May 1 2009 Modification of Existing Lease Agreement for Office Premises March 12 2009 Settlement Agreement with a Founder and Former Officer [Member] March 12 2009 Settlement Agreement with a Founder and Former Officer August 2 2011 Extension of an Existing Operating Lease [Member] August 2 2011 Extension of an Existing Operating Lease July 20 2011 Agreement for Investor Relations Services [Member] July 20 2011 Agreement for Investor Relations Services December 9, 2011 Amendment to Lease Agreement [Member] December 9, 2011 Amendment to Lease Agreement Commitments By Type of Commitment [Domain] Commitments By Type of Commitment Office Leases - Related party [Member] Office Leases - Related party Office Leases - Unrelated Party [Member] Office Leases - Unrelated Party Sub Lease Income [Member] Sub Lease Income Total Office Leases [Member] Total Office Leases Settlement Agreement [Member] Settlement Agreement [Member] Investor Relations [Member] Investor Relations Commitments 1 Commitments 1 Commitments 2 Commitments 2 Commitments 3 Commitments 3 Commitments 4 Commitments 4 Commitments 5 Commitments 5 Commitments 6 Commitments 6 Commitments 7 Commitments 7 Commitments 8 Commitments 8 Loss Per Common Share 1 Loss Per Common Share 1 Loss Per Common Share 2 Loss Per Common Share 2 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 1 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 1 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 2 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 2 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 3 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 3 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 4 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 4 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 5 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 5 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 6 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 6 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 7 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 7 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 8 Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 8 Significant Accounting Policies Schedule Of Product Warranty Liability 1 Significant Accounting Policies Schedule Of Product Warranty Liability 1 Significant Accounting Policies Schedule Of Product Warranty Liability 2 Significant Accounting Policies Schedule Of Product Warranty Liability 2 Significant Accounting Policies Schedule Of Product Warranty Liability 3 Significant Accounting Policies Schedule Of Product Warranty Liability 3 Significant Accounting Policies Schedule Of Product Warranty Liability 4 Significant Accounting Policies Schedule Of Product Warranty Liability 4 Significant Accounting Policies Schedule Of Product Warranty Liability 5 Significant Accounting Policies Schedule Of Product Warranty Liability 5 Significant Accounting Policies Schedule Of Product Warranty Liability 6 Significant Accounting Policies Schedule Of Product Warranty Liability 6 Significant Accounting Policies Schedule Of Product Warranty Liability 7 Significant Accounting Policies Schedule Of Product Warranty Liability 7 Significant Accounting Policies Schedule Of Product Warranty Liability 8 Significant Accounting Policies Schedule Of Product Warranty Liability 8 Equipment Property, Plant And Equipment 1 Equipment Property, Plant And Equipment 1 Equipment Property, Plant And Equipment 2 Equipment Property, Plant And Equipment 2 Equipment Property, Plant And Equipment 3 Equipment Property, Plant And Equipment 3 Equipment Property, Plant And Equipment 4 Equipment Property, Plant And Equipment 4 Equipment Property, Plant And Equipment 5 Equipment Property, Plant And Equipment 5 Equipment Property, Plant And Equipment 6 Equipment Property, Plant And Equipment 6 Equipment Property, Plant And Equipment 7 Equipment Property, Plant And Equipment 7 Equipment Property, Plant And Equipment 8 Equipment Property, Plant And Equipment 8 Equipment Property, Plant And Equipment 9 Equipment Property, Plant And Equipment 9 Equipment Property, Plant And Equipment 10 Equipment Property, Plant And Equipment 10 Equipment Property, Plant And Equipment 11 Equipment Property, Plant And Equipment 11 Equipment Property, Plant And Equipment 12 Equipment Property, Plant And Equipment 12 Equipment Property, Plant And Equipment 13 Equipment Property, Plant And Equipment 13 Equipment Property, Plant And Equipment 14 Equipment Property, Plant And Equipment 14 Equipment Property, Plant And Equipment 15 Equipment Property, Plant And Equipment 15 Equipment Property, Plant And Equipment 16 Equipment Property, Plant And Equipment 16 Equipment Property, Plant And Equipment 17 Equipment Property, Plant And Equipment 17 Equipment Property, Plant And Equipment 18 Equipment Property, Plant And Equipment 18 Equipment Property, Plant And Equipment 1 Equipment Property, Plant And Equipment 1 Equipment Property, Plant And Equipment 2 Equipment Property, Plant And Equipment 2 Equipment Property, Plant And Equipment 3 Equipment Property, Plant And Equipment 3 Equipment Property, Plant And Equipment 4 Equipment Property, Plant And Equipment 4 Equipment Property, Plant And Equipment 5 Equipment Property, Plant And Equipment 5 Equipment Property, Plant And Equipment 6 Equipment Property, Plant And Equipment 6 Equipment Property, Plant And Equipment 7 Equipment Property, Plant And Equipment 7 Equipment Property, Plant And Equipment 8 Equipment Property, Plant And Equipment 8 Equipment Property, Plant And Equipment 9 Equipment Property, Plant And Equipment 9 Equipment Property, Plant And Equipment 10 Equipment Property, Plant And Equipment 10 Equipment Property, Plant And Equipment 11 Equipment Property, Plant And Equipment 11 Equipment Property, Plant And Equipment 12 Equipment Property, Plant And Equipment 12 Equipment Property, Plant And Equipment 13 Equipment Property, Plant And Equipment 13 Equipment Property, Plant And Equipment 14 Equipment Property, Plant And Equipment 14 Equipment Property, Plant And Equipment 15 Equipment Property, Plant And Equipment 15 Equipment Property, Plant And Equipment 16 Equipment Property, Plant And Equipment 16 Equipment Property, Plant And Equipment 17 Equipment Property, Plant And Equipment 17 Equipment Property, Plant And Equipment 18 Equipment Property, Plant And Equipment 18 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 1 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 1 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 2 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 2 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 3 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 3 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 4 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 4 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 5 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 5 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 6 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 6 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 7 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 7 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 8 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 8 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 9 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 9 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 10 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 10 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 11 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 11 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 12 Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 12 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8 Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 1 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 1 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 2 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 2 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 3 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 3 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 4 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 4 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 5 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 5 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 6 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 6 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 7 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 7 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 8 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 8 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 9 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 9 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 10 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 10 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 11 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 11 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 12 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 12 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 13 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 13 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 14 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 14 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 15 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 15 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 16 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 16 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 17 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 17 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 18 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 18 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 19 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 19 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 20 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 20 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 21 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 21 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 22 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 22 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 23 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 23 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 24 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 24 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 25 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 25 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 26 Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 26 Stock Options Outstanding By Expiry Date [Axis] Stock Options Outstanding By Expiry Date Stock Options Outstanding By Expiry Date [Domain] Stock Options Outstanding By Expiry Date Options Expiring December 15 2013 [Member] Options Expiring December 15 2013 Options Expiring May 1, 2012 to September 26, 2016 [Member] Options Expiring May 1, 2012 to September 26, 2016 Options Expiring January 1 2012 to September 26 2016 [Member] Options Expiring January 1 2012 to September 26 2016 Options Expiring December 14 2014 [Member] Options Expiring December 14 2014 Options Expiring April 17 2014 [Member] Options Expiring April 17 2014 Options Expiring December 14, 2016 [Member] Options Expiring December 14, 2016 Options Expiring December 14 2015 [Member] Options Expiring December 14 2015 Options Expiring October 1 2012 to February 28 2015 [Member] Options Expiring October 1 2012 to February 28 2015 Options Expiring September 7 2016 [Member] Options Expiring September 7 2016 Options Expiring March 10 2016 [Member] Options Expiring March 10 2016 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 1 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 1 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 2 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 2 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 3 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 3 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 4 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 4 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 5 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 5 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 6 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 6 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 7 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 7 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 8 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 8 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 9 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 9 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 10 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 10 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 11 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 11 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 12 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 12 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 13 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 13 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 14 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 14 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 15 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 15 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 16 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 16 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 17 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 17 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 18 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 18 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 19 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 19 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 20 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 20 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 21 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 21 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 22 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 22 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 23 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 23 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 24 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 24 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 25 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 25 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 26 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 26 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 27 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 27 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 28 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 28 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 29 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 29 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 30 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 30 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 31 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 31 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 32 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 32 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 33 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 33 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 34 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 34 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 35 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 35 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 36 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 36 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 37 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 37 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 38 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 38 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 39 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 39 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 40 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 40 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 41 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 41 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 42 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 42 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 43 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 43 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 44 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 44 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 45 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 45 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 46 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 46 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 47 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 47 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 48 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 48 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 49 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 49 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 50 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 50 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 51 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 51 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 52 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 52 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 53 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 53 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 54 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 54 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 55 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 55 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 56 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 56 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 57 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 57 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 58 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 58 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 59 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 59 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 60 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 60 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 61 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 61 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 62 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 62 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 63 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 63 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 64 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 64 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 65 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 65 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 66 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 66 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 67 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 67 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 68 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 68 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 69 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 69 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 70 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 70 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 71 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 71 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 72 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 72 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 73 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 73 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 74 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 74 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 75 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 75 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 76 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 76 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 77 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 77 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 78 Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 78 Common Stock Schedule Of Nonvested Performance-based Units Activity 1 Common Stock Schedule Of Nonvested Performance-based Units Activity 1 Common Stock Schedule Of Nonvested Performance-based Units Activity 2 Common Stock Schedule Of Nonvested Performance-based Units Activity 2 Common Stock Schedule Of Nonvested Performance-based Units Activity 3 Common Stock Schedule Of Nonvested Performance-based Units Activity 3 Common Stock Schedule Of Nonvested Performance-based Units Activity 4 Common Stock Schedule Of Nonvested Performance-based Units Activity 4 Common Stock Schedule Of Nonvested Performance-based Units Activity 5 Common Stock Schedule Of Nonvested Performance-based Units Activity 5 Common Stock Schedule Of Nonvested Performance-based Units Activity 6 Common Stock Schedule Of Nonvested Performance-based Units Activity 6 Common Stock Schedule Of Nonvested Performance-based Units Activity 7 Common Stock Schedule Of Nonvested Performance-based Units Activity 7 Common Stock Schedule Of Nonvested Performance-based Units Activity 8 Common Stock Schedule Of Nonvested Performance-based Units Activity 8 Common Stock Schedule Of Nonvested Performance-based Units Activity 9 Common Stock Schedule Of Nonvested Performance-based Units Activity 9 Common Stock Schedule Of Nonvested Performance-based Units Activity 10 Common Stock Schedule Of Nonvested Performance-based Units Activity 10 Common Stock Schedule Of Nonvested Performance-based Units Activity 11 Common Stock Schedule Of Nonvested Performance-based Units Activity 11 Common Stock Schedule Of Nonvested Performance-based Units Activity 12 Common Stock Schedule Of Nonvested Performance-based Units Activity 12 Common Stock Schedule Of Nonvested Performance-based Units Activity 13 Common Stock Schedule Of Nonvested Performance-based Units Activity 13 Common Stock Schedule Of Nonvested Performance-based Units Activity 14 Common Stock Schedule Of Nonvested Performance-based Units Activity 14 Common Stock Schedule Of Nonvested Performance-based Units Activity 15 Common Stock Schedule Of Nonvested Performance-based Units Activity 15 Common Stock Schedule Of Nonvested Performance-based Units Activity 16 Common Stock Schedule Of Nonvested Performance-based Units Activity 16 Common Stock Schedule Of Nonvested Performance-based Units Activity 17 Common Stock Schedule Of Nonvested Performance-based Units Activity 17 Common Stock Schedule Of Nonvested Performance-based Units Activity 18 Common Stock Schedule Of Nonvested Performance-based Units Activity 18 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 1 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 1 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 2 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 2 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 3 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 3 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 4 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 4 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 5 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 5 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 6 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 6 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 7 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 7 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 8 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 8 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 9 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 9 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 10 Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 10 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 1 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 1 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 2 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 2 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 3 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 3 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 4 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 4 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 5 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 5 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 6 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 6 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 7 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 7 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 8 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 8 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 9 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 9 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 10 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 10 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 11 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 11 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 12 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 12 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 13 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 13 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 14 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 14 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 15 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 15 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 16 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 16 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 17 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 17 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 18 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 18 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 19 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 19 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 20 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 20 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 21 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 21 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 22 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 22 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 23 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 23 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 24 Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 24 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 1 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 1 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 2 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 2 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 3 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 3 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 4 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 4 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 5 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 5 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 6 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 6 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 7 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 7 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 8 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 8 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 9 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 9 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 10 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 10 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 11 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 11 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 12 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 12 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 13 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 13 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 14 Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 14 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 1 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 1 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 2 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 2 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 3 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 3 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 4 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 4 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 5 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 5 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 6 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 6 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 7 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 7 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 8 Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 8 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 1 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 1 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 2 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 2 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 3 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 3 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 4 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 4 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 5 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 5 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 6 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 6 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 7 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 7 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 8 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 8 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 9 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 9 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 10 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 10 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 11 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 11 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 12 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 12 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 13 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 13 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 14 Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 14 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 18 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 18 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 19 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 19 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 20 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 20 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 21 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 21 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 22 Income Taxes Schedule Of Deferred Tax Assets And Liabilities 22 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 1 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 1 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 2 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 2 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 3 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 3 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 4 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 4 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 5 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 5 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 6 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 6 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 7 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 7 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 8 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 8 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 9 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 9 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 10 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 10 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 11 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 11 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 12 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 12 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 13 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 13 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 14 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 14 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 15 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 15 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 16 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 16 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 17 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 17 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 18 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 18 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 19 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 19 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 20 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 20 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 21 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 21 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 22 Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 22 Income Taxes Summary Of Operating Loss Carryforwards 1 Income Taxes Summary Of Operating Loss Carryforwards 1 Income Taxes Summary Of Operating Loss Carryforwards 2 Income Taxes Summary Of Operating Loss Carryforwards 2 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 1 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 1 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 2 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 2 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 3 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 3 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 4 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 4 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 5 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 5 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 6 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 6 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 7 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 7 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 8 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 8 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 9 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 9 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 10 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 10 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 11 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 11 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 12 Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 12 Geographical [Axis] Segment, Geographical [Domain] North America [Member] Europe [Member] Asia and Africa [Member] Asia and Africa Latin America [Member] UNITED STATES [Member] CANADA [Member] UNITED KINGDOM [Member] CZECH REPUBLIC [Member] GERMANY [Member] FRANCE [Member] NETHERLANDS [Member] ICELAND [Member] AUSTRALIA [Member] SOUTH AFRICA [Member] JAPAN [Member] TUNISIA [Member] RUSSIAN FEDERATION [Member] MEXICO [Member] BRAZIL [Member] CHILE [Member] COLOMBIA [Member] DOMINICAN REPUBLIC [Member] Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 1 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 1 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 2 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 2 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 3 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 3 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 4 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 4 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 5 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 5 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 6 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 6 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 7 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 7 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 8 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 8 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 9 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 9 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 10 Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 10 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 1 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 1 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 2 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 2 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 3 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 3 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 4 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 4 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 5 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 5 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 6 Segmented Information Schedule Of Long Lived Assets By Geographical Areas 6 Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 1 Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 1 Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 2 Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 2 Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 1 Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 1 Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 2 Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 2 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 1 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 1 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 2 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 2 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 3 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 3 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 4 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 4 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 5 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 5 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 6 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 6 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 7 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 7 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 8 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 8 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 9 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 9 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 10 Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 10 Commitments Schedule Of Agreements By Year 1 Commitments Schedule Of Agreements By Year 1 Commitments Schedule Of Agreements By Year 2 Commitments Schedule Of Agreements By Year 2 Commitments Schedule Of Agreements By Year 3 Commitments Schedule Of Agreements By Year 3 Commitments Schedule Of Agreements By Year 4 Commitments Schedule Of Agreements By Year 4 Commitments Schedule Of Agreements By Year 5 Commitments Schedule Of Agreements By Year 5 Commitments Schedule Of Agreements By Year 6 Commitments Schedule Of Agreements By Year 6 Commitments Schedule Of Agreements By Year 7 Commitments Schedule Of Agreements By Year 7 Commitments Schedule Of Agreements By Year 8 Commitments Schedule Of Agreements By Year 8 Commitments Schedule Of Agreements By Year 9 Commitments Schedule Of Agreements By Year 9 Commitments Schedule Of Agreements By Year 10 Commitments Schedule Of Agreements By Year 10 Commitments Schedule Of Agreements By Year 11 Commitments Schedule Of Agreements By Year 11 Commitments Schedule Of Agreements By Year 12 Commitments Schedule Of Agreements By Year 12 Commitments Schedule Of Agreements By Year 13 Commitments Schedule Of Agreements By Year 13 Commitments Schedule Of Agreements By Year 14 Commitments Schedule Of Agreements By Year 14 Commitments Schedule Of Agreements By Year 15 Commitments Schedule Of Agreements By Year 15 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 1 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 1 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 2 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 2 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 3 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 3 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 4 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 4 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 5 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 5 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 6 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 6 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 7 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 7 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 8 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 8 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 1 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 1 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 2 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 2 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 3 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 3 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 4 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 4 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 5 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 5 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 6 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 6 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 7 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 7 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 8 Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 8 Total current assets Total Assets Unearned revenue Derivative liability Total current liabilities Total liabilities Treasury stock Total stockholders equity Liabilities and Stockholders Equity (LiabilitiesAndStockholdersEquity) Revenue From Software Total revenue Sales and marketing Research and development General and administrative Total operating expenses Loss from operations Interest expense Foreign exchange gain Fair value adjustment on derivative instruments Net loss for the year Basic (WeightedAverageNumberOfSharesOutstandingBasic) Diluted (WeightedAverageNumberOfDilutedSharesOutstanding) Depreciation Other comprehensive loss: Foreign currency translation adjustments Comprehensive loss Deferred lease inducements (AmortizationOfDeferredLeasingFees) Depreciation and amortization Foreign exchange gain (ForeignCurrencyTransactionGainBeforeTax) Accounts payable and accrued liabilities (IncreaseDecreaseInAccountsPayableAndAccruedLiabilities) Accounts receivable Accrued warranty (ProductWarrantyAccrualPeriodIncreaseDecrease) Customer deposits (IncreaseDecreaseInCustomerDeposits) Deferred lease inducements (IncreaseDecreaseInDeferredLeasingFees) Prepaid expenses and deposits (IncreaseDecreaseInPrepaidExpense) Other assets (IncreaseDecreaseInOtherNoncurrentAssets) Unearned revenue (IncreaseDecreaseInDeferredRevenue) Unrecognized tax benefit (IncreaseDecreaseInIncomeTaxes) Net cash used in operating activities Purchase of equipment Purchase of intangibles Net cash used in investing activities Common stock repurchased Net cash provided by (used in) financing activities Net increase (decrease) in cash Cash, beginning of the period Interest Income taxes paid Private Placement Private Placement (Shares) Issuance of common stock for services (StockIssuedDuringPeriodValueIssuedForServices) Issuance of common stock for services (Shares) Exercise of stock options Exercise of stock options (Shares) Share repurchase plan Cancellation of shares Stock-based compensation (AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue) Foreign currency translation adjustment Straightline Method Estimations [Table Text Block] Schedule Of Stockholders Equity Note Warrants Or Rights Activity [Text Block] Schedule Of Stockholders Equity Deferred Share Unit Plan Activity [Table Text Block] New Heights [Member] First Hand [Member] Bridge Port [Member] K R P [Member] Granted To Nonemployee Directors [Member] Nature Of Operations Zero Three Two Six Two Zero Wr K Z F T X J R Z Cx Nature Of Operations Zero Three Two Six Two Zero Four Onekybs Tng Mfl Nature Of Operations Zero Three Two Six Two Zero Threef H Z M Rq P C Nqn Nature Of Operations Zero Three Two Six Two Zero Four Md Two Zero P Four Ninetzh H Significant Accounting Policies Zero Three Two Six Two Zero Lwm Seven Snbvr B Ty Significant Accounting Policies Zero Three Two Six Two Zero Eightx K V Eight Fourmp S X Ln Significant Accounting Policies Zero Three Two Six Two Zero Two Z G F P Fv Six B X R F Significant Accounting Policies Zero Three Two Six Two Zeroct Zero One Two Nine Fiver H Pr Zero Significant Accounting Policies Zero Three Two Six Two Zero N Rg W Twonf Nfrmp Significant Accounting Policies Zero Three Two Six Two Zero S D Seven Sixgp Q Fqx N Five Significant Accounting Policies Zero Three Two Six Two Zero C V F Two F Zero Lt V Threem X Significant Accounting Policies Zero Three Two Six Two Zero S Cqv Q Pq J Eight V Threet Significant Accounting Policies Zero Three Two Six Two Zero Mhh J Sixz J Onexy Six W Significant Accounting Policies Zero Three Two Six Two Zero F Hn K T Tp Jrpsp Significant Accounting Policies Zero Three Two Six Two Zeros Two L Ry C Gd Eighttps Significant Accounting Policies Zero Three Two Six Two Zero P Two C Nm Qvp Gwc X Significant Accounting Policies Zero Three Two Six Two Zeror Tg N Three R Ninew G T W R Significant Accounting Policies Zero Three Two Six Two Zero Wvkw Gzw Seven Eight Sevenb Six Significant Accounting Policies Zero Three Two Six Two Zero Eight Zero K R B Hvtn S K Five Significant Accounting Policies Zero Three Two Six Two Zero F Sss N Fourz H D Oneq Nine Related Party Transactions Zero Three Two Six Two Zerovm Oneq W S T One D Ttv Related Party Transactions Zero Three Two Six Two Zeropt T Fived Fourb D Ninebs G Related Party Transactions Zero Three Two Six Two Zero C Nn V H Three Qxb Zero X One Related Party Transactions Zero Three Two Six Two Zero Eight Sevenp Twor Sixhxl Jzc Related Party Transactions Zero Three Two Six Two Zeron B P Zerok Jv L Zerov S S Related Party Transactions Zero Three Two Six Two Zerok Z Ld M Hwkyk F R Related Party Transactions Zero Three Two Six Two Zero C K Q T Sd Sixl One Eight One T Related Party Transactions Zero Three Two Six Two Zeron Rl X C Nv P Foury T Four Related Party Transactions Zero Three Two Six Two Zero Zdz Three T V K K Nrk Six Related Party Transactions Zero Three Two Six Two Zerogr Seven Qs Th P Eightxt Nine Related Party Transactions Zero Three Two Six Two Zero Threek Hf Eightt S M Seven W F T Related Party Transactions Zero Three Two Six Two Zero One Threec Rrr Two Seven G Hh H Common Stock Zero Three Two Six Two Zeromdwt C H Sixv Gc S Eight Common Stock Zero Three Two Six Two Zero R N Sszr B Lp Four Gx Common Stock Zero Three Two Six Two Zerob N Four Sevenwk V N P Three L C Common Stock Zero Three Two Six Two Zero K One Pf D Qsqx C Sixd Common Stock Zero Three Two Six Two Zero Six P T P Twodtpc C Nq Common Stock Zero Three Two Six Two Zero Fiveq K G T Sq Nr M Zero Six Common Stock Zero Three Two Six Two Zeror Eightp Zx K Sy Seven Zero S V Common Stock Zero Three Two Six Two Zeroqbt Ntzx G Gxtw Common Stock Zero Three Two Six Two Zero Mc Eight Nthwcqq Fourg Common Stock Zero Three Two Six Two Zero Two W D Q Four M Five Four Pc Mc Common Stock Zero Three Two Six Two Zero Zero Pl J T B S Dz S Ninep Common Stock Zero Three Two Six Two Zeroq R Eight Tp Kb B M Seven Nh Common Stock Zero Three Two Six Two Zerotd One Eight Seven Five Vfc T Q J Common Stock Zero Three Two Six Two Zero Six Zy W Zmwb Nine Kc T Common Stock Zero Three Two Six Two Zeroh D Rf Cv V Sixb G Z H Common Stock Zero Three Two Six Two Zerom Twor Tc Jkf R Dw Four Common Stock Zero Three Two Six Two Zero B Threeg D Fivedmxct Q G Common Stock Zero Three Two Six Two Zero Z T Ml Q Two C R Seven Wy X Common Stock Zero Three Two Six Two Zero G T Four K Tvbzv F Four Six Common Stock Zero Three Two Six Two Zero X T Ty Fiveqhwbcc B Common Stock Zero Three Two Six Two Zeros Wb K Threegsp Seven Q Tm Common Stock Zero Three Two Six Two Zero Nr Three Threegv Sixm Tv R W Common Stock Zero Three Two Six Two Zeroc N Seven One H L Q Zerod M Seven Q Common Stock Zero Three Two Six Two Zeron P Vl Threev Ty Four Lpp Common Stock Zero Three Two Six Two Zero Eightns One Nine G M Pk Onek Three Common Stock Zero Three Two Six Two Zeroq F Zerob R D F M Three Lx P Common Stock Zero Three Two Six Two Zerox H Qk Five C C Five Ones V Eight Common Stock Zero Three Two Six Two Zeroh Nine Tx C Threeb F Six D Vp Common Stock Zero Three Two Six Two Zero Qc Lr Fourvs N K Hn F Common Stock Zero Three Two Six Two Zeror F H C N Jx Zs M Three Five Common Stock Zero Three Two Six Two Zero Qz Fiver Seven T S Hm J Lc Common Stock Zero Three Two Six Two Zerozlx Threex T Eight T Z C Xt Common Stock Zero Three Two Six Two Zero Zero Plktxrdyqf V Common Stock Zero Three Two Six Two Zerobh D K B N Seven Vy Nine V Four Common Stock Zero Three Two Six Two Zero V Z Nine Seven P One M Three T Threel W Common Stock Zero Three Two Six Two Zero Z Vzs Rsn Vmdr Nine Common Stock Zero Three Two Six Two Zero Ncm Niner Bcwy Zero Eight D Common Stock Zero Three Two Six Two Zero C B Fourgh One M T Zn Sx Common Stock Zero Three Two Six Two Zeroq T Fivep L Jq Zerot Two Zerov Common Stock Zero Three Two Six Two Zero H Tz G C Eightb Wtf Tw Common Stock Zero Three Two Six Two Zeroclw Qb N T L Sixkr L Common Stock Zero Three Two Six Two Zero R Seven M C Six M T T Zg Zk Common Stock Zero Three Two Six Two Zero Ts Two Fourp R Five Tpy Pz Common Stock Zero Three Two Six Two Zeroc T C Q F V Nine R Lxh R Common Stock Zero Three Two Six Two Zero W B Five S Seven Jc Zero Kv L H Common Stock Zero Three Two Six Two Zero G One N F Cf Eight Tworlsb Common Stock Zero Three Two Six Two Zero W Twoys Nine Tb Clsmf Common Stock Zero Three Two Six Two Zerok Zero Cmv Dchg K Two Six Common Stock Zero Three Two Six Two Zero Onennm D Six J K Wn Ninez Common Stock Zero Three Two Six Two Zero Eight Zero F M Twod K Twos Jt H Common Stock Zero Three Two Six Two Zero Tdx H J Three Lyc L Q C Common Stock Zero Three Two Six Two Zero P Ldpv X Zero T Nknz Common Stock Zero Three Two Six Two Zero Seven Mx D Mmsf F Two B T Common Stock Zero Three Two Six Two Zero K T Qq N T Ninek P Seven Tz Common Stock Zero Three Two Six Two Zero D Eightk C Nine Two T One K Jp Two Common Stock Zero Three Two Six Two Zero R S J Lrm Four Z Qb Three V Common Stock Zero Three Two Six Two Zero Fp Zvw Hys Six Vky Common Stock Zero Three Two Six Two Zero X T Rdy Mx Two M C F P Common Stock Zero Three Two Six Two Zero K Vg T Zt L Five N Fivet G Common Stock Zero Three Two Six Two Zero K Myn L Threec Four M Z B F Common Stock Zero Three Two Six Two Zeroq J Q Eight Bv Threezt Sevenz X Common Stock Zero Three Two Six Two Zerop C Two Cy Two Kmt X Wq Common Stock Zero Three Two Six Two Zerom B Three M Zrm W Eight Six T J Common Stock Zero Three Two Six Two Zeroh Five Ghyppvm Tw Seven Common Stock Zero Three Two Six Two Zero Two K Lc Six Six Nine S Six Dvd Common Stock Zero Three Two Six Two Zero P Eight K One K Z V F Q S Ninec Common Stock Zero Three Two Six Two Zero Z Pz T Two Zlr Nn Ns Common Stock Zero Three Two Six Two Zero H One Zeror Seven Eight Seven Q Gpr G Common Stock Zero Three Two Six Two Zero J Jk Three Two D B R V Pf G Common Stock Zero Three Two Six Two Zero Gc Q Six Q Five Tss V N Z Common Stock Zero Three Two Six Two Zero K N W T H G Hq S L D C Income Taxes Zero Three Two Six Two Zero Ttlh Qdsqghvq December Three Zero Two Zero One Zero Lease Extension Agreement [Member] April Two Nine Two Zero Zero Five Lease For Office Premises [Member] July One Seven Two Zero Zero Nine Subleasing Arrangement [Member] January One One Two Zero One One Lease Agreement [Member] May One Two Zero Zero Nine Modification Of Existing Lease Agreement For Office Premises [Member] March One Two Two Zero Zero Nine Settlement Agreement With A Founder And Former Officer [Member] August Two Two Zero One One Extension Of An Existing Operating Lease [Member] July Two Zero Two Zero One One Agreement For Investor Relations Services [Member] December Nine Two Zero One One Amendment To Lease Agreement [Member] Office Leases Related Party [Member] Office Leases Unrelated Party [Member] Commitments Zero Three Two Six Two Zero Zero W Ninem T Fourp Zbc J D Commitments Zero Three Two Six Two Zero Gf Five F Six Nineb X P Kt Zero Commitments Zero Three Two Six Two Zerov Eightn Zeroh Tks R Zero Zero V Commitments Zero Three Two Six Two Zeroy Pk X Onex S Ninex N J L Commitments Zero Three Two Six Two Zero Eight C X F F B Four W Ld Onew Commitments Zero Three Two Six Two Zero Zerov Fgrlx S Pkv Seven Commitments Zero Three Two Six Two Zeropn T T H T Tm Fp Tb Commitments Zero Three Two Six Two Zero F Rmrs Three One Bqhy G Loss Per Common Share Zero Three Two Six Two Zero One Q Jd Js Z Eight Six X G H Loss Per Common Share Zero Three Two Six Two Zerowz Kv B R P Five Eight P Sz Schedule Of Accounts Notes Loans And Financing Receivable Zero Three Two Six Two Zerohky L Eight V Zero Pz J C Six Schedule Of Accounts Notes Loans And Financing Receivable Zero Three Two Six Two Zerocqn Four Kd G Zero Twov R Two Schedule Of Accounts Notes Loans And Financing Receivable Zero Three Two Six Two Zerox X Zero Zero R Hm T X R Two C Schedule Of Accounts Notes Loans And Financing Receivable Zero Three Two Six Two Zero Two Xyhp Sw W Xt Py Schedule Of Accounts Notes Loans And Financing Receivable Zero Three Two Six Two Zero Jg Rk Zbf J B Eight Kg Schedule Of Accounts Notes Loans And Financing Receivable Zero Three Two Six Two Zerozs Twohl Five Threemlxs F Schedule Of Accounts Notes Loans And Financing Receivable Zero Three Two Six Two Zeroh Zero Fivew Six Q Tc Xk Zero One Schedule Of Accounts Notes Loans And Financing Receivable Zero Three Two Six Two Zerok Py C Five Cqc Dn One D Schedule Of Product Warranty Liability Zero Three Two Six Two Zero R Zero Gv Two Fq L R Tpb Schedule Of Product Warranty Liability Zero Three Two Six Two Zeromtqz Sq Twoxw Pd Q Schedule Of Product Warranty Liability Zero Three Two Six Two Zeroqrb Zero Ninem V Zt Twold Schedule Of Product Warranty Liability Zero Three Two Six Two Zero Bwswb Onef J M Seven Q L Schedule Of Product Warranty Liability Zero Three Two Six Two Zero Xtdb D Twoqf Zero Two Jy Schedule Of Product Warranty Liability Zero Three Two Six Two Zero Six T Gl C Eight B Threem Twox V Schedule Of Product Warranty Liability Zero Three Two Six Two Zerogb Fours Th F Hf Pn J Schedule Of Product Warranty Liability Zero Three Two Six Two Zerohfv Rxpz K W Six Zero G Property Plant And Equipment Zero Three Two Six Two Zerok V F Sevenh Nrs T Seven Eightl Property Plant And Equipment Zero Three Two Six Two Zeroq Two F Zeros Sevenm P L H Eightg Property Plant And Equipment Zero Three Two Six Two Zero Dd Xtw Ns R Gq Nine R Property Plant And Equipment Zero Three Two Six Two Zero Three Ml Hqhkb Zero T C Nine Property Plant And Equipment Zero Three Two Six Two Zero H M Kv Five H V Fivesl Five V Property Plant And Equipment Zero Three Two Six Two Zerorn L W Seven Fm B Twoy Qx Property Plant And Equipment Zero Three Two Six Two Zerohm Lnfrmh Two G Ly Property Plant And Equipment Zero Three Two Six Two Zerowb M Threen P Zero Sb P Ninef Property Plant And Equipment Zero Three Two Six Two Zeroxs Nine Five Foury Cc R C V F Property Plant And Equipment Zero Three Two Six Two Zerom M Eight Sixf T J Zhr Zc Property Plant And Equipment Zero Three Two Six Two Zero Zw Lmmy G S Zero B Sq Property Plant And Equipment Zero Three Two Six Two Zero Z Km F L Tb C Seven G W T Property Plant And Equipment Zero Three Two Six Two Zero Six Rtb Six Hfmgth Three Property Plant And Equipment Zero Three Two Six Two Zerol Tq Threem Three Fb G Tqw Property Plant And Equipment Zero Three Two Six Two Zeropf Xg Fdl Nw Jx Five Property Plant And Equipment Zero Three Two Six Two Zeroh Wxy Four B S N Z R Kl Property Plant And Equipment Zero Three Two Six Two Zerohh B Tgc Knk G G One Property Plant And Equipment Zero Three Two Six Two Zero J Rt Eightgxnfy Twos K Property Plant And Equipment Zero Three Two Six Two Zero Eightl H W Rcq H Nvvk Property Plant And Equipment Zero Three Two Six Two Zero X Six J Fivebc C Zeroz N Eight Q Property Plant And Equipment Zero Three Two Six Two Zero Q Sixmz Kk Zerok Zeroz Zero H Property Plant And Equipment Zero Three Two Six Two Zero R M W H Zero M Eightd R Four Seven Three Property Plant And Equipment Zero Three Two Six Two Zero Pz Fourbf Q Eight Sz Twoc Six Property Plant And Equipment Zero Three Two Six Two Zero Fourdybw W T F Lq Eight L Property Plant And Equipment Zero Three Two Six Two Zero C Wcw Ltz Eight G Eight Tv Property Plant And Equipment Zero Three Two Six Two Zeroh R Nine Zero Byg T Ryc K Property Plant And Equipment Zero Three Two Six Two Zeroryg Ninec Ld Sevenhnp P Property Plant And Equipment Zero Three Two Six Two Zero R Mft Vdgk Three Five Sevenk Property Plant And Equipment Zero Three Two Six Two Zero T Zerohp Pdh Dkncy Property Plant And Equipment Zero Three Two Six Two Zerocy S Eight L Gm Six Six Cxw Property Plant And Equipment Zero Three Two Six Two Zerok H Seven L N Eight Ones J Zh L Property Plant And Equipment Zero Three Two Six Two Zerows H Nine One Three N R F Cwc Property Plant And Equipment Zero Three Two Six Two Zerofy Gg Cg Threeq G S V D Property Plant And Equipment Zero Three Two Six Two Zero S Eightn Twor Six Lt V F Zero P Property Plant And Equipment Zero Three Two Six Two Zero Cl Sixz Bxmxkwk Five Property Plant And Equipment Zero Three Two Six Two Zero V S Four Zero Fourk Rn T Jll Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zerowc W Fourx Eight Wshc Fourp Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zeromd N Zxc W Zeroqr Four T Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zero One V T Four W X Five Five Seven Four J L Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zero Fivep Z Vf Seven Eightm Q Bk K Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zero Six T Xc Mbvb Sh Twos Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zerohw Z Lnpnydbxn Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zerowk X Wr Lwg T M H T Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zerod B P V G T Three Zeroc Gr Four Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zero Fivek Eight X V Threeb Four My N Q Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zeroy Fourfm M Zerow Xw Sw Eight Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zeroqb Fivemswp M Seven Vwq Schedule Of Accounts Payable And Accrued Liabilities Zero Three Two Six Two Zeroqv T One Wgzgq Zero Pz Schedule Of Sharebased Payment Award Stock Options Valuation Assumptions Zero Three Two Six Two Zero Hbl Ry Seven J One Eightw H Six Schedule Of Sharebased Payment Award Stock Options Valuation Assumptions Zero Three Two Six Two Zerod D X Fourn F Hpmyc P Schedule Of Sharebased Payment Award Stock Options Valuation Assumptions Zero Three Two Six Two Zero Dn Nine Zl Three Four V Sx Tl Schedule Of Sharebased Payment Award Stock Options Valuation Assumptions Zero Three Two Six Two Zero Nwn V Qhv Onedndy Schedule Of Sharebased Payment Award Stock Options Valuation Assumptions Zero Three Two Six Two Zero Eightw G Fived W Xz J L Eightb Schedule Of Sharebased Payment Award Stock Options Valuation Assumptions Zero Three Two Six Two Zerov Z Qy Ntqfw Gy Seven Schedule Of Sharebased Payment Award Stock Options Valuation Assumptions Zero Three Two Six Two Zero M C C One Bs Four Sixlk F S Schedule Of Sharebased Payment Award Stock Options Valuation Assumptions Zero Three Two Six Two Zero One Zero Onev J Six Ln Pn Threeg Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero Ff Two X Ts B Eight G M T Four Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zerok Three F T N Sixm Seven Jq X V Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero Five D F Three V Zero W One Fiven J P Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero V Lg B Hqwb B Gp Q Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero L One V R K Nine Q Lkdm S Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero N B Tqb Two Nine P Five Four Hy Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zeroc Zeroy J D Q Wl H Sixx Z Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero C Four Rt Rf C W Four Bns Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero Eightpp M V D Sixy Two Cw Eight Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero Six Sx Eight Q Zero Pg Six Gz Eight Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero B B Kf Sd Twov Three One Jf Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero T Sevenssmzw Sevenld Sevenx Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero Five Six Z F Df Two Zerosv Six J Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zeron Seven Three C J Threek J Sixsz D Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zerowdb R G Nine One L One F Zero X Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zerokyrb Tp One Ninekglx Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero C Nined D N St Z Bh Z Two Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero Three Sevenh Q Eightr F S Six Kz K Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero Mvnn G Zero B Cv Ntl Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero Sevenc One Sy S H D Ninetdh Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zerod Wm Seventvg Z Zero Qlw Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zerov Threerbn One Nine One T M J X Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero B Sixc D D One Jy K Qnb Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zeroc Nfd Lc P C Six C Q One Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero Zero Q S Five N Z L Fivegy L Zero Schedule Of Sharebased Compensation Stock Options Activity Zero Three Two Six Two Zero Twol V R Six Eight Zhhzg T Options Expiring December One Five Two Zero One Three [Member] Options Expiring May One Two Zero One Two To September Two Six Two Zero One Six [Member] Options Expiring January One Two Zero One Two To September Two Six Two Zero One Six [Member] Options Expiring December One Four Two Zero One Four [Member] Options Expiring April One Seven Two Zero One Four [Member] Options Expiring December One Four Two Zero One Six [Member] Options Expiring December One Four Two Zero One Five [Member] Options Expiring October One Two Zero One Two To February Two Eight Two Zero One Five [Member] Options Expiring September Seven Two Zero One Six [Member] Options Expiring March One Zero Two Zero One Six [Member] Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Plm Three R Zero Twop T Five Xc Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Threedw S Xzsg R B Fg Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerowm Rl Twow J Kr H K X Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerolw H Ny Two Eight Seven Ldb L Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Five Six H T X Ph S Tf Wc Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeror Eight Fivevpfp Threebm Hs Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero T Gv K P Drs N V Bh Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Pmd Sixy Nh Xsv T S Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Three Tztg Six T Two Eight Three Q L Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Fxgy Four W M Cf N Sevent Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerowl Jlw Gt Nc V T F Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Seven Eight Qc Zerowz Bdd Z Zero Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero L Dkct Seven D W Threes T G Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Z T Zerorh Eight Vd Seven Eight Two Seven Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Fived Vvtwd G L Zero Q Z Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero T One Nm W Btv Vnkq Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Nine Gd Wk Five Wwb F N L Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeroc Zwv Pckk Pr G W Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Two Sevenc Eightt X Twoc Q Fiverg Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerot W Onef Four Threezvrr W Six Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerom J N Eight Nine B One Eightk H Four C Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerom Vs Eight Oneqcrp Pr Eight Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero L V L B Sevenbdg Fourc Vz Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeroh Ln M Seven Onepgy Threeq S Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerolsx Plp Four K Z N Five X Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero One W Five F Threen Xv Zero Ninev Nine Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero J C J Eightyh Stv Zero Four C Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeroxd Three P One J Nine Sy J Eight M Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero H Sh K G Wx Two Fq Ds Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeroc D Zero Sevenyyx Z T One F Nine Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Seven X L Nine Mn Six Mvkk K Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero J V S Pd Sevenm Z K Pqk Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero P Mh M Q Q One T Chls Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeronycx Onewm Six Fived Z J Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero G X Z J Ninet Tn M Six Two D Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Pm Lz Six Ts Sn R K F Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerolv Lcfs L Nine Eightwnf Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerocg Q Six G Four G Fh X F C Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero F Sixl Jg Ldy Fourv M Zero Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerobb R Cs Xnt B Br Two Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Eight Two Five T Onec S Eight Two Nineng Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerozsw V Fourvd Three Vx M R Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Ninew Sixpddq Six F Sevenvn Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Xkg Vkh Two Four C Db V Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerotg X Pkqz Wb V Fs Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Jp S Sevengy Kr K Nine Dv Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerogph Eightcn Vs Four Th J Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Nined Fys W X L Six Zerokg Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeroc H G N Tg Z Qb N Dd Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerob P J Tf F L X Tt L N Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerow Dh Rgcx M R Sevenr Five Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero K Vvr T Twof Z Sk Km Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerog Eightwfv Z Hx Qs N W Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeroh Nine Fiver Zr Sixx S T R T Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Threeh Xrxt K W Fls V Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerom Sc Wfqd Mpttg Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Xyy Sixq Two Nine Rw Onezv Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero One X Onew Q Six H V Cfq Seven Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Ws Km W W G B K S Six Seven Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Fq X Six Sevenxp Cc Seven Ky Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Six Hrw Two C Z T F Td V Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Eight X One L L Dbs D V J Three Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero T Q R Sevencx Nk Kq Two L Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeroh N Ninew Nine Zero Seveng W Br S Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeron R Zb Q Fivebx Two V M Seven Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero R Sixfxk P Kdt M L H Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero F F J T Sevenn Zero Tsw Rr Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero D N W Eight M Seveny Tqd L D Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeroy Threep Sixw P Sevensn Zr N Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeroz Three Crmg G Ninehth Three Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Six Cm Oner N Seven Zh Rb Two Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Sl P N Xxvndq Two D Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Gc Fourc Zero Six Cpk Three X One Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero N Jz Zr Nine Sixt Sixpxy Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerov Z N One Six T W Seven J Three Tk Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zero Gnx T H Pl Ndv B Q Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zeroh Sevenw Four T Z K H Ch Two C Disclosure Of Sharebased Compensation Arrangements By Sharebased Payment Award Zero Three Two Six Two Zerow Gn Zero J Nine Xz Two Mpp Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zero Kvf Six Khg Ninew M M Zero Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zero Sngmg X Vv Two Vg S Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zero X B Nl Zero Tk Z J Eight R Seven Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zero Qbnm K Kkt Mh Tk Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zero Nines Ch Z Three Threer Fourz Vv Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zero Sevenr Hqb Eightq Zero K Jwx Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zero V R W Two Nv Cqy Three Bf Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zerop Z V Two X L Z Z L R K Eight Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zero M K J B Gs Zv Fivekmf Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zerog Seven Kh Ninep N K Eightx Wr Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zerobd V M Qcm Q M Ts X Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zero L Ds Gkv X Fiver R T N Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zerohv Tbvz K Z Cnv H Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zeroc Six Sw G Zt N F F R Q Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zerod Sf F Six N Fourt K Oneb Six Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zeroy Two Py Q Kftx Xbb Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zerog Csf L Eightkz P Lcv Schedule Of Nonvested Performancebased Units Activity Zero Three Two Six Two Zerolt J Cd X V Tq F Four Nine Schedule Of Employee And Nonemployee Service Sharebased Compensation Allocation Of Recognized Period Costs Zero Three Two Six Two Zerof Qm G H Two Rb One Hs F Schedule Of Employee And Nonemployee Service Sharebased Compensation Allocation Of Recognized Period Costs Zero Three Two Six Two Zeroz P D Four Fourkknpb M Four Schedule Of Employee And Nonemployee Service Sharebased Compensation Allocation Of Recognized Period Costs Zero Three Two Six Two Zeroykmk Pbs One Xx C Eight Schedule Of Employee And Nonemployee Service Sharebased Compensation Allocation Of Recognized Period Costs Zero Three Two Six Two Zero Seveny Seven Eight T H V N Zeronv Zero Schedule Of Employee And Nonemployee Service Sharebased Compensation Allocation Of Recognized Period Costs Zero Three Two Six Two Zero X J M Eight R Gy P F Six Sevend Schedule Of Employee And Nonemployee Service Sharebased Compensation Allocation Of Recognized Period Costs Zero Three Two Six Two Zero Ll Oneb Jd Hmx Oneb Q Schedule Of Employee And Nonemployee Service Sharebased Compensation Allocation Of Recognized Period Costs Zero Three Two Six Two Zero R Lcc Rm T C Zerolfx Schedule Of Employee And Nonemployee Service Sharebased Compensation Allocation Of Recognized Period Costs Zero Three Two Six Two Zerof Lpg Two Vk Gf One Fiveg Schedule Of Employee And Nonemployee Service Sharebased Compensation Allocation Of Recognized Period Costs Zero Three Two Six Two Zero T Four Q Zero Nmt K Two Z T Zero Schedule Of Employee And Nonemployee Service Sharebased Compensation Allocation Of Recognized Period Costs Zero Three Two Six Two Zerob Five Jb Td Fr T Nine Eight X Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zerot Five One K Zerocm Fdz Three M Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zeroqcc C X H Gh Nine T Kh Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zeror P Wdbd M R Wb Eight One Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zerox Seven Ld Qmrw M Zv Q Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero Fivey Rx B Xl Zerofp Pk Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero C P B Br Nine Lx G T N T Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero Zero Bs Fourg H X K C Twols Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero T Two P Four R M P T Zero N X C Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero Three Z Wt Two Mf Sc Three Cw Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zeroq Nine Oneq Ninel Zvg Onexp Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero G Qt Bm One Fk Kt Threen Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zerokzw X Tf T Mcp Zerof Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zerowcs Two Zp D Twotrtp Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zeros Five T Seven T Xzc G Zero Fourg Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero Cfsx Kht Tqm K G Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero Three T Fourh B Four Nine Rwb Qm Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zeroh Zh H Six Three Twoh Z T H G Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zeropld D Two Nine Sixm Q Zero W Two Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero Six Ww Skbwfz Qq T Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero Threez W T D H M Six Ld Lp Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zerow F Ts Five C Js D R Vk Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zeror Mrzy T Z X Eightp Zero V Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero Five Lks Eightp Qq Four X C Z Schedule Of Stockholdersapos Equity Note Warrants Or Rights Activity Zero Three Two Six Two Zero M Zero R J Sn S Rp Zero Gc Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zero Qx T Pk P X Bp Four Fivet Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zeroy Krn Six G Sevenr Wy Jh Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zero Wg D Nine Zero Z Two M Sixskd Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zero F Ninenzy Zerot Fourc Smf Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zero T Twowv T Ninetd G Sf B Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zero R T L Nine S H B Two Zw M C Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zerowll Eight J Cb J T Hgy Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zero L Nineh Sixmc Zero Ck Three N Z Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zerok Db K Sevenz V Q D Eight Eight X Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zeroy F G Bl Tcz Msyh Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zeroh Sevenmnl S H Wgy Hx Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zeros Zerol Tf Gg Z Hkvs Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zeroy Zero J J Rg V B Eight Five T B Schedule Of Stockholders Equity Deferred Share Unit Plan Zero Three Two Six Two Zero Nine G Rb F Sixn Sixy Fivezy Schedule Of Stockholders Equity Non Vested Deferred Share Units Zero Three Two Six Two Zeros Z Shz Twy Eightx Pr Schedule Of Stockholders Equity Non Vested Deferred Share Units Zero Three Two Six Two Zero Threev N Pkw Sh Nine K Six W Schedule Of Stockholders Equity Non Vested Deferred Share Units Zero Three Two Six Two Zero N Cbh Qtt S W Jlx Schedule Of Stockholders Equity Non Vested Deferred Share Units Zero Three Two Six Two Zero Eightp Qy Six S X Jbr F Nine Schedule Of Stockholders Equity Non Vested Deferred Share Units Zero Three Two Six Two Zeropt Two Five Db Zm Five Zeroq N Schedule Of Stockholders Equity Non Vested Deferred Share Units Zero Three Two Six Two Zerod Szsmf P Trx Dw Schedule Of Stockholders Equity Non Vested Deferred Share Units Zero Three Two Six Two Zeroml Wd J K Two Qx Nine Fr Schedule Of Stockholders Equity Non Vested Deferred Share Units Zero Three Two Six Two Zero Ngx Cy Fxxrdk Eight Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero Three Three S Six Sz Dd Xy Nine R Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero Kly Zero Sg T Zv One Q Seven Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zerof Zero Bmd Fivew Six Mrdc Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero R D Pmrl Dn Eightn Kn Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero Ncm Sw F P Q Zerom J Z Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero Mz P One Pw Six F R Threel K Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero X T F Fivezpv Dcqsb Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero F Six D X Sqyx Four Ninety Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zerob C T T Q Tc N M X Zero J Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero Five Onexhb Two Hrh Cxf Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero Eightxn Twods Zero Five Nine K Nine X Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zerow Five Threes K Pc Nine Fivec Zeros Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero Pxcx Q P One Six Sevent R V Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units Zero Three Two Six Two Zero Threel One C H One T Twot J Q V Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zerox Five Dq Four Onem Hp R Wp Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zerox Zerol Zh J Zeroy Eight Five One Z Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero Six Tbf Zd Qs Sevenk T L Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero Lp X K Fived S L Jp Threez Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero Tz V Three H Z N Fourct Four Four Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero B Four Zddtl Dt S Eightd Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero Zerosq V Zero Four Seven Gtp Two H Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zerow V Five One C Zero R Sixs Dd T Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zerotx Foury Nine Byyl Kk Zero Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero Tr Jr Fourc F S One X Zd Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zerok Threeby L Qd X B Twoqs Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero T St J Fourv F M W M Oneb Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero D J C C Zeroz M X M Hsf Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zeron X Hf Three Sevennt Dq T L Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero C Tk V Seven C N Sc B Three C Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero F W S M Eightd G S Five N One B Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero Eight Tb Five One One Kd Six X Zc Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero L Four Z G K Twon Sixl W Zero G Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero Ncy Six K Twon Five F W Seven M Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zerory Zero Ninedl X J S W Threer Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zero Zf Q Eight Zero Z H Hv Ksy Schedule Of Deferred Tax Assets And Liabilities Zero Three Two Six Two Zerop W Five Fb Bdwf Ky T Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero G Two C F One Lts Kw Three Zero Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero Q T Q Four Vh Two Zero Fiverb L Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zerofftp Ns Ntxy Ck Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero W Vf Fz J Four G Five X Tz Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero M Zerotmfsr Sixr Onelp Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero T Nc V Three R N B W Seven Eightl Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zerod Threerq Nk Qx S V Gr Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero X Z Jc Zero One Dpp K Four L Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zeroxf Tfh Seven Ws B Eightt Two Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero T K Three Q M Ww M Zero Zero H R Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zerob Vs Dhqb Mr Q Jl Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zeroz Eight D T B Eightfr Zero B L Two Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero F Eight Wc F K F V Nine Nine T D Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero Sevenn Q Eight D X Threeb K Q Cd Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero Six Three Five Tdbz K K T T T Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zeroz M Zx Fk Q Eight Ninev One Six Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero T Lk T Fourt S G Oneh Ry Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zerof K T Nptvq Seven Eightd G Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero Q Fourb Oneq Six T Kh Eight Ty Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zerocn Rdz Six S Ninemh C Q Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zero J R Zerob V Three B Hr Hfd Schedule Of Components Of Income Tax Expensebenefit Zero Three Two Six Two Zerogt D X Ph X Four Hwv Nine Summary Of Operating Loss Carryforwards Zero Three Two Six Two Zero Qs S Pnzzd Z Zerocb Summary Of Operating Loss Carryforwards Zero Three Two Six Two Zero Fivef P Fourc Pbyxyd S Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero Sevenv Two Four Two Cb Four Eightpcv Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero Xl L Q One D Sr Sixn Six S Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero Five Three Six R Six Qf Gg Gp F Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero R S T S L Nine Jy N B J S Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero C L Three Mhk M Tg Kk Zero Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero F Seven X M Five P P Q C V J One Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero F H T Four Vqb Q Four C V M Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero K Z Sixw Kx C M X Three C Nine Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zeroz Wtsf Pz J Ninegr T Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero C Gls R Zeror B Bs M Two Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero X Mv H P Zero Tv L J V V Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Zero Three Two Six Two Zero Vx Twoxn Nine X Six Zd M Six Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Zero Three Two Six Two Zero Eight Zero T K Zqn Xq V B G Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Zero Three Two Six Two Zeron Dg Eight G Vq C S Tq Five Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Zero Three Two Six Two Zero Ld G R One T K Rw One Two Z Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Zero Three Two Six Two Zero Dql Nine P One Q Q Gl Ninek Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Zero Three Two Six Two Zeroxk Threebh Sixh Nineb N One Four Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Zero Three Two Six Two Zeroz X Six Sixv T Txb Wn C Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Zero Three Two Six Two Zerowyfp Bm T J T Six V S Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Zero Three Two Six Two Zero T Twoz Mn C Sp Threez S G Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Zero Three Two Six Two Zerop Four Twoh D K Z N N Nhm Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area Zero Three Two Six Two Zero One K Pg Three F Ninem K Threed S Schedule Of Long Lived Assets By Geographical Areas Zero Three Two Six Two Zerof Tv Four P M Three Three N Threet B Schedule Of Long Lived Assets By Geographical Areas Zero Three Two Six Two Zero Five Rm Q Tt Eight V Bd Vm Schedule Of Long Lived Assets By Geographical Areas Zero Three Two Six Two Zero Sevenl K Fiven Six Fx Dx Three H Schedule Of Long Lived Assets By Geographical Areas Zero Three Two Six Two Zerog C K Jn Nh Zeron X Five Z Schedule Of Long Lived Assets By Geographical Areas Zero Three Two Six Two Zero T Three C V Two Fiven Eightbs V Q Schedule Of Long Lived Assets By Geographical Areas Zero Three Two Six Two Zerol T Ls T K N V Twoh Pl Fair Value Assets Measured On Recurring Basis Zero Three Two Six Two Zero H One Qgw G P M H Pz M Fair Value Assets Measured On Recurring Basis Zero Three Two Six Two Zeron Tr C Zero Z Three Jq Seven K One Fair Value Assets Measured On Recurring Basis Zero Three Two Six Two Zero Tw Nine M Eight Gb S Nt H T Fair Value Assets Measured On Recurring Basis Zero Three Two Six Two Zero Eight F Jq Tr Threel N N Sevenf Fair Value Liabilities Measured On Recurring Basis Zero Three Two Six Two Zero Nine F Gtg Seven Wvpcfk Fair Value Liabilities Measured On Recurring Basis Zero Three Two Six Two Zero K S Four R Wg Tnxw D D Fair Value Liabilities Measured On Recurring Basis Zero Three Two Six Two Zero N Twoqv R W Lw Ts S L Fair Value Liabilities Measured On Recurring Basis Zero Three Two Six Two Zero Four B Z Jn Sevens Shd Three S Fair Value Liabilities Measured On Recurring Basis Zero Three Two Six Two Zeroh Ninew X H Nine Clg Eightx Eight Fair Value Liabilities Measured On Recurring Basis Zero Three Two Six Two Zero Sm Six H Threen S P Foursp Seven Fair Value Liabilities Measured On Recurring Basis Zero Three Two Six Two Zero Tq Qm Tnb C T M D W Fair Value Liabilities Measured On Recurring Basis Zero Three Two Six Two Zero Lf C Hp Gcg V Zeroq Seven Fair Value Liabilities Measured On Recurring Basis Zero Three Two Six Two Zerov Four Sixy T Nine Fp Hx Qn Fair Value Liabilities Measured On Recurring Basis Zero Three Two Six Two Zero Wt Q One Tb Pf Threer Pg Schedule Of Agreements By Year Zero Three Two Six Two Zero Kp Fourf Gt Xx Eightm Lp Schedule Of Agreements By Year Zero Three Two Six Two Zero P L Three F M Cr Three R T C C Schedule Of Agreements By Year Zero Three Two Six Two Zero One Drqt T P Zeroks Sevenv Schedule Of Agreements By Year Zero Three Two Six Two Zero Cv Q Qc Wp M Qr Tz Schedule Of Agreements By Year Zero Three Two Six Two Zeror S Fived Rf L Tw Knd Schedule Of Agreements By Year Zero Three Two Six Two Zero Fivetzd X Two Dbd Five Tb Schedule Of Agreements By Year Zero Three Two Six Two Zeroqg Xd Six G N Eightyt W One Schedule Of Agreements By Year Zero Three Two Six Two Zero Two Xx F V M Tn C T Nine Z Schedule Of Agreements By Year Zero Three Two Six Two Zerov Zerom Qr R J Cmp Zd Schedule Of Agreements By Year Zero Three Two Six Two Zeroc Three N Five Twocct M Nz Two Schedule Of Agreements By Year Zero Three Two Six Two Zero Six G Ht T T Xm Z Brq Schedule Of Agreements By Year Zero Three Two Six Two Zerox B N X Fivevh Four D P C Q Schedule Of Agreements By Year Zero Three Two Six Two Zeropcx F Z P Sixbgz Gn Schedule Of Agreements By Year Zero Three Two Six Two Zero Z T N Tkb Zsx Fg B Schedule Of Agreements By Year Zero Three Two Six Two Zeroy B M Tl Gnbl J M J Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zero Rzlh Seven J Fivexz H Kt Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zero J S Hsy F Four Eight X Seven Mz Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zero Vv W Pxtt One Z Hm B Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zeroz Fivet C H Ns Twoyyp Six Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zerot Txnywqlc L Cf Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zeron Bv Seven Four J F Bk Hz Z Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zerob Zw Mcxm Sixbcfh Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zeroxg N V Xfb Twoc Td S Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zerodd J F M Five Vgc T K T Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zero C Four Four Onels Z Pk R B Five Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zero L Six W Two Zero Jmyr D N Zero Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zerom F W Jr T Fgf X Tn Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zeroh R Xg Five Hkhf J D N Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zero N N Seven Vybrb Eightq Qy Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zero Mwq Mv Xmyrb Th Schedule Of Earnings Per Share Basic And Diluted Zero Three Two Six Two Zerozb One Tz H B F Zero Rv T EX-101.PRE 12 cpah-20160430_pre.xml XBRL PRESENTATION FILE GRAPHIC 13 exhibit23-1x1x1.jpg GRAPHIC begin 644 exhibit23-1x1x1.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# ! +# X,"A .#0X2$1 3&"@:&!86 M&#$C)1TH.C,]/#DS.#= 2%Q.0$17137!D>%QE9V/_ MVP!# 1$2$A@5&"\:&B]C0CA"8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V-C M8V-C8V-C8V-C8V-C8V-C8V-C8V-C8V/_P 1" U '0# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#M[R_M;'9] MJF$>_.W()SCKT^M2P3QW$*RPMOC89! ZUS7C;_ER_P"!_P#LM:_A_P#Y EK_ M +I_F:F^MCJG04:$:M]7_P $1_$&E1NR/>(&4X((/!_*D_X2+2/^?V/\C_A7 M#:I&LOB6>-L[7N=IQZ$UU)\&:9@XDN0?]\?X5URITXI.3>IPJ4GL;5IJ-G>Y M^RW,VU>2Y6Y:0"(*1L..N?\*UKWP5$8V:RN9!(!D++@@_B!52ITXOE;8E M*35T=6CJZAD8,IZ$'(-+7G>A:O/HU\+>)M'+;?MHS_ +C8 M_/%H ME*3V-BVO;6\7=;7$-O\ ER_X'_[+6OX?_P"0):_[I_F:A?$ST:O^YP]7^IPFKEQXBN3$,R"X MRH]\\5K37OBLQ,&AE4'J4B&:HW%M-<^+)EAC+E;G>V.RAADFN]-[:@9-S#_W MV*[JDU%1TN>3%7N>>Z/<6MGJBS:I%,9%;<"?X6]2#S77^*)$E\,W$D;!D8(0 M1T(W"N=\8WME=W4 M661T4AY$Y!Z8&?S_.K\JNOP^ ?KM4\^A?C],4YKF<9@ MM+HB\ _ZZ]_W4_F:[.N.\%1O:K<7%P/*BF"B-G.-V,YQGZUT%YK>GV<9:2ZC M) R$1@S'\!6-;6H[%1TCJ<7XO14U^;:/O*I/UQ_]:I_%,CO9:/N)YMMQ^N%J M@?M'B#6R0,/,W/HBC_ 5U'BO23/I,+VZ%GM!@ =TQS_(5T-J+@F9VO=HL^#U M5?#\!'5F.D4Z5"Y^\)@!^(-0> 78P7L9^ZK(P^I!S_(5G>+=9AU&2 M.WM6WQ1$L7'1F]OI_6NC\*:<^GZ4#,NV:9M[#N!V'^?6M7[M&SZDK69MT445 MRFARWC;_ )'S_Q);7_ '?ZFFZW9M<^1+':_:9(MVU"P"@G')R> M>G2L&;3O$4LA=A(N>R3*H'T -1L[GI0Y:V'C3ZJAW.?]HYY^E9/_"#S?\_T?_?L_P"-)_97B#_IO_X$#_XJC^RO$'_3?_P( M'_Q5:QQ$XJR,G@:;_P"7D?O+]AX-M8) ]U.UP01+%YX3O;Z8RW.I([=OW9 ] ,\5'#X'.\&:^!7N$CY_4U'_97B#_IO_X$ M#_XJC^RO$'_3?_P('_Q56L342LA?4*?_ #\C]YT^F:5::7$4M8\$_><\LWU- M7CS7%?V5X@_Z;_\ @0/_ (JC^RO$'_3?_P "!_\ %5DYMN[17U.'_/V)JZIX M3L[V1I8'-M*QR=HRI_"LK_A"+G.#>Q;?]P_RH_LKQ!_TW_\ @?_ !5']E>( M/^F__@0/_BJT6(J)61+P%-_\O(_>;&E>%[/3W6:0FXF7HS# 'T'^-;HKBO[* M\0?]-_\ P('_ ,56]X=M;^VAG%_OW,P*[Y-W&/J:EU)3=Y$5,+"G"ZFGZ&Q1 F110 GRAPHIC 14 form10kx35x1.jpg GRAPHIC begin 644 form10kx35x1.jpg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end XML 15 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
Document and Entity Information - USD ($)
12 Months Ended
Apr. 30, 2016
Jul. 08, 2016
Oct. 31, 2015
Document Type 10-K    
Amendment Flag false    
Document Period End Date Apr. 30, 2016    
Trading Symbol cpah    
Entity Registrant Name COUNTERPATH CORP    
Entity Central Index Key 0001236997    
Current Fiscal Year End Date --04-30    
Entity Filer Category Smaller Reporting Company    
Entity Common Stock, Shares Outstanding   4,555,348  
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Well Known Seasoned Issuer No    
Entity Public Float     $ 6,133,484
Document Fiscal Year Focus 2016    
Document Fiscal Period Focus FY    
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Apr. 30, 2016
Apr. 30, 2015
Current assets:    
Cash $ 2,159,738 $ 2,852,422
Accounts receivable (net of allowance for doubtful accounts of $547,173 (2015 - $294,719)) 3,209,279 3,305,466
Prepaid expenses and deposits 184,644 168,299
Total current assets 5,553,661 6,326,187
Deposits 93,868 97,667
Equipment 142,563 271,736
Goodwill 7,001,228 7,311,449
Other assets 174,811 216,125
Total Assets 12,966,131 14,223,164
Current liabilities:    
Accounts payable and accrued liabilities 1,943,108 2,305,580
Unearned revenue 1,808,857 1,866,986
Customer deposits 2,384 0
Accrued warranty 61,356 73,117
Total current liabilities 3,815,705 4,245,683
Deferred lease inducements 35,379 47,760
Unrecognized tax benefit 10,563 10,563
Total liabilities 3,861,647 4,304,006
Stockholders' equity:    
Preferred stock, $0.001 par value Authorized: 100,000,000 Issued and outstanding: April 30, 2016 - nil; April 30, 2015 - nil 0 0
Common stock, $0.001 par value Authorized: 100,000,000 Issued and outstanding: April 30, 2016 - 4,542,348; April 30, 2015 - 4,233,395 4,542 4,233
Treasury stock 0 (1)
Additional paid-in capital 70,065,082 67,638,003
Accumulated deficit (58,022,500) (55,330,905)
Accumulated other comprehensive income (loss) - currency translation adjustment (2,942,640) (2,392,172)
Total stockholders' equity 9,104,484 9,919,158
Liabilities and Stockholders' Equity $ 12,966,131 $ 14,223,164
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Apr. 30, 2016
Apr. 30, 2015
Allowance for Doubtful Accounts Receivable, Current $ 547,173 $ 294,719
Preferred Stock, Par Value Per Share $ 0.001 $ 0.001
Preferred Stock, Shares Authorized 100,000,000 100,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Par Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 100,000,000 100,000,000
Common Stock, Shares, Issued 4,542,348 4,233,395
Common Stock, Shares, Outstanding 4,542,348 4,233,395
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Revenue    
Software $ 6,031,618 $ 7,151,076
Service 5,049,740 4,852,007
Total revenue 11,081,358 12,003,083
Operating expenses:    
Cost of sales (includes depreciation of $7,225 (2015 - $32,710)) 1,667,087 2,222,071
Sales and marketing 4,145,351 4,935,671
Research and development 4,737,055 5,669,217
General and administrative 3,373,674 4,522,044
Total operating expenses 13,923,167 17,349,003
Loss from operations (2,841,809) (5,345,920)
Interest and other income (expense), net    
Interest and other income 5,211 21,669
Interest expense (2,310) (1,229)
Foreign exchange gain 195,003 883,613
Fair value adjustment on derivative instruments (47,690) 0
Net loss for the year $ (2,691,595) $ (4,441,867)
Net loss per share:    
Basic $ (0.61) $ (1.05)
Diluted $ (0.61) $ (1.05)
Weighted average common shares outstanding:    
Basic 4,433,402 4,249,252
Diluted 4,433,402 4,249,252
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Depreciation $ 7,225 $ 32,710
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Net loss for the year $ (2,691,595) $ (4,441,867)
Other comprehensive loss:    
Foreign currency translation adjustments (550,468) (1,408,044)
Comprehensive loss $ (3,242,063) $ (5,849,911)
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Cash flows from operating activities:    
Net loss for the year $ (2,691,595) $ (4,441,867)
Adjustments to reconcile net loss to net cash used in operating activities:    
Deferred lease inducements (9,882) (6,602)
Depreciation and amortization 199,335 209,382
Foreign exchange (gain) loss (248,371) (293,323)
Stock-based compensation 906,914 1,000,070
Issuance of common stock for services 38,783 0
Changes in assets and liabilities:    
Accounts payable and accrued liabilities (314,804) (150,819)
Accounts receivable 96,187 96,025
Accrued warranty (11,761) 3,958
Customer deposits 2,384 (9,553)
Deferred lease inducements 0 54,362
Prepaid expenses and deposits (14,884) (2,693)
Other assets 0 (21,412)
Unearned revenue (58,129) 241,160
Unrecognized tax benefit 0 (15,068)
Net cash used in operating activities (2,105,823) (3,336,380)
Cash flows from investing activities:    
Purchase of equipment (27,692) (214,514)
Purchase of intangibles (13,739) 0
Net cash used in investing activities (41,431) (214,514)
Cash flows from financing activities:    
Common stock issued 1,520,574 11,689
Common stock repurchased (38,882) (322,648)
Net cash used in by financing activities 1,481,692 (310,959)
Foreign exchange effect on cash (27,122) (458,523)
Decrease in cash (692,684) (4,320,376)
Cash, beginning of the year 2,852,422 7,172,798
Cash, end of the year 2,159,738 2,852,422
Supplemental disclosure of cash flow information Cash paid for:    
Interest 2,310 1,229
Taxes $ 0 $ 0
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)
Common Shares [Member]
Treasury Shares [Member]
Preferred shares [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Beginning Balance at Apr. 30, 2014 $ 4,260 $ (2) $ 0 $ 66,948,866 $ (50,889,038) $ (984,128) $ 15,079,958
Beginning Balance (Shares) at Apr. 30, 2014 4,259,987 (1,620) 0        
Exercise of stock options $ 7     (11,504)     (11,497)
Exercise of stock options (Shares) 6,789            
Share repurchase plan   $ (35)   (311,048)     (311,083)
Share repurchase plan (Shares)   (35,213)          
Cancellation of shares $ (36) $ 36          
Cancellation of shares (Shares) (35,632) 35,633          
Stock-based compensation       1,000,070     1,000,070
Employee share purchase program $ 2     11,619     11,621
Employee share purchase program (Shares) 2,251            
Net loss for the year         (4,441,867)   (4,441,867)
Foreign currency translation adjustment           (1,408,044) (1,408,044)
Ending Balance at Apr. 30, 2015 $ 4,233 $ (1) $ 0 67,638,003 (55,330,905) (2,392,172) 9,919,158
Ending Balance (Shares) at Apr. 30, 2015 4,233,395 (1,200) 0        
Private Placement $ 293     1,441,546     1,441,839
Private Placement (Shares) 293,000            
Issuance of common stock for services $ 10     38,773     38,783
Issuance of common stock for services (Shares) 10,000            
Share repurchase plan   $ (10)   (6,256)     (6,266)
Share repurchase plan (Shares)   (10,460)          
Cancellation of shares $ (11) $ 11   (32,616)     (32,616)
Cancellation of shares (Shares) (11,260) 11,260          
Stock-based compensation       906,914     906,914
Employee share purchase program $ 17     78,718     78,735
Employee share purchase program (Shares) 17,213            
Net loss for the year         (2,691,595)   (2,691,595)
Foreign currency translation adjustment           (550,468) (550,468)
Ending Balance at Apr. 30, 2016 $ 4,542   $ 0 $ 70,065,082 $ (58,022,500) $ (2,942,640) $ 9,104,484
Ending Balance (Shares) at Apr. 30, 2016 4,542,348 (400) 0        
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Nature of Operations
12 Months Ended
Apr. 30, 2016
Nature of Operations [Text Block]
Note 1 Nature of Operations

CounterPath Corporation (the “Company”) was incorporated in the State of Nevada on April 18, 2003. The shares of the Company’s common stock are quoted for trading on the NASDAQ Capital Market in the United States of America and on the Toronto Stock Exchange in Canada.

On August 2, 2007, the Company acquired of all of the shares of NewHeights Software Corporation (“NewHeights”) through the issuance of 7,680,168 shares of the Company’s common stock and 369,836 preferred shares issued from a subsidiary of the Company exchangeable into 369,836 shares of the Company’s common stock. For accounting purposes, the Company was deemed to be the acquirer of NewHeights based on certain factors including the number of common shares issued in the transaction as a proportion of the total common shares outstanding, and the composition of the board after the transaction.

On February 1, 2008, the Company acquired FirstHand Technologies Inc. (“FirstHand”), a private Ontario, Canada corporation, through the issuance of 5,900,014 shares of the Company’s common stock. For accounting purposes, the Company was deemed to be the acquirer of FirstHand based on certain factors including the number of common shares issued in the transaction as a proportion of the total common shares outstanding, and the composition of the board after the transaction.

On February 1, 2008, the Company acquired BridgePort Networks, Inc. (“BridgePort”), a private Delaware corporation, by way of merger in consideration for the assumption of all of the assets and liabilities of BridgePort. For accounting purposes, the Company was deemed to be the acquirer of BridgePort based on certain factors primarily being the composition of the board after the transaction.

On February 5, 2008, the Company's wholly-owned subsidiaries, NewHeights and CounterPath Solutions R&D Inc. were amalgamated under the name CounterPath Technologies Inc.

On November 1, 2010, the Company's wholly-owned subsidiaries, FirstHand and CounterPath Technologies Inc. were amalgamated under the name CounterPath Technologies Inc.

The Company focuses on the design, development, marketing and sales of software applications and related services, such as pre and post sales technical support and customization services, that enable enterprises and telecommunication service providers to deliver Unified Communications (UC) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol, or IP, based networks. The Company’s products are sold either directly or through channel partners, to small, medium and large businesses (“enterprises”) and telecom service providers, in North America, and in Europe, Middle East, Africa (“collectively EMEA”), Asia Pacific and Latin America.

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Significant Accounting Policies
12 Months Ended
Apr. 30, 2016
Significant Accounting Policies [Text Block]
Note 2 Significant Accounting Policies

These consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America and are stated in U.S. dollars except where otherwise disclosed. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for the period necessarily involves the use of estimates, which have been made using careful judgment. Actual results may vary from these estimates.

These consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities and commitments in the normal course of business.

  a) Basis of Presentation

These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, CounterPath Technologies Inc., a company existing under the laws of the province of British Columbia, Canada, and BridgePort incorporated under the laws of the state of Delaware. The results of NewHeights (which subsequently was amalgamated with another subsidiary to become CounterPath Technologies Inc.) are included from August 2, 2007, the date of acquisition. The results of FirstHand (which subsequently was amalgamated with CounterPath Technologies Inc.) and BridgePort are included from February 1, 2008, the date of acquisition. All inter-company transactions and balances have been eliminated.

  b) Significant Accounting Policies

Revenue Recognition:

The Company recognizes revenue in accordance with the Accounting Standard Codification (“ASC”) 985-605 “Software Revenue Recognition”. In accordance with these standards, revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collection of the related accounts receivable is deemed probable. In making these judgments, management evaluates these criteria as follows:

  •  

Persuasive evidence of an arrangement. The Company considers a noncancelable agreement signed by the Company and the customer to be representative of persuasive evidence of an arrangement.

     
  •  

Delivery has occurred. The Company considers delivery to have occurred when the product has been delivered to the customer and no post-delivery obligations exist. In instances where customer acceptance is required, delivery is deemed to have occurred when customer acceptance has been achieved.

     
 

Fees are fixed or determinable. The Company considers the fee to be fixed or determinable unless the fee is subject to refund or adjustment or is not payable within normal payment terms. If the fee is subject to refund or adjustment, the Company recognizes revenue when the refund or adjustment right lapses. If offered payment terms exceed the Company’s normal terms, the Company recognizes revenue as the amounts become due and payable or upon the receipt of cash when extended payment terms beyond 180 days are offered.

     
  •  

Collection is deemed probable. Collection is deemed probable if, based upon the Company’s evaluation, the Company expects that the customer will be able to pay amounts under the arrangement as payments become due. If the Company determines that collection is not probable, revenue is deferred and recognized upon the receipt of cash.

A substantial amount of the Company’s sales involve multiple element arrangements, such as products, support, professional services, and training. When arrangements include multiple elements, the Company allocates the total fee to delivered elements using the residual method when vendor specific objective evidence (VSOE) does not exist for the delivered element. Under the residual method, revenue is recognized when VSOE of fair value exists for all of the undelivered elements of the arrangement, but does not exist for one or more of the delivered elements of the arrangement. Each arrangement requires the Company to analyze the individual elements in the transaction and to estimate the fair value of each undelivered element, which typically represents support services.

Revenue is allocated to each of the undelivered elements based on its respective fair value.

For contracts with elements related to customized network solutions and certain network build-outs, for transactions accounted for as sales of products or services, we apply Financial Accounting Standards Board (“FASB”) ASC Subtopic 605-25 “Revenue Recognition – Multiple-Element Arrangements” and revenues are recognized under ASC 605-35”Revenue Recognition – Construction type and Production type Contract”, for long-term transactions entered to supply software, or software systems, that require significant modification or customization, generally using the percentage-of-completion method.

For multi-element arrangements, the Company allocates revenue to all deliverables based on their selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) VSOE, (ii) third-party evidence of selling price (“TPE”), and (iii) best estimate of selling price (“ESP”). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company’s best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis.

In using the percentage-of-completion method, revenues are generally recorded based on completion of milestones as described in the agreement. Profit estimates on long-term contracts are revised periodically based on changes in circumstances and any losses on contracts are recognized in the period that such losses become known.

Service revenue includes sales of support and other services, including professional services, training, and reimbursable travel. Support services include telephone support, e-mail support and unspecified rights to product updates and upgrades, and are recognized ratably over the term of the service period, which is generally twelve months. Support revenue is generally deferred until the related product has been accepted and all other revenue recognition criteria have been met. Professional services and training revenue is recognized as the related service has been performed.

Stock-Based Compensation :

The Company adopted ASC 718 “Compensation – Stock Compensation”, using the modified prospective method on May 1, 2006. Under this application, the Company is required to record compensation expense, based on the fair value of the awards, for all awards granted after the date of adoption and for the unvested portion of previously granted awards that remain outstanding as at the date of adoption. In accordance with ASC 718, the compensation expense is amortized on a straight-line basis over the requisite service period which approximates the vesting period.

Stock options granted to non-employees were accounted for in accordance with ASC 718 and ASC 505-50 “Equity based payments to non-employees” and were measured at the fair value of the options as determined by an option pricing model on the measurement date and compensation expense is amortized over the vesting period or, if none exists, over the service period. With the adoption of ASC 718, the Company has elected to use the Black-Scholes option pricing model to determine the fair value of stock options granted. The Company has estimated the fair value of option awards to employees and non-employees for the years ended April 30, 2016 and April 30, 2015 using the assumptions more fully described in Note 6.

Use of Estimates:

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the Company’s management to make estimates and assumptions which affect the amounts reported in these consolidated financial statements, the notes thereto, and the disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.

Equipment and Amortization:

Equipment is recorded at cost. Depreciation is provided for using the straight-line method over the estimated useful lives as follows:

  Computer hardware Two years
  Computer software Two years
  Leasehold improvements Shorter of lease term or estimated economic life
  Office furniture Five years
  Website Three years

Research and Development:

Research and development expense includes costs incurred to develop intellectual property. The costs for the development of new software and substantial enhancements to existing software are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. Management has determined that technological feasibility is established at the time a working model of software is completed. Because management believes that the current process for developing software will be essentially completed concurrently with the establishment of technological feasibility, no costs have been capitalized to date.

Website Development Costs:

The Company recognizes the costs associated with developing a website in accordance with ASC Topic 350-40 “Intangibles – Internal Use Software”.

Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Training costs are not internal-use software development costs and, if incurred during this stage, are expensed as incurred.

These capitalized costs are amortized based on their estimated useful life over three years. Payroll and other related costs are not capitalized, as the amounts principally relate to maintenance.

Accounts Receivable and Allowance for Doubtful Accounts:

Accounts receivable are presented net of an allowance for doubtful accounts.

      Years Ended April 30,  
      2016     2015  
               
  Balance of allowance for doubtful debts, beginning of year $ 294,719   $ 240,681  
  Bad debt provision   612,769     628,113  
  Write-off of receivables   (360,315 )   (574,075 )
  Balance of allowance for doubtful debts, end of year $ 547,173   $ 294,719  

The Company determines the allowance for doubtful accounts by considering a number of factors, including the length of time the accounts receivable are beyond the contractual payment terms, previous loss history, and the customer’s current ability to pay its obligation. When the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, the Company records a charge to the allowance to reduce the customer’s related accounts.

Foreign Currency Translation:

The Company’s functional currency is the U.S. dollar. The Company’s wholly-owned subsidiaries with a functional currency other than the U.S. dollar are translated into amounts in the reporting currency, U.S. dollars, in accordance with ASC Topic 830 “Foreign Currency Matters”. Revenues and expenses are translated at the average exchange rate prevailing during the periods. At each balance sheet date, assets and liabilities that are denominated in a currency other than U.S. dollars are adjusted to reflect the current exchange rate which may give rise to a foreign currency translation adjustment accounted for as a separate component of stockholders’ equity and included in comprehensive loss.

For transactions undertaken by the Company in foreign currencies, monetary assets and liabilities are translated into the functional currency at the exchange rate in effect at the end of the year. Non-monetary assets and liabilities are translated at the exchange rate prevailing when the assets were acquired or the liabilities assumed. Revenues and expenses are translated at the rate approximating the rate of exchange on the transaction date. Exchange gains and losses are included in the determination of net income (loss) for the year.

Accrued Warranty:

The Company’s warranty policy generally provides for one year of warranty for its products. The Company records a liability for estimated warranty obligations at the date products are sold. The estimated cost of warranty coverage is based on the Company’s actual historical experience with its current products or similar products. For new products, the required reserve is based on historical experience of similar products until such time as sufficient historical data has been collected on the new product. Estimated liabilities for warranty exposures, which relate to normal product warranties and a one-year obligation to provide for potential future liabilities for product sales for the years ended April 30, 2016 and 2015 were as follows:

      Years Ended April 30,  
      2016     2015  
               
  Balance, beginning of year $ 73,117   $ 69,159  
  Usage during the year        
  Additions (reductions) during the year   (11,761 )   3,958  
  Balance, end of year $ 61,356   $ 73,117  

Trademarks:

Costs related to trademark applications have been deferred and are included in other assets. Once granted, trademark costs will be amortized over their useful lives.

Fair Value of Financial Instruments:

The Company’s financial instruments consist of cash, accounts receivable, accounts payable and accrued liabilities, customer deposits, foreign exchange contracts, and derivative instruments. The fair value of the financial instruments approximate book value.

As a basis for considering market participant assumptions in fair value measurements, ASC 820-10 “Fair Value Measurements” establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

The fair value hierarchy, as defined by ASC 820-10, contains three levels of inputs that may be used to measure fair value as follows:

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals; and Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an entity’s own assumptions, as there is little, if any, related market activity.

In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.

The Company’s derivative financial instruments are valued using observable market-based inputs to industry valuation models. These valuation models require a variety of inputs, including contractual terms, market prices, yield curves, and measures of volatility obtained from various market sources.

The Company measures certain financial assets, including any foreign currency option or forward contracts at fair value. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments.

Income Taxes:

The Company accounts for income taxes by the asset and liability method in accordance with ASC Topic 740 “Income Taxes”. Under this method, current income taxes are recognized for the estimated income taxes payable for the current year. Deferred income tax assets and liabilities are recognized in the current year for temporary differences between the tax and accounting bases of assets and liabilities as well as for the benefit of losses available to be carried forward to future years for tax purposes that are likely to be realized. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized.

The Company has not recorded a deferred tax liability related to its investment in foreign subsidiaries. The Company has determined that its investment in these subsidiaries is permanent in nature and it does not intend to dispose of these investments in the foreseeable future. The amount of the deferred tax liability related to the Company's investment in foreign subsidiaries is not reasonably determinable.

We have $1,540,467 in cash held outside of the United States, and there is no intent to repatriate at this time. Should we decide to repatriate in the future, taxes would need to be accrued and paid.

Under ASC 740, the Company also adopted a two-step approach to recognizing and measuring uncertain tax positions taken or expected to be taken in a tax return. The first step is to determine if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained in an audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company recognizes interest and penalties accrued on unrecognized tax benefits within general and administrative expense. To the extent that accrued interest and penalties do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction in general and administrative expenses in the period that such determination is made.

Comprehensive Loss:

The Company has adopted ASC Topic 220 “Comprehensive Income”. Comprehensive loss is comprised of net profit or loss, and foreign currency translation adjustments.

Basic and Diluted Loss per Share:

The Company computes net loss per share in accordance with ASC Topics 260 and ASC 260-10 “Earnings per Share”.

ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the year. Diluted EPS gives effect to all dilutive potential common shares outstanding during the year including stock options and warrants using the treasury stock method. In computing diluted EPS, the average stock price for the year is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. For the year ended April 30, 2016, income per share excludes 812,169 (April 30, 2015 – 382,580) potentially dilutive common shares (related to stock options, deferred share units and warrants) as their effect was anti-dilutive.

Investment tax credits:

Investment tax credits are accounted for under the cost reduction method whereby they are netted against the expense or property and equipment to which they relate. Investment tax credits are recorded when the qualifying expenditures have been incurred and if it is more likely than not that the tax credits will be realized.

Goodwill:

Goodwill represents the excess purchase price over the estimated fair value of net assets acquired and liabilities assumed as of the acquisition date. ASC Topic 350 “Intangibles – Goodwill”. ASC 350 requires goodwill to be tested for impairment annually or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the Company's business enterprise below its carrying value. These events or circumstances could include a significant change in the business climate, legal factors, operating performance indicators, competition, or sale or disposition of a significant portion of a reporting unit. Recoverability of goodwill is measured at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair value of the reporting unit, which is measured based upon, among other factors, market multiples for comparable companies as well as a discounted cash flow analysis.

Management has determined that the Company currently has a single reporting unit which is CounterPath Corporation. If the recorded value of the assets, including goodwill, and liabilities (“net book value”) of the reporting unit exceeds its fair value, an impairment loss may be required.

Goodwill of $6,339,717 (CDN$6,704,947) and $2,083,960 (CDN$2,083,752) was initially recorded in connection with the acquisition of NewHeights on August 2, 2007 and FirstHand on February 1, 2008. Translated to U.S. dollars using the period end rate, the goodwill balance at April 30, 2016 was $5,341,481 (CDN$6,704,947) (April 30, 2015 - $5,578,159) and $1,659,747 (CDN$2,083,752) (April 30, 2015 - $1,733,290), respectively. During the fourth quarter of its fiscal year ended April 30, 2016, the Company performed its annual impairment test. In the first step, Management compared the fair value of the Company to its carrying value based upon the market capitalization of the Company as at April 30, 2016. On this basis Management determined that the Company’s fair value exceeded its carrying value and has not recognized any impairment of goodwill in the consolidated financial statements for the year ended April 30, 2016 (2015 - $nil).

Derivative Instruments:

The Company accounts for derivative instruments, consisting of foreign currency forward contracts, pursuant to the provisions ASC 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires the Company to measure derivative instruments at fair value and record them in the balance sheet as either an asset or liability and expands financial reporting about derivative instruments and hedging activities by requiring enhanced disclosures to enable investors to better understand their effects on an entity’s financial position, results of operations and cash flows. The Company does not use derivative instruments for trading purposes. ASC 815 also requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.

The Company also routinely enters into foreign currency forward contracts, not designated as hedging instruments, to protect against fluctuations in exchange rates. Gains or losses arising out of marked to market fair value valuation of forward contracts, not designated as hedges, and are recognized in net income.

The Company records foreign currency forward contracts on its Consolidated Balance Sheets as derivative instruments assets or liabilities depending on whether the net fair value of such contracts is a net asset or net liability, respectively (see Note 9 “Derivative Financial Instruments and Risk Management,” of the Notes to the Consolidated Financial Statements). The Company did not hold any foreign currency derivatives designated as cash flow hedges in the year ended April 30, 2016 (2015 - none).

  c) New Accounting Pronouncements

In May 2014, FASB issued ASU 2014-09, Revenue From Contracts With Customers (“Topic 606”). Topic 606 removes inconsistencies and weaknesses in revenue requirements, provides a more robust framework for addressing revenue issues, improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, provides more useful information to users of financial statements through improved disclosure requirements and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The guidance in this update supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance throughout the Industry Topics of the Codification. In August 2015, ASU 2015-14 was issued which delayed the effective date for public entities to reporting periods beginning after December 15, 2017. Early adoption is not permitted. The Company is currently evaluating the impact of the adoption of this new standard.

In August 2014, FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern , which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and provide related footnote disclosures. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. The standard allows for either a full retrospective or modified retrospective transition method. The Company does not expect this standard to have a material impact on the Company’s consolidated financial statements upon adoption.

In February 2016, FASB issued ASU 2016-02, Leases . The guidance would require lessees to recognize most leases on their balance sheets as lease liabilities with corresponding right –of-use assets. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2018. The Company is currently evaluating the impact of its pending adoption of ASU 2016-02 on its consolidated financial statements.

In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross versus Net), which clarifies the guidance in the new revenue standard on assessing whether an entity is a principal or an agent in a revenue transaction. This conclusion impacts whether an entity reports revenue on a gross or net basis. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies the guidance in the new revenue standard regarding an entity’s identification of its performance obligations in a contract, as well as an entity’s evaluation of the nature of its promise to grant a license of intellectual property and whether or not that revenue is recognized over time or at a point in time. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In May 2016, the FASB issued ASU 2016-11, Revenue Recognition: Customer Payments and Incentives, which clarifies the guidance in recognizing costs for consideration given by a vendor to a customer as a component of cost of sales. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In May 2016, the FASB issued ASU 2016-12, Revenue from Contracts with Customers: Narrow-Scope Improvements and Practical Expedients which amends the guidance in the new revenue standard on collectability, noncash consideration, presentation of sales tax, and transition. The amendments are intended to address implementation issues and provide additional practical expedients to reduce the cost and complexity of applying the new revenue standard. These amendments have the same effective date as the new revenue standard. While we are currently evaluating the method of adoption and the impact of the new revenue standard, as amended, on our Consolidated Financial Statements and related disclosures, we believe the adoption of the new standard may have a significant impact on the accounting for certain transactions with multiple elements or “bundled” arrangements because the requirement to have VSOE for undelivered elements under current accounting standards is eliminated under the new standard. Accordingly, we may be required to recognize as revenue a portion of the sales price upon delivery of the software, as compared to the current requirement of recognizing the entire sales price ratably over an estimated offering period. We continue to evaluate the impact of the new revenue standard on our Consolidated Financial Statements and related disclosures.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments: Measurement of Credit Losses on Financial Instruments which amends the guidance on measuring credit losses on financial assets held at amortized cost. The amendment is intended to address the issue that the previous “incurred loss” methodology was restrictive for Company’s ability to record credit losses based on not yet meeting the “probable” threshold. The new language will require these assets to be valued at amortized cost presented at the net amount expected to be collected will a valuation provision. The amendments will be effective for fiscal years beginning after December 15, 2019. We are evaluating the impact of this amendment on our consolidated financial statements and related disclosures.

XML 25 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equipment
12 Months Ended
Apr. 30, 2016
Equipment [Text Block]
Note 3 Equipment

      April 30, 2016  
            Accumulated        
      Cost     Depreciation     Net  
                     
  Computer hardware $ 1,049,179   $ 976,511   $ 72,668  
  Computer software   1,008,373     1,002,097     6,276  
  Leasehold improvements   263,003     237,147     25,856  
  Office furniture   190,754     186,325     4,429  
  Websites   120,953     87,619     33,334  
    $ 2,632,262   $ 2,489,699   $ 142,563  

      April 30, 2015  
            Accumulated        
      Cost     Depreciation     Net  
                     
  Computer hardware $ 1,072,376   $ 953,384   $ 118,992  
  Computer software   1,022,687     977,430     45,257  
  Leasehold improvements   280,893     238,818     42,075  
  Office furniture   204,680     197,601     7,079  
  Websites   122,161     63,828     58,333  
    $ 2,702,797   $ 2,431,061   $ 271,736  
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Accounts Payable and Accrued Liabilities
12 Months Ended
Apr. 30, 2016
Accounts Payable and Accrued Liabilities [Text Block]
Note 4 Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities at April 30, 2016 and 2015 are comprised of the following:

      April 30,  
      2016     2015  
  Accounts payable – trade $ 407,737   $ 500,739  
  Accrued commissions   272,282     184,791  
  Accrued vacation   617,589     688,965  
  Third party software royalties   343,447     568,814  
  Other accrued liabilities   302,053     362,271  
    $ 1,943,108   $ 2,305,580  
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions
12 Months Ended
Apr. 30, 2016
Related Party Transactions [Text Block]
Note 5 Related Party Transactions

During the year ended April 30, 2016, the Company through its wholly owned subsidiary, CounterPath Technologies Inc., paid $82,288 (2015 - $85,954) to Kanata Research Park Corporation (“KRP”) for leased office space. KRP is controlled by the Chairman of the Company.

On November 21, 2013, the Company, through its wholly owned subsidiary, CounterPath Technologies, entered into an agreement with 8007004 (Canada) Inc. (“8007004”) to lease office space. 8007004 is controlled by a member of the board of directors of the Company. CounterPath Technologies, paid $31,910 (2015 - $17,471) for the year ended April 30, 2016.

On July 31, 2015, the Company sold products and services to Magor Corporation for consideration of $134,250. Magor Corporation’s chairman of the board is also Chairman of the Company. As at April 30, 2016, the Company had an accounts receivable balance from Magor Corporation of $nil.

On September 4, 2015, the Company completed a non-brokered private placement (the “Private Placement”) of 293,000 units, at a price of $5.00 per unit, for gross aggregate proceeds of $1,465,000 less stock issuance costs of $23,161. In connection with the Private Placement, Kanata Research Park Corporation, a company controlled by the Chairman of the Company, purchased 150,000 units and a director of the Company purchased 10,000 units. Each unit consists of one share of common stock and one-half of one non-transferable common share purchase warrant.

The above transactions are in the normal course of operations and are recorded at amounts established and agreed to between the related parties.

XML 28 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Common Stock
12 Months Ended
Apr. 30, 2016
Common Stock [Text Block]
Note 6 Common Stock

Private Placement

On September 4, 2015, the Company issued an aggregate of 293,000 units under a non-brokered private placement at a price of $5.00 per unit for aggregate gross proceeds of $1,465,000 less issuance costs of $23,454. Each unit consists of one share of the Company’s common stock and one-half of one common share purchase warrant, with each whole warrant entitling the holder to purchase one additional common share of the Company’s common stock at an exercise price of $7.50 per share until September 4, 2017. The warrants were evaluated against ASC 815 Derivatives and Hedging, and determined to be equity instruments.

On April 4, 2016, the Company entered into an agreement to issue 25,000 shares of the Company’s common stock in exchange for advisory services. These shares would be issued in three tranches: (i) first tranche of 10,000 shares of the Company’s common stock issued before April 30, 2016; (ii) second tranche of 10,000 shares of the Company’s common stock issued before May 31, 2016; (iii) and the third tranche of 5,000 shares of the Company’s common stock issued before June 30, 2016.

Reverse Stock Split

On October 8, 2015 the Board approved a one for ten reverse stock split effected at the opening of trading on November 2, 2015. The impact of this reverse stock split has been reflected in these consolidated financial statements.

Stock Options

The Company has a stock option plan (the “2010 Stock Option Plan”) under which options to purchase common shares of the Company may be granted to employees, directors and consultants. The 2010 Stock Option Plan is effectively a merging of the Company’s 2004 and 2005 stock option plans. Stock options entitle the holder to purchase common stock at a subscription price determined by the Board of Directors of the Company at the time of the grant. The options generally vest in the amount of 12.5% on the date which is six months from the date of grant and then beginning in the seventh month at 1/42 per month for 42 months, at which time the options are fully vested.

The maximum number of shares of common stock authorized by the stockholders and reserved for issuance by the Board under 2010 Stock Option Plan is 786,000.

The Company uses the Black-Scholes option pricing model to determine the fair value of stock options granted. In accordance with ASC 718 “Share-Based Payment” for employees, the compensation expense is amortized on a straight-line basis over the requisite service period which approximates the vesting period. Compensation expense for stock options granted to non-employees is amortized over the vesting period or, if none exists, over the service period. Compensation associated with unvested options granted to non-employees is re-measured on each balance sheet date using the Black-Scholes option pricing model.

The expected volatility of options granted has been determined using the method described under ASC 718 using the historical stock price. The expected term of options granted to employees in the current fiscal period has been determined utilizing historic data as prescribed by ASC 718.

For non-employees, based on the Company’s history, the expected term of the options approximates the full term of the options. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The Company has not paid and does not anticipate paying dividends on its common stock; therefore, the expected dividend yield is assumed to be zero. In addition, ASC 718 requires companies to utilize an estimated forfeiture rate when calculating the expense for the period, whereas prior to the adoption of ASC 718 the Company recorded forfeitures based on actual forfeitures and recorded a compensation expense recovery in the period when the awards were forfeited. As a result, based on the Company’s experience, the Company applied an estimated forfeiture rate of 15% for year ended April 30, 2016 and 2015 in determining the expense recorded in the accompanying consolidated statement of operations.

For the majority of the stock options granted, the number of shares issued on the date the stock options are exercised is net of the minimum statutory withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. These withheld shares are not issued or considered common stock repurchases under our authorized plan and are not included in the common stock repurchase totals. In our consolidated financial statements, these withheld shares are netted against the number of shares that would have been issued upon vesting.

The weighted-average fair values of options granted during the years ended April 30, 2016 and 2015 were $2.35 and $4.10, respectively. The weighted-average assumptions utilized to determine such values are presented in the following table:

      Year Ended     Year Ended  
      April 30, 2016     April 30, 2015  
  Risk-free interest rate   1.66%     1.60%  
  Expected volatility   92.48%     57.58%  
  Expected term   3.7 yrs     3.7 yrs  
  Dividend yield   0%     0%  

The following is a summary of the status of the Company’s stock options as of April 30, 2016 and the stock option activity during the years ended April 30, 2016 and 2015:

      Number of     Weighted-Average  
      Options     Exercise Price per Share  
  Outstanding at April 30, 2014   370,554    

$9.40

 
  Granted   124,600    

$6.00

 
  Exercised   (33,473 ) (1)  

$14.40

 
  Forfeited / Cancelled   (45,983 )  

$10.30

 
  Expired   (3,917 )  

$9.40

 
  Outstanding at April 30, 2015   411,781    

$15.20

 
  Granted   114,900     $3.72  
  Exercised        
  Forfeited / Cancelled   (66,216 )   $8.87  
  Expired   (49,735 )   $15.63  
  Outstanding at April 30, 2016   410,730     $12.99  
               
  Exercisable at April 30, 2016   236,795     $16.77  
  Exercisable at April 30, 2015   210,544     $17.70  

  (1) In 2015 33,236 stock options were cashlessly exercised upon which 6,789 shares of common stock were issued.

The following table summarizes information regarding stock options outstanding as of April 30, 2016:

    Number of Aggregate   Number of Aggregate
  Exercise Options Intrinsic   Options Intrinsic
  Price Outstanding Value Expiry Date Exercisable Value
  $2.41 56,000 December 14, 2020
  $4.50 5,000 March 9, 2020 1,360
  $4.70 540 September 26, 2016 540
  $5.00 50,900 July 17, 2020 9,614
  $5.20 9,482 March 23, 2020 8,805
  $7.80 3,400 December 12, 2019 1,224
  $10.50 6,825 September 12, 2019 3,809
  $11.50 51,000 July 11, 2019 25,192
  $12.30 2,083 January 13, 2019 2,083
  $13.10 60,000 December 12, 2018 35,014
  $17.00 65,000 December 14, 2016 65,000
  $19.00 46,500 July 25, 2018 32,026
  $21.50 24,000 September 7, 2016 24,000
  $29.00 30,000 July 19, 2017 28,128
  April 30, 2016 410,730   236,795
             
  April 30, 2015 441,780 $6,183   210,544 $3,683

The aggregate intrinsic value in the preceding table represents the total intrinsic value, based on the Company’s closing stock price of $2.12 per share as of April 30, 2016 (April 30, 2015 – $5.00), which would have been received by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options vested and exercisable as of April 30, 2016 was nil (April 30, 2015 – 12,275). The total intrinsic value of options exercised during the year ended April 30, 2016 was $nil (2015 – $33,094). The grant date fair value of options vested during the year ended April 30, 2016 was $579,614 (April 30, 2015 – $698,238).

The following table summarizes information regarding the non-vested stock purchase options outstanding as of April 30, 2015:

      Number of     Weighted Average  
      Options     Grant-Date Fair Value  
               
  Non-vested options at April 30, 2014   193,791     $8.70  
  Granted   124,600     $4.10  
  Vested   (81,685 )   $8.50  
  Forfeited   (35,469 )   $6.80  
  Non-vested options at April 30, 2015   201,237     $6.20  
  Granted   114,900     $2.35  
  Vested   (83,318 )   $6.96  
  Forfeited   (58,884 )   $4.79  
  Non-vested options at April 30, 2016   173,935     $4.15  

As of April 30, 2016, there was $593,978 of total unrecognized compensation cost related to unvested stock options. This unrecognized compensation cost is expected to be recognized over a weighted average period of 2.08 years.

Employee and non-employee stock-based compensation amounts classified in the Company’s consolidated statements of operations for the year ended April 30, 2016 and 2015 are as follows:

      Years Ended  
      April 30,  
      2016     2015  
               
  Cost of sales $ 68,259   $ 75,535  
  Sales and marketing   253,913     279,121  
  Research and development   80,228     65,135  
  General and administrative   180,536     235,600  
  Total stock-based compensation $ 582,936   $ 655,391  

Warrants

On September 4, 2015, the Company completed a non-brokered private placement (the “Private Placement”) of 293,000 units, at a price of $5.00 per unit, for gross aggregate proceeds of $1,465,000 less stock issuance costs of $23,161. Each unit consists of one share of common stock and one-half of one non-transferable common share purchase warrant. Each whole warrant entitles the holder to purchase one additional share of the Company’s common stock at an exercise price of $7.50 per share until September 4, 2017.

The following tables summarize information regarding the warrants outstanding as of April 30, 2016 and April 30, 2015.

            Weighted        
      Number of     Average        
      Warrants     Exercise Price     Expiry Dates  
  Warrants at April 30, 2014   73,250     $32.50     June 19, 2014  
  Granted            
  Exercised            
  Expired   (73,250 )   $32.50      
  Warrants at April 30, 2015            
  Granted   146,500     $7.50     September 4, 2017  
  Exercised            
  Expired            
  Warrants at April 30, 2016   146,500     $7.50     September 4, 2017  

Employee Stock Purchase Plan

Under the terms of the Employee Stock Purchase Plan (the “ESPP”) all regular salaried (non-probationary) employees can purchase up to 6% of their base salary in common shares of the Company at market price. The Company will match 50% of the shares purchased by issuing or purchasing in the market up to 3% of the respective employee’s base salary in shares. During the year ended April 30, 2016, the Company matched $39,472 (2015 - $55,378) in shares purchased by employees under the ESPP. During the year ended April 30, 2016, 36,539 shares (2015 – 18,442) were issued or purchased by employees on the open market under the ESPP.

On September 28, 2015, the number of shares reserved for issuance under the ESPP plan was increased from 70,000 shares to 120,000 shares. As of April 30, 2016, a total of 86,203 shares were available for issuance under the ESPP.

Normal Course Issuer Bid Plan

Pursuant to a normal course issuer bid (“NCIB”) commencing on March 19, 2016 and expiring March 18, 2017, the Company was authorized to purchase 273,864 shares of the Company’s common stock through the facilities of the Toronto Stock Exchange (the “TSX”) and other Canadian marketplaces or U.S. marketplaces. Pursuant to an NCIB commencing March 19, 2014 and expiring March 18, 2015, the Company repurchased 36,133 shares at an average price of $9.30 (CDN$10.51) for an aggregate purchase price of $336,033. During the period from March 19, 2015 to March 18, 2016, the Company repurchased 11,360 shares at an average price of $3.80 (CDN$4.97) for a total of $43,168 and during the period March 19, 2016 to April 30, 2016, we repurchased 400 common shares at an average price of $2.14 (CDN$2.75) for a total of $856. As of April 30, 2016, a total of 75,788 shares have been cancelled and the remaining 400 repurchased shares are in the process of being cancelled since the NCIB was initiated.

Deferred Share Unit Plan

Under the terms of the DSUP which is effective as at October 22, 2009, each deferred share unit (each, a “DSU”) is equivalent to one share of common stock. The maximum number of shares of common stock that may be reserved for issuance to any one participant pursuant to DSUs granted under the DSUP and any share compensation arrangement is 5% of the number of shares of common stock of the Company outstanding at the time of reservation. A DSU granted to a participant who is a director of the Company shall vest immediately on the award date. A DSU granted to a participant other than a director will generally vest as to one-third (1/3) of the number of DSUs granted on the first, second and third anniversaries of the award date. Fair value of the DSUs, which is based on the closing price of the Company’s common stock on the date of grant, is recorded as compensation expense over the vesting period.

On September 28, 2015, the shares reserved for issuance under the DSUP plan was increased from 300,000 shares to 400,000 shares. During the year ended April 30, 2016, 55,034 (2015 – 32,661) DSUs were issued under the DSUP, of which 23,911 DSUs were granted to officers and 31,123 DSUs were granted to non-employee directors. As of April 30, 2016, a total of 121,048 shares were available for issuance under the DSUP.

The following table summarizes the Company’s outstanding DSU awards as of April 30, 2016 and 2015, and changes during the period then ended:

            Weighted Average Grant  
      Number of DSU’s     Date Fair Value per Unit  
               
  DSU’s at April 30, 2014   167,243     $10.90  
  Granted   32,662     $11.70  
  Conversions        
  Outstanding at April 30, 2015   199,905     $11.00  
  Granted   55,034     $5.20  
  Conversions        
  Outstanding at April 30, 2016   254,939     $9.79  

As of April 30, 2016, there was $189,523 (2015 – $227,324) of total unrecognized compensation cost related to unvested DSU awards. This unrecognized compensation cost is expected to be recognized over a weighted average period of 1.63 years (2015 – 1.85). The total fair value of DSUs that vested during the year was $338,912 (2015 – $344,678).

Employee and non-employee DSU based compensation amounts classified in the Company’s consolidated statements of operations for the year ended April 30, 2016 and 2015 are as follows:

      Year Ended  
      April 30,  
      2016     2015  
               
  Sales and marketing $   –   $ 1,667  
  Research and development   1,633     8,328  
  General and administrative   322,345     334,683  
  Total deferred share unit-based compensation $ 323,978   $ 344,678  

The following table summarizes information regarding the non-vested DSUs outstanding as of April 30, 2016:

            Weighted Average  
            Grant Date Fair  
      Number of DSUs     Value per Unit  
               
  Non-vested DSUs at April 30, 2014   15,678     $21.60  
  Granted   32,661     $11.70  
  Vested   (23,170 )   $16.50  
  Non-vested DSUs at April 30, 2015   25,169     $14.60  
  Granted   55,034     $5.20  
  Vested   (41,681 )   $8.13  
  Non-vested DSUs at April 30, 2016   38,522     $8.15  
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes
12 Months Ended
Apr. 30, 2016
Income Taxes [Text Block]
Note 7 Income Taxes

Deferred tax assets and liabilities are recognized for temporary differences between the carrying amount of the balance sheet items and their corresponding tax values as well as for the benefit of losses available to be carried forward to future years for tax purposes that are likely to be realized.

Significant components of the Company’s deferred tax assets and liabilities, after applying enacted corporate income tax rates, are as follows:

      Years Ended  
      April 30,  
      2016     2015  
  Tax loss carry forwards $ 18,796,000   $ 16,271,000  
  Capital losses carried forward   247,000     262,000  
  Equipment   242,000     184,000  
  Other   64,000     64,000  
  Bad debt   186,000     100,000  
  Nondeductible research and development expenses   3,084,000     3,266,000  
  Investment tax credits   490,000     494,000  
  Cumulative unrealized foreign exchange gain   410,000     467,000  
  Acquired technology and other intangibles   (1,115,000 )   (896,000 )
  Valuation allowance established by management   (22,404,000 )   (20,212,000 )
  Net deferred tax assets $   –   $   –  

The provision for income taxes differ from the amount calculated using the U.S. federal and state statutory income tax rates as follows:

      Years Ended  
      April 30,  
      2016     2015  
  Tax (recovery) based on U.S. rates $ (915,000 ) $ (1,510,000 )
  Foreign tax rate differential   (34,000 )   (75,000 )
  Non-deductible expenses        
  Change in fair value of derivative instrument        
  Non-deductible stock option compensation   295,000     374,000  
  Effect of reduction (increase) in foreign statutory rates   104,000      
  Foreign exchange gain (losses) on revaluation of deferred tax balances   384,000     787,000  
  Under provision relating to prior year   (2,026,000 )    
  Expiry of non-operating losses        
  Increase in valuation allowance   2,192,000     424,000  
  Income tax expense for year $   –   $   –  

The Company establishes its valuation allowance based on projected future operations. Management has determined that the allowance should be 100% of the deferred tax assets. When circumstances cause a change in management’s judgment about the recoverability of deferred tax assets, the impact of the change on the valuation allowance will be reflected in current income.

As at April 30, 2016, the Company had net operating loss carry-forwards available to reduce taxable income in future years as follows:

  Country   Amount     Expiration Dates  
               
  United States – US$ $ 39,431,000     2027 – 2036  
  Canada – CDN$ $ 15,717,000 (1)   2017 – 2034  

(1) These losses are subject to tax legislation that limits the use of the losses against future income of the Company’s Canadian subsidiaries.

The Company is subject to taxation in the U.S. and Canada. It is subject to tax examinations by tax authorities for all taxation years commencing in or after 2002. The Company does not expect any material increase or decrease in its income tax expense in the next twelve months related to examinations or changes in uncertain tax positions.

Changes in the Company’s uncertain tax positions for the year ended April 30, 2016 and April 30, 2015 were as follows:

      Years Ended  
      April 30,  
      2016     2015  
  Balance at beginning of year $ 25,631   $ 25,631  
  Increases related to prior year tax positions (interest and penalties)        
  Increases related to current year tax positions (interest and penalties)        
  Settlements        
  Lapses in statute of limitations   (15,068 )   (15,068 )
  Balance at end of year $ 10,563   $ 10,563  
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segmented Information
12 Months Ended
Apr. 30, 2016
Segmented Information [Text Block]
Note 8 Segmented Information

The Company’s chief operating decision maker reviews financial information presented on a consolidated basis, accompanied by disaggregated information about revenues by geographic region for purposes of making operating decisions and assessing financial performance. Accordingly, the Company has concluded that it has one reportable operating segment.

Revenues are based on the country in which the customer is located. The following is a summary of total revenues by geographic area for the years ended April 30, 2016 and 2015:

      Years Ended  
      April 30,  
      2016     2015  
  North America $ 7,192,010   $ 7,717,932  
  EMEA   2,459,541     2,520,381  
  Asia Pacific   699,203     1,288,848  
  Latin America   730,604     475,922  
    $ 11,081,358   $ 12,003,083  

As at July 31, 2015, the Company adjusted geographic regions to better reflect its current operations. In prior periods geographic groupings included North America, Europe, Asia and Africa and Latin America.

All of the Company’s long-lived assets, which includes equipment, goodwill, intangible assets, and other assets, are located in Canada and the United States as follows:

      As at April 30,  
      2016     2015  
  Canada $ 7,279,019   $ 7,714,307  
  United States   39,583     85,003  
    $ 7,318,602   $ 7,799,310  
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Financial Instruments and Risk Management
12 Months Ended
Apr. 30, 2016
Derivative Financial Instruments and Risk Management [Text Block]
Note 9 Derivative Financial Instruments and Risk Management

In the normal course of business, the Company is exposed to fluctuations in interest rates and the exchange rates associated with foreign currencies. The Company’s primary objective for holding derivative financial instruments is to manage foreign currency exchange rate risk.

Foreign Currency Exchange Rate Risk

A majority of our revenue activities are transacted in U.S. dollars. However, the Company is exposed to foreign currency exchange rate risk inherent in conducting business globally in numerous currencies, of which the most significant to our operations for the year ended April 30, 2016 is the Canadian dollar. The Company’s foreign currency risk management program includes foreign currency derivatives with cash flow hedge accounting designation that utilizes foreign currency forward contracts to hedge exposures to the variability in the U.S. dollar equivalent of anticipated non-U.S. dollar-denominated cash flows.

The Company periodically enters into foreign currency forward contracts, not designated as hedging instruments, to protect it from fluctuations in exchange rates. As of April 30, 2016, the Company had no foreign currency forward contracts. Notional amounts do not quantify risk or represent assets or liabilities of the Company, but are used in the calculation of cash settlements under the contracts.

Fair Value Measurements

When available, the Company uses quoted market prices to determine fair value, and classifies such measurements within Level 1. In some cases where market prices are not available, the Company makes use of observable market-based inputs to calculate fair value, in which case the measurements are classified within Level 2. If quoted or observable market prices are not available, fair value is based upon internally developed models that use, where possible, current market-based parameters such as interest rates, yield curves and currency rates. These measurements are classified within Level 3.

Fair value measurements are classified according to the lowest level input or value-driver that is significant to the valuation. A measurement may therefore be classified within Level 3 even though there may be significant inputs that are readily observable.

Fair value measurement includes the consideration of non-performance risk. Non-performance risk refers to the risk that an obligation (either by a counterparty or the Company) will not be fulfilled. For financial assets traded in an active market (Level 1), the non-performance risk is included in the market price. For certain other financial assets and liabilities (Level 2 and 3), our fair value calculations have been adjusted accordingly.

The following table presents the Company’s assets and liabilities, that are measured at fair value on a recurring basis as of April 30, 2016 and 2015:

        Carrying           Fair Value        
  As at April 30, 2016     Amount     Fair Value     Levels     Reference  
  Cash   $ 2,159,738   $ 2,159,738     1        

        Carrying           Fair Value        
  As at April 30, 2015     Amount     Fair Value     Levels     Reference  
  Cash   $ 2,852,422   $ 2,852,422     1        

  Forward contracts   April 30,     April 30,  
      2016     2015  
  Opening balance at the beginning of the year $   $  
  Fair value of forward, at issuance        
  Change in fair value of forward contracts since issuance   (47,690 )    
  Fair value of forward contracts settled during the year   47,690      
  Fair value of forward contracts at April 30 $   $  

Fair Values of Financial Instruments

In addition to the methods and assumptions the Company uses to record the fair value of financial instruments as discussed in the Fair Value Measurements section above, the Company used the following methods and assumptions to estimate the fair value of the Company’s financial instruments:

Cash – carrying amount approximates fair value.

Accounts receivable, net – carrying amount approximates fair value.

Forward contracts – the fair value of foreign currency and commodity forward, option and cross currency contracts is based on a valuation model that discounts cash flows resulting from the differential between the contract price and the market-based forward rate.

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments
12 Months Ended
Apr. 30, 2016
Commitments [Text Block]
Note 10 Commitments

  a) On November 27, 2013, the Company entered into an extension of an existing lease agreement, which commenced on October 1, 2014 and expires on September 30, 2019. The monthly lease payment under the extension agreement is $19,678 plus $19,308 in operating costs.
     
  b) On November 4, 2013, the Company entered into an extension of an existing lease agreement, which commenced on January 1, 2014 and expires on April 30, 2019. The monthly lease payment under the extension agreement is $3,550 plus $3,307 in operating costs. This lease expense is a related party transaction as it was incurred with a company with a director in common with the Company.
     
  c) From March 2013 to April 2014, the Company entered into various lease agreements with commencement dates between April 2013 and May 2014 and that expire between May 2016 and May 2017. The combined monthly lease payments are $7,198 plus $495 in operating expenses.

Total lease expense for the year ended April 30, 2016 is $642,377 (2015 $754,221).

Total payable over the term of the lease agreements for the years ended April 30, are as follows:

      Office Leases –     Office Leases –     Total Office  
      Related Party     Unrelated Party     Leases  
  2017 $ 82,288   $ 518,534   $   600,822  
  2018   82,288     496,235     578,523  
  2019   82,288     497,897     580,185  
  2020       207,457     207,457  
    $ 246,864   $ 1,720,123   $ 1,966,987  
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Loss per common share
12 Months Ended
Apr. 30, 2016
Loss per common share [Text Block]
Note 11 Loss per common share

Computation of loss per share:

      Year ended April 30, 2016  
                  Per Share  
      Income     Shares (1 )(2)     Amount  
  Basic EPS                  
  Income available to common stockholders $ (2,691,595 )   4,433,402   $ (0.61 )
                     
  Effect on dilutive securities                  
  (Gain)/Loss from derivative instruments              
  Diluted EPS $ (2,691,595 )   4,433,402   $ (0.61 )

      Year ended April 30, 2015  
                  Per Share  
      Income     Shares (1 )(2)     Amount  
  Basic EPS                  
  Income available to common stockholders $ (4,441,867 )   4,249,252   $ (1.05 )
                     
  Effect on dilutive securities                  
  (Gain)/Loss from derivative instruments              
  Diluted EPS $ (4,441,867 )   4,249,252   $ (1.05 )

(1) For the years ended April 30, 2016 and April 30, 2015, common share equivalents (consisting of shares issuable on exercise of options, deferred share units, and warrants) totalling 812,169, and 382,580, respectively, were not included in the computation of diluted earnings per share because the effect was anti-dilutive.

(2) Diluted by assumed exercise of outstanding common share equivalents using the treasury stock method.

XML 34 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Apr. 30, 2016
Basis of Presentation [Policy Text Block]
  a) Basis of Presentation

These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, CounterPath Technologies Inc., a company existing under the laws of the province of British Columbia, Canada, and BridgePort incorporated under the laws of the state of Delaware. The results of NewHeights (which subsequently was amalgamated with another subsidiary to become CounterPath Technologies Inc.) are included from August 2, 2007, the date of acquisition. The results of FirstHand (which subsequently was amalgamated with CounterPath Technologies Inc.) and BridgePort are included from February 1, 2008, the date of acquisition. All inter-company transactions and balances have been eliminated.

Revenue Recognition [Policy Text Block]

Revenue Recognition:

The Company recognizes revenue in accordance with the Accounting Standard Codification (“ASC”) 985-605 “Software Revenue Recognition”. In accordance with these standards, revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collection of the related accounts receivable is deemed probable. In making these judgments, management evaluates these criteria as follows:

  •  

Persuasive evidence of an arrangement. The Company considers a noncancelable agreement signed by the Company and the customer to be representative of persuasive evidence of an arrangement.

     
  •  

Delivery has occurred. The Company considers delivery to have occurred when the product has been delivered to the customer and no post-delivery obligations exist. In instances where customer acceptance is required, delivery is deemed to have occurred when customer acceptance has been achieved.

     
 

Fees are fixed or determinable. The Company considers the fee to be fixed or determinable unless the fee is subject to refund or adjustment or is not payable within normal payment terms. If the fee is subject to refund or adjustment, the Company recognizes revenue when the refund or adjustment right lapses. If offered payment terms exceed the Company’s normal terms, the Company recognizes revenue as the amounts become due and payable or upon the receipt of cash when extended payment terms beyond 180 days are offered.

     
  •  

Collection is deemed probable. Collection is deemed probable if, based upon the Company’s evaluation, the Company expects that the customer will be able to pay amounts under the arrangement as payments become due. If the Company determines that collection is not probable, revenue is deferred and recognized upon the receipt of cash.

A substantial amount of the Company’s sales involve multiple element arrangements, such as products, support, professional services, and training. When arrangements include multiple elements, the Company allocates the total fee to delivered elements using the residual method when vendor specific objective evidence (VSOE) does not exist for the delivered element. Under the residual method, revenue is recognized when VSOE of fair value exists for all of the undelivered elements of the arrangement, but does not exist for one or more of the delivered elements of the arrangement. Each arrangement requires the Company to analyze the individual elements in the transaction and to estimate the fair value of each undelivered element, which typically represents support services.

Revenue is allocated to each of the undelivered elements based on its respective fair value.

For contracts with elements related to customized network solutions and certain network build-outs, for transactions accounted for as sales of products or services, we apply Financial Accounting Standards Board (“FASB”) ASC Subtopic 605-25 “Revenue Recognition – Multiple-Element Arrangements” and revenues are recognized under ASC 605-35”Revenue Recognition – Construction type and Production type Contract”, for long-term transactions entered to supply software, or software systems, that require significant modification or customization, generally using the percentage-of-completion method.

For multi-element arrangements, the Company allocates revenue to all deliverables based on their selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) VSOE, (ii) third-party evidence of selling price (“TPE”), and (iii) best estimate of selling price (“ESP”). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company’s best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis.

In using the percentage-of-completion method, revenues are generally recorded based on completion of milestones as described in the agreement. Profit estimates on long-term contracts are revised periodically based on changes in circumstances and any losses on contracts are recognized in the period that such losses become known.

Service revenue includes sales of support and other services, including professional services, training, and reimbursable travel. Support services include telephone support, e-mail support and unspecified rights to product updates and upgrades, and are recognized ratably over the term of the service period, which is generally twelve months. Support revenue is generally deferred until the related product has been accepted and all other revenue recognition criteria have been met. Professional services and training revenue is recognized as the related service has been performed.

Stock-Based Compensation [Policy Text Block]

Stock-Based Compensation :

The Company adopted ASC 718 “Compensation – Stock Compensation”, using the modified prospective method on May 1, 2006. Under this application, the Company is required to record compensation expense, based on the fair value of the awards, for all awards granted after the date of adoption and for the unvested portion of previously granted awards that remain outstanding as at the date of adoption. In accordance with ASC 718, the compensation expense is amortized on a straight-line basis over the requisite service period which approximates the vesting period.

Stock options granted to non-employees were accounted for in accordance with ASC 718 and ASC 505-50 “Equity based payments to non-employees” and were measured at the fair value of the options as determined by an option pricing model on the measurement date and compensation expense is amortized over the vesting period or, if none exists, over the service period. With the adoption of ASC 718, the Company has elected to use the Black-Scholes option pricing model to determine the fair value of stock options granted. The Company has estimated the fair value of option awards to employees and non-employees for the years ended April 30, 2016 and April 30, 2015 using the assumptions more fully described in Note 6.

Use of Estimates [Policy Text Block]

Use of Estimates:

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the Company’s management to make estimates and assumptions which affect the amounts reported in these consolidated financial statements, the notes thereto, and the disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.

Equipment and Amortization [Policy Text Block]

Equipment and Amortization:

Equipment is recorded at cost. Depreciation is provided for using the straight-line method over the estimated useful lives as follows:

  Computer hardware Two years
  Computer software Two years
  Leasehold improvements Shorter of lease term or estimated economic life
  Office furniture Five years
  Website Three years
Research and Development [Policy Text Block]

Research and Development:

Research and development expense includes costs incurred to develop intellectual property. The costs for the development of new software and substantial enhancements to existing software are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. Management has determined that technological feasibility is established at the time a working model of software is completed. Because management believes that the current process for developing software will be essentially completed concurrently with the establishment of technological feasibility, no costs have been capitalized to date.

Website Development Costs [Policy Text Block]

Website Development Costs:

The Company recognizes the costs associated with developing a website in accordance with ASC Topic 350-40 “Intangibles – Internal Use Software”.

Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Training costs are not internal-use software development costs and, if incurred during this stage, are expensed as incurred.

These capitalized costs are amortized based on their estimated useful life over three years. Payroll and other related costs are not capitalized, as the amounts principally relate to maintenance.

Accounts Receivable and Allowance for Doubtful Accounts [Policy Text Block]

Accounts Receivable and Allowance for Doubtful Accounts:

Accounts receivable are presented net of an allowance for doubtful accounts.

      Years Ended April 30,  
      2016     2015  
               
  Balance of allowance for doubtful debts, beginning of year $ 294,719   $ 240,681  
  Bad debt provision   612,769     628,113  
  Write-off of receivables   (360,315 )   (574,075 )
  Balance of allowance for doubtful debts, end of year $ 547,173   $ 294,719  

The Company determines the allowance for doubtful accounts by considering a number of factors, including the length of time the accounts receivable are beyond the contractual payment terms, previous loss history, and the customer’s current ability to pay its obligation. When the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, the Company records a charge to the allowance to reduce the customer’s related accounts.

Foreign Currency Translation [Policy Text Block]

Foreign Currency Translation:

The Company’s functional currency is the U.S. dollar. The Company’s wholly-owned subsidiaries with a functional currency other than the U.S. dollar are translated into amounts in the reporting currency, U.S. dollars, in accordance with ASC Topic 830 “Foreign Currency Matters”. Revenues and expenses are translated at the average exchange rate prevailing during the periods. At each balance sheet date, assets and liabilities that are denominated in a currency other than U.S. dollars are adjusted to reflect the current exchange rate which may give rise to a foreign currency translation adjustment accounted for as a separate component of stockholders’ equity and included in comprehensive loss.

For transactions undertaken by the Company in foreign currencies, monetary assets and liabilities are translated into the functional currency at the exchange rate in effect at the end of the year. Non-monetary assets and liabilities are translated at the exchange rate prevailing when the assets were acquired or the liabilities assumed. Revenues and expenses are translated at the rate approximating the rate of exchange on the transaction date. Exchange gains and losses are included in the determination of net income (loss) for the year.

Accrued Warranty [Policy Text Block]

Accrued Warranty:

The Company’s warranty policy generally provides for one year of warranty for its products. The Company records a liability for estimated warranty obligations at the date products are sold. The estimated cost of warranty coverage is based on the Company’s actual historical experience with its current products or similar products. For new products, the required reserve is based on historical experience of similar products until such time as sufficient historical data has been collected on the new product. Estimated liabilities for warranty exposures, which relate to normal product warranties and a one-year obligation to provide for potential future liabilities for product sales for the years ended April 30, 2016 and 2015 were as follows:

      Years Ended April 30,  
      2016     2015  
               
  Balance, beginning of year $ 73,117   $ 69,159  
  Usage during the year        
  Additions (reductions) during the year   (11,761 )   3,958  
  Balance, end of year $ 61,356   $ 73,117  
Trademarks [Policy Text Block]

Trademarks:

Costs related to trademark applications have been deferred and are included in other assets. Once granted, trademark costs will be amortized over their useful lives.

Fair Value of Financial Instruments [Policy Text Block]

Fair Value of Financial Instruments:

The Company’s financial instruments consist of cash, accounts receivable, accounts payable and accrued liabilities, customer deposits, foreign exchange contracts, and derivative instruments. The fair value of the financial instruments approximate book value.

As a basis for considering market participant assumptions in fair value measurements, ASC 820-10 “Fair Value Measurements” establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

The fair value hierarchy, as defined by ASC 820-10, contains three levels of inputs that may be used to measure fair value as follows:

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals; and Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an entity’s own assumptions, as there is little, if any, related market activity.

In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.

The Company’s derivative financial instruments are valued using observable market-based inputs to industry valuation models. These valuation models require a variety of inputs, including contractual terms, market prices, yield curves, and measures of volatility obtained from various market sources.

The Company measures certain financial assets, including any foreign currency option or forward contracts at fair value. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments.

Income Taxes [Policy Text Block]

Income Taxes:

The Company accounts for income taxes by the asset and liability method in accordance with ASC Topic 740 “Income Taxes”. Under this method, current income taxes are recognized for the estimated income taxes payable for the current year. Deferred income tax assets and liabilities are recognized in the current year for temporary differences between the tax and accounting bases of assets and liabilities as well as for the benefit of losses available to be carried forward to future years for tax purposes that are likely to be realized. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized.

The Company has not recorded a deferred tax liability related to its investment in foreign subsidiaries. The Company has determined that its investment in these subsidiaries is permanent in nature and it does not intend to dispose of these investments in the foreseeable future. The amount of the deferred tax liability related to the Company's investment in foreign subsidiaries is not reasonably determinable.

We have $1,540,467 in cash held outside of the United States, and there is no intent to repatriate at this time. Should we decide to repatriate in the future, taxes would need to be accrued and paid.

Under ASC 740, the Company also adopted a two-step approach to recognizing and measuring uncertain tax positions taken or expected to be taken in a tax return. The first step is to determine if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained in an audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company recognizes interest and penalties accrued on unrecognized tax benefits within general and administrative expense. To the extent that accrued interest and penalties do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction in general and administrative expenses in the period that such determination is made.

Comprehensive Loss [Policy Text Block]

Comprehensive Loss:

The Company has adopted ASC Topic 220 “Comprehensive Income”. Comprehensive loss is comprised of net profit or loss, and foreign currency translation adjustments.

Basic and Diluted Loss per Share [Policy Text Block]

Basic and Diluted Loss per Share:

The Company computes net loss per share in accordance with ASC Topics 260 and ASC 260-10 “Earnings per Share”.

ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the year. Diluted EPS gives effect to all dilutive potential common shares outstanding during the year including stock options and warrants using the treasury stock method. In computing diluted EPS, the average stock price for the year is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. For the year ended April 30, 2016, income per share excludes 812,169 (April 30, 2015 – 382,580) potentially dilutive common shares (related to stock options, deferred share units and warrants) as their effect was anti-dilutive.

Investment tax credits [Policy Text Block]

Investment tax credits:

Investment tax credits are accounted for under the cost reduction method whereby they are netted against the expense or property and equipment to which they relate. Investment tax credits are recorded when the qualifying expenditures have been incurred and if it is more likely than not that the tax credits will be realized.

Goodwill [Policy Text Block]

Goodwill:

Goodwill represents the excess purchase price over the estimated fair value of net assets acquired and liabilities assumed as of the acquisition date. ASC Topic 350 “Intangibles – Goodwill”. ASC 350 requires goodwill to be tested for impairment annually or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the Company's business enterprise below its carrying value. These events or circumstances could include a significant change in the business climate, legal factors, operating performance indicators, competition, or sale or disposition of a significant portion of a reporting unit. Recoverability of goodwill is measured at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair value of the reporting unit, which is measured based upon, among other factors, market multiples for comparable companies as well as a discounted cash flow analysis.

Management has determined that the Company currently has a single reporting unit which is CounterPath Corporation. If the recorded value of the assets, including goodwill, and liabilities (“net book value”) of the reporting unit exceeds its fair value, an impairment loss may be required.

Goodwill of $6,339,717 (CDN$6,704,947) and $2,083,960 (CDN$2,083,752) was initially recorded in connection with the acquisition of NewHeights on August 2, 2007 and FirstHand on February 1, 2008. Translated to U.S. dollars using the period end rate, the goodwill balance at April 30, 2016 was $5,341,481 (CDN$6,704,947) (April 30, 2015 - $5,578,159) and $1,659,747 (CDN$2,083,752) (April 30, 2015 - $1,733,290), respectively. During the fourth quarter of its fiscal year ended April 30, 2016, the Company performed its annual impairment test. In the first step, Management compared the fair value of the Company to its carrying value based upon the market capitalization of the Company as at April 30, 2016. On this basis Management determined that the Company’s fair value exceeded its carrying value and has not recognized any impairment of goodwill in the consolidated financial statements for the year ended April 30, 2016 (2015 - $nil).

Derivative Instruments [Policy Text Block]

Derivative Instruments:

The Company accounts for derivative instruments, consisting of foreign currency forward contracts, pursuant to the provisions ASC 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires the Company to measure derivative instruments at fair value and record them in the balance sheet as either an asset or liability and expands financial reporting about derivative instruments and hedging activities by requiring enhanced disclosures to enable investors to better understand their effects on an entity’s financial position, results of operations and cash flows. The Company does not use derivative instruments for trading purposes. ASC 815 also requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.

The Company also routinely enters into foreign currency forward contracts, not designated as hedging instruments, to protect against fluctuations in exchange rates. Gains or losses arising out of marked to market fair value valuation of forward contracts, not designated as hedges, and are recognized in net income.

The Company records foreign currency forward contracts on its Consolidated Balance Sheets as derivative instruments assets or liabilities depending on whether the net fair value of such contracts is a net asset or net liability, respectively (see Note 9 “Derivative Financial Instruments and Risk Management,” of the Notes to the Consolidated Financial Statements). The Company did not hold any foreign currency derivatives designated as cash flow hedges in the year ended April 30, 2016 (2015 - none).

New Accounting Pronouncements [Policy Text Block]
  c) New Accounting Pronouncements

In May 2014, FASB issued ASU 2014-09, Revenue From Contracts With Customers (“Topic 606”). Topic 606 removes inconsistencies and weaknesses in revenue requirements, provides a more robust framework for addressing revenue issues, improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, provides more useful information to users of financial statements through improved disclosure requirements and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The guidance in this update supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance throughout the Industry Topics of the Codification. In August 2015, ASU 2015-14 was issued which delayed the effective date for public entities to reporting periods beginning after December 15, 2017. Early adoption is not permitted. The Company is currently evaluating the impact of the adoption of this new standard.

In August 2014, FASB issued ASU 2014-15, Presentation of Financial Statements – Going Concern , which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and provide related footnote disclosures. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. The standard allows for either a full retrospective or modified retrospective transition method. The Company does not expect this standard to have a material impact on the Company’s consolidated financial statements upon adoption.

In February 2016, FASB issued ASU 2016-02, Leases . The guidance would require lessees to recognize most leases on their balance sheets as lease liabilities with corresponding right –of-use assets. The guidance is effective for annual and interim reporting periods beginning on or after December 15, 2018. The Company is currently evaluating the impact of its pending adoption of ASU 2016-02 on its consolidated financial statements.

In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross versus Net), which clarifies the guidance in the new revenue standard on assessing whether an entity is a principal or an agent in a revenue transaction. This conclusion impacts whether an entity reports revenue on a gross or net basis. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing, which clarifies the guidance in the new revenue standard regarding an entity’s identification of its performance obligations in a contract, as well as an entity’s evaluation of the nature of its promise to grant a license of intellectual property and whether or not that revenue is recognized over time or at a point in time. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In May 2016, the FASB issued ASU 2016-11, Revenue Recognition: Customer Payments and Incentives, which clarifies the guidance in recognizing costs for consideration given by a vendor to a customer as a component of cost of sales. We are currently evaluating the impact of this standard on our Consolidated Financial Statements and related disclosures.

In May 2016, the FASB issued ASU 2016-12, Revenue from Contracts with Customers: Narrow-Scope Improvements and Practical Expedients which amends the guidance in the new revenue standard on collectability, noncash consideration, presentation of sales tax, and transition. The amendments are intended to address implementation issues and provide additional practical expedients to reduce the cost and complexity of applying the new revenue standard. These amendments have the same effective date as the new revenue standard. While we are currently evaluating the method of adoption and the impact of the new revenue standard, as amended, on our Consolidated Financial Statements and related disclosures, we believe the adoption of the new standard may have a significant impact on the accounting for certain transactions with multiple elements or “bundled” arrangements because the requirement to have VSOE for undelivered elements under current accounting standards is eliminated under the new standard. Accordingly, we may be required to recognize as revenue a portion of the sales price upon delivery of the software, as compared to the current requirement of recognizing the entire sales price ratably over an estimated offering period. We continue to evaluate the impact of the new revenue standard on our Consolidated Financial Statements and related disclosures.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments: Measurement of Credit Losses on Financial Instruments which amends the guidance on measuring credit losses on financial assets held at amortized cost. The amendment is intended to address the issue that the previous “incurred loss” methodology was restrictive for Company’s ability to record credit losses based on not yet meeting the “probable” threshold. The new language will require these assets to be valued at amortized cost presented at the net amount expected to be collected will a valuation provision. The amendments will be effective for fiscal years beginning after December 15, 2019. We are evaluating the impact of this amendment on our consolidated financial statements and related disclosures.

XML 35 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Significant Accounting Policies (Tables)
12 Months Ended
Apr. 30, 2016
Straight-line Method Estimations [Table Text Block]
  Computer hardware Two years
  Computer software Two years
  Leasehold improvements Shorter of lease term or estimated economic life
  Office furniture Five years
  Website Three years
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
      Years Ended April 30,  
      2016     2015  
               
  Balance of allowance for doubtful debts, beginning of year $ 294,719   $ 240,681  
  Bad debt provision   612,769     628,113  
  Write-off of receivables   (360,315 )   (574,075 )
  Balance of allowance for doubtful debts, end of year $ 547,173   $ 294,719  
Schedule of Product Warranty Liability [Table Text Block]
      Years Ended April 30,  
      2016     2015  
               
  Balance, beginning of year $ 73,117   $ 69,159  
  Usage during the year        
  Additions (reductions) during the year   (11,761 )   3,958  
  Balance, end of year $ 61,356   $ 73,117  
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equipment (Tables)
12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Property, Plant and Equipment [Table Text Block]
      April 30, 2016  
            Accumulated        
      Cost     Depreciation     Net  
                     
  Computer hardware $ 1,049,179   $ 976,511   $ 72,668  
  Computer software   1,008,373     1,002,097     6,276  
  Leasehold improvements   263,003     237,147     25,856  
  Office furniture   190,754     186,325     4,429  
  Websites   120,953     87,619     33,334  
    $ 2,632,262   $ 2,489,699   $ 142,563  
      April 30, 2015  
            Accumulated        
      Cost     Depreciation     Net  
                     
  Computer hardware $ 1,072,376   $ 953,384   $ 118,992  
  Computer software   1,022,687     977,430     45,257  
  Leasehold improvements   280,893     238,818     42,075  
  Office furniture   204,680     197,601     7,079  
  Websites   122,161     63,828     58,333  
    $ 2,702,797   $ 2,431,061   $ 271,736  
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Accounts Payable and Accrued Liabilities (Tables)
12 Months Ended
Apr. 30, 2016
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
      April 30,  
      2016     2015  
  Accounts payable – trade $ 407,737   $ 500,739  
  Accrued commissions   272,282     184,791  
  Accrued vacation   617,589     688,965  
  Third party software royalties   343,447     568,814  
  Other accrued liabilities   302,053     362,271  
    $ 1,943,108   $ 2,305,580  
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Common Stock (Tables)
12 Months Ended
Apr. 30, 2016
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
      Year Ended     Year Ended  
      April 30, 2016     April 30, 2015  
  Risk-free interest rate   1.66%     1.60%  
  Expected volatility   92.48%     57.58%  
  Expected term   3.7 yrs     3.7 yrs  
  Dividend yield   0%     0%  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
      Number of     Weighted-Average  
      Options     Exercise Price per Share  
  Outstanding at April 30, 2014   370,554    

$9.40

 
  Granted   124,600    

$6.00

 
  Exercised   (33,473 ) (1)  

$14.40

 
  Forfeited / Cancelled   (45,983 )  

$10.30

 
  Expired   (3,917 )  

$9.40

 
  Outstanding at April 30, 2015   411,781    

$15.20

 
  Granted   114,900     $3.72  
  Exercised        
  Forfeited / Cancelled   (66,216 )   $8.87  
  Expired   (49,735 )   $15.63  
  Outstanding at April 30, 2016   410,730     $12.99  
               
  Exercisable at April 30, 2016   236,795     $16.77  
  Exercisable at April 30, 2015   210,544     $17.70  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
    Number of Aggregate   Number of Aggregate
  Exercise Options Intrinsic   Options Intrinsic
  Price Outstanding Value Expiry Date Exercisable Value
  $2.41 56,000 December 14, 2020
  $4.50 5,000 March 9, 2020 1,360
  $4.70 540 September 26, 2016 540
  $5.00 50,900 July 17, 2020 9,614
  $5.20 9,482 March 23, 2020 8,805
  $7.80 3,400 December 12, 2019 1,224
  $10.50 6,825 September 12, 2019 3,809
  $11.50 51,000 July 11, 2019 25,192
  $12.30 2,083 January 13, 2019 2,083
  $13.10 60,000 December 12, 2018 35,014
  $17.00 65,000 December 14, 2016 65,000
  $19.00 46,500 July 25, 2018 32,026
  $21.50 24,000 September 7, 2016 24,000
  $29.00 30,000 July 19, 2017 28,128
  April 30, 2016 410,730   236,795
             
  April 30, 2015 441,780 $6,183   210,544 $3,683
Schedule of Nonvested Performance-based Units Activity [Table Text Block]
      Number of     Weighted Average  
      Options     Grant-Date Fair Value  
               
  Non-vested options at April 30, 2014   193,791     $8.70  
  Granted   124,600     $4.10  
  Vested   (81,685 )   $8.50  
  Forfeited   (35,469 )   $6.80  
  Non-vested options at April 30, 2015   201,237     $6.20  
  Granted   114,900     $2.35  
  Vested   (83,318 )   $6.96  
  Forfeited   (58,884 )   $4.79  
  Non-vested options at April 30, 2016   173,935     $4.15  
Schedule of Employee and Non-Employee Service Share-based Compensation Allocation of Recognized Period Costs [Table Text Block]
      Years Ended  
      April 30,  
      2016     2015  
               
  Cost of sales $ 68,259   $ 75,535  
  Sales and marketing   253,913     279,121  
  Research and development   80,228     65,135  
  General and administrative   180,536     235,600  
  Total stock-based compensation $ 582,936   $ 655,391  
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]
            Weighted        
      Number of     Average        
      Warrants     Exercise Price     Expiry Dates  
  Warrants at April 30, 2014   73,250     $32.50     June 19, 2014  
  Granted            
  Exercised            
  Expired   (73,250 )   $32.50      
  Warrants at April 30, 2015            
  Granted   146,500     $7.50     September 4, 2017  
  Exercised            
  Expired            
  Warrants at April 30, 2016   146,500     $7.50     September 4, 2017  
Schedule of Stockholders Equity Deferred Share Unit Plan [Table Text Block]
            Weighted Average Grant  
      Number of DSU’s     Date Fair Value per Unit  
               
  DSU’s at April 30, 2014   167,243     $10.90  
  Granted   32,662     $11.70  
  Conversions        
  Outstanding at April 30, 2015   199,905     $11.00  
  Granted   55,034     $5.20  
  Conversions        
  Outstanding at April 30, 2016   254,939     $9.79  
Schedule of Stockholders Equity Non Vested Deferred Share Units [Table Text Block]
      Year Ended  
      April 30,  
      2016     2015  
               
  Sales and marketing $   –   $ 1,667  
  Research and development   1,633     8,328  
  General and administrative   322,345     334,683  
  Total deferred share unit-based compensation $ 323,978   $ 344,678  
Schedule of Allocation of Share Based Compensation Costs for Deferred Share Units [Table Text Block]
            Weighted Average  
            Grant Date Fair  
      Number of DSUs     Value per Unit  
               
  Non-vested DSUs at April 30, 2014   15,678     $21.60  
  Granted   32,661     $11.70  
  Vested   (23,170 )   $16.50  
  Non-vested DSUs at April 30, 2015   25,169     $14.60  
  Granted   55,034     $5.20  
  Vested   (41,681 )   $8.13  
  Non-vested DSUs at April 30, 2016   38,522     $8.15  
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes (Tables)
12 Months Ended
Apr. 30, 2016
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
      Years Ended  
      April 30,  
      2016     2015  
  Tax loss carry forwards $ 18,796,000   $ 16,271,000  
  Capital losses carried forward   247,000     262,000  
  Equipment   242,000     184,000  
  Other   64,000     64,000  
  Bad debt   186,000     100,000  
  Nondeductible research and development expenses   3,084,000     3,266,000  
  Investment tax credits   490,000     494,000  
  Cumulative unrealized foreign exchange gain   410,000     467,000  
  Acquired technology and other intangibles   (1,115,000 )   (896,000 )
  Valuation allowance established by management   (22,404,000 )   (20,212,000 )
  Net deferred tax assets $   –   $   –  
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
      Years Ended  
      April 30,  
      2016     2015  
  Tax (recovery) based on U.S. rates $ (915,000 ) $ (1,510,000 )
  Foreign tax rate differential   (34,000 )   (75,000 )
  Non-deductible expenses        
  Change in fair value of derivative instrument        
  Non-deductible stock option compensation   295,000     374,000  
  Effect of reduction (increase) in foreign statutory rates   104,000      
  Foreign exchange gain (losses) on revaluation of deferred tax balances   384,000     787,000  
  Under provision relating to prior year   (2,026,000 )    
  Expiry of non-operating losses        
  Increase in valuation allowance   2,192,000     424,000  
  Income tax expense for year $   –   $   –  
Summary of Operating Loss Carryforwards [Table Text Block]
  Country   Amount     Expiration Dates  
               
  United States – US$ $ 39,431,000     2027 – 2036  
  Canada – CDN$ $ 15,717,000 (1)   2017 – 2034  
Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]
      Years Ended  
      April 30,  
      2016     2015  
  Balance at beginning of year $ 25,631   $ 25,631  
  Increases related to prior year tax positions (interest and penalties)        
  Increases related to current year tax positions (interest and penalties)        
  Settlements        
  Lapses in statute of limitations   (15,068 )   (15,068 )
  Balance at end of year $ 10,563   $ 10,563  
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segmented Information (Tables)
12 Months Ended
Apr. 30, 2016
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]
      Years Ended  
      April 30,  
      2016     2015  
  North America $ 7,192,010   $ 7,717,932  
  EMEA   2,459,541     2,520,381  
  Asia Pacific   699,203     1,288,848  
  Latin America   730,604     475,922  
    $ 11,081,358   $ 12,003,083  
Schedule of Long Lived Assets by Geographical Areas [Table Text Block]
      As at April 30,  
      2016     2015  
  Canada $ 7,279,019   $ 7,714,307  
  United States   39,583     85,003  
    $ 7,318,602   $ 7,799,310  
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Financial Instruments and Risk Management (Tables)
12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
        Carrying           Fair Value        
  As at April 30, 2016     Amount     Fair Value     Levels     Reference  
  Cash   $ 2,159,738   $ 2,159,738     1        
        Carrying           Fair Value        
  As at April 30, 2015     Amount     Fair Value     Levels     Reference  
  Cash   $ 2,852,422   $ 2,852,422     1        
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
  Forward contracts   April 30,     April 30,  
      2016     2015  
  Opening balance at the beginning of the year $   $  
  Fair value of forward, at issuance        
  Change in fair value of forward contracts since issuance   (47,690 )    
  Fair value of forward contracts settled during the year   47,690      
  Fair value of forward contracts at April 30 $   $  
 
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments (Tables)
12 Months Ended
Apr. 30, 2016
Schedule of Agreements by Year [Table Text Block]
      Office Leases –     Office Leases –     Total Office  
      Related Party     Unrelated Party     Leases  
  2017 $ 82,288   $ 518,534   $   600,822  
  2018   82,288     496,235     578,523  
  2019   82,288     497,897     580,185  
  2020       207,457     207,457  
    $ 246,864   $ 1,720,123   $ 1,966,987  
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Loss per common share (Tables)
12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
      Year ended April 30, 2016  
                  Per Share  
      Income     Shares (1 )(2)     Amount  
  Basic EPS                  
  Income available to common stockholders $ (2,691,595 )   4,433,402   $ (0.61 )
                     
  Effect on dilutive securities                  
  (Gain)/Loss from derivative instruments              
  Diluted EPS $ (2,691,595 )   4,433,402   $ (0.61 )
      Year ended April 30, 2015  
                  Per Share  
      Income     Shares (1 )(2)     Amount  
  Basic EPS                  
  Income available to common stockholders $ (4,441,867 )   4,249,252   $ (1.05 )
                     
  Effect on dilutive securities                  
  (Gain)/Loss from derivative instruments              
  Diluted EPS $ (4,441,867 )   4,249,252   $ (1.05 )
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Nature of Operations (Narrative) (Details)
12 Months Ended
Apr. 30, 2016
shares
Nature Of Operations 1 7,680,168
Nature Of Operations 2 369,836
Nature Of Operations 3 369,836
Nature Of Operations 4 5,900,014
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Significant Accounting Policies (Narrative) (Details) - 12 months ended Apr. 30, 2016
USD ($)
d
CAD
d
Significant Accounting Policies 1 | d 180 180
Significant Accounting Policies 2 $ 1,540,467  
Significant Accounting Policies 3 50.00% 50.00%
Significant Accounting Policies 4 812,169 812,169
Significant Accounting Policies 5 382,580 382,580
Significant Accounting Policies 6 $ 6,339,717  
Significant Accounting Policies 7 | CAD   CAD 6,704,947
Significant Accounting Policies 8 2,083,960  
Significant Accounting Policies 9 | CAD   2,083,752
Significant Accounting Policies 10 5,341,481  
Significant Accounting Policies 11 | CAD   6,704,947
Significant Accounting Policies 12 5,578,159  
Significant Accounting Policies 13 1,659,747  
Significant Accounting Policies 14 | CAD   CAD 2,083,752
Significant Accounting Policies 15 1,733,290  
Significant Accounting Policies 16 $ 0  
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Related Party Transactions (Narrative) (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
$ / shares
shares
Related Party Transactions 1 $ 82,288
Related Party Transactions 2 85,954
Related Party Transactions 3 31,910
Related Party Transactions 4 17,471
Related Party Transactions 5 134,250
Related Party Transactions 6 $ 0
Related Party Transactions 7 | shares 293,000
Related Party Transactions 8 | $ / shares $ 5.00
Related Party Transactions 9 $ 1,465,000
Related Party Transactions 10 $ 23,161
Related Party Transactions 11 | shares 150,000
Related Party Transactions 12 | shares 10,000
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2
Common Stock (Narrative) (Details) - 12 months ended Apr. 30, 2016
USD ($)
mo
yr
$ / shares
shares
CAD
mo
yr
shares
Common Stock 1 | shares 293,000 293,000
Common Stock 2 | $ / shares $ 5.00  
Common Stock 3 $ 1,465,000  
Common Stock 4 $ 23,454  
Common Stock 5 | $ / shares $ 7.50  
Common Stock 6 | shares 25,000 25,000
Common Stock 7 | shares 10,000 10,000
Common Stock 8 | shares 10,000 10,000
Common Stock 9 | shares 5,000 5,000
Common Stock 10 12.50% 12.50%
Common Stock 11 | mo 42 42
Common Stock 12 786,000 786,000
Common Stock 13 15.00% 15.00%
Common Stock 14 $ 2.35  
Common Stock 15 $ 4.10  
Common Stock 16 | shares 33,236 33,236
Common Stock 17 | shares 6,789 6,789
Common Stock 18 | $ / shares $ 2.12  
Common Stock 19 $ 5.00  
Common Stock 20 0 0
Common Stock 21 12,275 12,275
Common Stock 22 $ 0  
Common Stock 23 33,094  
Common Stock 24 579,614  
Common Stock 25 698,238  
Common Stock 26 $ 593,978  
Common Stock 27 | yr 2.08 2.08
Common Stock 28 | shares 293,000 293,000
Common Stock 29 | $ / shares $ 5.00  
Common Stock 30 $ 1,465,000  
Common Stock 31 $ 23,161  
Common Stock 32 | $ / shares $ 7.50  
Common Stock 33 6.00% 6.00%
Common Stock 34 50.00% 50.00%
Common Stock 35 3.00% 3.00%
Common Stock 36 $ 39,472  
Common Stock 37 $ 55,378  
Common Stock 38 | shares 36,539 36,539
Common Stock 39 18,442 18,442
Common Stock 40 | shares 70,000 70,000
Common Stock 41 | shares 120,000 120,000
Common Stock 42 | shares 86,203 86,203
Common Stock 43 | shares 273,864 273,864
Common Stock 44 | shares 36,133 36,133
Common Stock 45 $ 9.30  
Common Stock 46 | CAD   CAD 10.51
Common Stock 47 $ 336,033  
Common Stock 48 | shares 11,360 11,360
Common Stock 49 $ 3.80  
Common Stock 50 | CAD   CAD 4.97
Common Stock 51 $ 43,168  
Common Stock 52 | shares 400 400
Common Stock 53 $ 2.14  
Common Stock 54 | CAD   CAD 2.75
Common Stock 55 $ 856  
Common Stock 56 | shares 75,788 75,788
Common Stock 57 | shares 400 400
Common Stock 58 5.00% 5.00%
Common Stock 59 | shares 300,000 300,000
Common Stock 60 | shares 400,000 400,000
Common Stock 61 55,034 55,034
Common Stock 62 32,661 32,661
Common Stock 63 23,911 23,911
Common Stock 64 31,123 31,123
Common Stock 65 | shares 121,048 121,048
Common Stock 66 $ 189,523  
Common Stock 67 $ 227,324  
Common Stock 68 | yr 1.63 1.63
Common Stock 69 1.85 1.85
Common Stock 70 $ 338,912  
Common Stock 71 $ 344,678  
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes (Narrative) (Details)
12 Months Ended
Apr. 30, 2016
Income Taxes 1 100.00%
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments (Narrative) (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Commitments 1 $ 19,678
Commitments 2 19,308
Commitments 3 3,550
Commitments 4 3,307
Commitments 5 7,198
Commitments 6 495
Commitments 7 642,377
Commitments 8 $ 754,221
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.5.0.2
Loss per common share (Narrative) (Details)
12 Months Ended
Apr. 30, 2016
Loss Per Common Share 1 812,169
Loss Per Common Share 2 382,580
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Accounts, Notes, Loans and Financing Receivable (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 1 $ 294,719
Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 2 240,681
Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 3 612,769
Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 4 628,113
Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 5 (360,315)
Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 6 (574,075)
Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 7 547,173
Significant Accounting Policies Schedule Of Accounts, Notes, Loans And Financing Receivable 8 $ 294,719
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Product Warranty Liability (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Significant Accounting Policies Schedule Of Product Warranty Liability 1 $ 73,117
Significant Accounting Policies Schedule Of Product Warranty Liability 2 69,159
Significant Accounting Policies Schedule Of Product Warranty Liability 3 0
Significant Accounting Policies Schedule Of Product Warranty Liability 4 0
Significant Accounting Policies Schedule Of Product Warranty Liability 5 (11,761)
Significant Accounting Policies Schedule Of Product Warranty Liability 6 3,958
Significant Accounting Policies Schedule Of Product Warranty Liability 7 61,356
Significant Accounting Policies Schedule Of Product Warranty Liability 8 $ 73,117
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
Property, Plant and Equipment (Details) - USD ($)
12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Equipment Property, Plant And Equipment 1 $ 1,049,179  
Equipment Property, Plant And Equipment 2 976,511  
Equipment Property, Plant And Equipment 3 72,668  
Equipment Property, Plant And Equipment 4 1,008,373  
Equipment Property, Plant And Equipment 5 1,002,097  
Equipment Property, Plant And Equipment 6 6,276  
Equipment Property, Plant And Equipment 7 263,003  
Equipment Property, Plant And Equipment 8 237,147  
Equipment Property, Plant And Equipment 9 25,856  
Equipment Property, Plant And Equipment 10 190,754  
Equipment Property, Plant And Equipment 11 186,325  
Equipment Property, Plant And Equipment 12 4,429  
Equipment Property, Plant And Equipment 13 120,953  
Equipment Property, Plant And Equipment 14 87,619  
Equipment Property, Plant And Equipment 15 33,334  
Equipment Property, Plant And Equipment 16 2,632,262  
Equipment Property, Plant And Equipment 17 2,489,699  
Equipment Property, Plant And Equipment 18 $ 142,563  
Equipment Property, Plant And Equipment 1   $ 1,072,376
Equipment Property, Plant And Equipment 2   953,384
Equipment Property, Plant And Equipment 3   118,992
Equipment Property, Plant And Equipment 4   1,022,687
Equipment Property, Plant And Equipment 5   977,430
Equipment Property, Plant And Equipment 6   45,257
Equipment Property, Plant And Equipment 7   280,893
Equipment Property, Plant And Equipment 8   238,818
Equipment Property, Plant And Equipment 9   42,075
Equipment Property, Plant And Equipment 10   204,680
Equipment Property, Plant And Equipment 11   197,601
Equipment Property, Plant And Equipment 12   7,079
Equipment Property, Plant And Equipment 13   122,161
Equipment Property, Plant And Equipment 14   63,828
Equipment Property, Plant And Equipment 15   58,333
Equipment Property, Plant And Equipment 16   2,702,797
Equipment Property, Plant And Equipment 17   2,431,061
Equipment Property, Plant And Equipment 18   $ 271,736
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Accounts Payable and Accrued Liabilities (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 1 $ 407,737
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 2 500,739
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 3 272,282
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 4 184,791
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 5 617,589
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 6 688,965
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 7 343,447
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 8 568,814
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 9 302,053
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 10 362,271
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 11 1,943,108
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 12 $ 2,305,580
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)
12 Months Ended
Apr. 30, 2016
Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1 1.66%
Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2 1.60%
Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3 92.48%
Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4 57.58%
Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5 3.7
Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6 3.7
Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7 0.00%
Common Stock Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8 0.00%
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Share-based Compensation, Stock Options, Activity (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 1 $ 370,554
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 2 9.40
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 3 124,600
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 4 6.00
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 5 (33,473)
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 6 14.40
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 7 (45,983)
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 8 10.30
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 9 (3,917)
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 10 9.40
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 11 411,781
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 12 15.20
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 13 114,900
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 14 3.72
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 15 0
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 16 0
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 17 (66,216)
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 18 8.87
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 19 (49,735)
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 20 15.63
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 21 410,730
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 22 12.99
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 23 236,795
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 24 16.77
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 25 210,544
Common Stock Schedule Of Share-based Compensation, Stock Options, Activity 26 $ 17.70
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.5.0.2
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 1 $ 2.41
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 2 56,000
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 3 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 4 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 5 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 6 4.50
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 7 5,000
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 8 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 9 1,360
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 10 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 11 4.70
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 12 540
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 13 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 14 540
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 15 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 16 5.00
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 17 50,900
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 18 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 19 9,614
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 20 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 21 5.20
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 22 9,482
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 23 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 24 8,805
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 25 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 26 7.80
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 27 3,400
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 28 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 29 1,224
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 30 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 31 10.50
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 32 6,825
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 33 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 34 3,809
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 35 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 36 11.50
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 37 51,000
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 38 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 39 25,192
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 40 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 41 12.30
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 42 2,083
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 43 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 44 2,083
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 45 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 46 13.10
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 47 60,000
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 48 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 49 35,014
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 50 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 51 17.00
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 52 65,000
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 53 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 54 65,000
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 55 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 56 19.00
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 57 46,500
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 58 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 59 32,026
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 60 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 61 21.50
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 62 24,000
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 63 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 64 24,000
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 65 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 66 29.00
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 67 30,000
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 68 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 69 28,128
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 70 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 71 410,730
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 72 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 73 236,795
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 74 0
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 75 441,780
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 76 6,183
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 77 210,544
Common Stock Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 78 $ 3,683
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Nonvested Performance-based Units Activity (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Common Stock Schedule Of Nonvested Performance-based Units Activity 1 $ 193,791
Common Stock Schedule Of Nonvested Performance-based Units Activity 2 8.70
Common Stock Schedule Of Nonvested Performance-based Units Activity 3 124,600
Common Stock Schedule Of Nonvested Performance-based Units Activity 4 4.10
Common Stock Schedule Of Nonvested Performance-based Units Activity 5 (81,685)
Common Stock Schedule Of Nonvested Performance-based Units Activity 6 8.50
Common Stock Schedule Of Nonvested Performance-based Units Activity 7 (35,469)
Common Stock Schedule Of Nonvested Performance-based Units Activity 8 6.80
Common Stock Schedule Of Nonvested Performance-based Units Activity 9 201,237
Common Stock Schedule Of Nonvested Performance-based Units Activity 10 6.20
Common Stock Schedule Of Nonvested Performance-based Units Activity 11 114,900
Common Stock Schedule Of Nonvested Performance-based Units Activity 12 2.35
Common Stock Schedule Of Nonvested Performance-based Units Activity 13 (83,318)
Common Stock Schedule Of Nonvested Performance-based Units Activity 14 6.96
Common Stock Schedule Of Nonvested Performance-based Units Activity 15 (58,884)
Common Stock Schedule Of Nonvested Performance-based Units Activity 16 4.79
Common Stock Schedule Of Nonvested Performance-based Units Activity 17 173,935
Common Stock Schedule Of Nonvested Performance-based Units Activity 18 $ 4.15
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Employee and Non-Employee Service Share-based Compensation Allocation of Recognized Period Costs (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 1 $ 68,259
Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 2 75,535
Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 3 253,913
Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 4 279,121
Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 5 80,228
Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 6 65,135
Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 7 180,536
Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 8 235,600
Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 9 582,936
Common Stock Schedule Of Employee And Non-employee Service Share-based Compensation Allocation Of Recognized Period Costs 10 $ 655,391
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 1 $ 73,250
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 2 32.50
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 3 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 4 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 5 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 6 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 7 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 8 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 9 (73,250)
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 10 32.50
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 11 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 12 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 13 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 14 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 15 146,500
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 16 7.50
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 17 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 18 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 19 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 20 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 21 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 22 0
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 23 146,500
Common Stock Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 24 $ 7.50
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Stockholders Equity Deferred Share Unit Plan (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 1 $ 167,243
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 2 10.90
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 3 32,662
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 4 11.70
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 5 0
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 6 0
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 7 199,905
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 8 11.00
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 9 55,034
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 10 5.20
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 11 0
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 12 0
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 13 254,939
Common Stock Schedule Of Stockholders Equity Deferred Share Unit Plan 14 $ 9.79
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Stockholders Equity Non Vested Deferred Share Units (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 1 $ 0
Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 2 1,667
Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 3 1,633
Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 4 8,328
Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 5 322,345
Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 6 334,683
Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 7 323,978
Common Stock Schedule Of Stockholders Equity Non Vested Deferred Share Units 8 $ 344,678
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Allocation of Share Based Compensation Costs for Deferred Share Units (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 1 $ 15,678
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 2 21.60
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 3 32,661
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 4 11.70
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 5 (23,170)
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 6 16.50
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 7 25,169
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 8 14.60
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 9 55,034
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 10 5.20
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 11 (41,681)
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 12 8.13
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 13 38,522
Common Stock Schedule Of Allocation Of Share Based Compensation Costs For Deferred Share Units 14 $ 8.15
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Deferred Tax Assets and Liabilities (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1 $ 18,796,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2 16,271,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3 247,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4 262,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5 242,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6 184,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7 64,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8 64,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9 186,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10 100,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11 3,084,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12 3,266,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 13 490,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 14 494,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 15 410,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 16 467,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 17 (1,115,000)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 18 (896,000)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 19 (22,404,000)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 20 (20,212,000)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 21 0
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 22 $ 0
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Components of Income Tax Expense (Benefit) (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 1 $ (915,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 2 (1,510,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 3 (34,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 4 (75,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 5 0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 6 0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 7 0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 8 0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 9 295,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 10 374,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 11 104,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 12 0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 13 384,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 14 787,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 15 (2,026,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 16 0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 17 0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 18 0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 19 2,192,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 20 424,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 21 0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 22 $ 0
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Operating Loss Carryforwards (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Income Taxes Summary Of Operating Loss Carryforwards 1 $ 39,431,000
Income Taxes Summary Of Operating Loss Carryforwards 2 $ 15,717,000
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 1 $ 25,631
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 2 25,631
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 3 0
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 4 0
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 5 0
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 6 0
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 7 0
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 8 0
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 9 (15,068)
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 10 (15,068)
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 11 10,563
Income Taxes Summary Of Positions For Which Significant Change In Unrecognized Tax Benefits Is Reasonably Possible 12 $ 10,563
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 1 $ 7,192,010
Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 2 7,717,932
Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 3 2,459,541
Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 4 2,520,381
Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 5 699,203
Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 6 1,288,848
Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 7 730,604
Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 8 475,922
Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 9 11,081,358
Segmented Information Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area 10 $ 12,003,083
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Long Lived Assets by Geographical Areas (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Segmented Information Schedule Of Long Lived Assets By Geographical Areas 1 $ 7,279,019
Segmented Information Schedule Of Long Lived Assets By Geographical Areas 2 7,714,307
Segmented Information Schedule Of Long Lived Assets By Geographical Areas 3 39,583
Segmented Information Schedule Of Long Lived Assets By Geographical Areas 4 85,003
Segmented Information Schedule Of Long Lived Assets By Geographical Areas 5 7,318,602
Segmented Information Schedule Of Long Lived Assets By Geographical Areas 6 $ 7,799,310
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value, Assets Measured on Recurring Basis (Details) - USD ($)
12 Months Ended
Apr. 30, 2016
Apr. 30, 2015
Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 1 $ 2,159,738  
Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 2 $ 2,159,738  
Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 1   $ 2,852,422
Derivative Financial Instruments And Risk Management Fair Value, Assets Measured On Recurring Basis 2   $ 2,852,422
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value, Liabilities Measured on Recurring Basis (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 1 $ 0
Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 2 0
Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 3 0
Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 4 0
Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 5 (47,690)
Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 6 0
Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 7 47,690
Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 8 0
Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 9 0
Derivative Financial Instruments And Risk Management Fair Value, Liabilities Measured On Recurring Basis 10 $ 0
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Agreements by Year (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Commitments Schedule Of Agreements By Year 1 $ 82,288
Commitments Schedule Of Agreements By Year 2 518,534
Commitments Schedule Of Agreements By Year 3 600,822
Commitments Schedule Of Agreements By Year 4 82,288
Commitments Schedule Of Agreements By Year 5 496,235
Commitments Schedule Of Agreements By Year 6 578,523
Commitments Schedule Of Agreements By Year 7 82,288
Commitments Schedule Of Agreements By Year 8 497,897
Commitments Schedule Of Agreements By Year 9 580,185
Commitments Schedule Of Agreements By Year 10 0
Commitments Schedule Of Agreements By Year 11 207,457
Commitments Schedule Of Agreements By Year 12 207,457
Commitments Schedule Of Agreements By Year 13 246,864
Commitments Schedule Of Agreements By Year 14 1,720,123
Commitments Schedule Of Agreements By Year 15 $ 1,966,987
XML 73 R59.htm IDEA: XBRL DOCUMENT v3.5.0.2
Schedule of Earnings Per Share, Basic and Diluted (Details)
12 Months Ended
Apr. 30, 2016
USD ($)
Apr. 30, 2015
USD ($)
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 1 $ (2,691,595)  
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 2 $ 4,433,402  
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 3 (0.61)  
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 4 $ 0  
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 5 0  
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 6 (2,691,595)  
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 7 $ 4,433,402  
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 8 (0.61)  
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 1   $ (4,441,867)
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 2   $ 4,249,252
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 3   (1.05)
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 4   $ 0
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 5   0
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 6   (4,441,867)
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 7   $ 4,249,252
Loss Per Common Share Schedule Of Earnings Per Share, Basic And Diluted 8   (1.05)
EXCEL 74 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( #5#[D@:LHU,! ( .PC 3 6T-O;G1E;G1?5'EP97-= M+GAM;,W:S4[C,! '\%>IU6 MW17L4NE_:9J./3/))+]3S^^? J79SO5#6E9=SN$;8ZGIR)E4^T!#B:Q\=":7 MT[AFP30;LR8F%HLSUO@ATY#G>C8%]I^\'N/L8PJF$,FT MJ2/*KJ]3?NHI':N_C[Q4OJ*5>>CSNPH_W[LZ4C^M29T-SZ6N=R5+*K\MJQ)- M;ZIPN/%OG5DW#BT,Z]]VC.?_>"T'-W'K^JMH'NU!@>W)QC0>:V?L<&Q4CSYN M?GB_^E\9'>5'!<>,*7HC.1 MVN\YEOD>?S=^77"Z/L:Y3M__-/0IF-AT."$2[^I#@/0A0?I0('UHD#[.0/KX M#-+'%Y ^OH+TP1QW8OG*\M"_V/ MZ'D4X$G1H>)%]2-F Q+M*;V"^GH A3&^.R6:E((C-Z."N[_8_ )02P,$% M @ -4/N2/8!U;L. @ WB, !H !X;"]?36'%&F63:R0:07396;$!41>GL/L2#EOO! M40\LG0D((]WZ1Y]1P4.7Z]6/=&S*H>]R>QCRXN?IV.75]/NZ:DL95B'D39M. M3;[IA]1-=W?]>&K*=#GNP]!LWII]"E+7RS!>SJD>'_ZKJOQ>1NKQ6LS M[E-95Q_]^);;E$H.YU.\F1:8;G\.Z7^6[W>[PR8]]9OW4^K*/RK"KP6J,!\D M\T%""=+Y(*4$V7R048)\/L@I0@MI&=M]+#-T5N WL+16X#>PM%;@-["T5N WL+16X#>PM%; M@-["T5N WL+16X'>RM%;@=[*T5N!WDK:*T&;)1R]%>BM'+T5Z*TBM'+T5Z*TAM'+T-Z&TAMI+UNM-G-T=N WL;1 MVX#>QM';@-[&T=N WL;1VX#>QM';@=[.T=N!WL[1VX'>SM';@=[.T=N!WDYZ M5XE>5G+T=J"W<_1VH+=S]':@MW/T=J"W<_1>7NB=VV9,VYN7P>T_53SE-APX7695HIA?/QZG\=YZG?(>&O3WD>OP!02P,$% @ M-4/N2)?2D8K: P M X ! !D;V-0&ULO5??<^(V$/Y7 M-+PT-Y.<.>[2]C(<,Q2<268(>&(W-WT4\@*:R)(KR33N7]^5#,1<;!SNH;R@ M'_OM:O?;7*/2OJ$:4C1ZI/VPZ&7N2O13..QD0^4:TKKLV\U] M+)Y &^?II\''/OX.(=BO5[J!IERN(\JU&0VW]F8+S"J]HVEK?Y:E5#%'NGE* M\'RF1Y;4@!M^ZVVIYE3:'C'\7YP.>I79:M6/16ZL'GU7^MEL *P9!H=%/ZS+ MUL?\R^CZJY? T;%D%6@%FL(JKM_Q0*[],^$-=?>S7O]RH( ME2D)I<5T)/>R,H7DU4-R&$T6\W@QNY^.DW!*_AC/QO-)2.*[,$SB<^7)142[ M,7&"?P_A'.47MV01A8\_@;D^%S-9/$1G8\;QW=F8N_&\$3.GMM! U(HLL/8\ M'Z91,.9KR3$A, 7)F#%5((]R32*%70C;5B,F_+O@N6.^<7>GQ9"(EG0IP*<' M+NH"4C+CC9A'$-AN4N(2NR2)IM)0UGYH[&69DB2VBCTW"MQ+IC(@"7UI<2&& MM7, 379E[!0TW^+V%L@MEU0R3@6"<*MH#8$['[=NN]GZ3!E#D!?"*D>,:Z;- MYRRRC.K2$=G$U/F4#CZ=II1<)(XT\^%\;@>?.\DZK;W.VFG)1OI.0T[R./BM MB\?3RAL)/0UIJE!R,:=:^T.>S^SG9F;;2\M;>P=EAS-](!=3L+0YZX[)>Q_F M*+YO(.*<4._1S7'#VS MA(_V/H4OR5Q9P+^9ZL3@W9@6S)+OSHC$,+:TL=T; MLKPDD:#[B_&ULMY]MEIY=6+\0^S*7=B.X[*U)[5AW+L06OKLE!LFE-GEZ1M4 MIYVYDELP/OM ^SKM]B?,UJR8R-@9:[I$ZQC&BI"\EG/EJ[+I1=HT' M.X@OJ@EF=TL,7C&1,KSJ'L@G^6?#V89TGNT1MB +("NM,OS8L:"[\V"FW+FP M':2[")!E(^86G\?DB8H"+O>"#T!=SJ8$8]Z)F7&ZY(+[#[\=L)O3M0:HVM:R M)'\!U=TQ"*F6&&KC2J%*@\LW'PWUU_\/;_W@^!MU]!]02P,$% @ -4/N M2)4KO9@_ 0 :0, !$ !D;V-0%M9\*/'4]=^3>5W+@,MNW.K:[^/7<5(*5PCK MX880[]BCHL-7P$;9]F4 M:4 N.7*V!Z:N)R95*44A/'"TOL-+T>/=UM<$DX)!#1H,!I:/<"YE6JI0-ZV0]GO5.R,X'4XR$'V[>GOGQXHPY*N.536G(4CS#4C^BDU=5?0%02P,$% M @ -4/N2)E&UL[5I; M<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$8 M1V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I M.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R M#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2BW A(5M>5 TR 6'!VULS2 Y9>*?IUE!K9';O= M05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU M4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[ M!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^ M34@3_BNEVOZKR2.FJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2 MM!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-) MP>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(* M!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ .7\N?<^E[[GT/:'2MSAD6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q; MY.FOH70^+,_Y/%_GM,T+,T.WF)&Y"M-2D&_#^>G%>!KB.=D$N7V8 M5VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q& MMV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9E MM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+ M$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE M,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)D MU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;S MHYG@'K.'YA,L0Z1^P7V*BH 1JV*^NJ]/ M^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::Q MK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV M-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 " U0^Y(=Z#AK)(" ! #@ M#0 'AL+W-T>6QEB81DB&E'^7*R5*)49R9($:=L>M.'88(AX''<[9@ M*@.1R+GRX:R&0!$_%S'VX>/%QU^Y4+_L!.7$!0<7V,? MCJ83Z+R==.BZAXG-9(=\>B+Y:]P=ZMD1ZOG=EP/;TYG^N^ M.48O&".*8:Z/_8#^9QXOK6/F'DA4ZM*$E<1.X,@$.F7I!5XB>%.!8U@ @9<] M@0VBVM^Z1X(*"90N<9W!(APQ7'C,$26A) 9,$"-T5\!C ]BWHO1CA MIG"AMT.9GF$TO;R-!!X*5(*2[[0#Z"TE[M4+XX+C@N1 MUN^(]TJBW6@\V0NP@\X;"AEC66<>P0H*/(H3I0,D6:W-J$1JI NE!--&3-!* M<$0-9151&IHVPI0^F&_0SZ3%O4U X6/.V(7 J*A,O1&EV92!W51GGZW@WJ>= MG,4+MDF=0$>C-*6[.TI6W%2T$5M "U$^':,?': //%2Q@K60Y$G[FT*(-( E M!!LL%8GVD=\2I4N\564%.]ODD,)SE]QW34U^773_:4"F,[TWNFFK!6EZ',T9;YOVQLXJ M%.KK7"N+)HMQ@G*J?I"-4';2AXW]S<@?36NO94WAP\;^CF.2,WL9<)H[8_ ' M4$L#!!0 ( #5#[DBX),(#-04 D3 / >&PO=V]R:V)O;VLN>&UL ME9A;<]HX&(;_BL8WF\ZD"SZE3:9TA@9GDQD"3&#:V4MABZ"I;+&2G(3^^I5L M2%XW2BA7X(,>2Y\>?3I\T1>/4OU<2OF3/)6BTA=J$*R-V5ST>CI?LY+JO^6& M5?;92JJ2&GNI[GMRM>(Y&\F\+EEE>E&_?]933%##9:77?*.#'4W_"4UO%*.% M7C-F2M'"2LJKX.L7?;'B@GUG2ELPH9O-A)9L$#R)@ BJ359PPXI!D-A+^<@Z M-U2]^59SX2[2?AKT'&S?U)DBN2Q8"UNLN?ZQ>Q"0@JUH+*_9&6HF.=*"M&4<@^:0O8+^OF.K:/A>>=% M0Y=WKB<&P5G? A^XYDLNN-D.@N:_8*XEO=^:TH3_Y1^IFN#LNYC0JB!992R% MW%1MY]G0N#K8EV^*YL/J@ML_ZJ8(VU AZ'(ZF4_'-Z/A(AN1;\/Q<'*9D?EU MEBWF (D $AT%(2LRTRCD5EJ6-JG_O#%0R]#EIV\Z-*]5I @H8>@P<2ZV)=<]F M_29V>DT50P Z&/HDK,N2JJUSV.&]\5.XH1A4I&!Y3TU@7=C ZXZ06@I-&?2NHEH:W1L;9&GQ"%MD;O MV^JM"FH;_:FV7A+Z&WG\]:5@D02B4/#8(_@; M+NRAB$+#8X_A<[L2+VK1Z+!/ J=D(@VS/V.)*#0\]AB.J)F219T;\L-5J;(= MVID<8Y0]]LANB]OFF>TIF0FZ7W"^)#A$H>VQ+UM[&@A9#E=W:'OBLQU0VQ&5E1LAMZR=5"SW8U8B"FU/?.D<8^7&]%J* MPN[&_FJ4Z(0=;4\.V(ZHEK1%%-J>'+#]%2KYC"BT/?'8WE%4")FW$]:^-Q&% MMB<';!^Q%5/*=J#-7F2H->NLDU*T/3U@NS-)5DWJLE=-4D04VI[Z;']9,>VF M'#M)-$GLTN8'#'N*MJ<>VP$UDYJW$X35DSRN>;XFB$+;TP.VW[$'5M6,K)0L M2?9D-^IH>XJVIP=L'TO7.)O:BUW0R1)1G:V?Q_8KRA7Y3D7-3O?E;QEUP[L@ M5@I$H>VIQW9$C3EM]OUVE[3G(0IM3P_8/KQ7C+7SV')+_F54=6J%MJ<';,^H MJJP+VN685O931*'MZ?GNH.+E;*)@*UZQPIW+$G=:MY= MW\K"?MN=PP1D50MQ:>]-J[&DS6E%2]X?X'S]'U!+ P04 " U0^Y(Z+?% M 8P" "A"0 & 'AL+W=O,##()_;6--IFTVNQ>;3.9B]YJVM)I1<8'6V;=?0.L@PX[>5*#G?(.]UU?"M7PC1;@#@IX+4F#_1EC3RGPME-1:RRZZ MXS@LR;5%4!! MD( :EXV?9WKLA>49O8FJ;,@+\_BMKC'[NR,5[;8^]!\#K^6U$&H Y!D8>>>R M)@TO:>,QZZY>WW[TG@<9N*LP M$\2N1R"-@","R-A. 305V"&#CEP">Q,1NA '$Q'-3R&T<@PU/=3TV)FCB4CF M!2)+(#+HJ5/ 1*SF!6)+(#;H:Z> B8#!O$)B*20F'SHE)A T+Y%:$JG)=V[T M;@)9L-,K2V)E\JVM;GJ)'A(/683)>IW.ZZPMG;6IDSA3F4 62,# =F9@1EBY MO3G!K!>H?/(_-"*@P+5D^P'3KUD4QW$8+:AAB&PI9$JY:VR*65!DT#8[-+V, MW&4VQ2RH,V@['IJ&1NY#98I9HF+;'IJN1HEK:@4N."FA?0A T^+H/U4]P=A5#8P+KB;LJE\*W#O16R/ZFVP<'5\C MS_K.!A_P/&OQE?S$[%HVW#M2(:]9?<->*!5$3B)XDNM:R/?2V*G(1:AF*MNL M?T'T'4';QX-H?)7E_P!02P,$% @ -4/N2%W36-GZ P T1$ !@ !X M;"]W;W)K#JLOO4G-W)_[-OVKKL_67[FG;GUI6[,:BN4A3"I'5Y M/*TVZ_'>EW:S;M[ZZGAR7]JD>ZOKLOUWZZKF\K2"U<>-K\?70S_<2#?K]!JW M.];NU!V;4]*Z_=/J-W@L,!\DH^+OH[MTY#P9S#\WS;?AXL_=TTH,'ESE7OHA M1>D/[ZYP535D\BU_GY/^W^802,\_LO\^ENOM/Y>=*YKJG^.N/WBW8I7LW+Y\ MJ_JOS>4/-]>@AX0O3=6-O\G+6]!J/E^D?*^8P/@#G +P& M@/IE@)P#9!203L[&NCZ7?;E9M\TEZ<[E,-KPZ.7MD,1G3GPQW7@Y=M=T]WTC MQ3I]'_($DNTDP5&"G**@"@E72>K;9TU@9 +'^&R*Q_OQ,HJ78[RQ?B:)GDL6.68YZR?02:&5,??]Z,B/ MIGXTZT>3=L JHUC;12 S%O/\OAL3N3'4C6'=&-*,UEH: ZP=JC,2#=CLOI\L M\I-1/QGK)R/MY-(:?NX$JLR8!5YLY,52+VPK6TN'0*$V[(0OJ PSR.2">9-' M;G+JAIV?VYPTDPD!B'S?!#H)H-2"F0,BII4@CI1@'HII*Q9XBK$*E*L\H+:@ I ):S6[I(M(:$QN%ZP0B-$*E*V* M9ROHH'S+HS50+>F>F*M P:IXL$) 3)":E16!;%BN"U &,5>!@E7Q8 7*3&E! M9X+MPR(0*E3:6+G 4\Q7H(!5/&"!HE-J>>/)',A4EIDE8Q83%BAB%8]8H.P$ M<0OXOY#=WHC%@$4*6,T#%D4P9L8CBE]B@5!)H?P;Q )/,6(1",STDNWE3_M+ MI%4A7Q6RRR^HAY?<]A%#%2E4-0]5I*Q46K%NBU"%2#?ZHA M:G&CFT*I]IOY7"S8<6",5:18Y1]N6Z2T?,!%W2T6DE#E"MF"_@#%8D8)5 M\V!%2LPO[J^R M?3V>NN2YZ?U[_/@*OV^:WOE\XI.?IP=7[JX7E=OWPVGFS]OIB\-TT3?GCP\H MUZ\XF_\ 4$L#!!0 ( #5#[D@709*"+@( -\' 8 >&PO=V]R:W-H M965T&ULC97=DIL@&(9OQ?$"%L2_F#'.-'8Z[4%G=O:@/28) MB_?EQZ3$P61S$ &?]^,A42A'QM]%0X@,/CK:BTW82#FL 1#[AG18 MO+"!].K.D?$.2]7E)R &3O#!A#H*$(09Z'#;AU5IQEYY5;*SI&U/7GD@SEV' M^=\MH6SV-]?1 MWDF3*>8/H"F ;H'H<2"> O$L *R96==7+'%5ZB*H^50#,)9/*QE8CNI^BMA$4R M@Z1)'N6Q#ZM=#!6**Y[;Q#.;V+5!7AN+K P"7R#T.M?+U*)+,G-)7!?ODK<6 M20T2P>GC]7E,+CJE,Z?4=4J\3JDSD]_%3RPZ9#.'S'5(O0[94P<_L>B0SQQR MUR'S.N2?>DZ6J467UI<&9*T@3%B9>K M[S@4QW&1/O>)X'RO@ZY1X36:F.=*]Z#7"3A;\8!/Y"?FI[87P8Y)M:N;#?W( MF"2J''Q1+T2C3MM;AY*CU,U&PO=V]R:W-H965T&ULG9== MC]HX%(;_2L1])S[^BCUBD!I6J]V+2E4O=J\S8"!J/M@D#-U_7\<)S(GK%JM< MD,2\Y_CQUTO.^MIV7_N3,4/RK:Z:_F5U&H;SQFJLC&?NZ2_U'71_9^;JKV^ MK&!U:_A2'D_#V)!NUND];E_6ING+MDDZO>=["[]T-:WD%52%]^F:]FX MZW7Z1=["P@%T#J#W )"_#&!S 'L/X&ZD$YD;UQ_%4&S677M-^G,QKC8\6WDW M)K&9$SN8WCVZZ9I:WS896:=O8YZ%))\DU$G@KDAM\F /=-E#3E$X#76PQ0H6 MT0/SQL!>_')!'HGX B (FPA.T$%H<1A1[ M3)1Y1!E>D,*B4&5%9<$!81^V'Q.Q [?%HS!/L)]=X)8$+ M)B#(L]!I)F0,#Q#?%@@F"BYE/FOFKC*6$2&"2 NAD%)3B-B%\(-5 6;2829 M73&6,1G>L-N%D N[;IQ',%&?B2(F%3R#^:R9MQ+3U-I'>"\ME1GCVAZ0""K? M$(%AJN ^R6?-U-<'JC@H$IS3[5(I&!>:D@@JWV:!HU.K:$0&WQ@!.Z,*.R,L MK)%"^)0L5-2>;QV!X_LB8&-486,$N9AF!F&?7LJ TA@>WQ4APSS!LYC/FGF+ M:8$WV ((ZY1B$F(VHN^S@(U6A8T6L(-^X)G4/YDBK(O9?[[) G;9L)OGLT;. MRR4U"/T34ULH.;?G1T:X&O6=EA)\*E1$!M\7*?9%%?;%6:,G6O(DP\=B*8,G M$O'?2GU/I-@3PXN9SYJ'//0W>'PWI/C]4,>\P?K.17G$#'/\A\(9XR3X*KE= M"BG75$1X(?6]D(J(61:Q3.(A4XKJBMIT1U=O]V\%6/:[@.;3M8"PA>;*$)UN-WA\J=U-]-CT,[?E6;MYKWLUW4$L#!!0 ( #5#[D@=W^!!N@$ $$ 8 M >&PO=V]R:W-H965T&ULC5/;CILP$/T5BP]8@]TD:D20 M-E2K]J'2:A_:9P>&B]87UC9A^_?UA1 2155?L&YQ/2K^;#L"B3\&E M.22=M<,>8U-U()AY4@-(]Z=16C#K0MUB,VA@=2 )CDF:;K%@O4R*/.1>=9&K MT?)>PJM&9A2"Z3]'X&HZ)%ER2;SU;6=] AN-Y?U%]" MM\[]B1DH%?_=U[9S9M,$U="PD=LW-7V'N86-%ZP4-^&+JM%8)2Z4! GV&==> MAG6*?[9?9MIC ID)9"%DVW\2Z$R@5T*H@*.ST-P;47 M<Y@1PCA 1(MB"P$W]8@=Q6.)(5_6&!9(A]8"S^9;GMIT$E9=_'ASANE+#A[Z=,F09U[CTO MH;%^NW-['4WO/KB+U!+ P04 " U0^Y(N\[L]0D" !K!0 M& 'AL+W=O*RB'O>H1:LT;5L@&+'=?2< MKK;$(3S@5\TZ/=@#YWTGY8<+?AS64>(L,,[VQBE0NUS8EG'NA&SA/U?->TE' M'.YOZJ^^6^M^1S7;2OZ[/IC*FDTB<&!'>N;F77;?V;4%[ 3WDFO_!/NS-E+< M*!$0]#.L=>/7+KS!Y$J;)\ K ?:$]&M"=B5D=P+RG09GOJ\7:FA9*-D!W5+W ML=.5A2LG8I6!;4;[T!]7R%[*'!7QQ>F,()L @1Z2]HC8BL]6@.,*&SB@P[D" MVR$B^X\*V:2'S/,SSU\NQB6:8") B(=\@R1/<8[G@-L1$"&4+LGBL2,T<82\ MRB*<*G[,QQ,^'G24D]F. @0'HQ@GB"QG&QKA4I0L$X0>&R(30V1H:/Z(R?#D M,HA@0K)91R,@7J(\3ZZT6 GC;UB_G8=I33,.DR>[*%5=O+U 6='X[8+NU=A&(3 MR/8VVOKY6OX#4$L#!!0 ( #5#[DAT:1-O=00 .$4 8 >&PO=V]R M:W-H965T&ULC9A-CZ,X$(;_2I3[3*@JVYA6.M+ :K5[6&DT MA]TSG="=:"!D@>[,_OOEJ],N3S'Q)0'REOU6@1\JWE[KYGM[+(IN]:,JS^WC M^MAUEX?-IMT?BRIO/]>7XMS_\EPW5=[UI\W+IKTT17X8@ZIR@U%D-E5^.J]W MV_':UV:WK5^[\G0NOC:K]K6J\N:_M"CKZ^,:UN\7OIU>CMUP8;/;;FYQAU-5 MG-M3?5XUQ?/C^@L\9&0&R:CX^U1<6^=X-9A_JNOOP\F?A\=U-'@HRF+?#4/D M_==;D15E.8S4S_SO/.C'G$.@>_P^^N]CNKW]I[PMLKK\YW3HCKW;:+TZ%,_Y M:]E]JZ]_%',.>AAP7Y?M^+G:O[9=7;V'K%=5_F/Z/IW'[^OT2VSF,#D YP"\ M!<"O V@.H(\ -68Z.1OS^BWO\MVVJ:^K]I(/=QL>>GDS#-*/O.J3:;MV$<)DDG"8X2N"DV_>#B#,AG2-$)1VF"S%50P SDY4!C?#SED-R/ M5UZ\&N-IC+DI@D9I1\0I. 3K0DS)A0*076Q/<=:<^1=C*"*+H_@/$& M,$Y*RHHI31(].4VL13$?IC(FPOM>8L]+['B!"$0SL3,-) F17%U7AE%"-L". M]>Q89D?,.K5NUJ@LQ:+MC.MZVTCW#26>H809(M%0XDR41/WSIT0_KJQ_;J(H M#GAV(/*9$#%'XE3I+)KF(AM;T7C&9"%F?@(4L+6@ X9 ?PAT5X-6\,RX$'5D(0 [XS )B-3:R*7)ONP$93IDGBS"D2#X$P:6@6O"C6.X0&WE9 M,!TEV@;X\1$(VO4CXB"=-3,/R"[<,N#A6 "4 8^CQ%EZ=*G"E%F9.N&289R&,"UA7Z/$5@X)'; MG5ETNQ.1MBCSG2N)R) -J9'/:$2&^9#,?*0B1^I"G8EE%IM$[GL\'2CMO'*7 M/?E419>J /+20(Y5BDE^&IDNI,@^4U$S-W(KA@R7"A3)D.>ZX KY8$7CWOB0 M%8\^#Y%UF""_X)&UF!HC'6(N,=V:4>W-,A&A6R M/GPP(FLT07YO(&LAE87%!<(02OUZTP&%(I^-Q'I-D/L.BOBB!90]<9W25H?T MX^0CDA@B048D,?#U53(+;U@N5(01Q2; E4](0N9*;D'([4ZQSU\ME1^44+L2"9C&RMNU^X+#SI-W/86';-I[^QAFM[WD+\5?>?-R.K>KI[KKZFKMFIJ#KMG)SB!&L"L[4QFO_WZ(8A:M!WG M$&SR:W6[)?6_Y2P^\N)GN<^R:O+[=#R7C]-]55T>YO/R99^=TO);?LG.]5]> M\^*45O5M\38O+T66[EJCTW$.C.GY*3V)SRZ?6+'X>W?=5\,5\NYC>[W>&4GOC] _^D(@6:8F_ M#]E'Z5U/FN"?\_QG<_/G[G'*FABR8_92-4.D]<>O;)4=C\U(M>=_W:"?/AM# M__HZ^K9]W#K\Y[3,5OGQG\.NVM?1LNEDE[VF[\?J1_Z19.X95#/@2WXLV]^3 ME_>RRD]7D^GDE/[N/@_G]O.C^XLVSHPV &< -P,0@P;"&8A/ S5H()V!_#30 M@P;*&:B;@1@VT,Y ?WJP@P:1,XAN!FKX&8PS,#<#WF9IWDU'.YGKM$J7BR+_ MF)27M%GB_*'&BV:0>N1)/8-E>]NND>[;7TL.8C'_U0R$F+ACP#&28E:8412S MQHRFF UF(HK98L90S!-F+,4DB!'LQLSKO)')@R!YT X@W <.SEWR>L8W3(2 M-*.@E0_-@$+6/D(.LO$)K:TT1FL*W")OBAECF3 4^81(:^1=MCLN\3FN6&2M M,E^G4P3I%"B=9!KBCE$NG:LA0 M-Q*%6J=/DCD.,&FCKP-60< *!4SZB97G1T?&?NU%!UXT\J+(^='^RJ*9C?:? M6'#.)+WZ[C@CO@XZ"H*.4-#DQEE%R)$"/L*/"?P8Y(=<$;%!R:%C\1D/Z8W# M!G%8% >9V-CBY]7TGESY6$.-R IGH0XQ/QY&[J6-@Y2#ZI^(W-?)(-@?U)TX MG5T?&U-70JWA2&SHI1<[ MR-45VU,1?4FJ1^)*DG*1W(%&C%!V'JH71_(ER33&#E+7R!D;DZ10H#A2*+HI MBAWD.L^>E8[TR401FX_F<+50[PR8/NWB X,?0>/GT.8_T1A0('2.!Z^C= 19]I MRVG5'>+Z0PJU ? YA.[>P#^(P[! >;MR?Z@0VD + UT^P:H MF$>CSB$0EG+P2WE/_P9^)9]!/1&*ELYDF.R/*JSZ@*I^3_\&Z&"BZA.S[IF2 M(;#_O418U06NZG0I<9#KWA3=XZT11==CA$2,:<4,.=@6D3-E6-W*TSW+$T;! M2M#TXDH0:>OJ*\V(W2="?1)(G^B3>RQ\36ER)FAPA<"9[&G,$!56L;GW8O22 MOF5_I<7;X5Q.GO.JRD_MZ]77/*^R>B#VK2Y ^RS=W6Z.V6O57$;U==&] N]N MJOQR?:-_^[?"\G]02P,$% @ -4/N2'0A,TN6 0 < , !@ !X;"]W M;W)K MV&^>&%6.V M[D%Q>X4#:+_3HE'<^=1TS X&>!-)2K(\RVZ8XD+3JHRU%U.5.#HI-+P88D>E MN/G:@,1I31?T4'@57>]"@54EFWF-4*"M0$T,M&MZMUAMBH"(@#;$9) RT?I7O%Z0GV(RR#8(W2QB^I1^M0'2B4*/Z95J'C.J6=XGI/NTS( M]X1\)MQFT7AJ%&T^<,>KTN!$[,##W2U6'FZ"B%8 MO"4UCMJEV>?J_+CN\GBD/_"J''@'_[CIA+9DB\Y?3+R3%M&!-Y%=+2GI_?.? M$PFM"^$?'YOT(E+B<#B\[_DGJ[X!4$L#!!0 ( #5#[DCN_GW!E0$ ' # M 9 >&PO=V]R:W-H965T%%^8%M+0NDJU M9UM7.'DE#3Q;XB:MA?U[ (7SGF[H4GB1_>!C@=456WFMU&"<1$,L='OZL-D= MRHA(@-\29G<1D^C]B/@:DY_MGA;1 BAH?%0083G!(R@5A4+CM[/F1\M(O(P7 M]:4?V1K1^"V8*2%CHQ*?^"\P\XC["-@@TJE[ZDF9Q'O5 HT>(] MK]*D=CEV6%YT^$U MYOY3$W9Q)!ILGV[>D08GX_/L:W5]7 \\'>D'O*Y&T<,O87MI'#FB#Q>3[J1# M]!!,%'=;2H;P_-=$0>=C^#7$-K^(G'@]_F3U/U!+ P04 " U0^Y( MM#M@"Y8! !O P &0 'AL+W=O#-$C=I+>S?'2BE#ZO-KHR(!/@M879G,8G>]X@?,7EIM[2(%D!!XZ."",L!'D&I*!0: M?QXUOUM&XGE\4G]*TP;W>^'@$=4?V?HAF"TH::$3D_+O.#_#<81U%&Q0N?0E MS>0\ZA.%$BV^\BI-6N>\P\LC[3J!'PE\(=P7R7ANE&S^$E[4E<69N%'$NUMM M MQ&D:!,@C>7TC1]KA[J\KYBAZAS =EE"$^0U8)@0?QJ!W[98?2ENKRM!YY.]!M>5Z/HX578 M7AI']NC#O:0KZ1 ]!!/%S9J2(;S^)5'0^1C>A=CF!Y$3C^/I>2__6/T/4$L# M!!0 ( #5#[DBRT]<-E@$ ' # 9 >&PO=V]R:W-H965T#'$#DIQ\[4%B>.&+NBA\"K: MSH4"*PLV\VJA0%N!FAAH-O1^L=XN R("W@2,]B@FP?L.\2,D3_6&9L$"2*A< M4.!^V<,#2!F$?./_D^9/RT \C@_J_^*TWOV.6WA ^2YJUWFS&24U-'R0[A7' M1YA&6 7!"J6-7U(-UJ$Z4"A1_#.M0L=U3#NKZXEVF9!/A'PFW&;1>&H4;?[E MCI>%P9'8GH>[6ZP]W 01KTR\-QO3.'VJ[LO%ZJ9@^R!T@MDF3)XP,X)Y]8LM M\M,6V_R(GO].7YXY7$;Z]'A*>;NK D[.A(%IHTW;TF%@W9I]KDZ/Z[[ M/![I#[PL>M[",S>MT);LT/F+B7?2(#KP)K*K%26=?_YS(J%Q(;SQL4DO(B4. M^\/[GG^R\AM02P,$% @ -4/N2,%]S[*4 0 < , !D !X;"]W;W)K M&ULA5/;;N,@$/T5Q <4V^E-D6.IZ:KJ/JQ4]:%] M)O;81@7&"SAN_[Y<'#>)(O7%S SGG#D#N)S0?-@>P)%/);7=T-ZY8=X@? M(?G;;&@6+("$V@4%[I<]/(*40<@W_C]K_K0,Q./XH/X4I_7N=]S"(\IWT;C> MF\TH::#EHW2O.#W#/,)-$*Q1VO@E]6@=J@.%$L4_TRIT7*>T"&ULA5/;CML@$/T5Q ,=<,H(5[P!%,V.G0:N%#:GOF1@NB322M&"^*'=-"&EI7J?9LZPHG MKZ2!9TOC\AOL;D1WN@1;0 "AH?%418SO $2D6AT/C/HOG>,A*OXXOZMS1M M<'\2#IY0_9:M'X+9@I(6.C$I_X+S=UA&V$;!!I5+7]),SJ.^4"C1XBVOTJ1U MSCM\M]#N$_A"X"OA2Y&,YT;)YE?A15U9G(D;1;R[S3[ ;10)RB1X7'QR6B5XN#C_==7B+V7YH MPJZ.1(/MT\T[TN!D?)Y]K:Z/ZY&G(WV'U]4H>O@I;"^-(R?TX6+2G72('H*) MXF%+R1">_YHHZ'P,/X?8YA>1$X_CY7VO/UG]#U!+ P04 " U0^Y(#D7) MP98! !P P &0 'AL+W=OT'ZX'\.13*^-VM/=^V#+FZAZT<#@\ MZA.%$BT^\RI-6J>\PS4=J'(W/LR_5Y7$]\'2D7_"J'$0'?X3MI''D M@#Y<3+J3%M%#,%'_) I:'\.[$-O\(G+B<3B][^4GJ_X#4$L#!!0 M ( #5#[DA/6:/4E0$ ' # 9 >&PO=V]R:W-H965T9?=,<:%I5<;:LZE*')T4&IX-L:-2W/S;@<1I2U=T+KR(KG>A MP*J2+;Q&*-!6H"8&VBU]7&UV14!$P*N R9[%)'@_(+Z'Y$^SI5FP !)J%Q2X M7XZP!RF#D&_\<=+\:AF(Y_&L_BM.Z]T?N(4]RC?1N-Z;S2AIH.6C="\X_8;3 M".L@6*.T\4OJT3I4,X42Q3_3*G1%4: MG(@=>+B[U<;#31#QRL1[LS&-TZ?JL5K=_RS9,0A=8'8)DR?,@F!>_6:+_++% M+C^CY]_3BRN'1:07J?M#=M/A)>;:(SL[$@6FBS=O28VC=FGVI;H\KL<\'ND7 MO"H'WL%?;CJA+3F@\Q<3[Z1%=.!-9'=K2GK__)=$0NM"^.!CDUY$2AP.\_M> M?K+J/U!+ P04 " U0^Y(O[<7>I8! !P P &0 'AL+W=OM#)N3P?OQQUCKAE "W>' M(YBPTZ'5PH?4]LR-%D2;2%HQ7A1;IH4TM*Y2[=G6%4Y>20//EKA):V'_'4#A MO*<;>BZ\R'[PL<#JBJV\5FHP3J(A%KH]?=SL#F5$),!O";.[B$GT?D1\CU)7%F;A1Q+O;[ +<1I&@3((WE](T?:Z>ZLT#K]@I"EUA#AG# M,V9%L*!^LP6_;G'@%W3^.;W\X+!,]')Q6-YT>(WY\J$)NS@2#;9/-^](@Y/Q M>?:UNCZN1YZ.]!U>5Z/HX9>PO32.'-&'BTEWTB%Z"":*NWM*AO#\UT1!YV/X M$&*;7T1./([G][W^9/5_4$L#!!0 ( #5#[D@T4Y8JE0$ ' # 9 M>&PO=V]R:W-H965T<.0.XG-!^N![ DT^MC-O3 MWOMAQYBK>]#"W>$ )NRT:+7P(;4=:-K@_ M"@=/J-YEX_M@MJ"D@5:,RK_B] O.(VRB8(W*I2^I1^=1SQ1*M/C,JS1IG?(. MGVFW"?Q,X OAH4C&OOSE<)_KZ[/#^IL-KS/9;$W9Q M)!ILEV[>D1I'X_/L2W5Y7(\\'>D7O"H'T<&SL)TTCAS1AXM)=](B>@@FBKL- M)7UX_DNBH/4QW(;8YA>1$X_#_+Z7GZSZ!U!+ P04 " U0^Y(?ME)2I4! M !P P &0 'AL+W=O^>.V[D%Q>X4#:+_3HE'<^=1TS X&>!-)2K(\R_XPQ86F M51EK3Z8J<712:'@RQ(Y*]"@54E6WB-4*"M0$T,M%MZ MM]KLBH"(@!_6*+_+S%+C^AY[_3BQ\.BT@OC@YO M+SH\PZRS'TW8R9$H,%V\>4MJ'+5+LR_5Y7'=Y?%(O^%5.? .'KGIA+9DC\Y? M3+R3%M&!-Y%=75/2^^>_)!):%\(;'YOT(E+B<)C?]_*355]02P,$% @ M-4/N2!@NF;&$ @ KPH !D !X;"]W;W)K&UL MC5;!CILP$/T5Q 1VA>\9NI)M+PQ7XY"UDR;K3Q% MJI6<'6Q0744TCI.H9F43YID]>Y5Y)LZZ*AO^*@-UKFLF_VUY);I-2,+;P5MY M*G1_$.59-,8=RIHWJA1-(/EQ$SZ3]99:B$7\+GFG)NN@3WXGQ'N_^7G8A'&? M Z_X7O<4S+PN_(575<]DE/]>23\U^\#I^L;^W?ZN27_'%'\1U9_RH N3;1P& M!WYDYTJ_B>X'O_[#HB?)>-?7?#EV5R#7,'T&L M'0/2V"8^"-DTOS'-\DR*+E MZXM'U@8N>Q+#')CB* MV0X8.F!&1&38G1(42FSI))P^#I^A#&_+E-A- X:X^ GF4GU"L0R<4 MIL^[=2#(PP$$WWTR Q1N#R"0APD(OOYD#BC<-D @'Q_@#D 6@.*.#R#(QP>X M"9 $4-SQ 03Y^ #W 3*]Y)3<\0$$^?@ MP*2 HH[/H @'Q_@;D!6@.*.#R#( MPP<4]P,: PJW#Q#(PP<4]P-* (7;!PB$?1!-!HJ:RY.=FU2P%^=&#Y/#>#K. M9L_4#B2?\#QKV8G_8O)4-BK8"6W&&CO1'(70W&01/QG7%V9Z'#<5/^I^N31K M.CC-J_A]02P,$% @ -4/N2"'67(ZP 0 .@0 !D !X M;"]W;W)K&ULC53=;ML@%'X5Y ;4M@"-O2FI[2%KG MNCVEMFQ!<7N''6C_I4:CN/.E::CM#/ JDI2D+$WOJ>)")T4>>\^FR+%W4FAX M-L3V2G'S[P@2AT.2)9?&BVA:%QJTR.G,JX0";05J8J ^)(_9_K@+B CX+6"P M5WL2LI\07T/QLSHD:8@ $DH7%+A?SO $4@8A;_QWTGRW#,3K_47]>SRM3W_B M%IY0_A&5:WW8-"$5U+R7[@6''S =(28L4=KX2\K>.E072D(4?QM7H>,ZC%\> MODZT=0*;"&PF?$EC\-$HQOS&'2]R@P.Q'0]WE^T]W 01KTQ\-AO+>/JQ>RX8 M2W-Z#D(+S''$L(C)9@3UZJL6;&EQ9%=T]C%]KP#1QABTIL==NO,6Y.S^31Q:' MXQU>Y!UOX!&PO=V]R:W-H M965TXX+&+NQ92%'IS@"EX,LH.4S'SL M0>AQAS?XG'CE;>="@I0%F7DUEZ LUPH9:';X:;,]Y $1 ;\YC':Q1\'[4>NW M$/RL=S@+%D! Y8("\\L)#B!$$/*%_TZ:7R4#<;D_J_^(W7KW1V;AH,4?7KO. MF\TPJJ%A@W"O>GR&J87;(%AI8>,758-U6IXI&$GVGE:NXCJF/]\>)]HZ@4X$ M.A,>LG\2\HF07Q%(@"LT\8&C&;&4&\^FH)>EEB3Q=TNE;@L$3D_U$AOVHBC_Q\:N)AM8E+ MS..JCPM,GET9(8N3E6#:.'$657I0+KF?L_-0/]%P,U?YO1_V-)M?,F71LQ9^ M,=-R9=%1.W_O\&ULA5/;;J,P$/T5RQ]0$Z-L5Q%!:K):M0\K57W8?79@ *NVA[5- M:/^^MB'DHDA]P3/#.6?.,*88T;Z[#L"3#ZV,V]+.^W[#F*LZT,(]8 \FO&G0 M:N%#:EOF>@NB3B2M&,^R'TP+:6A9I-JK+0L@*LYLP/&'."!;4 M[[;@URUV_(+.OZ?G-P[S1,]GA_RNPVM,?M.$77P2#;9-FW>DPL'X:?:ENERN MI[0#=H:712]:^"-L*XTC!_1A,6DG#:*'8")[6%/2A>N_) H:'\/'$-OI1DR) MQ_YTOY>?K/P"4$L#!!0 ( #5#[DAYJ\( _P$ )\& 9 >&PO=V]R M:W-H965T0/6'S)78ZES595^U!IM0_M M,[$GL;5@7,#Q]N\+./$&%LEY,0#%^^R!E#H@]%6[J-:J6Z'L2QK M8$0^\0Y:_>;$!2-*A^*,92> 5);$*$[C>(49:=JHR&WN510Y[Q5M6G@52/:, M$?'O )0/^RB);HFWYEPKD\!%CB=>U3!H9<-;)."TCYZ3W2&Q$(OXW< @[_;( M%'_D_-T$/ZM]%)L:@$*IC 31RP5>@%*CI)W_7D4_/0WQ?G]3_VZ/J\L_$@DO MG/YI*E7K:N,(57 B/55O?/@!US,LC6#)J;1/5/92<7:C1(B1CW%M6KL.XYM- M?*6%">F5D'H$/!K9,K\118I<\ ')CICF)3L-%T9$*R-=F[2A/?V8O11IMLCQ MQ0@YF,.(22TFF1!8JP9.F9+!V!;=#$P2SB>9.59[)R!)*@B8MYH"=KSV3M"&1!$Q>SF#?9 M>"8;1R#<>!?S0..WGLG6$0@WWL4\T/@D]O^RV)$(M]X%+1_H??+E;TXBW%^CH'BW>TZF.ZDXC]02P,$% @ M-4/N2/A [NB\ 0 GP0 !D !X;"]W;W)K&UL MA53;;ILP&'X5BP>HB1-H%Q&DIM6T74RJ>K%=._ #5GU@M@G=V\\VA )"R@WV M__.=+!^R7ND/TP!8]"FX-*>HL;8]8FR*!@0U#ZH%Z?Y42@MJ7:EK;%H-M PD MP3&)XQ0+RF249Z'WIO-,=98S"6\:F4X(JO^=@:O^%.VB6^.=U8WU#9QG>.*5 M3( T3$FDH3I%S[OC.?6( /C-H#>S.?+9+TI]^.)G>8IB'P$X%-8K4#=XI&V32 C@:P(># *,5^II7FF58],2_W> M[8X.KKV(4T8NFPEE6/W0O>8DV6?XZH46F/. (0&SFQ#8J6]:D*7%FZ;'%8FAX5 NFFRQ#S>-TE6)LE"X&G39(GY=M\D79FD MWM.9C>I/P_4$L#!!0 M ( #5#[DC!C?3)H $ -4# 9 >&PO=V]R:W-H965TK#]DSL8QL5.![@N/OW ^RX M<12I+X9S_-VXY0/:=]<">/*AE7$'VGK?[1ES90M:N ?LP(0_-5HM?"AMPUQG M052)I!7C6;9C6DA#BSSU7FV18^^5-/!JB>NU%O;?$10.![JBE\:;;%H?&ZS( MV *EHE P_CMI?EI&XO7\HOZ<5AO2GX2#)U1_9.7;$#:CI():],J_X? "TQ*V M4;!$Y=*7E+WSJ"\42K3X&$=ITCB,?[YG$^T^@4\$?D-@HU&*^4-X4>06!^(Z M$<]NM0]P&T6",@G97"K3ZL?NN> [GK-S%%I@CB.&)\QJ1K"@?M>"+RV._(K. MOZ:O;Q*N$WT])5S?3;C$;+XVV=R8;!8"V[LF2\SNQH1=[;L&VZ3KY4B)O?'C M!L_=^08_\G1NG_ B[T0#OX1MI''DA#Z&PO=V]R:W-H965T&"Z*+\0V2_KW]84E@%#;%^P9SCES!GO(!JG>= -@T =G0A^C MQICN@+$N&N!4W\D.A'U32<6IL:&JL>X4T-*3.,,DCA\PIZV(\LSG7E2>R=ZP M5L"+0KKGG*K?)V!R.$9)=$N\MG5C7 +G&9YX9DTP(;-4W2Y!EB1.9T:LM/D/!%W_*O\R4Y4&(!/F3SK: T_J*I;H=%%&GNY_+VJI#1@S<5W]Q%J M[,Q/ 8/*N.W>[E48@Q 8V=V&>OJSY'\ 4$L#!!0 ( #5#[DAB]7JSE@$ M ' # 9 >&PO=V]R:W-H965T=L_$'MNHP+B X_3O%[#C)E6D7LS,\-Z;-X"+$>V; MZP \.6EEW(YVWO=;QES5@1;N#GLP8:=!JX4/J6V9ZRV(.I&T8CS+?C MI*%E MD6HOMBQP\$H:>+'$#5H+^[$'A>..KNBY\"K;SL<"*PNV\&JIP3B)AEAH=O1A MM=WG$9$ ?R6,[B(FT?L!\2TF?^H=S:(%4%#YJ"#"81T%*U0N?4DU.(_Z3*%$ MB].T2I/6<=I99S/M-H'/!+X0?B8"FQHEFT_"B[*P.!+7BWAWJVV VR@2E$GP MYE*:II^JQY)O\H(=H] 59C]A>,*L%@0+ZC=;\.L6>WY!Y]_3\R\.\T3/9X?W M-QU>8]9?FK"+(]%@VW3SCE0X&#_-OE27Q_7 TY%^PLNB%RT\"]M*X\@!?;B8 M="<-HH=@(KM;4]*%Y[\D"AH?PTV([?0BIL1C?W[?RT]6_@=02P,$% @ M-4/N2 !S/-ZQ 0 0 !D !X;"]W;W)K&UL MC5/+;MLP$/P5@A\0RA1B)X8L('91M(<"00[MF996$A$^5)*RTK\O'[(B&T+1 MB\A=S@_)]&&\F<#TU+;&^ MU9$D!:%9MB62<87+(N9>35GHP0FNX-4@.TC)S)\C"#T>\ 9?$V^\[5Q(D+(@ M,Z_F$I3E6B$#S0&_;/:G/" BX">'T2[V*'@_:_T>@N_U 6?! @BH7%!@?KG M"80(0K[P[TGSLV0@+O=7]:^Q6^_^S"RP\W0<0K(]^,C6$\KI2]E'2W+<@E"-U@C@E#(V8S(XA7 M7RU!;TLQ6F[C%/*WZN,4\WQDABY.58-HX M<195>E NN9^S\U"_T' S=_FC'_8TFY\R9=&S%GXPTW)ET5D[?^_QRANM'7AS MV<,C1IU_CG,@H'%AN_-[DR8T!4[WU_>V$X*#8FMEG2MZ]M6 ((*55OUI[AG_\; M:\=.!R'?5 V@T0=GK3IYM=;=T?=57@.GZDYTT)HOI9"<:A/*RE>=!%JX(LY\ M@G'B<]JT7I:ZW(O,4M%KUK3P(I'J.:?RSQF8&$Y>X-T2KTU5:YOPL]2?ZXJ& M0ZL:T2()YW](L2;#7X4)P_;%H!!KJT#-(K6$N MF'*_*.^5%OQ6XB%./\:U:=TZC%^B<"K;+R!3 9D+"':-CR#7YC/5-$NE&)#J MJ/WO@J.12VMBG)'I3;G0G7[,7C-RP*E_M48KS7G4$*<)9H5OW'<19(TXDT4Y M.?R#0;CI,70&X61 UCVV(V34Q$YSGQQPD!R^!D4;4+0"A;N@: $*DX=#F'S- MB3><>,6)=CGQ?W"2#2=9<>)=3K+@Q \8XR#:@/S%1'&0E;LX"N6B;_4X.G-V MOIN/Q$WDISQ+.UK!3RJKIE7H(K29:S?2I1 :3"/XSIRX-J_''# HM=W>F[T< M+]08:-'=GH?YCN[<4Z M/DIYND\2L3VRCHH[?F*]^F;/AXY*M1T.B3@-C.YT4-;/MZL]-GC ML%GQLVR;GCT.D3AW'1W^/K"67]8QQ->#I^9PE.-!LEDEM[A=T[%>-+R/!K9? MQU_@O@8R0C3B5\,NPEI'H_AGSE_&S8_=.DY'#:QE6SFFH.KQRFK6MF,FQ?QG M2OK..0;:ZVOV;[I<)?^9"E;S]G>SDT>E-HVC'=O34>X00;#U+B8+MGX.,RL$>T*PDP %*\966TO(H B^H?H3V*R< MPI-3.'+RH)S"XD%EAF>&X1/8K!SBR2&.'!R40ZQY*!"J""R8A](C*AVB(EB0 MP4!JF$B:5_D"ILICJAPF$BRILEJ7I26JB@6]T\(<>TD=JC)8U 1ZYR)XP13# M!RL#ARML(1/(<&&40U[" B[?K<"V*Y2&IP]L+UK\LL W)$ .%X3K0G9=F)2 M%_STP/ MJ0X=U3WMMFG97HY+HM:#N;F8C>2GZT7L=AO<_ -02P,$% @ -4/N2*0D M9%=6 @ [@< !D !X;"]W;W)K&ULC97;CILP M$(9?!?$ BVW.$4':;%6U%Y56>]%>.XD3T *FMI-LW[X^$-:FKL(-V.:?_YL1 M,%/=*'OG#2$B^.B[@6_#1HAQ$T7\T) >\R\S^[$A';]L0AO>#M_;<"'40U54T MQQW;G@R\I4/ R&D;/L/-#B9*HA4_6W+CUCI0R>\I?5>;[\=M"%0.I",'H2RP MO%W)"^DZY23)OR?33Z8*M-=W]Z^Z7)G^'G/R0KM?[5$T,EL0!D=RPI=.O-'; M-S+5D"K# ^VXO@:'"Q>TOX>$08\_S+T=]/UFGB3E%.8/0%, F@/B7"=N0#K- M+UC@NF+T%O 1JY<'-U+.E(ET#F1N7&]U]>;T6L<@JZ*K,G(T.Z-!6@-G123= MO0CD(G;("H]!_M@@7N08:X-X,BC<' <#,9I,:PJ$BN(Q)EE@$@=3>C%&DQI, M6J;)8TRZP*0V!@(O)K4P,2PMU7\QV0*3.1CHQ606!N9)ON+EY@M,[F"0%Y/; MF#A!Z8IRB@6G<#BQEU-8W\ *1+E E XB\2)*JQ14Q@"LX$"P_.> 0TJ]I$ED MJDE74/[YLZ%#R?P4:%%@DJ7K*D)+%G)8N9^%+!:2&:WXW."R%T"G&4!_,YA$ MTQ>G:EI3U+(?0*ENO6Z>WJI#V:SJ4W7L_O)2GP]EVQV>7]?-Z5R5ST.CPWXML\RN#^7N MN'S8#+]].3]LZO=VOSM67\Z+YOUP*,__;JM]?;E?BN7TP]?=ZUO;_[!^V*RO M[9YWA^K8[.KCXER]W"]_$7>%D[UD4/RUJRY-]'W1FW^LZV_]P1_/]\NL]U#M MJZ>V[Z+L/CZJHMKO^YZZR/^$3G_$[!O&WZ?>?QN&V]E_+)NJJ/=_[Y[;M\YM MMEP\5R_E^[[]6E]^K\(83-_A4[UOAO\73^]-6Q^F)LO%H?P^?NZ.P^=E_(MU MH1G=0(8&\MI YK,-5&B@K@V$'D8Z.AO&]6O9E@^;RGVUQU\G/?2== MSXMN,,UP.)RN\=>/!R6SS?JC[PAHMJ-&!HV@- 74R*MFW7D@C4AD1 X=J-"! M@D&.HY%18P:-]"K+,DI6S,A8.PK94<".)NV,&CMHS,]#:!1"@Q"&#*&C$$); MDS06@P(9$,B2@4P42"IM],_#6!3&@C".##-J_*!QJX23YE 0!X+D9! 7S[_A MKA)>Q9K)D9D5I:<*BAP]59R(-X/1*0 [%BJ:)2+&IUZ)A#B8GP( 5-.8$#$;N]6")V&:;U[&&\(,%0"BF@%% MS$?KID$C8YX)*1TI*V9DO"%,/@G(I^FL2,8I7LJP,M2 F%624!JS3-JB *B]'G,H(G M'PKC2@)<&1I70116B5?>I83"()( 1(8&41 )$99^1I[G8D;&&\(HD@!%AD:1 MC).UN3W1C([?%&%H*0 M0T-+?1):"D-+ 6@99O,E_L_62&$N*< E0W,IB*;= MD; )=UYULZ,$P#$T<(+H$QLDA9&C '(,F1IMD2BG1 4KXLU@*BE )>-I,[%( M>C(Y+U@1;P9S2P%N6;K8@41TM8,5\68PV10@FZ57MXK)IKQV*$0:D!*"V=R>AX MKYE;F9&7=3$CXPW=%.H !RV=[^@XB9-.Y?3E7\SI>$N8JQIPU=%YD39@"0E< MT9@<\3+>$&:K!D1T=/:DX_VK7_5)R(]_"1#5&*(:0-0Q"W<4B;$X+;*520F% M*:H!11U-41U35'6WF*1SB3&J 48=C5$-JG3BYG8V#9Z7\?5CC%$#,$KORK9! M-$ZN6B7SC#0:/ M >#):? $T3B3N4FH4QF,&@-0D]/YFHDK8LZXG-X>SLAX0QA(!@ IIX%D\I0+ MBQ/Q9C"R#$!6CI 54FLD,I2H8$7\>!M32CXRUA!%J 0/I*W=HXHS,FHQ]6%#,RWA FI06DI&N\6QM# M4$F+-VB3(5[&&\*TM("6GDZR+,CGE!>,(5[&&\)4M8"JGF:=!>F<$/2S]&)& MQANZ>>0+X(MW[I.AN!(HI,CHXF0QI^,M84Y;P&E/8]'&^VJ1>Y,T>DQ@"PCL MZ3S-QBFA[!)^F;(V,%\MH**G,[ @"E5'L:*W^L6,C'\,CQGK &,]S=@@ND;" MR)^>Q/,RWA FK .$]31A75PT5!UC4A[=.$Q.!\CIF9<0XN11:6UO*BKKZ$V= M4_E:_5F>7W?'9O%8MVU]&-[W>:GKMNIZZ_8LR\5;53Y?#_;52]M_==WW\_AZ MTGC0UJ?I;:OK*U\/_P%02P,$% @ -4/N2,N.[?V4 0 < , !D !X M;"]W;W)K&ULA5/;3L0@$/T5P@=(+U[BIMO$U1A] M,#$^Z#/;3ELB,!7H5O]>H-NZN]G$ES(SG'/F#-!B1/-I.P!'OI74=DT[Y_H5 M8[;J0'%[@3UHO].@4=SYU+3,]@9X'4E*LBQ)KIGB0M.RB+574Q8X."DTO!IB M!Z6X^=F Q'%-4SH7WD3;N5!@9<$67BT4:"M0$P/-FMZEJTT>$!'P+F"T!S$) MWK>(GR%YKMUYN+MTY>$FB'AEXKW9F,;II^JNS&]O"[8+ M0D>8S83)(B9=$,RKGVV1';?89 ?T[']Z?N(PC_0\TB^3Y*S#8\RI1W9P) I, M&V_>D@H'[:;9E^KRN.ZR>*1_\++H>0LOW+1"6[)%YR\FWDF#Z,";2"ZN*.G\ M\U\2"8T+X8V/S?0BIL1A/[_OY2&ULC97+;J,P&(5?Q>(! MBC&W$!&DTE'568Q4=3&S=A('4&W,V$[HO/WX0HB+D))-?.'\YSL0_%..7'S* MEA %OACMY2YHE1JV82@/+6%8/O&!]/K*B0N&E5Z*)I2#(/AHBQ@-$819R'#7 M!U5I]]Y%5?*SHEU/W@609\:P^%<3RL==$ 77C8^N:979"*LRG.N.'2.]['@/ M!#GM@N=H6T?02*SB=T=&Z0&L,#I]+^ M@L-9*LZN)0%@^,N-76_'T5V)DZELO0!-!6@N0"ZX ]F8/[#"52GX".2 S9\7 M;;5<&!/M#'0V:9?V[MWNI4H@*L.+,?JFJ9T&64TT*T+MOHI WQ$U\LH3&-\W MB*\&OU64 V/B1;A6P\ M2%*D]QG%@E'XC'R547B,+$%Q_L#SBN""8WK$#;19!4T:]R+G:8+0\L"%WOEF M1#2VC4EPX.=>N8,\[\ZM\AG9_G"35^6 &_(+BZ;K)=ASI;N,;3 GSA710>"3 M?@M;W':K>=/1O4?4$L#!!0 ( #5#[D@ZI(]Y ML $ -L# 9 >&PO=V]R:W-H965T5 #2/>G55I0ZTK=83-HH$T@"8Y)FFZQH$PF M51EZK[HJU6@YD_"JD1F%H/K?$;B:#DF67!IOK.NM;^"JQ NO80*D84HB#>TA M>E M)Z[G%_7GL%J7_D0-/"G^AS6V=V'3!#70TI';-S6]P+R$P@O6BIOP1?5HK!(7 M2H($_8@CDV&7[1U<>Q&G MC%PV$\JP^M@]5WF:E_CLA:XPQX@A 9,M".S4[UJ0:XLC6=')U_3-3<)-H&_F MA,5U0ADM(J8(F%U&LNWWKWWR&Y_\RF=[UR=?^6QVI-BE-SYXM?L"=!O?2EH)# M:_WTFYOK>/EB8=5P>4K+>Z[^ U!+ P04 " U0^Y(\&?I'QP" !3!@ M&0 'AL+W=O=\QX'OD M6)I,5;6+2J-9M&N2D-@:,"Z0>/KVY>)X;,MJL@D<_)__.]AP4O9"OJN:4@T^ M.&O5-JBU[C9AJ XUY40]B8ZVYLE)2$ZT">4Y5)VDY.B2. LQA&G(2=,&5>G6 M7F55BHMF34M?)5 7SHG\NZ-,]-L !;>%M^9<:[L05F4XYAT;3EO5B!9(>MH& MSVBS0]!*G.)70WLUF0-;_%Z(=QO\.&X#:&N@C!ZTM2!FN-(7RIAU,N0_@^DG MTR9.YS?W;VZ[IOP]4?1%L-_-4=>F6AB (SV1"]-OHO].ASTDUO @F'*_X'!1 M6O!;2@ X^?!CT[JQ]T]R.*2M)^ A 8\)V!?N0:[,KT23JI2B!ZHC]N.AC9%+ M:V*<@:E-N=#MWJ]>JQAF97BU1C/-SFNPTZ!1$1KW502>(W9XDA[#Z+Y!M*@Q M<@;18)#/:VP]Q&M2I\%%G*'B/B=><.(9IUCE>$WB.3%,\P=>2++@)%,.@JN< M9,))$<[2!_:3+CCIC(-6.>F4@W.$'O@^V8*3S3AXE9--.%^B%$8HN0_*%Z!\ M!HI60?D4E&3F3#\ *A:@8@:*5T'%!)28 Y<]\.807%X_.",EJZ1!])_#'4XN M/:?R['J; @=Q:;6_W>/JV#^?L6L:G_*J[,B9_B3RW+0*[(4VK<=UG9,0FII" MX),YE;7I\&/ Z$G;:6;FTO<\'VC1W5KX^#]2_0-02P,$% @ -4/N2'-! MVTX2 @ 008 !D !X;"]W;W)K&ULE95-CYLP M$(;_BL6]BPT!0D20-EM5[:'2:@_MV4DF :V-J>V$[;^O/P@+B%6VE]ACWGF? ML6Q/BD[(5U4!:/3&6:.V0:5UNPE#=:B 4_4@6FC,EY.0G&H3RG.H6@GTZ)(X M"R.,TY#3N@G*PJT]R[(0%\WJ!IXE4A?.J?R[ R:Z;4""V\)+?:ZT70C+(ASR MCC6'1M6B01).V^"1;'8$6XE3_*JA4Z,YLL7OA7BUP8_C-L"V!F!PT-:"FN$* M3\"8=3+D/[WI.],FCN!%/N%QTN2@M^2PD0IV]^K!LW=OY+%O=IRPE1GQ -"9$OW(-(T:4Z2 M_#XFF6&2"29?Q"0C#+Z/2&>(=(R(\"(B_3]$-D-D$P191&0CQ!=S).DG+L]Z MQEE/.-$B9SWBQ'FROD_)9Y1\0HD7*?GXZ$F-0GNA3:-Q/>8DA 93 M!WXPM[ R_7P(&)RTG69F+GV'\X$6[:UA#_\:Y3]02P,$% @ -4/N2(]( M_0 8! :A( !D !X;"]W;W)K&ULC9C;DMLH M$$!_1>4/B*!; C3E<55&6ZGLPU:E\K#[K+'QI2()KR2/LW^_Z&(/39B8>1A= MW'! @D.+]=5T/_JCUD/RLZG;_GEU'(;S4YKVVZ-NJOZ3.>O6_K(W75,-]K([ MI/VYT]5N*M34*3 FTJ8ZM:O->KKWK=NLS66H3ZW^UB7]I6FJ[K\779OK\XJO M;C>^GP['8;R1;M;IO=SNU.BV/YDVZ?3^>?69/Y6HQI IXN^3OO;.>3(V_M68 M'^/%G[OG%1O;H&N]'<8J*GMXTZ6NZ[$F2_YWJ?2=.19TSV^U?YFZ:YO_6O6Z M-/4_I]UPM*UEJV2G]]6E'KZ;ZU>]]"$?*]R:NI_^)]M+/YCF5F25--7/^7AJ MI^-U_B5G2[%P 5@*P+T %[\M@$L!?"^033V=6S;UZX]JJ#;KSER3_ER-;YL_ MV?!NK,36G-C.]-/E]+CFNV^;#/)U^C961&)>YAB88O@](K6U!Q% $2_@%(<0 MH'0C,(* 7B=P*H]+)P1EM',KYA@Q=X)E!9?%8U#F@3("DD'0')-/,844.8_H M4.YQ'#\ M%Q%P@LK"*.ZB $1+-\3G(@B"XN"$U-D MJA!%Q!,$7Q5 5)&%5;$$+:N@7>]%Q+ 7Q5 5!%>;\LEZ+;@2BNF"%F +PL@ ML@@ON26XLK!#'57$R !?%D#3B.#$*H'(@JNBB!@8X,L":"(1G%@EN++@S(Y! M%2%V\'T!U!?!J56"ZXM"2C?N8Y3O"Z"^",ZM$EQ?9#GD,9WR?0$THPC.K!)< M7X!BJH@9[;XP@.84P8E5 A$&*L4CTC'P?0$TL0BNP26XOLC KHP1";-O"Z2) M17 -+I$D%BP3*F)0H&\+I(E%V!;H)A;_*5P72W"*LBB5(+/WB M$OUU,74^X1O='::MC3[9FDL[S)_)][OW[9//,&X!>/=?^%,Y;X*\5[-9GZN# M_JOJ#J>V3U[-,)AFVEO8&S-HVT#VR;[BHZYV]XM:[X?Q5-KS;MX*F2\&<[[M M[-RWES;_ U!+ P04 " U0^Y('J:3V6D" #_!P &0 'AL+W=OQ%MP\^J[T;V M(A)Y'@8J_JQ9SR^K%*;7A=?N<%1F(6N;;/;;=0,;9W4T>=+4B3'=O3^>4;F_: 3< M[Z7]3;9GJ?AP=4F3 M@7ZXL1OM>'%?*C"YQ1W0Y(!F!^02=R";YA>J:-L(?DGDB9K#@X]:+DP0'3G1 MN4EKVMV[U?>V*(HF>S>! LW::9#5P%F1Z>A1! H1:^2Y%R"_'2!?Y)C; /F4 M(PYS'!W$:+;G'K!J0,.C')JCY,7N7^,_^5 L'Q\(""A*&D235=.[PD6=Z#^>>X)V0+_*6^; M$SVP'U0)'01#[%+>=EV=F[X7G&;M*TG;PPI&X4HKY MGS,0-IR\T'MLO+9U(_6&GV?^6%>V%#K1L@YQJ$[>4W@\AX&6&,7/%@8QF2,= M_L+8FUY\+T]>H#, @4)J"ZR&&SP#(=I)D7_?33^8NG Z?[A_-:^KXE^P@&=& M?K6E;%3:P$,E5/A*Y"L;OL']'?;:L&!$F$]47(5D]%'B(8K?[=AV9ASLDS2X MERT71/>":"P(8Q/<@DS,+UCB/.-L0*+'^L<+CTK.M8ER1BJ;,$OS]G;WEN_V M2>;?M)&C.5M-9#3AJ/"5^R(BK9=O9PFWIGQ[3Y@N)G0UAW7(;@;9 M30WB8!'B:C[Q1>QGD+UC$"U"7,UV'1+/(+%CL%N$N)K].B2901+'('8AG858 M3;@SHNTF6:>D,TKJ4))%2OK?E,.,S:27N'Q]VQ2SY%IC5\R/.LQS7\P+QN.X$N3*H&8WI+Q9@$ ME2+8J#/8J#X^+@A44D\3->>VL]F%9/VC48__%OE?4$L#!!0 ( #5#[DA? M/$%E/ , ,D- 9 >&PO=V]R:W-H965TX%='I(RMF>2=#KMH3.9'-HSL66;"2 7Y#C]]P6$'595QVH.X>'5 M?KO(?):69]6^=@5TVW6ART/MY%4;T_M>JE.NBH;^=0&W:FNB_;W@ZS4>;6 Q>7& M<[D_Z.%&M%Y&UW';LI9-5ZHF:.5NM;B'NP?D0\@8\:.4YVYV'@S%ORCU.EQ\ MVZX6\5"#K.1&#RF*_O F'V55#9EZ\J\IZ0=S&#@_OV3_,K;;E_]2=/)153_+ MK3[TU<:+8"MWQ:G2S^K\54X]9$/"C:JZ\7^P.75:U97#7A[=#DCYST-?6C9=C]^;N MVSIEL(S>AD0DYL'$X!CS$1'UV9T(I(@'G U/X^1V@L2J,1D3)%.-2&ML#,3$ MY&-,PN(L2V]S4HN3$D[BY)@8, ],A!Z4S*)DA)(Z*28F,T\+80J:FDI"YM.4K0<@?N!N/\!<$#[]V'( 8@?NML,4Y$^Q MW0!$#MPM!R!VR',$#ZFB;0 D3;%DAL(=RV0&J+F"4>7Q&T;8'$%L)M"Z2VP-!K MKFQ=(-&%<.L"Y[K )&?"9ZYL72#1A7#K HDN( ^9QT\(VKY X@OA]@7.?8$0 M9ZG'CPC:TD B#>&6QA0D3%,LM'N*9DOM6K;[<4?1!1MU:K194U_O7GYU6M*"AA V2=O9M]]\4,;G<-#8[KCO=+9?MTZZLBG91G\IC_Y_GNJF*KM]L7I;MJ2F+[7A0=5A" MEM&R*O;'^68][OO2;-;U:W?8'\LOS:Q]K:JB^>^A/-3O]W,S_]CQ=?^RZX8= MR\UZ>3ENNZ_*8[NOC[.F?+Z??S)W#WDV%!E+_+TOW]O@_6QH_&-=?QLV_MS> MS[.A#>6A?.J&*HK^Y:W\7!X.0TU]\K_G2G]D#@>&[S]J_WWL;M_\QZ(M/]>' M?_;;;M>W-IO/MN5S\7KHOM;O?Y3G/KBAPJ?ZT(Y_9T^O;5=7'X?,9U7Q?7K= M'\?7]^D_4\=N'@#G ^!R $P-GX+&9OY6=,5FW=3OL_94#%^>N>N+-T,E?!'A6815(WQ:1"XB^88,?8SHDQ[YA@]_H@]\DCGXCA[]AX]_H MX]]0 !"A@94:6*8!Z!K81 WLU?4 TP!N7! P#4P6,SFTD@/+.+ Z!S;D M@'*("9(<6,:!U3FPB1Q8R8%E'%B= QMR8/-@VG4[2')@&0=6Y\ F"D"(Z)@+H( M+E$$)T5P3 3413@7.D]Y(E8.G.3 ,0Z#X,+5 Q,QWW%2 \BOAZEX" X%NW$R@7^B/ M!($8"*2#0(D@D 2!& BD@T A"! ! DD0B(% .@C$%A#BI@=>@N 9"*2#X!-! M\!($ST @'03/+AAR Q%++UZ"X!D(I(/@$T'P$@3/0" =!!].#]!DWL9$21$\ M$\'K(GA,[)#4P#,-O*Z!#S4 2WX509R7)'A&@M=)\*DW&*_N,#(._(U;C"$' MB,;G,5'2!,],\+H)/C2!3,Q%D)*:"UU7PH0I@LO RYO;-4\E"SECP.@OG M0C0!1%=]6@;/$E1E\S(^,M'.GNK78S<]-'#9>WDLXQ.,SR+\*+Y9GXJ7\J^B M>=D?V]ECW75U-3[,\%S77=DW(UOTI^6N++:7C4/YW UOA_.UF1ZEF#:Z^O3Q M9,CE\93-_U!+ P04 " U0^Y(I=JMH<4" !^"@ &0 'AL+W=OZDJ<5=OT M_'D(Y+GKV/!GPUMQ68<07A=^-(>C&A>BNHIN?KNFX[UL1!\,?+\.'^%A0^+1 MQ%C\;/A%SL;!F/R+$*_CY-MN'<9C#KSE6S6&8/KQQI]XVXZ1-/GW%/2#.3K. MQ]?H7TRY.OT7)OF3:'\U.W74V<9AL.-[=F[5#W'YRJ<:LC'@5K32_ ?;LU2B MN[J$0[;/IS?-BWQ0PN?D=R.1 ;@[$)FY!)LW/3+&Z&L0ED"KOZ5F=%445O8R!DL[$VQ-C S2+2T;T(@A$;,G-/X^1^@,3) M,3$!DBG'$N?86XBUR6V.-"GH@D13AY,B#O5RK W8#U:N3HEW:@&%.A2***F70N?5)%F:+S@#$+N7,$:DS$N:C*:"\E6Y /3/;0<$ MROT@F-5$8B!)L0!%7!1!J,*/(K@FL@#DJ@,@>2C]\C 937<(4KKD#H$K$( 4 MHO0K!"")(*MDP 52^ZN*Q* 5(+Z50+F,@%%0I<< M"N+*!$$R0?TR,1G1JXB[H&C6'W1\.)@V2 9;<>Z5;01NJ[=6ZY&8_N+#O*Y. M[,"_L^'0]#)X$4IW*:9!V0NAN$XC7NFS>=3-X&W2\KT:AX4>#[8]LA,E3M=N M[]9RUG\!4$L#!!0 ( #5#[DA&PO=V]R:W-H M965T];I-R6-,8)TW^/9I^,DV@W[^Y?[7+U>D? MJ&0OO/E5'U6ELX5A<&0G>FG4&Q^^L7$-Q!B6O)'V&907J7A["PF#EGZXMNYL M.[@W*1S#U@/P&("G .P2=R";YA>J:)$+/@2RIV;ST%;+A3'1SH'.3=JA7;V; MO18DBW-P-48SS=YIL-6@20&T^RH"SQ%[[(5O8'3?(%KD&%F#:,PQF>?8.8C3 MQ%83IYAD]S&;!68SPZ2K&* M)X9PE1/[G"1#^('M31:<9,9!JYS$XZ00X_0^)EU@TAD&KV)2#Q,3],CN9 M, M-L-$JYC,PZ 4DBB^ST%P>?#@C+19)8VB<8,BXN_C_U'_G'$T0Y%U%/)0),79 M0ZO"2Q2>H>)U%/8/*S'_]P(%O"+6,G&VM5H&);]TRE6K:7:Z#Y[M=0 ^Y47> MTS/[0<6Y[F1PX$J74EM%3YPKIA.!3_J<5?K&F@8-.RG3371?N!KN!HKWMRMI MNA>+OU!+ P04 " U0^Y(ZE:M$=(" "I# &0 'AL+W=O+VKJ".,XBQI2M6%9Z+E'7A;L(NNJI8\\ M$)>F(?SWEM;LN@DAO$T\5<>3[":BLHB&=?NJH:VH6!MP>MB$][#>8M9)M.)' M1:]B=!]TS3\S]M(-ONTW8=SU0&NZDUT)HBZO]('6=5=)D7_U1=^9W<+Q_:WZ M%[U=U?XS$?2!U3^KO3RI;N,PV-,#N=3RB5V_TGX/:5=PQVJA/X/=14C6W):$ M04/>S+5J]?5JOEG&_3+_ NP7X+ 3>,&I-O\3"0I"\ZN@3B3[L>#M9+SKHBJ M'*C>A![JW9O9US*+\R)Z[0I9FJW1H-; H(A4=2\";<061\L7)=^C$D=3#K&0.S%&$VJ M-1-VDCF(S$* %Y'-0^0.(K<0Z$7D\Q!+![&T$(D7L9R'6#F(E858>!&K>0B( M78?%%B3U0GK1=,I?/@:+DODI,*)\FF@30!>%%BKWHW"^4\ U/EC.![_S>]'T M1^?Z'BSC@]_XO6@ZQ;4]6+Y'O^]AIO'!=3Y8UD>_]6&F]\$U/UCN1[_[86Q_ M6&1I/ 7EA@!8*8#^%.A%_9\MG_1?M%TBIL!:&4 ^C, 9V8 NAF 5@:@/P-P9@:@ MFP%H94#BSP!,_\,WZ 8!6D&0^(.@%ZW^89MH=)1L*#_J$[,(=NS22G-F'&:' M4_D]ZJ/HN[PLSN1(OQ-^K%H1/#.I#K3Z+'M@3%+517RG-GQ2[PW#H*8'V=WF MZIZ;D[092':^O1@,;R?E'U!+ P04 " U0^Y(Z?B^[WD" # " &0 M 'AL+W=O\K>^(40$;RW M3<>WX46(ZR:*^.%"6LQ7]$HZ>>=$68N%G+)SQ*^,X*,.:IL( 9!%+:Z[L"KU MV@NK2GH33=V1%Q;P6]MB]F='&MIO0Q@^%E[K\T6HA:@JHS'N6+>DXS7M D9. MV_ );G8P4Q*M^%F3GD_&@2I^3^F;FGP_;D.@:B -.0B5 LO+G3R3IE&9)/GW MD/2#J0*GXT?VKWJ[LOP]YN29-K_JH[C(:D$8',D)WQKQ2OMO9-A#JA(>:,/U M=W"X<4';1T@8M/C=7.M.7WMS)X^','\ &@+0&(!,X0:DR_R"!:Y*1ON 7['Z M\^!&RIE*(C,'LC:NIWKW9O5>93$JH[M*9&EV1H.T!HZ*2&;W(I"-V*%)> +B M^02Q4V.L$\1#C;%=8V<@1I.9&K,<)0LXB<-)+$[BY1@--#\8!*MB'I,ZF-3" MI%Z,T:1:$Z,L0_.8S,%D%B;S8C)K-W"5SV-R!Y-;F-R+R2>[ ?.(M8-86XBU M%['^/T3A( H+47@1Q00!BZ( Z3P' O=Y U-2 KRD032@%CQR\--C#2T,]&/@ M!).F8'+D_TU"+@E9).0GH>E!2U<+CC-T70!:-I#X;6 0+3X'T/4 :)E XC>! M0;2!051H4;'*U\7TXU"C28=I M"3OK1LJ# [UUPK22<75LUD](=Z@/>55>\9G\P.Q<=SS84R'[G&YQ)TH%D36! ME=S^1;Y.C).&G(0:YG+,3(,U$T&OC_>%\:6E^@M02P,$% @ -4/N2&%S MH6@7 @ 1@8 !D !X;"]W;W)K&ULC97;CILP M$(9?Q>(!%K Y1@1ILU757E1:[45[[21.0&MC:CMA^_;U@;"814IN8H_YY__& M#AZJ@8MWV1"BP >CG=P&C5+])@SEH2$,RR?>DTX_.7'!L-*A.(>R%P0?;1*C M(8RB+&2X[8*ZLFNOHJ[X1=&V(Z\"R MC6/S;$)\?G/_;K>KR]]C25XX_=,>5:.KC0)P)"=\H>J-#S_( MN(?4&!XXE?87'"Y2<79+"0##'VYL.SL.[DE>CFGK"7!,@%,"=(4[D"WS&U:X MK@0?@.RQ^?/BC98+8Z*=@:Y-VM#NWJU>ZRS)J_!JC#S-SFF@U<23(M3NJPCH M(W9PEIY$Z+X!6M2(K $::RS\&CL'<9K,:J+[B&2!2#Q$N8IPFM0=0Y;E]RGI M@I+.*6FT2DD]"GK@N+(%)?,H\2HEFU$*!(O[E'Q!R3T*7*7D,PJ"$"7I?4ZQ MX!0>!ZURBCD')5GQP*F5"T[I<9)53NGM!Y7Y ^<61\L;%WFD=)4TBMS[C)(D M^X(*9_><$7&V[4R" []TREWH:75JF<_0]HE/>5WU^$Q^87%N.PGV7.EN8QO- MB7-%="'1DWX?&]W4IX"2DS+37,^%:W,N4+R_=>WITU'_!U!+ P04 " U M0^Y(8@;[F-STI='M)4[L^LHS+A%];K)T1&,'HQ1UZ8( ))VM.GCNC)KSZ*N^%6U3<^>122O74?%WQUK^6T;P_B^\-*< MSFI82.LJG>P.3<=ZV? ^$NRXC1_APPZ206(4OQIVD[-Q- 3_ROG;,/EQV,9@ MB(&U;*\&%U3?WMD3:]O!DR;_&9U^,@?#^?CN_9M)5X?_2B5[XNWOYJ#..EH0 M1P=VI-=6O?#;=S;F@ >'>]Y*)HXY^V'O3F_O-/BG!:!8V0*,! MF@R0#=R"3)A?J:)U)?@MDA0JR&V!@Q*?G;ZQTUG,Z)DZFMM37E<7>F(_J3@UO8Q>N=*=SS2](^>*Z3! HA,^ZP/&-&G940W#0H^% M;;EVHOCE?H*8CC'U/U!+ P04 " U0^Y(F*,KPN8" N# &0 'AL M+W=OYA4]6%[3L% U"1FL2G=?S\G#F![ENJ]D-B<[SOGQ\>Q.(O^31XX5\E'VW1R MF1Z4.CYDF=P<>%O)>W'DG?YF)_JV4GK8[S-Y['FU'1>U38:$T*RMZBY=+<:Y MYWZU$"?5U!U_[A-Y:MNJ_[/FC3@O4T@O$R_U_J"&B6RUR*[KMG7+.UF++NGY M;ID^PL,:\R%DC/A9\[.TSI.A^%]50==+4F3+=]5IT:]B/,W/NUA/B3< MB$:.G\GF))5H+TO2I*T^S+'NQN/9?$/S:5EX 4X+\+H 3>$&-);YI5+5:M&+ MS+ZO: &+['U(Y,2L30R.,;>(3&:.Z0\2)I;),R+* [U.-3AS(,<:G,H1G$*CU,X'!KD%,Y^XCC,XS"' M4P0YS+Y#+(_BE!ZG=#@LR"DM#HW# /'?/^* RB!H"OH_TC]O.M@D1L(D<*Y= MW%L$Z*/004$8A3:*D#B4[P9PY,#"_ZCZO=U M)Y-7H717.3:4.R$4US60>ZV2@V[>KX.&[]1P6NCSWK2S9J#$\=*=7_\BK/X" M4$L#!!0 ( #5#[DB&PO=V]R:W-H965T S=U]!X1/5UW8\,J/E(K@O6M[O@Z/0ISNHXAOC[0C_(Z= M:"^O[-G0$2&7PR'BIX&2G4KJV@CC.(\ZTO1A7:F]IZ&NV%FT34^?AH"?NXX, M?S>T99=U".%UX[DY',6X$=55=,O;-1WM>O=]_JO$RKZ&TL9,5L= RJ&+A%1+*Z%X$V8H-&>AHGGQ=(G!X352"9>LSL M'GL-T3&YBOE20A;'\>>@U &E%BCW@G1,ID&003R+E#FDS"(57E)FDI)T%B=W M.+G%67DYN1+D, M ;'[P<46!+V0*6@^Y;_/&BQ*XJ> 0<%RWIL'=%%HH5(_"@U44LS[,X,K D@L ME-\$4Y!&03P3Y:H 4@OE=P&D"U^3JP'(+(K? V"*(%G-O"'7!)!;*+\*P'1! ML2KFH5P90&&A_#8 4P=?,,9\'LS5 EA> +\78*$8P#4#6&H OQI@H1O0=0-: M;@"_&W"A&]!U UIN +\;T'(#E#CK[: K![3D 'XYH"F'%.?]P=&5 UIR +\< M,%GX\%POH.4%\'MA"LJ]E,@8T#HZ'-0&ULA5/+;MLP$/P5@A\0ZN4X,60!<8JB/10(_R0[@Z%1P3 "X/)K&+DO1^5>O/) M[V:/$V\!.-36,U"WG. 1./=$3OCOF?-3TC>NXYG]9]BMPL83UHJ;\$7U:*P23$C#[F/U5&W3;4E.GN@" MJ?BB5%PHW5]5*E9*Z<:=V?]*9'4' G071LV@6HW2QL->JLLT/V3A#C_A53G0 M#OY0W3%IT%%9-PEA"%JE+#@GRV82UEOXDB4=6DQ>*! M]:137XZ,MUBJD)\BT7."#R:II1$"((U:W'1A69BS9UX6["QITY%G'HASVV+^ M>TE$P[J D^,V?(2;'5QIB5'\:,@@9OM MF]\S]JJ#;X=M"+0'0DDE=0FLE@MY(I3J2HK\:RSZSM2)\_VU^A=S765_CP5Y M8O1G@,0%-"<@:MR!C\S.6N"PX&P+18_WGP8V2BDS M!(KHH@LYFIW5(*.!DR)2U;T(Y")V:):^ O''!>*%Q]@4B$>/T/7868C5I$:# MDC2^P>=J@5DY&.3%6$UR#R998!('$WLQR0P#/D:D"T3J(%9>1'H?(EL@,@>1 M>!'9?8A\@<@=1.I%Y/43S !:7X#"BU1:(Z*@1^%_@>U['SHM'[L;_U19%$0J*Z\@;1L?NAT?^SO M_E&4_I,4S1[?EO"3F3$BJ-BYD_:5G4ZG.?:(S./]+B^+'I_(=\Q/32>"/9-J M!)C7_\B8),H'>%#O0ZTF[110)<58RKX:)M.;L-*J7X31?)0L9;*)]ZS3J^Q6!O+0M%?]VK.'#-H3A;>*M M/E?*3$1E$4UVQ[IEG:QY%PAVVH;/<+.#R$BLXG?-!NGU Q/\GO-W,_AYW(; MQ, :=E#&!=7-E;VPIC&>-/GOZ/23:0S]_LW[=[M='?Z>2O;"FS_U454Z6A & M1W:BET:]\>$'&_>0&(<'WDC[#0X7J7A[,PF#EGZXMNYL.[@5 D:S=0,T&J#) M +G 'RTSC(OH:AS--#NG M058#)T6DO:\BT!RQ0YYY#/!]!W@1([8.\!AC/(^Q!R)"2$SN@_(%*/=!,5@%Y?Y= MP" %\7T.!,L7"&8DN$H:10X59TF.'KAU\,MCAS,46D=!__@@(! G#YP?1$L8 MFL'P.@QY[Q;JBH$!6=Z*R,MH+1-GF[AE<."73KG4-'9UH;H4UX6/3VS M7U2ZYT7K4I]<2Y8CH4\*0?7*7+US1HV$F9;J;[PB5T-U"\O]6GJ4B6 M_P%02P,$% @ -4/N2&C'0[_\ 0 ?P4 !D !X;"]W;W)K&ULC93;CILP%$5_Q>(#!G,U1 1I,E75/E0:S4/[["0G 8V- MJ>V$Z=_7EX0!A)1YB2_LL];,%2'!CA53Z*' MSCPY"&VTWPKH*Q[ICRZ%3K>B0A-,V>(XVN\(JG.!W"X.:S)'-OA?B MW2Y^'K/#^1MG ZO[M_=Z!!,N5]TN"@M^+TD0)Q^^+'MW#CX)R2_E:T7 MQ+>">"R(?7 /XC6YU\2DQ%'Y M&)0N0.D,E*^"O";S&A*E"2:/0=D"E,U 9!6434!)F15?>''Y I//,,4J)I]@ MB@Q_Y?N0!8;,,.4JADQ?6Q(5.8X?@XH%J)B",KP**J9_!%*62807H'!R0SC( MLVL$"AW$I=/^*HR[8Z]YCMT-^Y3754_/\(O*<]LIM!?:W%-W14]":#!!\)/Y M@(WIAN."P4G;*3%SZ1N$7VC1W]O=V'/K_U!+ P04 " U0^Y(DO"\ZMT! M ;!0 &0 'AL+W=O2_D MNVH -/IDE*M=T&C=;<-0'1M@1#V)#KAY4PG)B#:AK$/522 G1V(TQ%&4A8RT M/"AREWN512[.FK8<7B529\:(_+T'*OI=$ ?7Q%M;-]HFPB(/1]ZI9;?#]M LB6P)0.&JK0,QR@1(HM4+&^&/0 MO%E:XG1_57]QW9KJ#T1!*>BO]J0;4VP4H!-4Y$SUF^B_P=!":@6/@BKW1,>S MTH)=*0%BY-.O+7=K[]]LHH'VF( ' AX)XL] MGM#Q(X-RBDC^P2&9-9$X?C(T,?/@O@J/R7P5-LIF1MER1V6V:!1.?CH&LG;#J-!1G+GV'W;,CO/^ MC.U/.\OOS3W@Q_8F4^0=J>$'D77+%3H(;4;"34,EA 938/1DCJ(Q-]484*BT MW:[-7OKA]8$6W?4J&N_#X@]02P,$% @ -4/N2'@[8W$6 @ _@8 !D M !X;"]W;W)K&ULE95-C]L@$(;_"O*]"R;^2"+' MTF:KJCU46NVA/9.$Q-:"<8'$VW]?/ARO\5K=Y!(8_,[[S"AB*#HA7U5%J09O MG#5J$U5:MVL(U;ZBG*@'T=+&?#D*R8DVH3Q!U4I*#BZ),X@1RB G=1.5A3M[ MEF4ASIK5#7V60)TY)_+OEC+1;:(XNAZ\U*=*VP-8%G#(.]2<-JH6#9#TN(D> MX_4VQE;B%+]JVJG1'MCB=T*\VN#'81,A6P-E=*^M!3'+A3Y1QJR3(?_I3=^9 M-G&\O[I_<^V:\G=$T2?!?M<'79EJ400.]$C.3+^([COM>TBMX5XPY7[!_JRT MX->4"'#RYM>Z<6OGORQ1GS:?@/L$/"1@7[@'N3*_$DW*0HH.J);8/R]>&[FT M)L89F-J4"UWW_O12YFE2P(LU"C1;K\%.$P\*:-QG$3A$;/$H/4&+SPT6DQH7 MSF#1UYB&-38>XC69TZ#/$FMB'2"2 -$/HM([T-D$T06():S MB.P^1#Y!Y %B-8O(1X@O29ZM;N L)YSEF).A6<[ROE96$\0J0,2SB-4(<6,G M,9I>,12 \"RH%]W<3/SA(L^DX"D%!Y1DGH+_O@N+XN6G.A/(D]UH\!.:#,EW8 \"J&IJ0$]F*M4F<=H M"!@]:KO-S5[Z\>P#+=KK:S,\>>4_4$L#!!0 ( #5#[D@UDI(ACP( #@) M 9 >&PO=V]R:W-H965TD*;6???A&L(PQ)W;U1P/^<[X#Z0WD5_9L\ MVY;U?]:\$==5#./;P&M].*IA(*G*9(K;U2WO M9"VZJ.?[5?P$']>0#!*C^%GSJYRUHZ'XC1!O0^?[;A6#H0;>\*T:4C!]N_!G MWC1#)DW^/2;]8 Z!\_8M^UA77;WR< M0SXDW(I&FFNT/4LEVEM('+7LW=[KSMRO]DF&Q[!P !H#T!2 ;.$69,K\PA2K MREY<(WEBP\N#CUK>#TETYDC7)DW7S-Z.7BJ"\S*Y#(DK5F)H$Z5@C=FOL+,1JL-%0A"B]C\D\3.9@2!!C-;G1Y)#F M:7:?DWN?<3 >D;W.=CC8(=3!#EXQEFX;,3#D#F&@""&S#!9@5&: MW^=0CT,=#@QRZ/SU$)JC!5];X7$*AX."G.+?EPT"_\\##B@-@D;1;>4(+<@" MU*>?'#JH+(R"\\6C0'_="U#(1R$'E8=1:(8""RB^(T#'$DC8$D:1I2! LGS) MVOFN !U;(&%;@-G_H'QC@(XSD+ SP+DUH Q3O,""H.\-T#$'$C8'.'<'2!" M2_XGZ!L$=!R"AAUB%%D#AP7&!?67,)GM;"WO#V8#E]%6G#MEM[!I=#HD/"&S M,W[(J_+$#OP'ZP]U)Z.-4'I_-5OK7@C%=27@02_P41]CID[#]VIH$MWN[<9N M.TJ<;N>4Z;!4_0502P,$% @ -4/N2"&^ZKN9 @ #@H !D !X;"]W M;W)K&ULG99-C]L@$(;_BN7[QH#Q5^18VKBJVD.E MU1[:,TE(8JUM4B";[;\O8)+8U%H[O<1 WIF'KQDFOS#^)HZ42N^CJ5NQ\H]2 MGI9!(+9'VA"Q8"?:JG_VC#=$JBX_!.+$*=D9HZ8.$ !QT)"J]8O&>.#<-X7_6M&:7E0_]Z\!K=3A*/1 4>7"SVU4-;47%6H_3_A&]MJ^[U8^T'.@-=U*[8*HSSLM:5UK3XK\VSJ],[5A MOWWU_M4L5TU_0P0M6?VKVLFCFBWPO1W=DW,M7]GE&[5KB+3#+:N%^?6V9R%9 MC3ADLEY]J)\NRIQ0C3-=O5C;X720KSX%T[&FC6G089S5T1*.^C"#1$K%'/ M'(-P#%'V-4F*IB&ALX[0. BM P?2=A/I-+'1/*$X@U$639.P0\(#$AXEX1X) MXS#$8,:2(@<4#4#1**C3P.[\GL BGG$^L<.)!YQXE!/W%@2F$8F#2 :(9!31 M::*YB-1!I -$.HI(>XCY%R!S2-F E(V2LO^Y !"XP0GZJ R,HJSHL3L _\D# M<#J 2BNR$80QAFF8#(=4J45 M/7H?W#P!T^F8*JWHD_L0])[9AO*#*3^$MV7G5G8/V6WT5N(\(_U,.^-K7?J8 MY_ONILA/Y$!_$'ZH6N%MF%1%@'G_]XQ)JB8(%NI\CZHXNW5JNI>ZF:@V[\J5 MKB/9Z5I]W4K XB]02P,$% @ -4/N2,W'O@RW>P I#0" !0 !X;"]S M:&%R9613=')I;F=S+GAM;.R]V7+C6)8@^-SX"EB:YY1D!C$(@.#B65UF"KDB MPBLCW-4N]XPI*YL'B 0E5%"$$B!=KGRJ?YBG-IMYZ4^K+YFSW@4+28^,K,5Z MS*HRY.3E7YQ\TTR'D^_>_^X>^;\A_^?OGHK.E\<4?._N T2OZQ7>;_+[][3K?-)UIS!HW M15U6")55^";?=<;I$8/_]M_ZSO&QSE?E]CZ\?7F\JS;M;Y=/^4/[,P'_A^*^ M;'9U#CMXES]VEKUZ_^G=Q^L/-YR6<*X?RKR>O"H%Q?CR44Z'ECJNW)3U.$5_.Z^JCOKW#[F&_S^0_%4 MU3N$R%7U^)1O.P-UX]7C(R#>[:Y:_A*%MP]Y733A^_VNV0&*PL^'?B;'LB\Y',\*=J P\LK^5 G6'OJH$?_EQL-N$?M]4S[+K(FVI;K,*W M3;,OZH$?W.SO-N42,++*=X/8Y][+=_!A9S_MD8*NO6._^Z7 M'Z_?A-]>_GCY[NHZO/WA^OKC[?"C=U]UYVWJ#>1-4^R:UYVO\Z:#\9?+)1*U M)JR+95%^SN\V17BV+79AM0X!:ZKG?+LL0J!&X:K:W^W6^TV8ZT]@R*ML,HOB M61J>X7Y@VZ^2Q22:Q8OSSLYOZN(I+U=A\05H9 ,8A?1N!;C2E+L.M#Y6.X#G MTCM/!_H#O[W^\[Y\PFMI?_%]5:V>RTV'$KS?/<#KZ%^$-W+9^YV">U/F=^6F MW)5%%^8&OD_Y"P$73PT0K/> HLX/V[_[M 6L0S2NB\_%=M^E0?MF5SW"MH<@ M>"EK/.<>>.D#2Q+E>:@V*Z !?Q<6<)^[EPYD 9]D8PT3JE?CT7@< Z#K M\'.^V1?AY7[W4-6XF]=A/!Y'8_Y_I@PKNHG*4K77(;RM5%NPV7^5,+-]_G&_ >:"[W5=+KLWZ@ZIZ#4M@DZ][? M'*+#9S8V440XCM'!>6#O\$R$0,!;F MPT=_(]S:8MRIOV!VKR+"[W,& 8"S[T$^O;:KU[[CGY;5%_+I>=CQG=!PC_^Z>B MSDFZ4D;:Y?-50_R[R3< R3-X?)O]"OX"5@$$NN37ALQ[%B5)9EEWF@#G'GAGE!MEZ">X8-A7()/\>\ESKYO !M ECAI:O?2F"0\HN;XE]Y;[+RA,WQ$ MY[UP(H)_<9?C9O#" *2]SEP,J4KNH!)4\NU]"9ONI3G>KOMV M<&S7ZW(+=W!DUZZ$'9:'F#T/ 653CM 9U]GTW4OO'HXB8+%>%TNBT,L>S?I- ML:Q%8^K]'L$0@8IT7VZWN#! >HAJ\] "F=#PH-O]T].&%#/@FZNR6<+#V->, MV@IQV(LU+-(]D$H.GW4 KBRMPY?S+SU7>H N_7#Y[OOKV_#M._CB_=4??WC_ MXYOK#[?A]?_X]/;C/QV@52*Z,2?YYY^*Q[NB_K\&=9PCXQQE\?! 1RVZ$;7H MBM6BX9\XRL\;UH].&LO\Q"?Z;T4L^9$4I<%35SUJVK<&D[[--T34\EWHFHLF MQW]QQF \/_K3ZR]%O2R9/O"#JYYZ1:_!@6:M#A[CQ\[[#9]@;R<-&ISR"@^W MV1C!EW'@M%&#DUX_/FVJEZ+@<:'=25W=U_GC5PX?7.9$8:)KYUP=0(6.K: U M? @/.K^[(#VD;? MF/"?/Q9?=N&W&SA0YSF_JP! <=#[.W(Y%?5-OGN O^NGBK\(SY -_-N__C]B MR?^W?_U_S\/GO"']A$=\5G_-5C@R+K4@Q.8#&Z2C\^% 8H9U9 MC)GX?S;^=2#V_GE?X?RD:8B3I>*UWEW>OKG\'X9F_D0*HV[DT[;P_;W]X#W84+;GT7NAH&! M@U"#E)XMV'H>>[IWQ?,/I+:J+1X&LRBZ7P< MQ=-Y<"KPMJL@G2ZB>3H-GMH\B<4:%HKRL-G?->6J1&^(/ZL10,B>#-)99:8\ M;1>C$(B*FO'Q[H 8/54-FD;<91"=5@4\VA5*^'<%?2G0K5N 9%$;):&BWH%8 M'JY!CJIJPL?-GA $?[W=(S]S7[AWCU75DWNQ]P MG8_%\F%;;:I[M#H"!Q\1"IGO$8,B.@63PO?HXBJK2! Z7%KZ[J7]#2J!=LOVW?\)MBDQ-9\:[V#L%- MCQFHWCW9DF R'TKH?;&<@-JY?[Q20_D$+%^?1._M9OYK6[>.?S@U<.!'P&7 M-R\P@2+ 5UY'Z%Y'UG,=?]>$SP_59O-R43VC0\S0Q1*/Y- @A(K++F^KS9Z9 MZ(?_(W]\^L,;OKIG4&O"_#'?W,/_(#O:;U>RKVW^6'A3=%\V[/9=]9G$ M>/P5N[6OJ;W9[DI_W3X_.E>]1G\TH@F_O571@$ 9N6;:R%IV:6=L.4896!ED M#LHE<&J&)PZI"]9B5#*+X*AH_T6D8"_G$YJA>:8=[@\M>##H"=\Y#5B2#U/, M/M2HVH$[5*'&L MRV)%(0WF)R!%?KHZ=Q:T%.QS!9]$(4X$!/JQ:)K\7H&RA&O-[U1*6.^W2U84 MR]U+%%:?^6[*.B3-&0UB-W4%I+C:P+?PZ4TD[V@KI,2[)"+@<(35?HFH#"!L MJLTJ+$I2$E?P*)<[>&9$()A#H RP+=![5^^V<.P(S]U@J =N?%7N'YE.Y$!K MPKM]4V[A-"A! ^ERH$KRC0/9+CP1/H#T->"9R&M,>^'3ZSV0;8#73^5J!9=U MG3> 2I=KDNEP'019@0:5 O9^_=/U)5/*RZ;,0;U>PMTL::H?T=*ELX\ZRAZ@ M*P[%>)Q+2]=N*L#(/N_QX>''1?$D.#8%7%Q3$/&&3U;T#L2"1'Y*^(#MI0\Y MZ/1W1;'%1P$7Q0P0:7.](L[^#/<;WK-39(.<9UD\D3W=(=\UH&?YM&&+XU$Q MFE!GI^+_I]'M*%PAXL*[ +D19@?ZA)2%W!G/J)F+K:A8C<)OBV4.I()864%J M^ZH 3'F$LRD]?R0.V<^'2O(Q%4"G &[[)WHEI-.@*VLG#(@A8>;KA9LRPB<. MJ-D62WR)Q&C*[>=J\QEI"GR_%S-FLRN11L(*SP\E4"$+]\=\A<,0D$L #?ID M_V6_NL=E1G"UNSUYVIK]!E9]!.[\&=D02> [NF,S]>BON724.7VQ:#G"D ME:58[P5]MF@!Q*GW-8-/B<,HR,\#=/\04MT 6-"82!=UZMG%URC"A(T3\L0K MI!V[@WSR(&]#26MI5*&2S* HXPR2A_QT8=]R&"-$ T#&A<<'=^C+P'XL;'H T,9\*I7WL2E8ES:M1- MWT?7\1#.]+>HN: @?%6M:'5C;;B\O2(VO)AG%]-QAG8=8YGHV0N,'0%H^]9K M"#=I&7A&9F]-Z$1F ?W?(F4%Y9)LS@6R>7DD.6R*.6\."!?^0HDZXKC,]I7@?_]J__*[@YY>PC M&OJF[^#\U7=%P8):[]%YS)4]>M^Y+NEMP7WMD(SFCPB,/L6>A6CA?.$CO%24 M!P"K^>#.KCTQG(7)2&7N"#]: YUG]X85?TGZJT&O PB/PI\1/=PI#5%O+]S2 M*#%<=*GP%_4=L<.*XW!X_:GP9,8&H';(AQ^+W4,E^ F(NT*[[U/!4F)U]R\L M2-HK._O3[?OK6O)@R\%5R%!Q89G\+.@I1SE M'%E%YYBJN%MX@AJPW_7MNMH6B$6/%1N!>P_1-^$(Y&Z\4/7;(-E\ M8J&B,7J@8N'($#JX L4D7AFG/P1B8YTHB9(@RA"BV%VR201EJ3I']8JHI?F] M4B-82S52JZ6A&K:WO$4-(/KMW;[Q%">-U:M-HJ>X]H M<+&:C='O*EKUL(\F_);,*61CO+S]EC@'<)#P=G^WJP#4(;"0BX2X2 _S@(__ M[_ G>L&'@ MAD]O/KN2BX&)&(J;:GM_@;34AR=IK7Q1B#X *#5/D(9M;!7-2P/RJ!H2Y"V$ MC]-/E?E*I MA I6 (I+D*(&VX3OW?VZ>[Q=7A6GA.)C."O$CTE9;VZ0)O$ MB\=<_740=S_>7(O=%$7-$G]\1R%T2FEZ?W5]>X._&C%9MA#!#E9%K12-BR!WW5E+ M?WY?%\*FX-VO2P\&6^>I6_+,].9SBD[R4U&[?L&DHE$HD;J.M"\QM=92ZA@V18WKL2\.2& J?45" M>,O'.U#."4OAJ\_%!G;08IA6U09<>7K 6S=R7G'QF)>^K76_%5$*4TI8+X6G M+'PHW#^MZ$)HY--]G:]4+FP!#=X+[.K%F#M#NCK5BM5R2" UMHW&0:;=,6N 8B0K! MSL[5>++Q@)28-][>% IF;P .#+I"O8'C$K\E-+YRXA(]Y3)?5704Y+"S>*Y> M?C,6&2M[Q]V/B7G:U\X63M5\9G_'=YCFE+ANHF, 6#%,4-T&2K?[RG2$ ]H MW89/2#6J?0/(8V;CR442P,1;UXE(OL==[V*]&K9<260<7>W#D_3*0:QJ]L, M=WQP%YM2*;-]/@33!A"R]7CD[=1(\$!#JO30&)!;;2\* M"3EJQ)?DB:,]]@I%. 0S_IV!>)>-$?\X<48N]BE_,=' WC(J.-)JCQ28AS>P M&\ #W35Q#9%)B-'F6_F.&"(>%["YV"A&RX<9Z]\**,=JUS$XB>9W%ROTP>#S1X^*W =:JO'K;SNVZSU3=T=0(+?+=!1\8H/TM4H(;'4[Q6/ OG2DLXBHOX%;I4^% M)CG.L3@!Y![S7QPG ;,?Y\#RC#E0F*#QJ!8OI%M&##G%N!Z)]5YH05WL*AL$ MT0KX);?!OA M_4YX*$F6L)EEU0 /]A("RD9]D$RQ+$KY)%6YFKY9B_GPZ-#A@Q)ZXUD!\3[W MR&9 NE^1SOCQN6(,M]\9?=)^]R,&=&,Z(7IL:HP#(.2[?<"[I*@)3I)EJ:AV MMH)9$Z!A+F$SZR)XOUXC55GO:\ YO+/OD#WS&C\7=\00/CZ X"R?>>E5;ZS? M_G4XE'AE::!*J@AADAK)ALE4AH:3/9WLE'C1&(A3@/;&%(5_9&UJ=GXXZ[9X M=@($MBO/FEEL'Y"S&$YA/#7V%^@8Y%V2$&6V)O*><20LR9 (C).P]\5*5@!> MD$;+Y@&-T?E.[4WE8Q&R(&5BN?D<1IF23%?D"R.0AM26L7GQ>[#\*/ MJE#(B6LBZ^S7@F4O$!_,G;J/3L9O5R2R=/<%J$6;B 8?EW%C.]=F=V&EI9;M MJ8>FK@LEN89.@1*5O]359N-HP:H6^4=UEH]4@5+6*)Q9C \;,CHCHT7P((<" M_.I)JV9FQ*[--M]U1ETN/S%*/@GDHBN?8DH0(D(_R<+-+I\ MN)3&JKA#ONXE 2$DPU>!U-$(X*_).)K.8YAN13]@KHB*:C"-DV@V70339![% M<1K\C+KM1;5>XT3VB$UPED['40I[.@_.LMDD&L_PSY,W**E'LC6I^1'83;J/ MVM!/N=4C143N7DP0)#]Q&T J48:N_80<\<7V?L1 QO9S*Y";-59P]<_6+A"ZZ]$ MA\A@>Q^DQF,QC^XIVP[:4:!I*%>:AO+1IJ&\[@2RV> XF[/F)CZ(#2']"!KF=C=D8=<1D)N4*9OZ%%-6C($4$0T%M/JSOYW^=9$,M&87E9+\.ZR?800"*N$EJ7UV'H!6 M;A5,"5VRAW$8""OU]WAE^%L<@_,8@QZ;1(IO;'?C2 MZC2.TFP:F$U@5<@"TQU '2"=U T V>F7?L*#57>-4TJ=8RYE88[)=!)310 9 MQ3X;.3.++4)4]:Z!NJP]PQ7(7FB\_9,:;VUPR%M;#*9'!#/#G)HQ+&KS2U]2 M48$>R=GY\$C1NLA(C:8,760XHR'9Q@,;B9&JKYH-TZ.NDZ#_&(Y?)+RKJE\T MS.<2B22[6-8<\6,4"TYPH6R)$K5+-HT:0RTE-9G%'1<#[!JEO7DROHA9U+.W M\9,S#)T?UAJ$^W#F:KB%U.:_4W MV?N-"%E)@&"SQH;/3550+(Q0DM4X&=+2" W7]95WJI?LT M:." W\E,1/N(71B V9.CA+&%\B\-1RVU1%;-B1H=,B&?(R*]E,4&T\/JSZZF MXFR'' :8& H+R(%H?@ ^P($RB@0M'%CTX=/PN=1U@]*J"6 T;Q .8S?:M%B M6R],MD.B6J)1Z24RW$;07^K-O)"_&6DWMLXQ!JLM3,(+09S0U6#' M?-]HR'3B]511&C@UAW[R^NJY\,14U .:1X<4[MSTT<98XY4B6>V5!%UT+GVMG$OJ:$ON9@)_=U\WL7P!): M?JY0_:<7Z#,W7!6-=#*;\#I?4S(3F41E R^FF>Y.)8[/-T"H5[_&K] _[@:0 M[;R8XD_;#?IB;"(=NF;1,D_H:_TY3"*>RBU)\.K2<0)K. P<<[0YMM5!?*6: MD;-#D&M (55ZK+Y!2^_I#MWDM9ZL6042'$AJN#D.V*,P,>1(31LA\/4\L%H MZEH27M3O>M \-E,_C%V93&).R)&&'ZJ6Z"W?"C]3$\1H8"/", MIUWBS/Y@A1?!*!+:PK$#VZ+0>AFJ#U.I@[Q MJPL0]9]8D473O<14(L'1>@/,S#BY5?D9O6&IK@&G(>,T6@*_/)E(,RSE09^3 M-1]_ +*OI9$SS5F=X:T=MGXH68<80Y0P= :(E"&R)A(?A3L-K)- 4 M!%&K1P/"!_/VDH3I'%CRSF7.@*J2>,/>6(N! #)XU:+][-0R)I$1^@(;C+=9 MN>=4)4VWI#15G,]4)@$K_?)C4"&4CH9G"K+Q[_MI)2>Z8^('F2. !.TTX6P@ MUL&H0H0ZQ3;?,.$7A,+9!BKI-RIUWP_6459#.ZQ>B6&?WP,1?%EB8 >KBJY. MS[)1MZ4RUL@XSW0BO4^F_"L)7U^+T90<-<:$%YZT;T.N.H'YOB)$(M8*J(=? M0!$+)[[N$&$WI)H%DR09:V!UN_HB"2C=6KP:MU-37H*X#)XXI8%REAHA1BLZ MK]%,ZZR')P]DD-5HGMQ" %@N "1>,K(MI?X ;[UPI^-=4<+.S2UEJ)EP\*4A MY"*'F6C#4<@ @9\HL&GF.Y2O@ (A73!G]R0@MTJ4>/]4*E#EAH6W M3,TC(*=8D?_+L#M7S8WLIEIK= FZ^[,[KZV#RS]YN M!6*TA-UOY/F5^3>.9PSF<1+%TT5PUHH\1@]".D^B;#X^M]>!0H?>D7\S M9XYHX^TULK(0+[W?ECO_5LZ%?6"$%.,#U4> %2]T-52[C(2$I)R5-R!2_9^S M>]WS=]L:%.2ELP35)DS7!:,[1YK!(R&,)U>HNGV M'.6VHT.;-.*S\1#_&93^[JZNQ@\AMWG9MEB%.*:]N,2^ MH$3=-_$='(WC#/6]UU.):,=)+Z2G ULH:[$U;3E=4?/'U[6IV$%V1Z[ PQ4, MZ!'Z:7-B@B60LZ#;>R5.N%#74V-5 JTGXQ3OPIA6+#^-)GQX.X0B8D9AU&<]URSSAB2X.2DJRK+C=TGU&X*>[1-:I19+:BNF1DY8Y$2R,HB60G M2B\ZJ?,-O1C6KDQ).W\7CD::.^X/)!8C2HBF]%"Q:*WM?9+IP\^1\7\M5M$[ MYORYX1G^*(Y*4YBR?.8*TKI>U&/0[/B&<$(G;\_LCZV'*.B2"(@61K+Y&]B* M44XK1*C[#;=-/)J+M;3,&SEE+0BALS7*J4@!Y:\>B\QVA2,3V/S X4%PG$T' MHN9D V5U@=XI2(2V^9EK'1NBA6Z;-*#L@R3$NB=9#.H#.9&H8M5PJ)^Y'YS4 M?>4D]XCO2>,B+ '$J5]-HS1=1+-X%IQ=O7D'_YR-)]%B,F,'W:LD&L_3:#$= M\]?\SUF6:.W@4EBE.3ZGU6REAHF)&7>IG%_LJ&H7YZ6%;4VAJEM\\%F7OXRZ@-H\*CI>>.'YC7=>86?W9 &/-FK+$HG<329QQVXM,6'"QR88 MIR!0BZ-I!D"=S#I0Z_EQ',W2-$H6X_/(*4:Q>0$9THI]ZVJ/Y?2 7VK>" =Y M4A?! ]*0B_$FK90+@A$'<+$%.05)A3M/[8_<5\4OM.C+$7.7$O.73[D=HD"# MA028R&[/7V7L($WWAJBH)EEGV'/O[._ B^<@![+7BV/B;"VO9*VW)S/@K>6&?.4/R&;X[OCY>(-)1# FTZ2F?' M?1&A!(0%A8UKR\21-^P"C[,HM-MC2?>'8D4%,*5,%0[B^@ORC\%2,VIOZ=^^ M[TL1LP&E%,,TCX:E>_&LF-3(KN9\V^>PE2A#^(\;_6(I+4<=#.T'443.:EN M(//E W)$ Z4TK9QD.TYMVHI+&47EB@N0WJ$(+J([*7Z>FM!T?*;V4RIN%],PAZMVJ[^@/L?9*ETEPJ2?0[GL,]-\DW"X MWXX"?D676V_VZ%LU04M^^,0H_)X )?:HPGH'Z;K63*0Y:(7)M0-RZ^-A>G+: MI@<*17"-)%'?^\-9CP-*BSI=N618DU9ND2A(]GC_D^Z+DI$"I=*Q #17B8SA M=E:M3&NJKF,V@]GD5BL,*5QUYP;"N.P^/&N*@O.:%ZCT.62_-X"/8/@!D--A M?Q'&E D#?<=IO^I]<>!AI[LU;.F\117*%=T>9:[VNKV=5]JZ8RN7\VTK;3[. M\#"C'AC>\CP ^="KLUA7VVJOR:'!6RY'@6UFHA K6FFM^,O;3_3IQ7@1F9J, MWZ&-ZV?\=D[XVN GR3(A9^QDB%P[WM.L'1J MR8,"8OMPZ[S?UZA!R(_>%;MSU?66(&MC5!US\?M]N1+=6%[&LRE]HM4EB8%1 M6(WD""ACEO#"DHOZZT8K9MKWXB;,;3TIMQ3\QP/(NI032SYP(9M5#J1*IDC@OP:^,LR?-\4!&/_[20K<6NL-U2/+F MAW'DXC'J\,2+?TL1@&Q@NW%L&._=J'\,?BN7Z+C >D*_^G[KXA[^P[Y(5T[A M*$1;/(U5%]>BXN8@<$:1'"CRE']OUL)C/K0ITPU'$B,>)6N((JHI%V+)%LUU M?P([&VH%>85K M3:OP&RW<@BN]W6(U,!;+CB&)ZYFV%0'\WA7H%:%$J5QK=U*&EPD0)ZN,EZNU M=-O4_A> ;W+R.WT'ZF?U?'&[!$P,W[J5(KC\(=([U/2OOSR!4,IUWCC:%$:M MOHX(2XI*;E/TM\2RO=N).DX\Z,I!-D MW3O0>C?%BLI!N76$[Z34!1M 2<-4SQ-MBDHZJL.K6S"8O& F_]INTA2\IH@T M4^G;[9?BP&!$DBAQMLT+0:]E475#<0A;] +S=O 9OR%V)Y$9S)3)U@&F/&G> M.+:VRHLF="'!6?N&UNYL5+6[EE>$+]\Z'JP*HQ#=^F _%UX+ 2V1?2*J_C:T M]1_WV^(H<4VCH<0F)\D&]WK%L:\_&C- OSHU3$_);ZJ151)):XT*[8!ACD#+ M=TZ>%I!9\7=,X4A:%@L+B6(<=U,=FE>3!IH8@+H&3?[S%B M0%RJ'/S-P84"&O9(2N!Y!T1.30TY.NG.'%_5"EBS>9:TFAMO:HR4'<9DBMT8 M^HX@LI>?4JB*/Q9!'%,ZPRLIA-HRR.,4\RB:;3 M>;<.%@X'+36=I?17$HT7LV :);/I0%VL()FF,# -DG06Q9-9D&31/)MVJE\% M\6(SP/8.Q9GZ< H&4^PV23 "J PCH,9 M#/-@A-$P<0 0GR?S((-[2JE"2S2#FYHM9@RC%+8WQ4M.9NBHZO0W-?5Q;IS, M3\U]_]&:T7[M[XXC^20X>:[+$]-4>YR")L^9N_0Y47WLGL,@=Z %KX.^5.?. MNF@GHOQ>P)?)> : 17!G8\#J=&%*!U K'BHP"[<..)7,$\#X"5Q.;,9\SEFO M#J;Q+,KFBV Z!T2;9L%'K*L=631&+)@'WENZ! M19#BPX7'E$YA!S-$A3A:P*_C\9Q0)!UG&#K5OIL/0LIN: 7! MTYK,XO/COEL"\C_N 6PI SCS\8O*L-O2&EO;#1&/_5-^3R*;Q82NU01C-N)T M @QB/.K^@&-[6@C *$N&4TUB!Z4"M\F>^T*M2NZU9[:6>IX)3M']QRXZVVY M(?#<8F55NK!)'XAL]<&U=4OA%3:*_7)-@87P;33,EP"9X)D@>+$.* X MS$B,=!S,!QO*1O#5$_E<,8@)8*2X>\LU:1^*%DEE@79@P+Q-9:P,N)5IV M1&7B\KOJ<]'JDU);*U>[-UW+[^W%G>8[XR;VZG#B."15HEW8;#Q3/AYS?7MD M\2O>/A75/O3=<48V#=SQ00=)3G@YHB(3W54$;C\"L7$Q0^Z)GK,J:T'ZJM:.F&1NVK1$9 R$Y6DW% M1DB1*BT5S[S$W_?JBIKT\8%A-H]Q7XB%J+CA]9_8Y-X-2R#D6H$&7V'"@FGV MQ"9;F<_V.'%ZA&/U#:02RP?M,L,Q;/(9/@4A:*?NBB>_*]#YW6*,?^#F-9(U M]ALM@3X%D1MX@=*62:$V.>Y"7P=@;QVRKUF1!7T42#R94MT^@=R/ 7;O@3D@ M"LXE5!$7X$92E(/XN9":4Y+8O"5C8-UHQDA#\["IQ5IT@#IKI2>-**IGET:6[1OB>LS>\FJ02$^QD=R!QW!J1 ]MXA^[/D5)O M2>Y@"LOF1$UB<[V#%M(D*&&SJCO.NL=OVOTCF&860Q2S0P))CUC6I>UB4(1^*P>+9;"] M-P,2O%.#?XU;C;R8))23Q)_!>@DD2\/3M,N0[9_^YZ7W MG4M8'GK,OY2/^\=NDE5' -OO'JJ:BS,S8-UBEV)OI!IYDAZB;-J[!D;G0=P* M9O,I4J*1]WSVC3B%_V;=*X9[K5 S5(2(M,T1)S9:K:D&HGU/[$3\C^_)=J/WC&".5*-4AX-9_ M67?V9#B$0V:N#BP,0O#2+>![FD MWMU2^2_J9+!K*KWL7T0T7)#3%*_>]9W$HT9M-$;2U#=2 M&D1CW.P:A3*OD)=7T"FWJ:E6_$2Q7#MBE*8 H3$B#>[3>RS]]3O(ND-"L$8] M8W0Q!ISM*&6=$V&I=,'*Q)*Z-/4/N%)-4E0+8OHS*594MG->_U+45:M(BF*9 MB9VV.4_8_T>JOGGN6EAX77 #$*F33 T5-EB&RKBB7 I"#D337:U :"/JH4H0W#1#1.*( 4^G@LN;R_E6!3+D'8\<;&4'<@OZ%]E MZ83<+15*44:%WSM,6A4_6A0?EB:4:P<,.9\UDXK?Q$A!=:'BJ!H_< %'-B*Y M7DU%7"3'+_T\,!TWK.:(A9,\O)$H)KUGZ29@=^[22;9U\J,9 !1-(AR?13$M M8W"AB?Q6K&KZF%2KQL!)Y7Y?):,T"RCE;3+"L%0_?ZUW&V[%3J%Q*U\&I"AZ MV:C?:L/4)1)O6X@VO()+#7.E8??/ML?;=^Y^Z.=/03R:3G^/_SO^?7#=E3&" M13*:S'\?9+-1-G=&X.:#=#0+7NK&_/>-QQ0"F!'^[Z-W @I[!H@\YDX4$+ZU M7J6^]6YI3,\-M9^XJ1GYE;?\.GBG2!C\K!=YR1<9J-I\K4:MFUI$2*X-$KQW MVR:V/ N3()V-HRR;!*\6H\DX^)ZQ$%2R230=CX-74[0XZM2KX"Q-H\DLQ6XD M\7GP*I[@C[Y3UA!^$UZA1(E6\>!LDD6+.0Y]%8]'*<[RA&%:,$>TB&?X.2UY M:'M9,,%:T?,8YLA&B;._>!(M<']PQ8FS/ZU$/;"EZ31* 5AZ?EH/K,[FBRB M69K15K/1-#VXIRGL"?W#L#@HKHN%KJ[U35N#DW0:S189#)Z.9K.#@[,@@9FS M"5Q&/!O-Q@1CH&KT%>:FIM/ QSQZ_4C@T;Y+S925>Q A(KTG@/7GBV! .7WF M^EM(O$:M)['C9LOT)J3\$86*$R;;*/-6F1"_1V?G7;BH?*FVZ][/]%(-@K_= M[N#1-.6RYQ/">??: BKTS#?\$KYQ)L13R;= -R=QD)'B3&ACPXS(X)J,#4(! M8LXN+ALPO^R!N1D*OB@7[$M/QL3&N,'Y*Z,9S+C M(IK"XY2!]._)/'%63E(9.(_FXXP'SD;S<0#OLW,8-N1/S( 60*R#@4<"X:39T70!=Y\M7\0*'3Z91YFXZR71FV$@RY:$) MG0]HGO[8@F.F[]A^^2JAF=-Q"QP+=A($V-,IF=,7 Y0#OU+"T!D&1&^"1 ^I M;Q0#K Q52*,I_).<<<;M4^H;$%.-BO+H%%[99]PJK4(R4_NW!X1YC(*SC]VZ M39)1G#ANDUY.V%/GASU9)HNI+4RQ0]O:RX1[JL6,_-]8-\'_V!*_'67L^NR9 MZ[=389>/!@!6MBNW%_ K:L'R8GXI]A7.3W;H=M\IG_,FV):;WJI&,4;L9.?N MRNUKXYVO:E>(8'*)-#*%KK +,:+B2S(=E+2.?JZR9ICGKY:-F/RU'NS MT\4<.-7\_%>R$W8F;R]D4X)PQO=W&IOIE9C"ML1$PL0%\H;0]@8(WMG%#09U MI*9XD5+X%\@1LQZI":7PX$\T27 VC^'99BQT9(ZT!()0%DVF"_QFBJ3[A)4S M#&0#\,[P)WWR$&D"9N4T2H'2T?R+J;MR!FQC/L%O@%\M3EEY&L0S$-Q@=CQ= M%ESV/(*(S3*") "BQ6P>X-LCE/=J(WKV"*F.90J)&,MFQY:$QR(&UZ+]$@%P#7F\+RG-[6U!PQJ<=@=E#S7MM3NT MRP4S4="DT'8O@JR M>0(8B &]TRR+4GA_TM6I^=\JH.D_( *(U^P+U! C]/$XC7^? (T^IM-8KG. MZ9BHCF,J#(U1Y9)B,J\H(NS$XZFOHKF[2F$$]O ;(;I*AJIL@""AH0$3- MB:'_JJ;@_W>U8?Y4=%V9[EPGQ"\'5\^\.0RW$:&:+Z5S"4=VX'XVN/#T^")* MC-D=>J-HAP[1X)-)(:-6!HIVAWYC7OWU[0W'_.:4/W-/K26 4N94J/T,7PZE MX!!>UR_GCE-I"=,8_-\_P7,(IK^7Q4' 0*+&,[%E]E $0K[SVB_XCA3*H $L M!NT>RQNKO8HGLF4][S@8C8(,:OW<\9#+ KS1U,QCK8?F:/106]OGY;SR6">& M=]/."PSP!;5VEM@ 7Z3JL_FYG=T_C 6T31'$VSIQ#P%H7%EJ3"%G5CZ?1Y,) MUE*SQA '8.VU13W"$!H#07\[/C=*YBX[ZIB3^WW__HQL'.=2;\NZ,#5;@YD7 MY@2WB"DW]A/RU?2(:;F(9$"EYM,H&:/,Q5Z#VQI!$(CA7Q><&C)8^]@+$:=O[MZ^RT].'P0V).3HY'8T"&D;JI5HKBB MDWS'D)WYV$657*U?P6%)(+NDT7PZ.35<2\/P.1IBJ5DI\K./55UAY!W3$M/& M4LG(Q]O_DZF(Z:A-X?9EKEA#\@:EWE+A//?#4>B!;QLBB%SP>+"9'(!-2PBR M;I,5OH8X-3?/C-<(Q(;O+M"<0^7ST&0DP?=>;&N[/NL:]<]I-$Y3[UV*C"V1 MZ<[V,XZY=S8]'=YTS*:V(YM.49VB34]&BYGLV>!\^ K39J9S\IATVO*V\0XV MUWX^SX6W)S2X^;1\:%_)"+5FJD4XFF7=?N6$][='9L^OS,A8C*L2/:]\5Y!TUTP'/D%Q_PD-;' M@TSXS>VG&QOA99- N<2@ACLF7(82;H%B57HJ.H=G^ U"!LLTW7ZBUX8S_GD/ M8OM&XF 'Q6+FJ"='<;G]X_I)-KW4%UK0;8WG%N^#75I/GZ6G!!%2D# WY4%3 MVZQ6:9/Q,=0K,YSZZ*Y;0D7E^S7Q9_DYYWX>3= M0.74V(PTB)C?#DZ1;[=8%:#A9B@RE;OY[SJ%-W%ZIPZO9T]5&ZHA!P=YCQLJ MH,&.D9:^X:".IC^J8R#R[*!4-T8LV9 M:*F?3H'ST-VY,IJ_L0CAQ"ZO!$T5<6!_X" 8I[-QX&60QE&9GS[].IL(3'#69MC'&?<_XCB1@9U!KY0NGJ&425IH>]K?#Z!^ZF=<= MTVE(&J#5<4,BN_^S"5I&5/(^(R,(9$"?"74ZBY))2JZHA;5DTF4GY'*:C8.K M:HLOD,RUJC,>=AC'BT6T&&.68Y)-D%J7)A$G2K[6'VCO^=S&&QN@+Y_@$1UD:S7U7AN]4H*=$S'+ MK4 2M,YO-#$\UE,)M%TAGZ#8;LKGO\_M]7U@-&UQZ@:OF*'8A #TL^&3:KP M-4CJPKI?GI$IW[S:IJPQ1[^XKOX33PXA!#'PP(Z M7AIZN:$A+#[1:8(6G7G76K"'WF1T)/3U3EOD)E9RHXX3M+3.R$863]'Z=&SV MC%S@TP5%Q$P'J(Y./D%_4,S^H#@].O2)0D-S]I)BVZ#QD/?'<]\G'EM M)FW3Q=.[+9[66;'5\D %(3\8O81Y&E5C2@SJJ]$J56W%I?W%!*;]IVBZ>.LV MM]!2>;WVA6[?PPY8(ZEY8PJH%=M\R56/.1/9-&"B'G'23.\K/4 ?L4D@^B3H M.A02Z L"'7RVX) 8^ >6B>&PCRNN#Z\P;<$P2"8S&I9,$_JOK7B33/@3+)F! M_Z42%\&4_R'_^39'@G>WHTHR-%A$1W@=*VZ;PU$,_032]" +TF@LRZ11,N6Y M^EOA!),%+S%9\ ^NN,@,JJ+(5J5)7*?=-8:&4B '_7;*I[[41C,[+6/PXAA^ M2MLX)C@#B3-F;\]Y<#872)\3/6LWZG23H^]>G,ZT0*&2:#*>Z#3).$KB1/[U M#I,Y>M!,>0W^[\<'IXI\MWDLOUV;:9SZN56H:%6>[E5PME"(XC_B*)/;.4>7-]V>+FX;:I?Y)CA+#01G>B5( MCAV,,XBED&A+A<.D@5O))WQUJZY.Q4IZ-H]ZDP5 MKW.OO@CI!D>ESRMV9RQG@T\%H]( M9"6\J"2[ >DIH"=&6@E\C2>(PFQ13K#M?7@_!FAOY9AXRIX^MD&"46?\#"4Z MZZU%-3?[@F2Y-OJ;+&KSR+B-2U_'7(-V<-9_87%:&(:3*'!*UQL[9?,@R=-( MZHQ!I^?=8FU+-.[YW96H'F/N=%)JM:VVW33[2N4CA=912^W75_ M :W]-[I^(]^DD=I"=&;/$='8&B^-0**D=+0L>R7B<#'2G8&TR%"<>D#P* M99-G2CU/[)/EALF=!VG*XH(X"E+A!@BF9/@Z&J]W(,PJ$7-%N1WJJ3L*K^R8 MMM0UU(?W-&6O%>7&]IROX&'?VA9'-DD9WI:0)5 =IBF5=N,_E.QY +'DM'6$ ML_Z6L.<=*NI-YW5$_\H);TVC7$NJ?\R?I ,LLR%BB5C1E8L,H]@#?&TZI\0! M_':;P[BZLLVDJ:3,NC5,4$YS9/+4RD+:J#;&X;;R MYF+Z+@5@Z?'?%]5]G3\]E$M4RE6^,[I,A:O68]@!.;QM;)[Y5 MB-$:_\3G;9+-PSND9;H9JW2-YPSQ4;L,HTN;7URH(9P MG>2*"H_D]) Y9 !4L&KNT8.C.3G'GOV["EN%7<(>03$$K)ZQN!*C7C4C!K%( MD^#ZI^M++/"8+:)L$L-?&0CSZ3P&=EGFX4V^1+TRF"X6Y*:/L9I=-)_,X<4! M^'3V8 9+3\>38 )R[ )M!>@H'<_C*,W0GD.Z04J!]\R%#]1&XT;'V^KO9/)78<-BE^'JRB\'J/O0"BD&! )'A- M0*0>">[! 1>Y@5Z;XF^J[?W%AH+(5; 1KPPOV=@&JI'3#-!J:N9G5HTSGZ A M@%$.<5+XO_I/NC1/^1T?2N=)")2_F @PB*EUXJ,^;,FDKIMH$:(KD6>V,\ M=]L[CL(?JFY4$E<$0B)9NR?UX\)*_30A78_VOV-UKC:-^%R=@T_M!E-4 M:Z=, SMFG)$7JV);:07_H2YWS RP?,>_2^\UK)&')JQCO=<&_7F^9GK*-D?8 M\(L#GM4KM:IHZ]Q";RUH4M4V)6N@X9G/U2)X$VR#UF[O;$R7FA-LMB&X-U8^ M]SJ0ZPX#QT_KU.AOV,Y@M&L? %1)Z,_["B'OQJ4V?LZXWP-W93UR#:>3/[KK M(<;#.7ZD;LE&1)J0RQ0PJB8]A8.G,.Q)IK $4KB M)>:TI1M%A?)&53 MX-=:M-!2-WXK'ZEVPLD@2;THF4,_RU6I4,H$Y ,WQLVTZ=80IC31Q:HN.#U8!)_4101ZQ*K$ M8"=S^4,@L(Q!'JA?7Y@"S9WV7,3@PW<]GZ(T7M2&I--'O)^MT]0K/),NK%2L MF=MWUUR87'BBO*-SMN:%UB6& < QJT]#JLT'UTXD@Y5+@P&#[F3SM M\\@XA3M;+QTMP ]+E[CW[YQ6-M*\O+V%ME]2UDWHBQ161QG >6 .U73C)XWF MDUO]MJU3LOKJY=*Z,L&01\]@A]LYWG4@<&L]?&PD_E!ALX-A/*]!:6!'JD// M>VVL:NETAA%\FN!#(1Y:F L8!U:1C[%A=LH5Y?7O^-2ELJ]::IZ!VIMP#PC] M.T8!UN>HCF[=ISJ]ETJ63A]Q=@([AC8C[[D^ #]X3Q@YY7)I=-91GT]7SN)( M63/!V60631?J]NA=T?TQ,>Y.Q$P@DYPRA7,CWSG*I82DJX,)LQ M"YF*,1W1P#:SX6!Y;YN]N@UZ2,IFN6\<<69(,FFD>#?5H.X()K*F>:.#FZY, MQ:F>7;:?NHO M;DUW$@EW&MW+/:Y(,;6%[^6?)AC;)K*9NH!7VNIB>1Y\9_,]$/HVG2*A/K^# M=X%Z*>KZ+;BKGBQ@)WBLR#RC,49F]I3@KQV*Q:J3[^1&S'CM(.F.ED+?L,H= M^6][;XDEV%=HUE5DG"PR_QXT?& DL7C^79QDBW@UG6 ;HQG'2B(U#WDN;6)C MXKW=*HP=L!TV;;?#AZ2+D;1"IOC8SB>\"_[<;_\2?-K6WK_Y5P$Y0E\%TI/E M59#%\RBCCE#3\3B: _^GRBSR_60QC9(T"[+9G()IJ7J,^6X6S1>S()N/HWB. M51&D5D\RGD63;&;^"\+%9$HY7QAD.4O&%.]-O7.FTV@QG[4IZH]411\;%CH9 M/2<-.H%0QT'_+Z^H&Y61_#^ MS;'2R/7-K49(>#YT-^] BZF\PJB-Z2*.L@66KIA$$ZS\13;FL_%HBN&+&IJR M!5JPV9/SE<\_T QTG!/+'O@"8L_[[G3 M+66]/N:;^_S1NBCR+6O,MFT4N_ (X0^"Y%Q2 T4S)W2]W-^#?LS- <:2=*OY M2?F2:V^7VN_1V?EWF%_U \+DY(T?VYL/W^Y6ORON:BN*C><'-HL.1+*"72@* M^#UNMBL3 .?8"FR[VDXSFIY>WJ>\E-X6X*[QW$1:V\ZV9;?Z.I[3>=NWVA'V MJEK9YN^8=7UY>T49DXMY=C$=9U2N7?O3]>P%QO96>]]Q0Q!MY1L-=&FGFL+ MTD Q;JBP %7DY'>4^QF.6A7=-.6E^($E2Z-\D>N"YE^77]C0J@9H5L*X*P,U M)A6&RN%O+)'TM@^C(F).UIQI^\H31'MC O%H7U#T1";LTDC'-RRD[64(< MO9[32O<[O:I;T0H;]L2[9>T0.\@KT6U%;:*6@3R5*ZR9+:7G"3\!<5=8[O^I MH*@+QVMKKNP,>UV?NP%Q@*Q&N.XL.0IM$G1KR8,OA3IJH^G$FBCX69A0/KFQ MWH[;FJIJXHYY=8UQ.A1TQ;&V>DR:4BD#NNS7UT]W[(:TZW[S\15I7;ZE M.T+!3"ZV'T\+W:Z.6&L*KH'4V:OJY;N7)W$S.I4/!2>==D8?[!4H)O'*./TA M$)L I9(HB2F88G@DU;U+]B?<&_9CUJ_]=N[ M?;E976!*%1>7\OD5DS=)Q\GU'<-93+]#1''S#I\+3C1Q;((][*.1+B3(.+ / M.'$.K%-_N[_;50#J$%C(14)Z>>\U2RWHD"@RS-F 1XP'F$-WQZ\]F57 Q,Q%"DB"%2H3UXJE$"+@K1 M9_/B-(>O;/O@L'EI,&=)3/W:=MMU%#VZ'!A10^Y=6@O:?'9+I8!A+E%BOB\N MJO6%5#"C*$,B(8QB1"$O^NER/ZE4PH./<[/1!\^ELMS(NQ(19;,Q2>L7;F<9;U))IB([KA WW":7M3?[=/?(7<601$;<_HO2 M]2_8F.4R5W\=Q-V/-]>(NLQ^N+/7'3H9#:7I_=7U+16$&C%9MAXAH-EQ$/BWRS15"5.MJ\;4< 7#GFFIJE2#XN+.>0L]UWD MFTJ[\1"&G(S D?_>+61-D0.#CLYO,8*U!#S8P:KL1S#M5[3+@]J]1OCN,1G0 M@<'6>>J.YX3HS6>JN^J%J=@=V/AR/QE#*W=(9AQMUI_6D#&_T09=)CTG^:EH M9K]L084=A;?2#[?\W+C;6F_%5$*3EZSZLK1.4B)P_W3RH3; M[9_NT8TL8%$"@Z[BH/LV MS8& U:)G0QJ7HDQ&5Z#SU@Y?,FJ!U2#A!3!V=J[&DXT'I,2\\?:F4#![$S][ MCWI*Y:JD)]>5FP!^@HXZ^%M73Z56-FB7LWW O+'(H[EFEOLQ\6&G(Q0Q2X:Z M$:Y$5J_8:,^J_=2*V&7#S666PE%;D8G"DU>.K[*O?DJK"G;72<@%&"(CB4O1 M#:T_O@O:JJ8&HZ("X*57M" E3ML9*_F8TG%Z'BD8(@_%QZ(>?M MQ0ZU9OO/TW+MMJ^'3K>!&:?<>))MC^E#$8X"QN'O#"3%;$PE';FWJD9!B?NF MO8S*H+2:&ZC1CP=.?7&_=R)&W?1UV!.,I(J'?L7A:?_4CCR53OJ0B@!>T8(H(]J?T/2 M5WQ-JUB-(Q-R4A>[*C+A^AA-LJ'@9BZ#1H=TPFL[U2M\PDEHUM>>%O1AZJZF M%NTE2<=^BCQVRC,@Z."!J87 F,9/^F2F._SKUZ']SJL,MJ, @%'X!FT?F+,@ MQD#R7D@7.0?%?1*O7%9IB'V)0 0 ^<,-=[3V_ M,ZJR_8[\PNA?PXQC[&7,F'S[@(A!M5[8C\T"7^UL!6NU@?*\A,VL"W5.K_?U MEIO(?8?B J_QLQ!NGK,1)9OO^W[X.AZKY.)FP(L]S MB6\3<$$$E(:38X*LN8B V+NM !U7@Q,:QZWOSH^QH\6SA3<597!LOL7V(9?8 M"::>ZO*ROZA-D,(J=&-!1"HV'IDEF5M!)I , B-_.J4KVJUU649T^KX=8ZS$,THCE<>6W/73:V3/PH_+;@-'N'W-V!YEU\ MUHHP)$5)H+66SUR339XNPP.IILC#&*X^L7%+TF/2)$^T>7'Z:^H1]%H'#XS9 M$0))MQZH 27A%-8L;*.OO@X7ZZ]HGA-P?_#'@XZKG4'<=C:5 S.L2<83#PAY M'\GBF&;CBPF)=V]M?172+MY*R'R(S%2=6N+ DF\X-$O^T7I_;DV\6AQ]]8O6 M?D#6<-]](F0G$4]@)QR^"'^X!E_'9%DEUW7QCQCIN( M!A^JQNF[*&!W887*EK6OA]2O38"1(9\C[.5<5YN-8W=01=0_JK-\I"JKLG^1 M/L3<0VD8)$P@>+:49]Q&-Q-Q^<%Z[H@EFCH4^/C>5/N['>[=##\!DW_EU*_# MGBC05K-$:>*9N_4RB$CH9.J0'+D9Q;UIHIHPC]/USX4UE+#-<%^9@<4DFE%B M:3(94P4R+;ID*[@$TSB)9M-%,,4>5G$:_(QVBXMJO>8*-'K$)CA+I^,HC2GN M),-:-;/,R>@_ND$_WS^;S*)XAF%9NDF7?!BJ+_AS&(JH@&DJ!1,36_QUG5,) M3])&QUFDO.4.&0'/#_EF,;?$%.TE1PDGK&]'7YF^? MA5/,[;I'O:$N&_:-=?,]=PY6\AJLF+6=KKEQ]-AZ@,;X(0&%@%&47KL35Y"3 M!86_J8L'C/S^7! 585>?YYDDE^@.E.]MVU'D5 5S4Z6QN=T.)9D#Y1S;V$A: M<0]2"SKX<,346M;S]6LF\VI^X>RUK]Q&[TH.PMENY3R=V K%UBOJD3<_-X3_ M.KRG5:TYTX21B/' [*[J!C-PK?!KM_2:'%JJ4[K1:_+J352/208LM) 6EVT[ M]^Q:?:)2C16RI;_.RXDRD/>;+ME\UMF>>#)K7A+#0F-B2HBSH[M1?T(VVYV- M$!IU5 1F+AN3C;[V%'XSDR:V;@D4+\8"% ][?2OBY2D M-;NHYN1-9#T7XUW0+E*2^FSG 6CE5E&70#E[>&>#(V.&]%\HWHR!HJDHH+XW M*\Q+<0YUG,E/2C424K5^1A2;I,H.0D0F+EM4[5A=UH)N[7WHY.P3_8H"/@?K M>!T2O_O%ZUD* C/F&TP7F#@9?&H0L]JI?!K:?2GVCP:+6TI<"KSI]O S['Y- M\>YIM,CF=@>^_#S%.C_8%H\WT7[8']&UBDFU)ZE"=O1KL00XL4H[_=+UM+DV M!^,_53^N2]G<,CJC\#UBLMC_(V=F,0B)O:3K "EKSQ#9%25M$N%@JN,I$N7Q M:7H$R]Y41VG3IQ4:HC[UPOE0$WL(A$*4O6QB4_MJ55#=-G9&^A4^G<(9;'_L M2S60[.:.:VL@8]-Z\\*[JOI%X]PP$U@<@VL.>3/:EZ9R.RT]7-^ GU'K5@>( M2(:=)^.+F 78_LQ0=-FY!3QS=SXG HFB9MC*N>>1FOYU9(>&$,LX(I[5'<;C M::QY4^UKCHV ZT"28^-IK?".1 R(Y9E3$J)=.&"@#D$3QDRS=%)SK'.GSX^_ M#C>'>-YZ1^%*<4?.>[;?=K9:541GD&(Y6IQ#@I[@M*HIG+,>Y90O8&S&:+(= M\*BU_T-(?NA#3//K345#\95V:J/LT:." 7[D9K>PN#,"46@Z,L+[97Q<,.!Y824WJ6UIAV$W@V^#K9$<:V3P6'Z_FS)*P1(/;BU=8Y! MB&WYMJ>RRH%**D.GYMAG7E^=4NU:&$WSZ)!#.[G8"(4,48=-V6BL<3,H9:[$ZOZ0/4\W(V6$M?0.H:@U>?LD54J5$?C. )1WI MU&_*<5P,=X-=FSIZ5=#YY5?0ZIW7$ZF>^"EV=7.9M">0P#!9(A(#OL)?JB='*OR+_)#OFRP7L5L%! B"YAS/^XWZ8H M^(40+)* G7+QA33@.S"HH$4>P.. MOG-Y.Z"J)*ZQQ]MB(( ,7K4H3SNU]4G,C+Y :<#IG%-U/-V2TE0))=B@'Q(+ MU?-C4!F6CH9GHN;HO;222RMBXA19,VS)S*Y96B)7^JOB&X3"V=Q>?,YN3:'+ M^\'.;>I]@-4K\7;P>R""+TL,[$#*B^I9-NH:5L8:&8^B3F2[=2#E7TGZAW;N MR+E D";+G;1O0ZXZB2V^'D42VJH;V7'E^;NH0,8)HE'W5Z\[E-Q-1F#I)DG& MFI)@?\RR#DDY5QW?FX:%U90<),Z8)\XKHL3!1BC:B>["KE#(Q4@H@E!J?I@Z M,=Q4^01H')O#A\V2HS(;.HM?;^:@<-B$R71L(NSA;['/7>?UEDJZF_40F($, MLHK:DUL#!,MU@R!/MD/>^DJV7KC3\:XH$>_FEC)/36Z&;:0K\J&)VQV%IL*+ MWA_-3,T4@#(BO3)G[ZW]@JMJ[1>1J#N],FULR=)K .[F:+2,^J/0K>MR3[&T MXC75?$RM'6.='R?/[E!C/]">$AO8 >/FP>]J(K$O,EKS2M]N!6*TA-UOY 4! M\&\X>=&K954VIDJQ$@#3&;+=LEKXWZ MVG#ZMW(N; WC\!@?J#0*K'BAJ_5HDWVM[4[3*_M^^3HX.O6E975M@IO9&6_"V@&.QM:EXL3HT":-?F#B M OZ\!YZ_?C'EV%84(NXZK4R$)%M.A=;:%.O:% PJN3#C9S(L8G44 M[A#E]T=CZS;=%BL!O;?IA*L-%@,%=JLDC[-(*RRG9B M$,"0A'S#;;I(\RR-I.[MPM'6<\>SA 1K1,46_"9RYC[)+.0GS?F_%H/S'4L? MN>%;_BB.BO2;Q+I*AFW6TK45=]QN.*&3$VSV9^NKDWB,QEMRIQC8BKU3J\^H M9Q.W37+"4KHS>::?G'*0A$;:5@Y4 (5RXT_H$&@$-),.\,#Q9%B.N@-1GY9%.L#.9&H8L4-%?V> .XK M)]E+W'H:!3,*#-F#J5]-HS1=8+.DX R;ZTVCV7@2+28S]GV^2K"G4;28COEK M_NTL"UI!M^WBXV-3/ I M"P)>=*)7&P%U)30&U?2\\4/SFIQZUJT %FJ@GD7I)(XF\[@#E[8(DUD':CT_CJ-9FD;)8GP>.85NL#+Z&RMZKJL]-G "5JN)6QQD MW*#C](!$YF*\25D/63)"#N!B"W**D?;]L2:1R'U5_$*+OJ11=RDQ#?J4VVVZ M@(.%!)@(NN052+ M J!GPP+,(\[:2NU8O<7C-6G/%#.VY>:\(^HXS9R^,N"F_Y<'?![],2V1AMM( M?-8IK65 E,**[<;]:!(B&@Y3P!YI;YQ>/0C_'Z3YC-32PT%<)$;^,5@/2XU: M_=MO-09@VXP65G\TLH$728WITAP.D&_[G.H2WPK_<2.4+,GFR)"A_2"NR5F= M_E!WZGWEJ!/**%PY.;B<6;@5MS^*ZU7M-I C]8&T6$_G:;I^?J<)H<@LD5M= MTNGM1,[?@=9#QOZ.65<#1Y5B6EPT19PN]C[)'&PNE;2*'<_AGIIA:2K'\:;( M7E;<:\PB\P"G^5,DW8$&YW,QXM'40,6I.^'$**5)]\EB3I^\)4&*O*ZP'EZYKS=2> M XN8[CL@]UICG[SI@6HV7,A-;!']4= G-/22RG-7+CW7[*M;) I2EZ+_2??V MF^+H-0()!I@4$KU$BGN[A@.5 #.;H9KR1KT,*-84!5=,6*#V M^&NZ_T48]R><^!U7 U 7EP,/.]VMX6_G+:I0KNCV* >]-S3!;='FWW&K5YNQ M@1_GG%BKH\LY0>CTJC+7U;;:FSSM$QCH\CPX.$?PUE2[GT0AEO&C3B5D'?]$ MGUZ,%U&@=?6H!^:"3M[\N5*.WRTIY- MO2],S M/4L)MF8@U02ZI^/).Y>Z;S]SAJ356Z4TKJH(;D]Y3F VQ\/V3$=?KHA"S)\< M+D8J@6GZ<.CB,=+TQ(M_2U&?;#2\<8PK[]WD$PQX+)?H*,(B:K_Z?K&K3I_P_%)&T'<@B/ M8HM'7K5N12#,C[+VZ7@(GA6[>&#-=\17J')HCK+T\@Y-(7 M$F$,HU9?1X0E4RJW%3>V) )XMQ-U/)R'%#J*BUB%I%]-I8VK\(44': M+ :(_K782Z62I?X+VPR=$FJZ!8,O:-4DX/BV==VT9*Q:26WM=#GTLGP)XSM% MT)%T@NQ\!UKTIEA1X3JW>/J=5*YARRQIK.I-HTU1'5MUXG6KI)-GSQ0FL)LT M5?XIC-!T0'!<@2X,1B2)2A]%@E[+U.O&3Q&VF#;4[8A!?D/LYR+[G.D-H -, M3>:\<8R E1<"ZD*"RUD86KNSD?3N6E[ET7SKN-8J#!UU*QG^7(C2S/6*M2_ MB:CZV]#6?]QOBZ/$-8V&DMF7!^?"Q,6+*7$'4@P ML JNW+1H]Q(9;/T,K1OJ'<;D5J#@\X)>(]"_%:M@<>V]@.MB@E/S8+*3$1= M:;_?8SB%^'HYX)\C0K7'*KE*)=F@ R*GV(PNCW>[? #I84,:@!8\ MBMCP$@%]R$49$OI :K"IFG,<./]_U2/9Y"&P2_L"6]#A1V/=_\T@_%\NL=U6 MOQQZNS>BHD;AS2:7]##[J^.0:W=27B[WC]0R?A5@;KQ?8/-=L>NIA(F]!L<3 M@-T,L7 QFT99'..1DF@ZG7>?/PX?SZ,4, /_2J+Q8A9,HV0V'2 '03)-86 : M)"D@U&06)%DT!ZBU'WT0+\;1+)L$\7P:I4F&??62A;[_)HB3,=Q%&LQGT11> M3)I&*?5FA'VF291,N5/S9+Z(I@L\2CQ)HFR:'@19]NM!-L.NEWCWL*+19)/\P2V.=\!@">19-T'$RR*,EF@R";CZ/Y D$VC^;Q/("CX%ON@"P9 M3V#6,8 .@#*.@QD,\T"&88-Q !6TH..9G!QL\6,09;"]J9XY\D, MO>G3P>IS-T[FOY9C^=&-P1AB43T$^NAD7X']#JVX;%. (^2"=I- &\SZ9XF9/@/9LPNY43@A2?$Z!X.H4=S&+N M PJ_CL?<\3P=9QCJV=>-&9"5BY6?<@<4 "W9GV(+"B^YOSA/\EZC0O]DQ*]+ M)PO_-)+.%#UP_FR3*_\IHA/E8HU^#;#;*YLX(%#J"=#0+7D"*T/^^*2GK1++) YAQ_/M3(>6V ^@ ZE(RMD^ MS3L-,8:'RO':%Y<\6UV\%=DR"=#:.,J"@KQ:C MR3CXGFN7 !4 (C$>!Z^F(_A?G7H%T@+@)9!Q;LWY*I[@C[ZKZG5!N5#?8+O( M)9I382B0J\46A[0-"1JX*(\RK.1HFSOW@2 M+7!_<$F)LS_EV0-;F@+3 22"I>#::==[L&Z\:^!":>3VH MT*8Z^'*_"N\N[^_1J@]OJ^\SO0&#C6^WH'MNFW+9\PDAJ OC@*J@\'6\A&^< M"7%_\NTK>+(Q$$20"[@OLM7'J VZ=$O&_W\U&67C(#,CV8>VD%$@@$W'.FX& MXR;\+]O3/9G*Y>E7KS)\!MF8< X_^,?]YB6,9S(CB _PDF0@_7L"O,"NG*0R M$(CY...!LQ'P8&P!W#Y,PLHE;#-)9%)X/W">*3#DK+53,QJX]7@AHV,Z?6R. MSYN-922(4O$BD:$)/DP*EN.1VNT]U<'FJU=Q.HIA$^,>^/,FYD$*(%= ;# MN&DV=%T 7>?+5Z!-PY\3D"3=32>9S@P;2:8\-*'S 8'2'UMPS/31V2]?)31S M.FZ!@[ !R!#J1R#GD*#?_\RI![>\XLXPH% 3I%!(*J,88&6>< I25D>2=/G$ MNTK[I3CN.'FGGRB5XJ]B$&&;01#MO,#7%=K20P&6+Y1MF+R:#I.(%RF)-4 V M9SU,8H*8\2>:)#B;QW#PC&ELYC 'H/M9- &5]!RY"@#LA)6Q"SJ\ Q2_IKWD M'_ WLRN#4 VX0O,OIN[*(,7.0=P^IQ>_.&7E:0!Z;+2 V?%TV:%[O):^'"25 MXM3F ^UV-4RJI3$&0B' M<,9;^IR2?2E2"&ERDB&?!H2>@:*7Q,%0[?\ ](X$7A"\YABF^GXPLQ*$8W@: M*;+$C/#F([4VI9PB 8[7,@8D[GD"5X *TS3+HG01'Q2[G#JD?Q=*>QPTZ$1J M82 7PP>*@?X:X2O\\KAYW3SER^*__^Y)"AK^[A_TF;GL4!Z<+M<2R5S^UIA! M/:\-$"_)4+9)\ &1!5S(U<2\ &5U^/]=\8<_%>%&ICO7"?'+P=4S;P[SWH0P M ]>""2R]G0@1/;P#][/!A:?'%@E/O7R]>U-G@_--D:22R>2$]]2FH2$!PEYU M^.;V$]K1@Q8U):D;%PID0!\MGB\(*K/#AKS^BX :&'(M+GO M+KY2)>PC:SUD"Z@&<7T0GZ;3V3#1@J_3%.2Q%"C7 9*5)J!!3[(@3=%HD@K) MZLE[["=@*4A^BQDJXND$)IC-#UHY/&; @.KI2W=E8BA^)5 [ @+A2FA0V4?S M)FAAML,\\>L^#,_PJ"2H35L('BN"*\\& ,4S(DZ@'V7CH[-G)+^"%(&ZYW0 MSW7R24SF<1)%@),=FWL:I/,H2Q(:WF'Y7I6C4RPFYGK@)V@*T2([7V>P.L;: M<7)*.J)\"@VK128?ST%F8W4)_H'F5E8)KCC[0UU]K9(](#O/:%@R3>B_QK8, MW_ G:.3"_Y)1*ICR/^0_ZHH@BRP-'K/D#%9S)N7+N?4? M4Z(8A:O#ML\6"C#\1QQE OSS0(OY4YD8)$2FT&"9;T!S, ":*<3Q,3L(9?!& M^=J523SUX[Q[X\?-KUJSNOGN'FT/D@5O))WQUJXYO9V<:YHU?E9NEUB+H#CW M2A+M\MT>NVKH0&P0GK4?[.BAAV30P-N1ES.;,U)S02#C M'&37,CFO,.>@!%;"'BQ2L@6^1H"C@!3L/VAS4*WODJYP[N;][A4,#_6]\;46K+5RUSGO\7V3V[)'GR5WVK)GA); 9G25S!C4WZU M-[OW[7]K\SI[_=4@#J3D*N(_%%V\*MP6#5NUI<[Z:P2==[#/F\XKD?>5$]Z: MRDD6Q7_,GZ0D$#]?(B48+<8!C,@-@!Y,YV08U[\JV]P$QP:7BYV]7EW5Z 9#JH$-Y+!MSW175?YT^ M8>$EP/4W0(]W%>;17L(& %?1^\[D($:Q9$;/89$FP?5/UY?H6,P643:)X:\, M>&$*TMME4^;A34[%3H,I:#GP5M X.I]'\\D<;@:H@,X.JO,XFHXGP03XQ (E MN2"&ASE'GSM*X<1:4;(X:)C[$9/G?P0.L5*QS8,+0!0A&O@CJV ME/*3[IP'VX>EP&6W7"O44#)*U76IO,D/A:+Z7DY4G1#2;M M%.D,F3R.WZ2$=4B>&!ER.I^PL8(___^:NY8>MW$D?.]?H4,.W4!OQY8EVWU9 MP)V>+ +,P$%VL(L].EDE,29M![([.PW,CU]2\D.:HNK!1WE.0Q)#F4^NFA6CTV^SV_G][*J,0< M-7_8T4%V M+JT49L!IUPZMBER/[IJLL^,7R.9\D-?."D2;)G)M]PK?O&X:KSW)W;F/]A25 MW0/=:')N"Y5)6\@85HR-*\T:(_/"#!7*QLCQW:A,W4($.5BO.^U06YXW^U_; MO3\-XTUV_5CMS2-#CS8->G?RN/:,M@'P90\<+)XX2^6L4F#XY"Q5B-.57<^? M_2T;Y_:BM_W7SO5'YR8 M\W_\S&[?G7S7R#+BT?P?Y1!X^R/3%P)-"%5 ;1F M.;H;.7*,"!AQ<\-53:(":&NJPLRTGVEW:34X34Y4N/?C@8-FLL;8DTGL%&/X MB4+5*#QM$_L!#+K>Z*(]*^JXVTLN:H<(?I6]/IQ!Z58YA!-H'5(6O!FD+'@G M2%D0CDA9\ :0LI*VM_$G;KRYJ71N>T%%L$"(O2$0>ECAL<]SF%YCJ%8_^S5B MK_.T?:DIOS4A:HLQ+!M^[%ZQ''UAO:+ @7N_ I?M_5KR::8\PX?=LU=LSBMV MSRL&/6]LTR) =]NO9%_%TQ8O Y2D_S-H^W'IZN;[E?!7 J6[_S/S/8R9+V*, M2T._+%"#OL_B&>DY4/#^SWA3Y[B;YWBCYGBCYB#V^S_;MGRI\3),C\[O!9&- M-^@$;]")1$- ZTY)/Y[@33X!33ZA(?'W, $3!_V?F:]@@KMQ,>+!%$PI+YA] M5C%AEBN8Y7"?+Z;NH66_$-[B!;/%"[S%RQ'#E!+W]I+9RB6N(^7 @+M?"&_9 MDBG1)5.B2_#M1'UO\95Y)IR;015X\I[LO3.2WR M4]R/X?:._L^@#?OY1YR/JEX-@#<>.6<9>K/7OI]NS#E;#GQ3U MQET,?G4';/L>-)'Z7#Z1+@=)%T.D,.4Y(9EXDB*$3#R_$4(FGAL+(1//IX20 MB>?D0LB *J8D0Y-ED<,#HL0I@A\4D@AN4/0AN$&!AN &Q12"&Q0^"&Y0I""X M04&!X +_QT]^Z$Y=#73#Y\)_AEKTH("'!FW(G C M;D7DK ^\(G $;D4P F4[ !B.+W&KNGM/W#NF%W3VX/& M^,83]ED=@]\ ?T98#""XQ@-D)>!2:>F 'Z:E@Z?-)*4#'I^6#H1)6CKZ')JH M=" @T]*!*$Y+![J/Q&$..IW$?,JZXL@!B'B^SJ V]Z:5NH:',L(9)7OHCAH] M:,WFM!\U>B#;[9%":OQ Q]NSC-3X\6GMF$SX3&U,)B#G@S.D2>C109K\5*DP M1>!QX#/]8=CX,D$8-K[&$(:-+U"$8?M%'0_;+\YXV/AR2A@V")N(V/@:3F#L MX"M @> I(Y/(= D$3QF;1#Y-('C*Z(33!C'!4\8GG'R("9XR0HDDI4#PI'UG MR@@ETJL"P5-&*)':%0@.(C3Z@8V\(5V'%GF0/NT#1HM[:G0ZW'>CT^'>')T. M]^_H=+C'1Z?#>ZGH='B_%9T.[\FBT^%]6_PPQ[N[^'S*ND(,6^/S*2L+,;B- MSZ>L+<00.#Z?LKH0 ^7X?,KZ0@RGX_-ICUN4]848A\?G4]878K0>GT]97W)E M?VE76EU)97TIE?8%[9Q/S*>O+5%E?B'W \?F4]878J1R?3UE? MIMIK1\KZ0FSRCL^GK"_$#O3XBW'*^@+WR"?F4]:7F;*^S)3U9::L+S/MQ6EE M?<&O%Q)<-RC/'!: \].>!*#\="B6H2>)*D,DK04T26?C&X>0W MG\H[HI,%BX-)E8])RV&3^*&6W!1^?"8WA1_4R4WA*T%R4_CRD=P4ON8D-X4O M5,E-X0\Y8]MB,RF)8.)L'&"D\&P>X*3P;!%@M/!L$^ M"T\&P68+3P;!GBA/!L'&*$\&P>XH3P;!%BG?B!-LE/*E2!_5DFV-OA3IXUJR MQ=&7(GUD2[8[^E*DCVW)UD=?BO31+=D&Z4NAT&>GCV[)QDA?"GCJXL#8[ CJ MN"6^.2,L<$!&PON]41+6[RV2L'YOCH3UTV(2UD]_25@_S25A_726A/735A+6 M3T_IAA[U$ M"CWL55+H8=I)H8=)*(4>IJ04>IB@4NCX6:&]>?NVV@.<:&HGDNQ=]9%"JS]S M1?"^'>+E!UL'C!V0J\NOJ=WN88K5O;W!A'5O=NR"G:[D+=;$A M3J4.0@.O,0@-O*,@-/ "@M" A@>A 84.0@/Z&X0&U#4(#6AGF/<"90R#BQL- M4-7"X.+& U2D,+BX$0%GSL/@XL8$G!$/@XL;%7"F.PPN!WSI!O]X!.<_LP"4KP<"4+XJ"$#Y MVB Y2N$ )2O$P)0OEH(0/F:(0#E*X?$^?D"(D%-$E."3E:"FB2J!%VN!#5) M7 DZ8 EJDL@2=,<2U"2Q)>B<):AI^BO853\_/:WJ%]LW+[]7]MK3S9>LN;7T MS:JN7SYO:[N'A_VQ>D!;$FC$PS%1L(=YO]VM[6=\.]O[OZ_K3U^S[@5X;[[: MW4O9>F,^Y^MSPJ%MML-X9)>M=]F':K7;;E8?O[U8Q-T:O7!UZ"'.MMC9A'\/ MV?(.L^6=VQ9V0R:T@=!K%1L(=5>Q@>@+5&P@>@X5&XA^1L4&HE=2L8'HPU1L M('H\'8TB.D@=(_X*2HE?M?6A^E%MGJOL<[U],GWWOJHWJV_9F^?=WMA9F^_N M_;Y>?WRV"Z3[K36N,E:9WO]Y8_Z_:HYH_T>U_5*OOAN;LT5=K9 [AZLO=H>N M@7JW:;9:-5/>W5'%T9JWM#6_NJQY@-; &XHO805\!Y>P MY^? DKX!K&):R M-RM?P@IX#_,EK("W-E_""IAK<0DK0.=U&=5"MQW]O+7?)NL?!O P/=J384-N M09#O)_J9(,6#D\)#7KG0'IK)A?800BZTA[IQH3TDBPL-=.CM:ETW5_-5M\>: MOYB"SW9:WG!\J#X]U[7]1'Y8[=8[SH7KCU6]_F$L_&$"9;U9;3ZM#?N[S6Y? M/[?G>=@I_@_KW6_9+ZO-JCWD(\/,6$(S@#=JD (_[=;OKEFP&C#Z$S@M4&D[ M+C-H0#5FH -JS$ FU)B!BJ@QPSNAM)C! $>-&0QJU)C!0$9/2=#!R^)+79WO M]_I/M:KQ%-CUOBW)8[)9%;.<2WW%M?N97A4+,3P3^M MZHV)]IT]*:%-3[QM(O]3DVWXN/[6?.H,!O7B>WV734:W63X:EP.#Q6;AQ<(? M$RJ;),BNU<-&+#I&@'<7"QB\UUC X)W' @;^$ L8^$HL8"!3L8"!AL4"[@C< MZ]UN__?_ U!+ 0(4 Q0 ( #5#[D@:LHU,! ( .PC 3 M " 0 !;0V]N=&5N=%]4>7!E&UL4$L! A0#% @ -4/N2$AU M!>[% *P( L ( !-0( %]R96QS+RYR96QS4$L! A0# M% @ -4/N2/8!U;L. @ WB, !H ( !(P, 'AL+U]R M96QS+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( #5# M[DAWH.&LD@( $ . - " 2 1 !X;"]S='EL97,N>&UL M4$L! A0#% @ -4/N2+@DP@,U!0 "1, \ ( !W1, M 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ -4/N2!=!DH(N @ MWP< !@ ( !,2 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -4/N2+O.[/4) @ :P4 !@ M ( !5"@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ -4/N2'0A,TN6 0 < , !@ ( !;30 'AL+W=O&UL4$L! M A0#% @ -4/N2+0[8 N6 0 ;P, !D ( !!3@ 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -4/N M2&E3W'&6 0 < , !D ( !:CT 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -4/N2+^W%WJ6 0 < , M !D ( !T$( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -4/N2!@NF;&$ @ KPH !D M ( !-4@ 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ -4/N2!WTHQ&5 0 < , !D ( !OTX 'AL+W=O M:O" /\! "? M!@ &0 @ &+4 >&PO=V]R:W-H965T&UL4$L! A0#% @ -4/N2,&- M],F@ 0 U0, !D ( !M%0 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ -4/N2 !S/-ZQ 0 0 !D M ( !4%H 'AL+W=O&PO M=V]R:W-H965T !X;"]W;W)K&UL4$L! A0#% @ -4/N2*0D9%=6 @ [@< !D ( ! M)6$ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ -4/N2* RT0,6 @ /@8 !D ( !,FP 'AL+W=O&UL4$L! A0#% @ -4/N2'-!VTX2 M @ 008 !D ( !N7( 'AL+W=O&PO=V]R:W-H965TII/9:0( /\' 9 " 5%Y !X;"]W;W)K&UL4$L! A0#% @ -4/N2+)IDRG_ 0 .08 !D M ( !\7L 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ -4/N2*7:K:'% @ ?@H !D ( !CH< M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M-4/N2.GXON]Y @ P @ !D ( !!Y 'AL+W=O&PO=V]R:W-H965T]+M $ .$# 9 " =^= !X;"]W;W)K&UL4$L! A0#% @ -4/N2'2"#QDV @ VP< !D M ( !RI\ 'AL+W=O&PO=V]R:W-H M965TD !X;"]W;W)K&UL4$L! M A0#% @ -4/N2)+PO.K= 0 &P4 !D ( !ZJ8 'AL M+W=O#MC<18" M #^!@ &0 @ '^J >&PO=V]R:W-H965T&UL4$L! A0#% @ -4/N M2"&^ZKN9 @ #@H !D ( !$:X 'AL+W=O^#+=[ "D- ( % M @ 'AL >&PO XML 75 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 76 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 78 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 35 662 1 false 6 0 false 8 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.counterpath.com/taxonomy/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.counterpath.com/taxonomy/role/BalanceSheet CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.counterpath.com/taxonomy/role/BalanceSheetParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.counterpath.com/taxonomy/role/IncomeStatement CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 105 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Sheet http://www.counterpath.com/taxonomy/role/IncomeStatementParenthetical CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Statements 5 false false R6.htm 106 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.counterpath.com/taxonomy/role/ComprehensiveIncomeStatement CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Statements 6 false false R7.htm 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.counterpath.com/taxonomy/role/CashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 108 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY Sheet http://www.counterpath.com/taxonomy/role/StockholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY Statements 8 false false R9.htm 109 - Disclosure - Nature of Operations Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperationsTextBlock Nature of Operations Notes 9 false false R10.htm 110 - Disclosure - Significant Accounting Policies Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Significant Accounting Policies Notes 10 false false R11.htm 111 - Disclosure - Equipment Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock Equipment Notes 11 false false R12.htm 112 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock Accounts Payable and Accrued Liabilities Notes 12 false false R13.htm 113 - Disclosure - Related Party Transactions Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock Related Party Transactions Notes 13 false false R14.htm 114 - Disclosure - Common Stock Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Common Stock Notes 14 false false R15.htm 115 - Disclosure - Income Taxes Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock Income Taxes Notes 15 false false R16.htm 116 - Disclosure - Segmented Information Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock Segmented Information Notes 16 false false R17.htm 117 - Disclosure - Derivative Financial Instruments and Risk Management Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock Derivative Financial Instruments and Risk Management Notes 17 false false R18.htm 118 - Disclosure - Commitments Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsCommitmentsDisclosureTextBlock Commitments Notes 18 false false R19.htm 119 - Disclosure - Loss per common share Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Loss per common share Notes 19 false false R20.htm 121 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock 20 false false R21.htm 122 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables Significant Accounting Policies (Tables) Tables http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock 21 false false R22.htm 123 - Disclosure - Equipment (Tables) Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables Equipment (Tables) Tables http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock 22 false false R23.htm 124 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables Accounts Payable and Accrued Liabilities (Tables) Tables http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock 23 false false R24.htm 125 - Disclosure - Common Stock (Tables) Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables Common Stock (Tables) Tables http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock 24 false false R25.htm 126 - Disclosure - Income Taxes (Tables) Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables Income Taxes (Tables) Tables http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock 25 false false R26.htm 127 - Disclosure - Segmented Information (Tables) Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables Segmented Information (Tables) Tables http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock 26 false false R27.htm 128 - Disclosure - Derivative Financial Instruments and Risk Management (Tables) Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlockTables Derivative Financial Instruments and Risk Management (Tables) Tables http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock 27 false false R28.htm 129 - Disclosure - Commitments (Tables) Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsCommitmentsDisclosureTextBlockTables Commitments (Tables) Tables http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsCommitmentsDisclosureTextBlock 28 false false R29.htm 130 - Disclosure - Loss per common share (Tables) Sheet http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Loss per common share (Tables) Tables http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock 29 false false R30.htm 131 - Disclosure - Nature of Operations (Narrative) (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureNatureOfOperationsDetails Nature of Operations (Narrative) (Details) Details http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperationsTextBlock 30 false false R31.htm 132 - Disclosure - Significant Accounting Policies (Narrative) (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureSignificantAccountingPoliciesTextBlockDetails Significant Accounting Policies (Narrative) (Details) Details http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables 31 false false R32.htm 133 - Disclosure - Related Party Transactions (Narrative) (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureRelatedPartyTransactionsDisclosureTextBlockDetails Related Party Transactions (Narrative) (Details) Details http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock 32 false false R33.htm 134 - Disclosure - Common Stock (Narrative) (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureStockholdersEquityNoteDisclosureTextBlockDetails Common Stock (Narrative) (Details) Details http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables 33 false false R34.htm 135 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureIncomeTaxDisclosureTextBlockDetails Income Taxes (Narrative) (Details) Details http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables 34 false false R35.htm 136 - Disclosure - Commitments (Narrative) (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureCommitmentsDisclosureTextBlockDetails Commitments (Narrative) (Details) Details http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsCommitmentsDisclosureTextBlockTables 35 false false R36.htm 137 - Disclosure - Loss per common share (Narrative) (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureEarningsPerShareTextBlockDetails Loss per common share (Narrative) (Details) Details http://www.counterpath.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables 36 false false R37.htm 138 - Disclosure - Schedule of Accounts, Notes, Loans and Financing Receivable (Details) Notes http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlockDetails Schedule of Accounts, Notes, Loans and Financing Receivable (Details) Details 37 false false R38.htm 139 - Disclosure - Schedule of Product Warranty Liability (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfProductWarrantyLiabilityTableTextBlockDetails Schedule of Product Warranty Liability (Details) Details 38 false false R39.htm 140 - Disclosure - Property, Plant and Equipment (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentTextBlockDetails Property, Plant and Equipment (Details) Details 39 false false R40.htm 141 - Disclosure - Schedule of Accounts Payable and Accrued Liabilities (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlockDetails Schedule of Accounts Payable and Accrued Liabilities (Details) Details 40 false false R41.htm 142 - Disclosure - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlockDetails Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) Details 41 false false R42.htm 143 - Disclosure - Schedule of Share-based Compensation, Stock Options, Activity (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlockDetails Schedule of Share-based Compensation, Stock Options, Activity (Details) Details 42 false false R43.htm 144 - Disclosure - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureDisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlockDetails Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) Details 43 false false R44.htm 145 - Disclosure - Schedule of Nonvested Performance-based Units Activity (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlockDetails Schedule of Nonvested Performance-based Units Activity (Details) Details 44 false false R45.htm 146 - Disclosure - Schedule of Employee and Non-Employee Service Share-based Compensation Allocation of Recognized Period Costs (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlockDetails Schedule of Employee and Non-Employee Service Share-based Compensation Allocation of Recognized Period Costs (Details) Details 45 false false R46.htm 147 - Disclosure - Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfStockholdersEquityNoteWarrantsOrRightsActivityTextBlockDetails Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) Details 46 false false R47.htm 148 - Disclosure - Schedule of Stockholders Equity Deferred Share Unit Plan (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfStockholdersEquityDeferredShareUnitPlanActivityTableTextBlockDetails Schedule of Stockholders Equity Deferred Share Unit Plan (Details) Details 47 false false R48.htm 149 - Disclosure - Schedule of Stockholders Equity Non Vested Deferred Share Units (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfStockholdersEquityNonVestedDeferredShareUnitsTableTextBlockDetails Schedule of Stockholders Equity Non Vested Deferred Share Units (Details) Details 48 false false R49.htm 150 - Disclosure - Schedule of Allocation of Share Based Compensation Costs for Deferred Share Units (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfAllocationOfShareBasedCompensationCostsForDeferredShareUnitsTableTextBlockDetails Schedule of Allocation of Share Based Compensation Costs for Deferred Share Units (Details) Details 49 false false R50.htm 151 - Disclosure - Schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlockDetails Schedule of Deferred Tax Assets and Liabilities (Details) Details 50 false false R51.htm 152 - Disclosure - Schedule of Components of Income Tax Expense (Benefit) (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlockDetails Schedule of Components of Income Tax Expense (Benefit) (Details) Details 51 false false R52.htm 153 - Disclosure - Summary of Operating Loss Carryforwards (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureSummaryOfOperatingLossCarryforwardsTextBlockDetails Summary of Operating Loss Carryforwards (Details) Details 52 false false R53.htm 154 - Disclosure - Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureSummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlockDetails Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible (Details) Details 53 false false R54.htm 155 - Disclosure - Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlockDetails Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area (Details) Details 54 false false R55.htm 156 - Disclosure - Schedule of Long Lived Assets by Geographical Areas (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlockDetails Schedule of Long Lived Assets by Geographical Areas (Details) Details 55 false false R56.htm 157 - Disclosure - Fair Value, Assets Measured on Recurring Basis (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureFairValueAssetsMeasuredOnRecurringBasisTextBlockDetails Fair Value, Assets Measured on Recurring Basis (Details) Details 56 false false R57.htm 158 - Disclosure - Fair Value, Liabilities Measured on Recurring Basis (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureFairValueLiabilitiesMeasuredOnRecurringBasisTextBlockDetails Fair Value, Liabilities Measured on Recurring Basis (Details) Details 57 false false R58.htm 159 - Disclosure - Schedule of Agreements by Year (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfAgreementsByYearTableTextBlockDetails Schedule of Agreements by Year (Details) Details 58 false false R59.htm 160 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details) Sheet http://www.counterpath.com/taxonomy/role/DisclosureScheduleOfEarningsPerShareBasicAndDilutedTableTextBlockDetails Schedule of Earnings Per Share, Basic and Diluted (Details) Details 59 false false All Reports Book All Reports cpah-20160430.xml cpah-20160430.xsd cpah-20160430_cal.xml cpah-20160430_def.xml cpah-20160430_lab.xml cpah-20160430_pre.xml true true ZIP 80 0001062993-16-010548-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001062993-16-010548-xbrl.zip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
  •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end

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